PT J
AU Koch, J
   Freisinger, P
   Feichtinger, RG
   Zimmermann, FA
   Rauscher, C
   Wagentristl, HP
   Konstantopoulou, V
   Seidl, R
   Haack, TB
   Prokisch, H
   Ahting, U
   Sperl, W
   Mayr, JA
   Maier, EM
AF Koch, Johannes
   Freisinger, Peter
   Feichtinger, Rene G.
   Zimmermann, Franz A.
   Rauscher, Christian
   Wagentristl, Hans P.
   Konstantopoulou, Vassiliki
   Seidl, Rainer
   Haack, Tobias B.
   Prokisch, Holger
   Ahting, Uwe
   Sperl, Wolfgang
   Mayr, Johannes A.
   Maier, Esther M.
TI Mutations in <i>TTC19</i>: expanding the molecular, clinical and biochemical phenotype
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE TTC19; Mitochondrial respiratory chain complex III deficiency; Neonatal lactic acidosis; Regression; Loss of speech; Leigh syndrome; Hypertrophic olivary nucleus degeneration; Neurodegenerative disorder
ID hypertrophic olivary degeneration; complex iii deficiency; leigh-syndrome; mitochondrial-dna; necrotizing encephalomyelopathy; cerebellar-ataxia; mr findings; disease; child
AB Background: TTC19 deficiency is a progressive neurodegenerative disease associated with isolated mitochondrial respiratory chain (MRC) complex III deficiency and loss-of-function mutations in the TT19 gene in the few patients reported so far. Methods: We performed exome sequencing and selective mutational analysis of TTC19, respectively, in patients from three unrelated families presenting with initially unspecific clinical signs of muscular hypotonia and global developmental delay followed by regression, ataxia, loss of speech, and rapid neurological deterioration. One patient showed severe lactic acidosis at the neonatal age and during intercurrent illness. Results: We identified homozygous mutations in all three index cases, in two families novel missense mutations (c.544 T > C/p.Leu185Pro; c.917 T > C/p.Leu324Pro). The younger sister of the severely affected patient 3 showed only mild delay of motor skills and muscular hypotonia so far but is also homozygous for the same mutation. Notably, one patient revealed normal activities of MRC complex III in two independent muscle biopsies. Neuroimaging of the severely affected patients demonstrated lesions in putamen and caudate nuclei, cerebellar atrophy, and the unusual finding of hypertrophic olivary nuclei degeneration. Reviewing the literature revealed striking similarities regarding neuroimaging and clinical course in pediatric patients with TTC19 deficiency: patterns consistent with Leigh or Leigh-like syndrome were found in almost all, hypertrophic olivary nucleus degeneration in all patients reported so far. The clinical course in pediatric patients is characterized by an initially unspecific developmental delay, followed by regression, progressive signs and symptoms of cerebellar, basal ganglia and brainstem affection, especially loss of speech and ataxia. Subsequently, neurological deterioration leading to a vegetative state occurs. Conclusions: Our findings add to the phenotypic, genetic, and biochemical spectrum of TTC19 deficiency. However, TTC19 deficient patients do show characteristic clinical and neuroimaging features, which may facilitate diagnosis of this yet rare disorder. Normal MRC complex III activity does not exclude the diagnosis.
C1 [Koch, Johannes; Feichtinger, Rene G.; Zimmermann, Franz A.; Rauscher, Christian; Sperl, Wolfgang; Mayr, Johannes A.; Maier, Esther M.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
   [Freisinger, Peter] Kreisklinken Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany.
   [Wagentristl, Hans P.] Krankenhaus Barmherzigen Brueder, Dept Pediat, A-7000 Eisenstadt, Austria.
   [Konstantopoulou, Vassiliki; Seidl, Rainer] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.
   [Haack, Tobias B.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.
   [Haack, Tobias B.; Prokisch, Holger; Ahting, Uwe] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany.
C3 Paracelsus Private Medical University; Konventhospital Der Barmherzigen Bruder; Medical University of Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich
RP Maier, EM (corresponding author), Paracelsus Med Univ Salzburg, Dept Pediat, Muellner Hauptstr 48, A-5020 Salzburg, Austria.
EM esther.maier@med.uni-muenchen.de
FU Salzburg Center Foundation; Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung; German Bundesministerium fur Bildung und Forschung (BMBF) through German Network for mitochondrial disorders (mitoNET) [01GM1113C]; BMBF through Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; German Bundesministerium fur Bildung und Forschung (BMBF) through E-Rare project GENOMIT [01GM1207]
CR Atwal PS, 2014, JIMD REP, V14, P43, DOI 10.1007/8904_2013_282
   Aulbert W, 2014, NEUROPEDIATRICS, V45, P346, DOI 10.1055/s-0034-1383823
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Bindu PS, 2014, BRIT J RADIOL, V87, P0, DOI 10.1259/bjr.20130478
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   DAYAN AD, 1970, ARCH DIS CHILD, V45, P39, DOI 10.1136/adc.45.239.39
   Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Feichtinger RG, 2014, GLIA, V62, P514, DOI 10.1002/glia.22621
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Kinghorn KJ, 2013, J NEUROL, V260, P3, DOI 10.1007/s00415-012-6564-9
   Kulkarni PK, 1999, MOVEMENT DISORD, V14, P689, DOI 10.1002/1531-8257(199907)14:4<689::AID-MDS1022>3.0.CO;2-8
   Kunii M, 2015, J HUM GENET, V14, P43, DOI 10.1038/jhg.2015.7
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   MEDINA L, 1990, AM J ROENTGENOL, V154, P1269, DOI 10.2214/ajr.154.6.2159689
   Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104
   Melchionda L, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00397
   Meoded A, 2013, CEREBELLUM, V12, P469, DOI 10.1007/s12311-013-0448-0
   Morino H, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-5
   Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1
   Nowak J, 2014, CHILD NERV SYST, V30, P959, DOI 10.1007/s00381-013-2296-0
   Patel KP, 2014, MOL GENET METAB, V106, P385
   Phatouros CC, 1998, PEDIATR RADIOL, V28, P830, DOI 10.1007/s002470050475
   Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sanverdi SE, 2012, BRIT J RADIOL, V85, P511, DOI 10.1259/bjr/60727602
   SAVOIARDO M, 1991, J NEUROL NEUROSUR PS, V54, P888, DOI 10.1136/jnnp.54.10.888
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vossough A, 2012, PEDIATR RADIOL, V42, P481, DOI 10.1007/s00247-011-2330-x
NR 33
TC 20
Z9 21
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-1172
EI 
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD APR 2
PY 2015
VL 10
IS 
BP 
EP 
DI 10.1186/s13023-015-0254-5
PG 12
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA CH4PN
UT WOS:000354015500001
PM 25887401
DA 2024-11-01
ER

PT J
AU Lodi, T
   Dallabona, C
   Nolli, C
   Goffrini, P
   Donnini, C
   Baruffini, E
AF Lodi, Tiziana
   Dallabona, Cristina
   Nolli, Cecilia
   Goffrini, Paola
   Donnini, Claudia
   Baruffini, Enrico
TI DNA polymerase γ and disease: what we have learned from yeast
SO FRONTIERS IN GENETICS
LA English
DT Review
ID progressive external ophthalmoplegia; in-vitro supplementation; p55 accessory subunit; encoding mip1 gene; mitochondrial-dna; saccharomyces-cerevisiae; ribonucleotide reductase; nucleoside analogs; pathogenic mutations; depletion syndrm
AB Mip1 is the Saccharomyces cerevisiae DNA polymerase gamma (Pol gamma), which is responsible for the replication of mitochondrial DNA (mtDNA). It belongs to the family A of the DNA polymerases and it is orthologs to human POLGA. In humans, mutations in POLG(1) cause many mitochondria' pathologies, such as progressive external ophthalmoplegia (PEO), Alpers' syndrome, and ataxia-neuropathy syndrome, all of which present instability of mtDNA, which results in impaired mitochondria' function in several tissues with variable degrees of severity. In this review, we summarize the genetic and biochemical knowledge published on yeast mitochondria' DNA polymerase from 1989, when the MIP1 gene was first cloned, up until now. The role of yeast is particularly emphasized in (i) validating the pathological mutations found in human POLO and modeled in MIP1, (ii) determining the molecular defects caused by these mutations and (iii) finding the correlation between mutations/polymorphisms in POLGA and mtDNA toxicity induced by specific drugs. We also describe recent findings regarding the discovery of molecules able to rescue the phenotypic defects caused by pathological mutations in Mip1, and the construction of a model system in which the human Pol gamma holoenzyme is expressed in yeast and complements the loss of Mip1.
C1 [Lodi, Tiziana; Dallabona, Cristina; Nolli, Cecilia; Goffrini, Paola; Donnini, Claudia; Baruffini, Enrico] Univ Parma, Dept Life Sci, I-43124 Parma, Italy.
C3 University of Parma
RP Baruffini, E (corresponding author), Univ Parma, Dept Life Sci, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM enrico.baruffini@unipr.it
CR Aiyar RS, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6585
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2007, GENETICS, V177, P1227, DOI 10.1534/genetics.107.079293
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Baruffini E, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0034322
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Chabes A, 1999, J BIOL CHEM, V274, P36679, DOI 10.1074/jbc.274.51.36679
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chatterjee N, 2013, BIOCHEM BIOPH RES CO, V431, P270, DOI 10.1016/j.bbrc.2012.12.119
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cheng X, 2010, EUR J CELL BIOL, V89, P742, DOI 10.1016/j.ejcb.2010.06.008
   CHI NW, 1994, J BIOL CHEM, V269, P29984
   Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409
   Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007
   Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108
   Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497
   Duchniewicz M, 1999, MOL CELL BIOL, V19, P8201
   DUJON B, 1974, GENETICS, V78, P415
   Dujon B, 1981, MOL BIOL YEAST SACCH, V0, P505
   Dzierzbicki P, 2004, DNA REPAIR, V3, P403, DOI 10.1016/j.dnarep.2003.12.005
   ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740
   EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0
   ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929
   Estep PA, 2011, BIOCHEMISTRY-US, V50, P6376, DOI 10.1021/bi200280r
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7
   FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   Foury F, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027847
   GAILLARD C, 1980, NATURE, V283, P218, DOI 10.1038/283218a0
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002
   Germaniuk A, 2002, J BIOL CHEM, V277, P27801, DOI 10.1074/jbc.M201756200
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Koczor CA, 2010, EXPERT OPIN DRUG MET, V6, P1493, DOI 10.1517/17425255.2010.526602
   Koprowski P, 2002, MOL GENET GENOMICS, V266, P988, DOI 10.1007/s00438-001-0621-x
   Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605
   Lasserre JP, 2013, BIOCHIMIE, V95, P759, DOI 10.1016/j.biochi.2012.11.003
   Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewandowska A, 2006, BBA-MOL CELL RES, V1763, P141, DOI 10.1016/j.bbamcr.2006.01.007
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466
   Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Phadnis N, 2004, J MOL BIOL, V342, P1115, DOI 10.1016/j.jmb.2004.07.096
   PUTRAMENT A, 1975, J GEN MICROBIOL, V90, P265, DOI 10.1099/00221287-90-2-265
   Qian YF, 2014, J BIOL CHEM, V289, P5970, DOI 10.1074/jbc.M113.526418
   REENAN RAG, 1992, GENETICS, V132, P975
   RICHARDSJP, 1973, J MOL BIOL, V78, P715, DOI 10.1016/0022-2836(73)90291-X
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   ROPP PA, 1995, GENE, V165, P103, DOI 10.1016/0378-1119(95)00412-Y
   Schacherer J, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000322
   Sen Sribir, 1994, ACTA BIOCHIMICA POLONICA, V41, P79
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHERMAN F, 1963, GENETICS, V48, P375
   SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3
   Slonimski PP, 1977, MITOCHONDRIA 1977: GENETICS AND BIOGENESIS OF MITOCHONDRIA, V0, P39
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004748
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690
   Viikov K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033482
   Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007
   WINTERSBERGER U, 1976, EUR J BIOCHEM, V68, P199, DOI 10.1111/j.1432-1033.1976.tb10779.x
   WINTERSBERGER U, 1970, EUR J BIOCHEM, V13, P20, DOI 10.1111/j.1432-1033.1970.tb00894.x
   Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644
   Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
   Zhao XL, 2000, MOL CELL BIOL, V20, P9076, DOI 10.1128/MCB.20.23.9076-9083.2000
NR 117
TC 21
Z9 26
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND
SN 1664-8021
EI 
J9 FRONT GENET
JI Front. Genet.
PD MAR 17
PY 2015
VL 6
IS 
BP 
EP 
DI 10.3389/fgene.2015.00106
PG 16
WC Genetics & Heredity
SC Genetics & Heredity
GA CF7XA
UT WOS:000352768500001
PM 25852747
DA 2024-11-01
ER

PT J
AU Biancheri, R
   Lamantea, E
   Severino, M
   Diodato, D
   Pedemonte, M
   Cassandrini, D
   Ploederl, A
   Trucco, F
   Fiorillo, C
   Minetti, C
   Santorelli, FM
   Zeviani, M
   Bruno, C
AF Biancheri, Roberta
   Lamantea, Eleonora
   Severino, Mariasavina
   Diodato, Daria
   Pedemonte, Marina
   Cassandrini, Denise
   Ploederl, Alexandra
   Trucco, Federica
   Fiorillo, Chiara
   Minetti, Carlo
   Santorelli, Filippo M.
   Zeviani, Massimo
   Bruno, Claudio
TI Expanding the Clinical and Magnetic Resonance Spectrum of Leukoencephalopathy with Thalamus and Brainstem Involvement and High Lactate (LTBL) in a Patient Harboring a Novel <i>EARS2</i> Mutation
SO JIMD REPORTS, VOL 23
LA English
DT Article; Book Chapter
ID deficiency
AB Leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL) is a novel mitochondrial disease caused by mutations in EARS2, which encodes the mitochondrial glutamyl-tRNA synthetase (mtGluRS). A distinctive brain MRI pattern is the hallmark of the disease. A 6-year-old boy presented at 3 months with feeding difficulties and muscle hypotonia. Brain MRI, at 8 months, showed hyperintensity of the deep cerebral and cerebellar white matter, thalamus, basal ganglia, brainstem, and thin corpus callosum. From the second year of life onward, the child reported global clinical improvement, parallel to partial resolution of brain MRI pattern. However, the last neuroimaging assessment revealed novel lesions within the left caudate and pallidum nuclei. DNA genomic sequencing analysis identified a novel EARS2 mutation. This case expands the clinical and neuroradiological phenotype of LTBL presenting intermediate clinical manifestations between the severe and milder forms of the disease and previously unreported brain MRI features.
C1 [Biancheri, Roberta; Ploederl, Alexandra] Ist Giannina Gaslini, Child Neurol & Psychiat, I-16148 Genoa, Italy.
   [Lamantea, Eleonora; Diodato, Daria; Zeviani, Massimo] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Milan, Italy.
   [Severino, Mariasavina] Ist Giannina Gaslini, Neuroradiol Unit, I-16148 Genoa, Italy.
   [Pedemonte, Marina; Trucco, Federica; Minetti, Carlo] Ist Giannina Gaslini, Pediat Neurol Unit, I-16148 Genoa, Italy.
   [Cassandrini, Denise; Fiorillo, Chiara; Santorelli, Filippo M.] IRCCS Stella Maris, Neuromuscular & Mol Med Unit, Pisa, Italy.
   [Bruno, Claudio] Ist Giannina Gaslini, Dept Neurosci, Ctr Myol & Neurodegenerat Disorders, I-16148 Genoa, Italy.
C3 University of Genoa; IRCCS Istituto Giannina Gaslini; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Fondazione Stella Maris; University of Genoa; IRCCS Istituto Giannina Gaslini
RP Bruno, C (corresponding author), Ist Giannina Gaslini, Dept Neurosci, Ctr Myol & Neurodegenerat Disorders, I-16148 Genoa, Italy.
EM claudio2246@gmail.com
CR Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Giribaldi G, 2012, DEV MED CHILD NEUROL, V54, P472, DOI 10.1111/j.1469-8749.2011.04151.x
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Steenweg ME, 2012, ARCH NEUROL-CHICAGO, V69, P718, DOI 10.1001/archneurol.2011.1048
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Talim B, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws197
   van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795
NR 10
TC 18
Z9 20
U1 0
U2 4
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2015
VL 23
IS 
BP 85
EP 89
DI 10.1007/8904_2015_434
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BE8SP
UT WOS:000376988300011
PM 25854774
DA 2024-11-01
ER

PT J
AU Brecht, M
   Richardson, M
   Taranath, A
   Grist, S
   Thorburn, D
   Bratkovic, D
AF Brecht, Marcus
   Richardson, Malcolm
   Taranath, Ajay
   Grist, Scott
   Thorburn, David
   Bratkovic, Drago
TI Leigh Syndrome Caused by the <i>MT-ND5</i> m.13513G&gt;A Mutation: A Case Presenting with WPW-Like Conduction Defect, Cardiomyopathy, Hypertension and Hyponatraemia
SO JIMD REPORTS, VOL 19
LA English
DT Article; Book Chapter
ID complex-i-deficiency; mitochondrial m.13513g-greater-than-a mutation; antidiuretic-hormone secretion; wolff-parkinson-white; 13513g-greater-than-a mutation; g13513a mutation; dna; features; frequent; disease
AB Mitochondrial disease can present with a wide range of clinical phenotypes, and knowledge of the clinical spectrum of mitochondrial DNA mutation is constantly expanding. Leigh syndrome (LS) has been reported to be caused by the m.13513G> A mutation in the ND5 subunit of complex I (MT-ND5 m. 13513G>A). We present a case of a 12-month-old infant initially diagnosed with tachyarrhythmia requiring defibrillation, subsequent presentation with hypertension and hyponatraemia secondary to renal salt loss and presumed inappropriate ADH secretion. Complex I activity in the muscle tissue was 54%, and mutation load in the muscle and lymphocytes was 50%. This case of Leigh syndrome caused by the m. 13513G>A mutation in the ND5 gene illustrates that hyponatraemia due to renal sodium loss and inappropriate ADH secretion and hypertension can be features of this entity in addition to the previously reported cardiomyopathy and WPW-like conduction pattern and that they present additional challenges in diagnosis and management.
C1 [Brecht, Marcus; Richardson, Malcolm; Taranath, Ajay; Bratkovic, Drago] Womens & Childrens Hosp Adelaide, 72 King William St, Adelaide, SA 5006, Australia.
   [Grist, Scott] Genet & Mol Pathol Directorate, Dept Mol Pathol, Flinders Med Ctr, Bedford Pk, SA 5042, Australia.
   [Thorburn, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
C3 Flinders Medical Centre; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute
RP Brecht, M (corresponding author), Womens & Childrens Hosp Adelaide, 72 King William St, Adelaide, SA 5006, Australia.
EM marcus_brecht@web.de
CR Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Kent AL, 2007, PEDIATR NEPHROL, V22, P1743, DOI 10.1007/s00467-007-0561-8
   Lohmeier K, 2007, NEUROPEDIATRICS, V38, P148, DOI 10.1055/s-2007-985903
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Narita T, 1998, NEUROPEDIATRICS, V29, P265, DOI 10.1055/s-2007-973572
   PAMPHLETT R, 1985, MED J AUSTRALIA, V143, P306, DOI 10.5694/j.1326-5377.1985.tb123019.x
   Rivkees SA, 2008, CURR OPIN PEDIATR, V20, P448, DOI 10.1097/MOP.0b013e328305e403
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Saito Y, 2009, BRAIN DEV-JPN, V31, P529, DOI 10.1016/j.braindev.2009.01.009
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Southgate HJ, 2000, ANN CLIN BIOCHEM, V37, P805, DOI 10.1258/0004563001900002
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Swiderska N, 2010, J CHILD NEUROL, V25, P782, DOI 10.1177/0883073809347594
   van Karnebeek CDM, 2011, DEV MED CHILD NEUROL, V53, P565, DOI 10.1111/j.1469-8749.2010.03907.x
   Wang Shi-Bing, 2008, PEDIATRICS AND NEONATOLOGY, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Zelnik N, 1996, PEDIATR NEUROL, V14, P251, DOI 10.1016/0887-8994(96)00046-X
NR 17
TC 31
Z9 34
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2015
VL 19
IS 
BP 95
EP 100
DI 10.1007/8904_2014_375
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BE8SL
UT WOS:000376982900012
PM 25681084
DA 2024-11-01
ER

PT J
AU Kaliszewska, M
   Kruszewski, J
   Kierdaszuk, B
   Kostera-Pruszczyk, A
   Nojszewska, M
   Lusakowska, A
   Vizueta, J
   Sabat, D
   Lutyk, D
   Lower, M
   Piekutowska-Abramczuk, D
   Kaniak-Golik, A
   Pronicka, E
   Kaminska, A
   Bartnik, E
   Golik, P
   Tonska, K
AF Kaliszewska, Magdalena
   Kruszewski, Jakub
   Kierdaszuk, Biruta
   Kostera-Pruszczyk, Anna
   Nojszewska, Monika
   Lusakowska, Anna
   Vizueta, Joel
   Sabat, Dorota
   Lutyk, Dorota
   Lower, Michal
   Piekutowska-Abramczuk, Dorota
   Kaniak-Golik, Aneta
   Pronicka, Ewa
   Kaminska, Anna
   Bartnik, Ewa
   Golik, Pawe
   Tonska, Katarzyna
TI Yeast model analysis of novel polymerase gamma variants found in patients with autosomal recessive mitochondrial disease
SO HUMAN GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; dna-polymerase; saccharomyces-cerevisiae; polg mutations; pathogenic mutations; defects; maintenance; phenotype; spectrum; subunit
AB Replication of the mitochondrial genome depends on the single DNA polymerase (pol gamma). Mutations in the POLG gene, encoding the catalytic subunit of the human polymerase gamma, have been linked to a wide variety of mitochondrial disorders that show remarkable heterogeneity, with more than 200 sequence variants, often very rare, found in patients. The pathogenicity and dominance status of many such mutations remain, however, unclear. Remarkable structural and functional conservation of human POLG and its S. cerevisiae ortholog (Mip1p) led to the development of many successful yeast models, enabling to study the phenotype of putative pathogenic mutations. In a group of patients with suspicion of mitochondrial pathology, we identified five novel POLG sequence variants, four of which (p.Arg869Ter, p.Gln968Glu, p.Thr1053Argfs*6, and p.Val1106Ala), together with one previously known but uncharacterised variant (p.Arg309Cys), were amenable to modelling in yeast. Familial analysis indicated causal relationship of these variants with disease, consistent with autosomal recessive inheritance. To investigate the effect of these sequence changes on mtDNA replication, we obtained the corresponding yeast mip1 alleles (Arg265Cys, Arg672Ter, Arg770Glu, Thr809Ter, and Val863Ala, respectively) and tested their effect on mitochondrial genome stability and replication fidelity. For three of them (Arg265Cys, Arg672Ter, and Thr809Ter), we observed a strong, partially dominant phenotype of a complete loss of functional mtDNA, whereas the remaining two led to partial mtDNA depletion and significant increase in point mutation frequencies. These results show good correlation with the severity of symptoms observed in patients and allow to establish these variants as pathogenic mutations.
C1 [Kaliszewska, Magdalena; Kruszewski, Jakub; Vizueta, Joel; Sabat, Dorota; Lutyk, Dorota; Bartnik, Ewa; Golik, Pawe; Tonska, Katarzyna] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, PL-02106 Warsaw, Poland.
   [Kierdaszuk, Biruta; Kostera-Pruszczyk, Anna; Nojszewska, Monika; Lusakowska, Anna; Kaminska, Anna] Med Univ Warsaw, Dept Neurol, PL-02097 Warsaw, Poland.
   [Lower, Michal] Univ Warsaw, Dept Virol, Fac Biol, PL-02096 Warsaw, Poland.
   [Piekutowska-Abramczuk, Dorota; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Kaniak-Golik, Aneta; Bartnik, Ewa; Golik, Pawe] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland.
   [Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, PL-04730 Warsaw, Poland.
C3 University of Warsaw; Medical University of Warsaw; University of Warsaw; Children's Memorial Health Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Children's Memorial Health Institute
RP Golik, P (corresponding author), Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Pawinskiego 5a, PL-02106 Warsaw, Poland.
EM pgolik@igib.uw.edu.pl; kaska@igib.uw.edu.pl
FU EU Operational Programme Innovative Economy via the Foundation for Polish Science [TEAM/2010-6/6, VENTURES/2011-8/3]; National Science Center of Poland [NCN 2012/05/B/NZ2/01627]
CR Aanen DK, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0438
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Chan SSL, 2009, MITOCHONDRION, V9, P340, DOI 10.1016/j.mito.2009.05.002
   Chiron S, 2005, GENETICS, V169, P1891, DOI 10.1534/genetics.104.037473
   CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   FOURY F, 1989, J BIOL CHEM, V264, P20552
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   GROUDINSKY O, 1981, MOL GEN GENET, V184, P493, DOI 10.1007/BF00352529
   Holt IJ, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0451
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005
   Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010
   Lipinski KA, 2010, BBA-BIOENERGETICS, V1797, P1086, DOI 10.1016/j.bbabio.2009.12.019
   Lodi T, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00106
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI 10.1586/ERM.09.84
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928
   Palin EJH, 2010, BBA-MOL BASIS DIS, V1802, P545, DOI 10.1016/j.bbadis.2010.02.003
   Puchta O, 2010, GENETICS, V184, P959, DOI 10.1534/genetics.110.113969
   Qian YF, 2014, J BIOL CHEM, V289, P5970, DOI 10.1074/jbc.M113.526418
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004748
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Viikov K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033482
   Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zheng L, 2004, NUCLEIC ACIDS RES, V32, P0, DOI 10.1093/nar/gnh110
NR 67
TC 13
Z9 14
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD SEP 15
PY 2015
VL 134
IS 9
BP 951
EP 966
DI 10.1007/s00439-015-1578-x
PG 16
WC Genetics & Heredity
SC Genetics & Heredity
GA CO8EY
UT WOS:000359399900003
PM 26077851
DA 2024-11-01
ER

PT J
AU Lindgren, U
   Roos, S
   Oldfors, CH
   Moslemi, AR
   Lindberg, C
   Oldfors, A
AF Lindgren, Ulrika
   Roos, Sara
   Oldfors, Carola Hedberg
   Moslemi, Ali-Reza
   Lindberg, Christopher
   Oldfors, Anders
TI Mitochondrial pathology in inclusion body myositis
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Inclusion body myositis; Mitochondrial DNA; mtDNA; Cytochrome c oxidase deficiency
ID progressive external ophthalmoplegia; dna deletions; synonymous mutations; parkinson-disease; diagnosis; polg1; pathogenesis; childhood; depletion; ant1
AB Inclusion body myositis (IBM) is usually associated with a large number of cytochrome c oxidase (COX)-deficient muscle fibers and acquired mitochondrial DNA (mtDNA) deletions. We studied the number of COX-deficient fibers and the amount of mtDNA deletions, and if variants in nuclear genes involved in mtDNA maintenance may contribute to the occurrence of mtDNA deletions in IBM muscle. Twenty-six IBM patients were included. COX-deficient fibers were assayed by morphometry and mtDNA deletions by qPCR. POLG was analyzed in all patients by Sanger sequencing and C10orf2 (Twinkle), DNA2, MGME1, OPA1, POLG2, RRM2B, SLC25A4 and TYMP in six patients by next generation sequencing. Patients with many COX-deficient muscle fibers had a significantly higher proportion of mtDNA deletions than patients with few COX-deficient fibers. We found previously unreported variants in POLG and C10orf2 and IBM patients had a significantly higher frequency of an RRM2B variant than controls. POLG variants appeared more common in IBM patients with many COX-deficient fibers, but the difference was not statistically significant. We conclude that COX-deficient fibers in inclusion body myositis are associated with multiple mtDNA deletions. In IBM patients we found novel and also previously reported variants in genes of importance for mtDNA maintenance that warrants further studies. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lindgren, Ulrika; Roos, Sara; Oldfors, Carola Hedberg; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
   [Lindberg, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, Dept Neurol, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital
RP Oldfors, A (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Dept Pathol, SE-41345 Gothenburg, Sweden.
EM anders.oldfors@gu.se
FU Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Research Fund for Neuromuscular Disorders in West Sweden; Swedish Research Council [07122]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   [Anonymous], 2012, POLYPHEN 2, V0, P0
   [Anonymous], 2014, EXOME VARIANT SERVER, V0, P0
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Badrising UA, 2005, J NEUROL, V252, P1448, DOI 10.1007/s00415-005-0884-y
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Brady S, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2013-004552
   Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Greenberg SA, 2012, CURR OPIN NEUROL, V25, P630, DOI 10.1097/WCO.0b013e328357f211
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Oldfors A, 2005, CURR OPIN NEUROL, V18, P497, DOI 10.1097/01.wco.0000183115.14175.29
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
NR 39
TC 32
Z9 35
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR 15
PY 2015
VL 25
IS 4
BP 281
EP 288
DI 10.1016/j.nmd.2014.12.010
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CG2CE
UT WOS:000353081700001
PM 25638290
DA 2024-11-01
ER

PT J
AU Janer, A
   van Karnebeek, CDM
   Sasarman, F
   Antonicka, H
   Al Ghamdi, M
   Shyr, C
   Dunbar, M
   Stockler-Ispiroglu, S
   Ross, CJ
   Vallance, H
   Dionne, J
   Wasserman, WW
   Shoubridge, EA
AF Janer, Alexandre
   van Karnebeek, Clara D. M.
   Sasarman, Florin
   Antonicka, Hana
   Al Ghamdi, Malak
   Shyr, Casper
   Dunbar, Mary
   Stockler-Ispiroglu, Sylvia
   Ross, Colin J.
   Vallance, Hilary
   Dionne, Janis
   Wasserman, Wyeth W.
   Shoubridge, Eric A.
TI RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID mitochondrial translation defect; sideroblastic anemia-mlasa; complex deficiency; mutation; myopathy; proteins; gene
AB RMND1 is an integral inner membrane mitochondrial protein that assembles into a large 240 kDa complex to support translation of the 13 polypeptides encoded on mtDNA, all of which are essential subunits of the oxidative phosphorylation (OXPHOS) complexes. Variants in RMND1 produce global defects in mitochondrial translation and were first reported in patients with severe neurological phenotypes leading to mortality in the first months of life. Using whole-exome sequencing, we identified compound heterozygous RMND1 variants in a 4-year-old patient with congenital lactic acidosis, severe myopathy, hearing loss, renal failure, and dysautonomia. The levels of mitochondrial ribosome proteins were reduced in patient fibroblasts, causing a translation defect, which was rescued by expression of the wild-type cDNA. RMND1 was almost undetectable by immunoblot analysis in patient muscle and fibroblasts. BN-PAGE analysis showed a severe combined OXPHOS assembly defect that was more prominent in patient muscle than in fibroblasts. Immunofluorescence experiments showed that RMND1 localizes to discrete foci in the mitochondrial network, juxtaposed to RNA granules where the primary mitochondrial transcripts are processed. RMND1 foci were not detected in patient fibroblasts. We hypothesize that RMND1 acts to anchor or stabilize the mitochondrial ribosome near the sites where the mRNAs are matured, spatially coupling post-transcriptional handling mRNAs with their translation, and that loss of function variants in RMND1 are associated with a unique constellation of clinical phenotypes that vary with the severity of the mitochondrial translation defect.
C1 [Janer, Alexandre; Sasarman, Florin; Antonicka, Hana; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.
   [van Karnebeek, Clara D. M.; Al Ghamdi, Malak; Stockler-Ispiroglu, Sylvia] Univ British Columbia, Dept Pediat, Div Biochem Dis, BC Childrens Hosp, Vancouver, BC V6T 1W5, Canada.
   [van Karnebeek, Clara D. M.; Shyr, Casper; Stockler-Ispiroglu, Sylvia; Ross, Colin J.; Vallance, Hilary; Wasserman, Wyeth W.] Treatable Intellectual Disabil Endeavour British, Vancouver, BC, Canada.
   [van Karnebeek, Clara D. M.; Shyr, Casper; Ross, Colin J.; Wasserman, Wyeth W.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada.
   [van Karnebeek, Clara D. M.; Shyr, Casper; Ross, Colin J.; Wasserman, Wyeth W.] Univ British Columbia, Dept Med Genet, BC Childrens & Womens Hosp, Vancouver, BC, Canada.
   [Dionne, Janis] Univ British Columbia, Dept Pediat, Div Pediat Nephrol, BC Childrens Hosp, Vancouver, BC V6T 1W5, Canada.
   [Dunbar, Mary; Vallance, Hilary] Univ British Columbia, Dept Pediat, Dept Pathol & Lab Med, BC Childrens & Womens Hosp, Vancouver, BC V6T 1W5, Canada.
C3 McGill University; BC Childrens Hospital; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia
RP Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Human Genet, Mol Neurogenet, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.
EM eric@ericpc.mni.mcgill.ca
FU BC Children's Hospital Foundation; Genome BC [SOF-195]; Michael Smith Foundation for Health Research; Canadian Institutes for Health Research;  [MT-15460]
CR Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   van Karnebeek CDM, 2014, MOL GENET METAB, V111, P428, DOI 10.1016/j.ymgme.2014.01.011
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 16
TC 24
Z9 28
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD OCT 15
PY 2015
VL 23
IS 10
BP 1301
EP 1307
DI 10.1038/ejhg.2014.293
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CS0KK
UT WOS:000361747700007
PM 25604853
DA 2024-11-01
ER

PT J
AU Lakshmanan, LN
   Gruber, J
   Halliwell, B
   Gunawan, R
AF Lakshmanan, Lakshmi Narayanan
   Gruber, Jan
   Halliwell, Barry
   Gunawan, Rudiyanto
TI Are mutagenic non D-loop direct repeat motifs in mitochondrial DNA under a negative selection pressure?
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID multiple mtdna deletions; synonymous codon usage; skeletal-muscle fibers; tandem repeats; control region; life-span; genome sequences; mutations; evolution; disease
AB Non D-loop direct repeats (DRs) in mitochondrial DNA (mtDNA) have been commonly implicated in the mutagenesis of mtDNA deletions associated with neuromuscular disease and ageing. Further, these DRs have been hypothesized to put a constraint on the lifespan of mammals and are under a negative selection pressure. Using a compendium of 294 mammalian mtDNA, we re-examined the relationship between species lifespan and the mutagenicity of such DRs. Contradicting the prevailing hypotheses, we found no significant evidence that long-lived mammals possess fewer mutagenic DRs than short-lived mammals. By comparing DR counts in human mtDNA with those in selectively randomized sequences, we also showed that the number of DRs in human mtDNA is primarily determined by global mtDNA properties, such as the bias in synonymous codon usage (SCU) and nucleotide composition. We found that SCU bias in mtDNA positively correlates with DR counts, where repeated usage of a subset of codons leads to more frequent DR occurrences. While bias in SCU and nucleotide composition has been attributed to nucleotide mutational bias, mammalian mtDNA still exhibit higher SCU bias and DR counts than expected from such mutational bias, suggesting a lack of negative selection against non D-loop DRs.
C1 [Lakshmanan, Lakshmi Narayanan; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland.
   [Lakshmanan, Lakshmi Narayanan] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117585, Singapore.
   [Gruber, Jan] Natl Univ Singapore, Neurobiol & Ageing Program, Dept Biochem, Yale NUS Coll, Singapore 117599, Singapore.
   [Halliwell, Barry] Natl Univ Singapore, Ctr Life Sci CeLS, Neurobiol & Ageing Program, Dept Biochem, Singapore 117599, Singapore.
   [Gunawan, Rudiyanto] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore; National University of Singapore; Yale NUS College; National University of Singapore; Swiss Institute of Bioinformatics
RP Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, HCI F101,Vladimir Prelog Weg 1, CH-8093 Zurich, Switzerland.
EM rudi.gunawan@chem.ethz.ch
FU ETH Zurich; Swiss National Science Foundation [150522]; Ministry of Education Singapore [MOE2010-T2-2-048]
CR Achaz G, 2002, NUCLEIC ACIDS RES, V30, P2987, DOI 10.1093/nar/gkf391
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Aledo JC, 2011, AGING CELL, V10, P198, DOI 10.1111/j.1474-9726.2010.00657.x
   Casane D, 1997, MOL BIOL EVOL, V14, P779, DOI 10.1093/oxfordjournals.molbev.a025818
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chung SS, 1996, AGE, V19, P117, DOI 10.1007/BF02434081
   Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x
   DOBSON GP, 1995, P NATL ACAD SCI USA, V92, P7317, DOI 10.1073/pnas.92.16.7317
   Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568
   Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409
   James RC, 2000, LONGEVITY RECORDS LI, V0, P0
   Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259
   Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903
   Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008
   Kitazoe Y, 2011, GENOME BIOL EVOL, V3, P1233, DOI 10.1093/gbe/evr079
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lakshmanan LN, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035271
   Larizza A, 2002, J MOL EVOL, V54, P145, DOI 10.1007/s00239-001-0063-4
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058
   LEVINSON G, 1987, MOL BIOL EVOL, V4, P203
   Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x
   Meganathan PR, 2012, GENE, V492, P121, DOI 10.1016/j.gene.2011.10.038
   Merker S, 2014, J MOL EVOL, V79, P40, DOI 10.1007/s00239-014-9631-2
   Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005
   Pfeuty A, 2001, J MOL BIOL, V314, P709, DOI 10.1006/jmbi.2001.5160
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   PIERCE JC, 1991, NUCLEIC ACIDS RES, V19, P3901, DOI 10.1093/nar/19.14.3901
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, P0, DOI 10.1371/journal.pcbi.1000572
   Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011
   SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853
   Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003
   Schmitz J, 2002, MOL BIOL EVOL, V19, P544, DOI 10.1093/oxfordjournals.molbev.a004110
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Tian XJ, 2011, MOL BIOL EVOL, V28, P899, DOI 10.1093/molbev/msq266
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Wilkinson GS, 1997, GENETICS, V146, P1035
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Yang JN, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073318
   Zhao Liang, 2012, ZOOLOGICAL RESEARCH, V33, PE47, DOI 10.3724/SP.J.1141.2012.E03-04E47
NR 64
TC 4
Z9 5
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 30
PY 2015
VL 43
IS 8
BP 4098
EP 4108
DI 10.1093/nar/gkv299
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CJ2LV
UT WOS:000355317200026
PM 25855815
DA 2024-11-01
ER

PT J
AU Reddy, P
   Ocampo, A
   Suzuki, K
   Luo, J
   Bacman, SR
   Williams, SL
   Sugawara, A
   Okamura, D
   Tsunekawa, Y
   Wu, J
   Lam, D
   Xiong, X
   Montserrat, N
   Esteban, CR
   Liu, GH
   Sancho-Martinez, I
   Manau, D
   Civico, S
   Cardellach, F
   O'Callaghan, MD
   Campistol, J
   Zhao, H
   Campistol, JM
   Moraes, CT
   Belmonte, JCI
AF Reddy, Pradeep
   Ocampo, Alejandro
   Suzuki, Keiichiro
   Luo, Jinping
   Bacman, Sandra R.
   Williams, Sion L.
   Sugawara, Atsushi
   Okamura, Daiji
   Tsunekawa, Yuji
   Wu, Jun
   Lam, David
   Xiong, Xiong
   Montserrat, Nuria
   Esteban, Concepcion Rodriguez
   Liu, Guang-Hui
   Sancho-Martinez, Ignacio
   Manau, Dolors
   Civico, Salva
   Cardellach, Francesc
   O'Callaghan, Maria del Mar
   Campistol, Jaime
   Zhao, Huimin
   Campistol, Josep M.
   Moraes, Carlos T.
   Belmonte, Juan Carlos Izpisua
TI Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing
SO CELL
LA English
DT Article
ID dna mutations; disease; transmission; heteroplasmy; degradation; sequence; embryos; drift
AB Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the trans-generational transmission of human mitochondrial diseases caused by mutations in mtDNA.
C1 [Reddy, Pradeep; Ocampo, Alejandro; Suzuki, Keiichiro; Luo, Jinping; Sugawara, Atsushi; Okamura, Daiji; Wu, Jun; Lam, David; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.
   [Bacman, Sandra R.; Williams, Sion L.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Tsunekawa, Yuji] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo 6500047, Japan.
   [Xiong, Xiong; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Montserrat, Nuria] Inst Bioengn Catalonia IBEC, Pluripotent Stem Cells & Organ Regenerat, Barcelona 08028, Spain.
   [Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Liu, Guang-Hui] Ctr Mol & Translat Med CMTM, Beijing 100101, Peoples R China.
   [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.
   [Manau, Dolors; Civico, Salva] Univ Barcelona, Hosp Clin, Inst Clin Gynecol Obstet & Neonatol ICGON, E-08036 Barcelona, Spain.
   [Cardellach, Francesc] Univ Barcelona, IDIBAPS CIBER Rare Dis, Mitochondrial Res Lab, E-08036 Barcelona, Spain.
   [Cardellach, Francesc] Univ Barcelona, Dept Internal Med, Hosp Clin, E-08036 Barcelona, Spain.
   [O'Callaghan, Maria del Mar; Campistol, Jaime] Hosp Univ St Joan de Deu, Neuropediat Dept CIBERER, Esplugas de Llobregat 08950, Spain.
   [Campistol, Josep M.] Univ Barcelona, IDIBAPS, Hosp Clin, Renal Div, E-08036 Barcelona, Spain.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 Salk Institute; University of Miami; RIKEN; University of Illinois System; University of Illinois Urbana-Champaign; University of Barcelona; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Miami
RP Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.
EM belmonte@salk.edu
FU Leona M. and Harry B. Helmsley Charitable Trust; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship; National Basic Research Program of China (973 Program) [2015CB964800, 2014CB964600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; National Natural Science Foundation of China (NSFC) [81271266, 31222039, 31201111, 81371342]; NIH [5R01EY010804, 1R01AG036871]; JDM Fund; Muscular Dystrophy Association; United Mitochondrial Disease Foundation; Florida Department of Health [3KN09]; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]
CR Alexeyev M, 2013, COLD SPRING HARB PER, V5, P0
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hayden EC, 2013, NATURE, V502, P284, DOI 10.1038/502284a
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vogel G, 2014, SCIENCE, V343, P827, DOI 10.1126/science.343.6173.827
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
NR 32
TC 219
Z9 251
U1 0
U2 102
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD APR 23
PY 2015
VL 161
IS 3
BP 459
EP 469
DI 10.1016/j.cell.2015.03.051
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CG8JN
UT WOS:000353553600008
PM 25910206
DA 2024-11-01
ER

PT J
AU Ripolone, M
   Ronchi, D
   Violano, R
   Vallejo, D
   Fagiolari, G
   Barca, E
   Lucchini, V
   Colombo, I
   Villa, L
   Berardinelli, A
   Balottin, U
   Morandi, L
   Mora, M
   Bordoni, A
   Fortunato, F
   Corti, S
   Parisi, D
   Toscano, A
   Sciacco, M
   DiMauro, S
   Comi, GP
   Moggio, M
AF Ripolone, Michela
   Ronchi, Dario
   Violano, Raffaella
   Vallejo, Dionis
   Fagiolari, Gigliola
   Barca, Emanuele
   Lucchini, Valeria
   Colombo, Irene
   Villa, Luisa
   Berardinelli, Angela
   Balottin, Umberto
   Morandi, Lucia
   Mora, Marina
   Bordoni, Andreina
   Fortunato, Francesco
   Corti, Stefania
   Parisi, Daniela
   Toscano, Antonio
   Sciacco, Monica
   DiMauro, Salvatore
   Comi, Giacomo P.
   Moggio, Maurizio
TI Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy
SO JAMA NEUROLOGY
LA English
DT Article
ID c-oxidase deficiency; motor-neuron protein; dna depletion; cellular-differentiation; smn protein; mouse model; gene; survival; complex; dysfunction
AB IMPORTANCE The important depletion of mitochondrial DNA (mtDNA) and the general depression of mitochondrial respiratory chain complex levels (including complex II) have been confirmed, implying an increasing paucity of mitochondria in the muscle from patients with types I, II, and III spinal muscular atrophy (SMA-I, -II, and -III, respectively). OBJECTIVE To investigate mitochondrial dysfunction in a large series of muscle biopsy samples from patients with SMA. DESIGN, SETTING, AND PARTICIPANTS We studied quadriceps muscle samples from 24 patients with genetically documented SMA and paraspinal muscle samples from 3 patients with SMA-II undergoing surgery for scoliosis correction. Postmortem muscle samples were obtained from 1 additional patient. Age-matched controls consisted of muscle biopsy specimens from healthy children aged 1 to 3 years who had undergone analysis for suspected myopathy. Analyses were performed at the Neuromuscular Unit, Istituto di Ricovero e Cura a Carattere Scientifico Foundation Ca' Granda Ospedale Maggiore Policlinico-Milano, from April 2011 through January 2015. EXPOSURES We used histochemical, biochemical, and molecular techniques to examine the muscle samples. MAIN OUTCOMES AND MEASURES Respiratory chain activity and mitochondrial content. RESULTS Results of histochemical analysis revealed that cytochrome-c oxidase (COX) deficiency was more evident in muscle samples from patients with SMA-I and SMA-II. Residual activities for complexes I, II, and IV in muscles from patients with SMA-I were 41%, 27%, and 30%, respectively, compared with control samples (P < .005). Muscle mtDNA content and cytrate synthase activity were also reduced in all 3 SMA types (P < .05). We linked these alterations to downregulation of peroxisome proliferator-activated receptor coactivator 1a, the transcriptional activators nuclear respiratory factor 1 and nuclear respiratory factor 2, mitochondrial transcription factor A, and their downstream targets, implying depression of the entire mitochondrial biogenesis. Results of Western blot analysis confirmed the reduced levels of the respiratory chain subunits that included mitochondrially encoded COX1 (47.5%; P = .004), COX2 (32.4%; P < .001), COX4 (26.6%; P < .001), and succinate dehydrogenase complex subunit A (65.8%; P = .03) as well as the structural outer membrane mitochondrial porin (33.1%; P < .001). Conversely, the levels of expression of 3 myogenic regulatory factors-muscle-specific myogenic factor 5, myoblast determination 1, and myogenin-were higher in muscles from patients with SMA compared with muscles from age-matched controls (P < .05). CONCLUSIONS AND RELEVANCE Our results strongly support the conclusion that an altered regulation of myogenesis and a downregulated mitochondrial biogenesis contribute to pathologic change in the muscle of patients with SMA. Therapeutic strategies should aim at counteracting these changes.
C1 [Ripolone, Michela; Violano, Raffaella; Fagiolari, Gigliola; Lucchini, Valeria; Colombo, Irene; Villa, Luisa; Sciacco, Monica; Moggio, Maurizio] Univ Milan, Ist Ricovero & Cura Carattere Sci IRCCS Fdn Ca Gr, Dino Ferrari Ctr, Neuromuscular Unit, Milan, Italy.
   [Ronchi, Dario; Bordoni, Andreina; Fortunato, Francesco; Corti, Stefania; Comi, Giacomo P.] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
   [Vallejo, Dionis] Univ Antioquia, Sien Serv Integrales Neurol, Medellin, Colombia.
   [Barca, Emanuele; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   [Berardinelli, Angela; Balottin, Umberto] C Mondino Natl Neurol Inst, Child Neuropsychiat Unit, Pavia, Italy.
   [Morandi, Lucia; Mora, Marina] IRCCS Fdn, Carlo Besta Neurol Inst, Dept Clin Neurosci, Neuromuscular Dis & Neuroimmunol Unit, Milan, Italy.
   [Parisi, Daniela; Toscano, Antonio] Univ Messina, Azienda Osped Univ Policlin G Martino, Dept Neurosci, Reference Ctr Rare Neuromuscular Disorders, Messina, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universidad de Antioquia; Columbia University; IRCCS Fondazione Casimiro Mondino; Fondazione IRCCS Istituto Neurologico Carlo Besta; AOU Policlinico Gaetano Martino; University of Messina
RP Moggio, M (corresponding author), Ist Ricovero & Cura Carattere Sci Fdn Ca Granda O, Neuromuscular Unit, Dino Ferrari Ctr, Via F Sforza 35, I-20122 Milan, Italy.
EM maurizio.moggio@unimi.it
FU National Institutes of Health [P01HD032062-20]; Foundation Cariplo [2012-0513]; Telethon network of Genetic biobanks [GTB12001]
CR Acsadi G, 2009, J NEUROSCI RES, V87, P2748, DOI 10.1002/jnr.22106
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Baldelli S, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.458
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Boyer JG, 2014, HUM MOL GENET, V23, P4249, DOI 10.1093/hmg/ddu142
   BRESOLIN N, 1987, ANN NEUROL, V21, P564, DOI 10.1002/ana.410210607
   Bricceno KV, 2014, HUM MOL GENET, V23, P4745, DOI 10.1093/hmg/ddu189
   BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0
   Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147
   Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205
   Da Cruz S, 2012, CELL METAB, V15, P778, DOI 10.1016/j.cmet.2012.03.019
   Di Meo I, 2011, ANTIOXID REDOX SIGN, V15, P353, DOI 10.1089/ars.2010.3520
   Dubowitz V, 1999, EUR J PAEDIATR NEUROL, V3, P49
   Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, PE802, DOI 10.1152/ajpendo.00343.2001
   Engel AGF-AC, 1994, MYOLOGY, V2nd, P0
   Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2
   Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390
   Gabanella F, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000921
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Gavrilov DK, 1998, NAT GENET, V20, P230, DOI 10.1038/3030
   Germain-Desprez D, 2001, GENE, V279, P109, DOI 10.1016/S0378-1119(01)00758-2
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Gómez-Curet I, 2007, NEUROGENETICS, V8, P271, DOI 10.1007/s10048-007-0093-1
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Guettier-Sigrist S, 2002, MUSCLE NERVE, V25, P700, DOI 10.1002/mus.10081
   Hausmanowa-Petrusewicz I, 2005, NEUROREPORT, V16, P657, DOI 10.1097/00001756-200505120-00001
   Hayhurst M, 2012, DEV BIOL, V368, P323, DOI 10.1016/j.ydbio.2012.05.037
   Ito Y, 2011, BRAIN DEV-JPN, V33, P321, DOI 10.1016/j.braindev.2010.06.009
   Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009
   La Bella V, 1998, EUR J NEUROSCI, V10, P2913
   Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4
   Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0
   Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Martínez-Hernández R, 2014, J NEUROPATH EXP NEUR, V73, P559, DOI 10.1097/NEN.0000000000000078
   Martínez-Hernández R, 2009, J NEUROPATH EXP NEUR, V68, P474, DOI 10.1097/NEN.0b013e3181a10ea1
   Meister G, 2001, EMBO J, V20, P2304, DOI 10.1093/emboj/20.9.2304
   Montes Jacqueline, 2014, J NEUROMUSCUL DIS, V1, P151
   Montesano A, 2013, J TRANSL MED, V11, P0, DOI 10.1186/1479-5876-11-310
   MULLERHOCKER J, 1989, HUM PATHOL, V20, P666, DOI 10.1016/0046-8177(89)90154-8
   OLDFORS A, 1989, ACTA NEUROPATHOL, V77, P267, DOI 10.1007/BF00687578
   Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0
   Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962
   Pronicki M, 2010, EUR J PAEDIATR NEURO, V14, P253, DOI 10.1016/j.ejpn.2009.09.008
   Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029
   Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862
   Sciacco M, 2001, NEUROLOGY, V56, P1070, DOI 10.1212/WNL.56.8.1070
   Simonds AK, 2002, SEM RESP CRIT CARE M, V23, P231, DOI 10.1055/s-2002-33031
   Sossi V, 2001, EUR J HUM GENET, V9, P113, DOI 10.1038/sj.ejhg.5200599
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045
   Tarnopolsky MA, 2004, AM J MED GENET A, V125A, P310, DOI 10.1002/ajmg.a.20466
   Terns MP, 2001, CURR BIOL, V11, PR862, DOI 10.1016/S0960-9822(01)00517-6
   Tsunemi T, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003799
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wadman RI, 2012, NEUROLOGY, V79, P2050, DOI 10.1212/WNL.0b013e3182749eca
   ZEVIANI M, 1985, ANN NEUROL, V17, P414, DOI 10.1002/ana.410170422
   Zheng B, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001059
NR 63
TC 98
Z9 102
U1 0
U2 12
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD JUN 15
PY 2015
VL 72
IS 6
BP 666
EP 675
DI 10.1001/jamaneurol.2015.0178
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA CK1BC
UT WOS:000355939400011
PM 25844556
DA 2024-11-01
ER

PT J
AU Carelli, V
   Musumeci, O
   Caporali, L
   Zanna, C
   La Morgia, C
   Del Dotto, V
   Porcelli, AM
   Rugolo, M
   Valentino, ML
   Iommarini, L
   Maresca, A
   Barboni, P
   Carbonelli, M
   Trombetta, C
   Valente, EM
   Patergnani, S
   Giorgi, C
   Pinton, P
   Rizzo, G
   Tonon, C
   Lodi, R
   Avoni, P
   Liguori, R
   Baruzzi, A
   Toscano, A
   Zeviani, M
AF Carelli, Valerio
   Musumeci, Olimpia
   Caporali, Leonardo
   Zanna, Claudia
   La Morgia, Chiara
   Del Dotto, Valentina
   Porcelli, Anna Maria
   Rugolo, Michela
   Valentino, Maria Lucia
   Iommarini, Luisa
   Maresca, Alessandra
   Barboni, Piero
   Carbonelli, Michele
   Trombetta, Costantino
   Valente, Enza Maria
   Patergnani, Simone
   Giorgi, Carlotta
   Pinton, Paolo
   Rizzo, Giovanni
   Tonon, Caterina
   Lodi, Raffaele
   Avoni, Patrizia
   Liguori, Rocco
   Baruzzi, Agostino
   Toscano, Antonio
   Zeviani, Massimo
TI Syndromic parkinsonism and dementia associated with <i>OPA1</i> missense mutations
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID dominant optic atrophy; mitochondrial-dna deletions; multiple deletions; external ophthalmoplegia; gene; instability; prevalence; disorders; variants; patient
AB ObjectiveMounting evidence links neurodegenerative disorders such as Parkinson disease and Alzheimer disease with mitochondrial dysfunction, and recent emphasis has focused on mitochondrial dynamics and quality control. Mitochondrial dynamics and mtDNA maintenance is another link recently emerged, implicating mutations in the mitochondrial fusion genes OPA1 and MFN2 in the pathogenesis of multisystem syndromes characterized by neurodegeneration and accumulation of mtDNA multiple deletions in postmitotic tissues. Here, we report 2 Italian families affected by dominant chronic progressive external ophthalmoplegia (CPEO) complicated by parkinsonism and dementia. MethodsPatients were extensively studied by optical coherence tomography (OCT) to assess retinal nerve fibers, and underwent muscle and brain magnetic resonance spectroscopy (MRS), and muscle biopsy and fibroblasts were analyzed. Candidate genes were sequenced, and mtDNA was analyzed for rearrangements. ResultsAffected individuals displayed a slowly progressive syndrome characterized by CPEO, mitochondrial myopathy, sensorineural deafness, peripheral neuropathy, parkinsonism, and/or cognitive impairment, in most cases without visual complains, but with subclinical loss of retinal nerve fibers at OCT. Muscle biopsies showed cytochrome c oxidase-negative fibers and mtDNA multiple deletions, and MRS displayed defective oxidative metabolism in muscle and brain. We found 2 heterozygous OPA1 missense mutations affecting highly conserved amino acid positions (p.G488R, p.A495V) in the guanosine triphosphatase domain, each segregating with affected individuals. Fibroblast studies showed a reduced amount of OPA1 protein with normal mRNA expression, fragmented mitochondria, impaired bioenergetics, increased autophagy and mitophagy. InterpretationThe association of CPEO and parkinsonism/dementia with subclinical optic neuropathy widens the phenotypic spectrum of OPA1 mutations, highlighting the association of defective mitochondrial dynamics, mtDNA multiple deletions, and altered mitophagy with parkinsonism. Ann Neurol 2015;78:21-38
C1 [Carelli, Valerio; Caporali, Leonardo; La Morgia, Chiara; Valentino, Maria Lucia; Maresca, Alessandra; Rizzo, Giovanni; Avoni, Patrizia; Liguori, Rocco; Baruzzi, Agostino] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Carelli, Valerio; Zanna, Claudia; La Morgia, Chiara; Valentino, Maria Lucia; Maresca, Alessandra; Rizzo, Giovanni; Avoni, Patrizia; Liguori, Rocco; Baruzzi, Agostino] Univ Bologna, Dept Biomed & Neuromotor Sci, Neurol Unit, I-40139 Bologna, Italy.
   [Musumeci, Olimpia; Toscano, Antonio] Univ Messina, Dept Neurosci, Messina, Italy.
   [Del Dotto, Valentina; Porcelli, Anna Maria; Rugolo, Michela; Iommarini, Luisa] Univ Bologna, Dept Pharm & Biotechnol, I-40139 Bologna, Italy.
   [Barboni, Piero; Carbonelli, Michele] Studio Oculist DAzeglio, Bologna, Italy.
   [Trombetta, Costantino] Univ Messina, Ophthalmol Clin, Messina, Italy.
   [Valente, Enza Maria] San Giovanni Rotondo, IRCCS Casa Sollievo Sofferenza, Mendel Lab, Foggia, Italy.
   [Patergnani, Simone; Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.
   [Tonon, Caterina; Lodi, Raffaele] Univ Bologna, Dept Biomed & Neuromotor Sci, St Orsola Malpighi Polyclin, Funct Magnet Resonance Unit, I-40139 Bologna, Italy.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Messina; University of Bologna; University of Messina; IRCCS Casa Sollievo Della Sofferenza; University of Ferrara; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna
RP Carelli, V (corresponding author), Univ Bologna, Dept Biomed & NeuroMotor Sci DiBiNeM, Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Via Altura 3, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it
FU Telethon-Italy [GGP06233, GPP10005, GGP14187]; Programma di ricerca Regione-Universita [PRUa1RI-2012-008]; European Research Council ERC-FP7 advanced grant [322424]; European Research Council (ERC) [322424] Funding Source: European Research Council (ERC)
CR Agier V, 2012, BBA-MOL BASIS DIS, V1822, P1570, DOI 10.1016/j.bbadis.2012.07.002
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Hannah-Shmouni F, 2014, JIMD REP, V12, P17, DOI 10.1007/8904_2013_239
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Mancuso M, 2008, J AFFECT DISORDERS, V106, P173, DOI 10.1016/j.jad.2007.05.016
   Maresca A, 2013, MOL CELL NEUROSCI, V55, P62, DOI 10.1016/j.mcn.2012.08.004
   Marongiu R, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20719
   Milone M, 2009, MITOCHONDRION, V9, P279, DOI 10.1016/j.mito.2009.03.001
   Müller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036
   Narendra D, 2012, COLD SPRING HARB PERSPECT BIOL, V4, P0
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Patergnani S, 2015, METHODS MOL BIOL, V1241, P181, DOI 10.1007/978-1-4939-1875-1_15
   Patergnani S, 2013, AUTOPHAGY, V9, P1367, DOI 10.4161/auto.25239
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Porcelli AM, 2009, J BIOL CHEM, V284, P2045, DOI 10.1074/jbc.M807321200
   Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Savini G, 2010, J GLAUCOMA, V19, P369, DOI 10.1097/IJG.0b013e3181bdb55d
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 53
TC 143
Z9 148
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JUL 15
PY 2015
VL 78
IS 1
BP 21
EP 38
DI 10.1002/ana.24410
PG 18
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CL3AQ
UT WOS:000356821200003
PM 25820230
DA 2024-11-01
ER

PT J
AU Sobenin, IA
   Zhelankin, AV
   Mitrofanov, KY
   Sinyov, VV
   Sazonova, MA
   Postnov, AY
   Orekhov, AN
AF Sobenin, Igor A.
   Zhelankin, Andrey V.
   Mitrofanov, Konstantin Y.
   Sinyov, Vasily V.
   Sazonova, Margarita A.
   Postnov, Anton Y.
   Orekhov, Alexander N.
TI Mutations of Mitochondrial DNA in Atherosclerosis and Atherosclerosis-Related Diseases
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Atherosclerosis; atherogenesis; mitochondrial DNA; mutations; heteroplasmy; coronary heart disease
ID maternally inherited hypertension; smooth-muscle-cells; point mutation; microsatellite instability; risk-factor; damage; gene; heterozygosity; mtdna; cardiomyopathy
AB Atherosclerosis, the primary cause of cardiovascular disease, is a complex and multifactorial pathology resulted from the harmful interactions between genetic and environmental factors. There is a growing body of evidence in support of the role of mitochondrial factors in the pathogenesis of atherosclerosis. Impaired mitochondrial function and structural and qualitative changes in mitochondrial components such as mitochondrial DNA (mtDNA) damage may be directly involved in the development of multiple mechanisms of atherogenesis. Recent findings show that several heteroplasmic mutations of mtDNA are related to atherosclerosis, coronary heart disease and several atherosclerosis-related diseases such as arterial hypertension and diabetes mellitus. Therefore, heteroplasmic mtDNA mutations could represent a promising molecular biomarker of genetic susceptibility to atherosclerosis and related pathologies. This review is focused on the latest findings in the studies of mutations of mitochondrial genome, which are associated with atherosclerosis and atherosclerosis- related diseases.
C1 [Sobenin, Igor A.; Zhelankin, Andrey V.; Sinyov, Vasily V.; Sazonova, Margarita A.; Postnov, Anton Y.] Russian Cardiol Res & Prod Complex, Med Genet Lab, Moscow 121552, Russia.
   [Sobenin, Igor A.; Mitrofanov, Konstantin Y.; Sinyov, Vasily V.; Sazonova, Margarita A.; Orekhov, Alexander N.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow 125315, Russia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow 143025, Russia.
C3 National Medical Research Center of Cardiology; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS
RP Sobenin, IA (corresponding author), Russian Cardiol Res & Prod Complex, Med Genet Lab, 15-a 3rd Cherepkovskaya Str, Moscow 121552, Russia.
EM sobenin@cardio.ru
FU Russian Scientific Foundation [14-14-01038]
CR Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M
   Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Borghini A, 2013, ATHEROSCLEROSIS, V230, P202, DOI 10.1016/j.atherosclerosis.2013.07.038
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Chung IM, 1998, AM J PATHOL, V152, P913
   Clark KJ, 2001, ARTERIOSCL THROM VAS, V21, P555, DOI 10.1161/01.ATV.21.4.555
   Dandona Sonny, 2009, CURR CARDIOL REP, V11, P282
   Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7
   Diehl AM, 1999, J BIOENERG BIOMEMBR, V31, P493, DOI 10.1023/A:1005452624640
   Döring Y, 2012, ARTERIOSCL THROM VAS, V32, P182, DOI 10.1161/ATVBAHA.111.232686
   Fiotti N, 2006, ARTERIOSCL THROM VAS, V26, P1330, DOI 10.1161/01.ATV.0000219233.31702.c9
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Fujimoto H, 2010, CIRC J, V74, P353, DOI 10.1253/circj.CJ-09-0491
   Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620
   Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007
   Grati FR, 2001, ATHEROSCLEROSIS, V159, P261, DOI 10.1016/S0021-9150(01)00466-X
   Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392
   Izzotti A, 2001, FASEB J, V15, P752, DOI 10.1096/fj.00-0312com
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   KOWALD A, 1993, MUTAT RES, V295, P93, DOI 10.1016/0921-8734(93)90011-Q
   Lee SH, 2001, TRENDS CARDIOVAS MED, V11, P148, DOI 10.1016/S1050-1738(01)00094-9
   Li RL, 2001, ATHEROSCLEROSIS, V154, P729, DOI 10.1016/S0021-9150(00)00582-7
   Li RH, 2009, HYPERTENSION, V54, P329, DOI 10.1161/HYPERTENSIONAHA.109.129270
   Li ZB, 2008, BIOCHEM BIOPH RES CO, V367, P906, DOI 10.1016/j.bbrc.2007.12.150
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008
   Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007
   Malik Q, 2012, FREE RADICAL RES, V46, P554, DOI 10.3109/10715762.2012.663913
   Markowitz SD, 1997, J CLIN INVEST, V100, P2143, DOI 10.1172/JCI119749
   McCaffrey TA, 1997, J CLIN INVEST, V100, P2182, DOI 10.1172/JCI119754
   Mercer JR, 2011, CIRC RES, V108, PE2, DOI 10.1161/RES.0b013e31820a13f1
   Miniati P, 2001, INT J BIOL MARKER, V16, P167, DOI 10.1177/172460080101600302
   Mueller EE, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016455
   Murry CE, 1997, AM J PATHOL, V151, P697
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360
   PARKES JL, 1991, AM J PATHOL, V138, P765
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Ross JS, 2001, ANN NY ACAD SCI, V947, P271
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SCHWARTZ CJ, 1993, AM J CARDIOL, V71, PB9, DOI 10.1016/0002-9149(93)90139-4
   Schwartz SM, 1998, ANNU REV MED, V49, P437
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Singh R, 2006, J MOL DIAGN, V8, P225, DOI 10.2353/jmoldx.2006.050067
   Sivapalaratnam S, 2011, CURR ATHEROSCLER REP, V13, P225, DOI 10.1007/s11883-011-0173-4
   Smith PM, 2011, J INHERIT METAB DIS, V34, P309, DOI 10.1007/s10545-010-9122-6
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, WORLD J CARDIOL, V5, P132, DOI 10.4330/wjc.v5.i5.132
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046573
   Sobenin IA, 2012, CLIN DEV IMMUNOL, V0, P0, DOI DOI 10.1155/2012/832464
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Stary HC, 1990, PATHOBIOLOGY HUMAN A, V0, P93
   Tabas I, 2001, CIRC RES, V88, P747, DOI 10.1161/hh0801.090536
   Tatarková Z, 2011, PHYSIOL RES, V60, P281, DOI 10.33549/physiolres.932019
   Van Schooten FJ, 1998, FASEB J, V12, P1409, DOI 10.1096/fasebj.12.13.1409
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang YC, 2011, J NEPHROL, V24, P351, DOI 10.5301/JN.2010.5816
   Weinberg RA, 1996, MOL ONCOLOGY, V0, P179
   Wong LJC, 1997, CLIN CHEM, V43, P1857
   Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
   Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111
NR 83
TC 23
Z9 28
U1 3
U2 15
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD JUN 15
PY 2015
VL 21
IS 9
BP 1158
EP 1163
DI 10.2174/1381612820666141013133000
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CB2NE
UT WOS:000349463600008
PM 25312735
DA 2024-11-01
ER

PT J
AU Rose, MR
   Jones, K
   Leong, K
   Walter, MC
   Miller, J
   Dalakas, MC
   Brassington, R
   Griggs, R
AF Rose, Michael R.
   Jones, Katherine
   Leong, Kevin
   Walter, Maggie C.
   Miller, James
   Dalakas, Marinos C.
   Brassington, Ruth
   Griggs, Robert
TI Treatment for inclusion body myositis
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID mitochondrial-dna deletions; intravenous immunoglobulin; double-blind; therapy; trial; methotrexate; association; prevalence; prednisone; update
AB Background Inclusion body myositis (IBM) is a late-onset inflammatory muscle disease (myopathy) associated with progressive proximal and distal limb muscle atrophy and weakness. Treatment options have attempted to target inflammatory and atrophic features of this condition (for example with immunosuppressive and immunomodulating drugs, anabolic steroids, and antioxidant treatments), although as yet there is no known effective treatment for reversing or minimising the progression of inclusion body myositis. In this review we have considered the benefits, adverse effects, and costs of treatment in targeting cardinal effects of the condition, namely muscle atrophy, weakness, and functional impairment. Objectives To assess the effects of treatment for IBM. Search methods On 7 October 2014 we searched the Cochrane Neuromuscular Disease Group Specialized Register, the Cochrane Central Register for Controlled Trials (CENTRAL), MEDLINE, and EMBASE. Additionally in November 2014 we searched clinical trials registries for ongoing or completed but unpublished trials. Selection criteria We considered randomised or quasi-randomised trials, including cross-over trials, of treatment for IBM in adults compared to placebo or any other treatment for inclusion in the review. We specifically excluded people with familial IBM and hereditary inclusion body myopathy, but we included people who had connective tissue and autoimmune diseases associated with IBM, which may or may not be identified in trials. We did not include studies of exercise therapy or dysphagia management, which are topics of other Cochrane systematic reviews. Data collection and analysis We used standard Cochrane methodological procedures. Main results The review included 10 trials (249 participants) using different treatment regimens. Seven of the 10 trials assessed single agents, and 3 assessed combined agents. Many of the studies did not present adequate data for the reporting of the primary outcome of the review, which was the percentage change in muscle strength score at six months. Pooled data from two trials of interferon beta-1a (n = 58) identified no important difference in normalised manual muscle strength sum scores from baseline to six months (mean difference (MD) -0.06, 95% CI -0.15 to 0.03) between IFN beta-1a and placebo (moderate-quality evidence). A single trial of methotrexate (MTX) (n = 44) provided moderate-quality evidence that MTX did not arrest or slow disease progression, based on reported percentage change in manual muscle strength sum scores at 12 months. None of the fully published trials were adequately powered to detect a treatment effect. We assessed six of the nine fully published trials as providing very low-quality evidence in relation to the primary outcome measure. Three trials (n = 78) compared intravenous immunoglobulin (combined in one trial with prednisone) to a placebo, but we were unable to perform meta-analysis because of variations in study analysis and presentation of trial data, with no access to the primary data for re-analysis. Other comparisons were also reported in single trials. An open trial of anti-T lymphocyte immunoglobulin (ATG) combined with MTX versus MTX provided very low-quality evidence in favour of the combined therapy, based on percentage change in quantitative muscle strength sum scores at 12 months (MD 12.50%, 95% CI 2.43 to 22.57). Data from trials of oxandrolone versus placebo, azathioprine (AZA) combined with MTX versus MTX, and arimoclomol versus placebo did not allow us to report either normalised or percentage change in muscle strength sum scores. A complete analysis of the effects of arimoclomol is pending data publication. Studies of simvastatin and bimagrumab (BYM338) are ongoing. All analysed trials reported adverse events. Only 1 of the 10 trials interpreted these for statistical significance. None of the trials included prespecified criteria for significant adverse events. Authors' conclusions Trials of interferon beta-1a and MTX provided moderate-quality evidence of having no effect on the progression of sporadic inclusion body myositis. Overall trial design limitations including risk of bias, low numbers of participants, and short duration make it difficult to say whether or not any of the drug treatments included in this review were effective. An open trial of ATG combined with MTX versus MTX provided very low-quality evidence in favour of the combined therapy based on the percentage change data given. We were unable to draw conclusions from trials of IVIg, oxandrolone, and AZA plus MTX versus MTX. We need more randomised controlled trials that are larger, of longer duration, and that use fully validated, standardised, and responsive outcome measures.
C1 [Rose, Michael R.; Jones, Katherine] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London SE5 9RS, England.
   [Leong, Kevin] Univ London Imperial Coll Sci Technol & Med, NHLI, London W12 0HS, England.
   [Walter, Maggie C.] Univ Munich, Lab Mol Myol, Friedrich Baur Inst, Dept Neurol, Munich, Germany.
   [Miller, James] Royal Victoria Infirm, Newcastle Tyne Hosp Trust, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Dalakas, Marinos C.] Thomas Jefferson Univ, Dept Neurol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.
   [Brassington, Ruth] Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Griggs, Robert] Univ Rochester, Dept Neurol, Rochester, NY USA.
C3 King's College Hospital NHS Foundation Trust; Imperial College London; University of Munich; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Jefferson University; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Rochester
RP Rose, MR (corresponding author), Kings Coll Hosp NHS Fdn Trust, Acad Neurosci Ctr, Dept Neurol, Denmark Hill, London SE5 9RS, England.
EM m.r.rose@kcl.ac.uk
FU Wissenschaftliches Institut, Private Europaische Medizinische Akademie der Klinik Bavaria in Kreischa GmbH, Kreischa, Germany; Lehrstuhl Therapiewissenschaften, SRH Fachhochschule fur Gesundheit Gera gGmbH, Gera, Germany; Gesundheitswissenschaften/Public Health, Medizinische Fakultat Carl Gustav Carus der TU Dresden, Dresden, Germany; University of Southampton, UK; University College London Hospital (UCLH) NHS Foundation Trust, UK; National Institute for Health Research (NIHR); Association Francaise contre les Myopathies, France
CR Amato AA, 1998, NEUROLOGY, V51, P598, DOI 10.1212/WNL.51.2.598
   AMATO AA, 1994, NEUROLOGY, V44, P1516, DOI 10.1212/WNL.44.8.1516
   [Anonymous], 2001, PHYSIOTHERAPY, V0, P0, DOI DOI 10.1016/S0031-9406(05)60764-X
   [Anonymous], 2014, REV MAN REVMAN VERS, V0, P0
   Arnardottir S, 2003, J REHABIL MED, V35, P31, DOI 10.1080/16501970306110
   Aronson JK, 2006, MEYLERS SIDE EFFECTS OF DRUGS: THE INTERNATIONAL ENCYCLOPEDIA OF ADVERSE DRUG REACTIONS AND INTERACTIONS, V0, P0
   Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385
   Badrising UA, 2002, ANN NEUROL, V51, P369, DOI 10.1002/ana.10121
   Beaston-Blaakman A, 2007, AIDS CARE, V19, P996, DOI 10.1080/09540120701335238
   Benveniste Olivier, 2010, NEUROMUSCUL DISORD, V20, P414, DOI 10.1016/j.nmd.2010.03.014
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
   Breithaupt M, 2013, CURR RHEUMATOL REP, V15, P0, DOI 10.1007/s11926-013-0329-z
   BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307
   Chalker J, 2000, MEYLERS SIDE EFFECTS, V0, P0
   CONVERY FR, 1977, ARCH PHYS MED REHAB, V58, P494
   Cortese A, 2013, NEUROMUSCULAR DISORD, V23, P404, DOI 10.1016/j.nmd.2013.02.010
   Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217
   DALAKAS MC, 1995, ANN NEUROL, V37, P806, DOI 10.1002/ana.410370615
   DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704
   Dalakas MC, 2001, NEUROLOGY, V56, P323, DOI 10.1212/WNL.56.3.323
   Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712
   DANON MJ, 1982, ARCH NEUROL-CHICAGO, V39, P760, DOI 10.1001/archneur.1982.00510240022006
   DANON MJ, 1986, CAN J NEUROL SCI, V13, P334
   Department of Health, 2011, CIN GUID IMM US UPD, V0, P0
   Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140
   Fergusson D, 2005, TRANSFUSION, V45, P1640, DOI 10.1111/j.1537-2995.2005.00581.x
   Fujii M, 1997, NEUROLOGY S2, V48, P0
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   GUTMANN L, 1985, ARCH NEUROL-CHICAGO, V42, P1021, DOI 10.1001/archneur.1985.04060090107026
   Higgins J, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.ED000049
   Hill M, 2004, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004303.pub2
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI 10.1016/j.nmd.2010.07.087
   Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001
   Jackson CE, 2008, MUSCLE NERVE, V37, P473, DOI 10.1002/mus.20958
   JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I
   Joint Formulary Committee, 2014, BRIT NATL FORMULARY, V68, P0
   KHRAISHI MM, 1992, J RHEUMATOL, V19, P306
   Kosmidis ML, 2013, J NEUROL SCI, V334, P123, DOI 10.1016/j.jns.2013.08.007
   LANE RJM, 1985, J NEUROL NEUROSUR PS, V48, P270, DOI 10.1136/jnnp.48.3.270
   LEFF RL, 1993, MEDICINE, V72, P225, DOI 10.1097/00005792-199307000-00002
   Lindberg C, 2003, NEUROLOGY, V61, P260, DOI 10.1212/01.WNL.0000071852.27182.C7
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Lindberg C, 1990, J NEUROLOGICAL SCI S, V98, P178
   Loke YK, 2007, BMC MED RES METHODOL, V7, P0, DOI 10.1186/1471-2288-7-32
   LOTZ BP, 1989, BRAIN, V112, P727, DOI 10.1093/brain/112.3.727
   Machado P, 2014, COMMUNICATION, V0, P0
   Machado P, 2013, ANNALS OF THE RHEUMA, V72, P0
   Machado P, 2013, CURR OPIN RHEUMATOL, V25, P763, DOI 10.1097/01.bor.0000434671.77891.9a
   Mastaglia FL, 1998, J NEUROL NEUROSUR PS, V65, P107, DOI 10.1136/jnnp.65.1.107
   Mowzoon N, 2001, J NEUROL SCI, V185, P119, DOI 10.1016/S0022-510X(01)00478-6
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Phillips BA, 2000, MUSCLE NERVE, V23, P970, DOI 10.1002/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I
   Pongratz D, 1998, MUSCLE NERVE S7, V21, P0
   RIGGS JE, 1984, ARCH NEUROL-CHICAGO, V41, P93, DOI 10.1001/archneur.1984.04050130099033
   Rose MR, 2001, NEUROLOGY, V57, P548, DOI 10.1212/WNL.57.3.548
   Rose MR, 2014, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001555.pub4
   Rose MR, 1999, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001555
   Rose MR, 2007, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001555.pub2
   Rutkove SB, 2002, NEUROLOGY, V58, P1081, DOI 10.1212/WNL.58.7.1081
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Smith GI, 2012, BIOL SEX DIFFER, V3, P0, DOI 10.1186/2042-6410-3-11
   SODEN M, 1994, J RHEUMATOL, V21, P344
   SOUEIDAN SA, 1993, NEUROLOGY, V43, P876, DOI 10.1212/WNL.43.5.876
   Tateyama M, 2003, INTERNAL MED, V42, P1035, DOI 10.2169/internalmedicine.42.1035
   Tawil R, 2004, NEUROLOGY, V63, P718
   Tawil R, 2001, NEUROLOGY, V57, P1566
   Verschuuren JJ, 1997, DIAGNOSTIC CRITERIA, V0, P81
   VISSER LH, 1994, ANN NEUROL, V35, P749
   Voet NBM, 2013, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003907.pub4
   Walter MC, 2000, J NEUROL, V247, P22, DOI 10.1007/s004150050005
NR 76
TC 16
Z9 18
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PD JUN 15
PY 2015
VL 0
IS 6
BP 
EP 
DI 10.1002/14651858.CD001555.pub5
PG 67
WC Medicine, General & Internal
SC General & Internal Medicine
GA CM3TE
UT WOS:000357606400006
PM 35658164
DA 2024-11-01
ER

PT J
AU Zhang, YC
   Ma, YN
   Bu, DF
   Liu, H
   Xia, CY
   Zhang, Y
   Zhu, SN
   Pan, H
   Pei, P
   Zheng, XF
   Wang, ST
   Xu, YF
   Qi, Y
AF Zhang, Yanchun
   Ma, Yinan
   Bu, Dingfang
   Liu, Hui
   Xia, Changyu
   Zhang, Ying
   Zhu, Sainan
   Pan, Hong
   Pei, Pei
   Zheng, Xuefei
   Wang, Songtao
   Xu, Yufeng
   Qi, Yu
TI Deletion of a 4977-bp Fragment in the Mitochondrial Genome Is Associated with Mitochondrial Disease Severity
SO PLOS ONE
LA English
DT Article
ID skeletal-muscle; common-deletion; copy number; quantitative-analysis; dna deletion; bp deletion; disorders; diagnosis; mutation; breast
AB Large deletions in mitochondrial DNA (mtDNA) may be involved in the pathogenesis of mitochondrial disease. In this study, we investigated the relationship between a 4,977-bp deletion in the mitochondrial genome (Delta mtDNA(4977)) and the severity of clinical symptoms in patients with mitochondrial disease lacking known point mutations. A total of 160 patients with mitochondrial disease and 101 healthy controls were recruited for this study. The copy numbers of Delta mtDNA(4977) and wild-type mtDNA were determined by real-time quantitative PCR and analyzed using Spearman's bivariate correlation analysis, t-tests, or one-way ANOVA. The overall Delta mtDNA(4977) copy number per cell and the proportion of mtDNA(4977) relative to the total wild-type mtDNA, increased with patient age and symptom severity. Surprisingly, the total mtDNA copy number decreased with increasing symptom severity. Our analyses revealed that increases in the proportion and total copy number of Delta mtDNA(4977) in the blood may be associated with disease severity in patients with mitochondrial dysfunction.
C1 [Zhang, Yanchun; Ma, Yinan; Bu, Dingfang; Zhang, Ying; Pan, Hong; Pei, Pei; Zheng, Xuefei; Wang, Songtao; Xu, Yufeng; Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100034, Peoples R China.
   [Liu, Hui] Beijing Childrens Hosp, Dept Resp, Beijing 100045, Peoples R China.
   [Xia, Changyu] Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100034, Peoples R China.
   [Zhu, Sainan] Peking Univ, Hosp 1, Dept Biostat, Beijing 100034, Peoples R China.
C3 Peking University; Capital Medical University; Peking University; Peking University
RP Ma, YN (corresponding author), Peking Univ, Hosp 1, Dept Cent Lab, 8 West Dist, Beijing 100034, Peoples R China.
EM mayinan1014@163.com; qiyu0724@163.com
FU National Natural Science Foundation of China [81271256, 81471153]; Beijing Municipal Science & Technology Commission [Z131107002213062]
CR Akouchekian M, 2011, J RES MED SCI, V16, P50
   Aral C, 2010, GENET MOL BIOL, V33, P1, DOI 10.1590/S1415-47572009005000102
   Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Cho YM, 2007, DIABETES RES CLIN PR, V77, PS172, DOI 10.1016/j.diabres.2007.01.052
   Czarny P, 2014, MUTAT RES-FUND MOL M, V760, P42, DOI 10.1016/j.mrfmmm.2013.12.001
   Kamalidehghan B, 2013, ARCH MED RES, V44, P79, DOI 10.1016/j.arcmed.2012.11.004
   Kato T, 1997, BIOL PSYCHIAT, V42, P311, DOI 10.1016/S0006-3223(96)00377-0
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Liu H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067146
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Nie HR, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067953
   Obara-Moszynska M, 2013, BMC PEDIATR, V13, P0, DOI 10.1186/1471-2431-13-27
   Ohnuki Y, 2014, INTERNAL MED, V53, P1365, DOI 10.2169/internalmedicine.53.1320
   Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009
   Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0
   Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shao JY, 2004, WORLD J GASTROENTERO, V10, P1560, DOI 10.3748/wjg.v10.i11.1560
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sun MJ, 2009, INT UROGYNECOL J, V20, P867, DOI 10.1007/s00192-009-0871-4
   Thayer RE, 2003, EXP GERONTOL, V38, P567, DOI 10.1016/S0531-5565(03)00033-0
   Upadhyay R, 2009, CANCER GENET CYTOGEN, V195, P175, DOI 10.1016/j.cancergencyto.2009.06.017
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005
   Wang J, 2009, CHINESE MED J-PEKING, V122, P431, DOI 10.3760/cma.j.issn.0366-6999.2009.04.0014
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   Ye CZ, 2008, BREAST CANCER RES TR, V108, P427, DOI 10.1007/s10549-007-9613-9
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008
NR 39
TC 23
Z9 26
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2015
VL 10
IS 5
BP 
EP 
DI 10.1371/journal.pone.0128624
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ2MQ
UT WOS:000355319400099
PM 26024530
DA 2024-11-01
ER

PT J
AU Yokota, M
   Hatakeyama, H
   Okabe, S
   Ono, Y
   Goto, YI
AF Yokota, Mutsumi
   Hatakeyama, Hideyuki
   Okabe, Saki
   Ono, Yasuha
   Goto, Yu-ichi
TI Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID pluripotent stem-cells; lactic-acidosis; point mutation; encephalopathy; segregation; myopathy; genome; lines; gene
AB Mitochondrial dysfunction caused by pathogenic mutations in mitochondrial tRNA genes emerges only when mutant mitochondrial DNA (mtDNA) proportions exceed intrinsic pathogenic thresholds; however, little is known about the actual proportions of mutant mtDNA that can affect particular cellular lineage-determining processes. Here, we mainly focused on the effects of mitochondrial respiratory dysfunction caused by m.3243A>G heteroplasmy in MT-TL1 gene on cellular reprogramming. We found that generation of induced pluripotent stem cells (iPSCs) was drastically depressed only by high proportions of mutant mtDNA (>= 90% m.3243A>G), and these proportions were strongly associated with the degree of induced mitochondrial respiratory dysfunction. Nevertheless, all established iPSCs, even those carrying similar to 100% m.3243A>G, exhibited an embryonic stem cell-like pluripotent state. Therefore, our findings clearly demonstrate that loss of physiological integrity in mitochondria triggered by mutant mtDNA constitute a roadblock to cellular rejuvenation, but do not affect the maintenance of the pluripotent state.
C1 [Yokota, Mutsumi; Hatakeyama, Hideyuki; Okabe, Saki; Ono, Yasuha; Goto, Yu-ichi] NCNP, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo 1878551, Japan.
   [Yokota, Mutsumi; Hatakeyama, Hideyuki; Goto, Yu-ichi] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Hatakeyama, H (corresponding author), NCNP, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.
EM hideyuki@ncnp.go.jp; goto@ncnp.go.jp
FU Japan Society for the Promotion of Science [25860732]; Ministry of Health, Labour and Welfare, Japan; AMED-CREST from the Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [25860732] Funding Source: KAKEN
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002
   Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Lehtinen SK, 2000, GENETICS, V154, P363
   Okita K, 2011, NAT METHODS, V8, P409, DOI 10.1038/NMETH.1591
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 25
TC 36
Z9 36
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 15
PY 2015
VL 24
IS 16
BP 4698
EP 4709
DI 10.1093/hmg/ddv201
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CR4OU
UT WOS:000361315400018
PM 26025377
DA 2024-11-01
ER

PT J
AU Al-Hassnan, ZN
   Al-Dosary, M
   Alfadhel, M
   Faqeih, EA
   Alsagob, M
   Kenana, R
   Almass, R
   Al-Harazi, OS
   Al-Hindi, H
   Malibari, OI
   Almutari, FB
   Tulbah, S
   Alhadeq, F
   Al-Sheddi, T
   Alamro, R
   AlAsmari, A
   Almuntashri, M
   Alshaalan, H
   Al-Mohanna, FA
   Colak, D
   Kaya, N
AF Al-Hassnan, Zuhair N.
   Al-Dosary, Mazhor
   Alfadhel, Majid
   Faqeih, Eissa A.
   Alsagob, Maysoon
   Kenana, Rosan
   Almass, Rawan
   Al-Harazi, Olfat S.
   Al-Hindi, Hindi
   Malibari, Omhani I.
   Almutari, Faten B.
   Tulbah, Sahar
   Alhadeq, Faten
   Al-Sheddi, Tarfa
   Alamro, Rana
   AlAsmari, Ali
   Almuntashri, Makki
   Alshaalan, Hesham
   Al-Mohanna, Futwan A.
   Colak, Dilek
   Kaya, Namik
TI <i>ISCA2</i> mutation causes infantile neurodegenerative mitochondrial disorder
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID multiple respiratory-chain; iron-sulfur clusters; friedreichs-ataxia; protein mutations; human-disease; biogenesis; deficiency; maturation; gene; myopathy
AB Background There are numerous nuclear genes that cause mitochondrial disorders and clinically and genetically heterogeneous disorders whose aetiology often remains unsolved. In this study, we aim to investigate an autosomal recessive syndrome causing leukodystrophy and neuroregression. We studied six patients from five unrelated consanguineous families. Methods Patients underwent full neurological, radiological, genetic, metabolic and dysmorphological examinations. Exome sequencing coupled with autozygosity mapping, Sanger sequencing, microsatellite haplotyping, standard and molecular karyotyping and whole mitochondrial DNA sequencing were used to identify the genetic cause of the syndrome. Immunohistochemistry, transmission electron microscopy, confocal microscopy, dipstick assays, quantitative PCR, reverse transcription PCR and quantitative reverse transcription PCR were performed on different tissue samples from the patients. Results We identified a homoallelic missense founder mutation in ISCA2 leading to mitochondrial depletion and reduced complex I activity as well as decreased ISCA2, ISCA1 and IBA57 expression in fibroblasts. MRI indicated similar white matter abnormalities in the patients. Histological examination of the skeletal muscle showed mild to moderate variation in myofibre size and the presence of many randomly distributed atrophic fibres. Conclusions Our data demonstrate that ISCA2 deficiency leads to a hereditary mitochondrial neurodegenerative white matter disease in infancy.
C1 [Al-Hassnan, Zuhair N.] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia.
   [Al-Hassnan, Zuhair N.; Al-Mohanna, Futwan A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   [Al-Dosary, Mazhor; Alsagob, Maysoon; Kenana, Rosan; Almass, Rawan; Almutari, Faten B.; Tulbah, Sahar; Alhadeq, Faten; Al-Sheddi, Tarfa; Alamro, Rana; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
   [Alfadhel, Majid] King Saud Bin Abdulaziz Univ Hlth Sci, Genet Div, Dept Pediat, King Abdulaziz Med City, Riyadh, Saudi Arabia.
   [Faqeih, Eissa A.; AlAsmari, Ali] King Fahad Med City, Childrens Hosp, Sect Med Genet, Riyadh, Saudi Arabia.
   [Al-Harazi, Olfat S.; Colak, Dilek; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Biostat & Sci Comp, Riyadh 11211, Saudi Arabia.
   [Al-Hindi, Hindi] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia.
   [Malibari, Omhani I.] Matern & Childrens Hosp, King Abdullah Med City, Dept Pediat, Riyadh, Saudi Arabia.
   [Almuntashri, Makki; Alshaalan, Hesham] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, Dept Radiol, Riyadh, Saudi Arabia.
   [Al-Mohanna, Futwan A.] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia.
C3 King Faisal Specialist Hospital & Research Center; Alfaisal University; King Faisal Specialist Hospital & Research Center; King Saud Bin Abdulaziz University for Health Sciences; King Fahad Medical City; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Faisal Specialist Hospital & Research Center
RP Kaya, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Neurogenet Unit, MBC 03, Riyadh 11211, Saudi Arabia.
EM nkaya@kfshrc.edu.sa
FU King Faisal Specialist Hospital and Research Center's seed grants (KFSHRC-RAC) [2120022]; King Abdulaziz Center for Science and Technology, Biotech Initiative (KACST) [12-BIO2221-20]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Alzahrani AS, 2012, CLIN ENDOCRINOL, V76, P540, DOI 10.1111/j.1365-2265.2011.04258.x
   Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107
   Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238
   Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423
   Capriotti E, 2005, NUCLEIC ACIDS RES, V33, PW306, DOI 10.1093/nar/gki375
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962
   Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918
   Kohler C, 2009, MOL CANCER, V8, P0, DOI 10.1186/1476-4598-8-105
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Melin M, 2006, J HUM GENET, V51, P864, DOI 10.1007/s10038-006-0035-z
   Mi HY, 2007, NUCLEIC ACIDS RES, V35, PD247, DOI 10.1093/nar/gkl869
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Mondal R, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057771
   Mühlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152
   Mühlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Reva B, 2011, NUCLEIC ACIDS RES, V39, PE118, DOI 10.1093/nar/gkr407
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218
   Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006
   Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772
   Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
   Yue P, 2006, BMC BIOINFORMATICS, V7, P0, DOI 10.1186/1471-2105-7-166
NR 39
TC 75
Z9 91
U1 0
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD MAR 15
PY 2015
VL 52
IS 3
BP 186
EP 194
DI 10.1136/jmedgenet-2014-102592
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA CB8JD
UT WOS:000349874700006
PM 25539947
DA 2024-11-01
ER

PT J
AU Garrido-Maraver, J
   Paz, MV
   Cordero, MD
   Bautista-Lorite, J
   Oropesa-Avila, M
   de la Mata, M
   Pavón, AD
   de Lavera, I
   Alcocer-Gómez, E
   Galán, F
   González, PY
   Cotán, D
   Jackson, S
   Sánchez-Alcázar, JA
AF Garrido-Maraver, Juan
   Villanueva Paz, Marina
   Cordero, Mario D.
   Bautista-Lorite, Juan
   Oropesa-Avila, Manuel
   de la Mata, Mario
   Delgado Pavon, Ana
   de Lavera, Isabel
   Alcocer-Gomez, Elizabet
   Galan, Fernando
   Ybot Gonzalez, Patricia
   Cotan, David
   Jackson, Sandra
   Sanchez-Alcazar, Jose A.
TI Critical role of AMP-activated protein kinase in the balance between mitophagy and mitochondrial biogenesis in MELAS disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE MELAS syndrome; Mitochondrial biogenesis; Mitophagy; AMPK; PGC-1 alpha; AICAR; Coenzyme Q(10)
ID c-oxidase deficiency; lactic-acidosis; skeletal-muscle; oxidative stress; gene-expression; coenzyme q(10); human-cells; pink1/parkin-mediated mitophagy; direct phosphorylation; transcription factor
AB MELAS syndrome is a mitochondrial disorder that is caused mainly by the m3243A>G mutation in mitochondrial DNA. Here, we report on how the severity of pathophysiological alterations is differently expressed in fibroblasts derived from patients with MELAS disease. We evaluated mitophagy activation and mitochondrial biogenesis which are the main mechanisms regulating the degradation and genesis of mitochondrial mass in MELAS fibroblasts and transmitochondrial cybrids. Our results suggest a critical balance between mitophagy and mitochondrial biogenesis which leads to the expression of different degrees of pathological severity among MELAS fibroblast cell lines according to their heteroplasmy load and the activation of AMP-activated protein kinase (AMPK). AMPK-activators such as 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR) or coenzyme Q(10) (CoQ) increased peroxisome proliferator-activated receptor alpha (PGC-1 alpha.) nuclear translocation, mitochondrial biogenesis, antioxidant enzyme system response, autophagic flux and improved pathophysiological alterations in MELAS fibroblasts with the most severe phenotype. Our findings support the hypothesis that mitochondrial biogenesis, increased antioxidant response and autophagy clearance serve as compensatory mechanisms in response to mitophagic degradation of dysfunctional mitochondria and point out that AMPK is an important player in this balance. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Garrido-Maraver, Juan; Villanueva Paz, Marina; Oropesa-Avila, Manuel; de la Mata, Mario; Delgado Pavon, Ana; de Lavera, Isabel; Alcocer-Gomez, Elizabet; Cotan, David; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, CSIC, CABD, Inst Salud Carlos III, Seville 41013, Spain.
   [Garrido-Maraver, Juan; Villanueva Paz, Marina; Oropesa-Avila, Manuel; de la Mata, Mario; Delgado Pavon, Ana; de Lavera, Isabel; Alcocer-Gomez, Elizabet; Cotan, David; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, CSIC, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain.
   [Cordero, Mario D.] Univ Seville, Fac Odontol, Seville, Spain.
   [Bautista-Lorite, Juan] Hosp Quiron, Serv Neurol, Seville, Spain.
   [Galan, Fernando] Hosp Univ Virgen Macarena, Seville, Spain.
   [Ybot Gonzalez, Patricia] Hosp Virgen de Rocio, CSIC, Inst Biomed Sevilla IBIS, Seville, Spain.
   [Jackson, Sandra] Uniklinikum CG Carus, Dept Neurol, Dresden, Germany.
C3 Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Universidad Pablo de Olavide; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Sevilla; Hospital Universitario Virgen Macarena; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Technische Universitat Dresden
RP Sánchez-Alcázar, JA (corresponding author), Univ Pablo Olavide, CSIC, CABD, Carretera Utrera Km 1, Seville 41013, Spain.
EM jasanalc@upo.es
FU FIS [PI13/00129]; Ministerio de Sanidad, Spain; Fondo Europeo de Desarrollo Regional (FEDER-Union Europea); Proyecto de Investigacion de Excelencia de la Junta de Andalucia [CTS-5725]; AEPMI (Asociacion de Enfermos de Patologia Mitocondrial)
CR Abadi A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0060722
   Alcocer-Gómez E, 2015, BBA-MOL BASIS DIS, V1852, P1257, DOI 10.1016/j.bbadis.2015.03.005
   Armstrong JS, 2003, J BIOL CHEM, V278, P49079, DOI 10.1074/jbc.M307841200
   Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BYRNE E, 1988, AUST PAEDIATR J, V24, P58
   Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121
   Chen HC, 2005, HUM MOL GENET, V14, PR283, DOI 10.1093/hmg/ddi270
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cordero MD, 2013, ANTIOXID REDOX SIGN, V19, P1356, DOI 10.1089/ars.2013.5260
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Davidson MM, 2009, J MOL CELL CARDIOL, V46, P936, DOI 10.1016/j.yjmcc.2009.02.011
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004
   Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200
   Garrabou G, 2007, ANTIMICROB AGENTS CH, V51, P962, DOI 10.1128/AAC.01190-06
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717
   Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Golubitzky A, 1900, V6, V0, P0
   Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114
   Jacobson J, 2002, J NEUROCHEM, V82, P224, DOI 10.1046/j.1471-4159.2002.00945.x
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Janssen AJM, 2008, ANN NEUROL, V63, P473, DOI 10.1002/ana.21328
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirino Yohei, 2005, RNA BIOL, V2, P41, DOI 10.4161/rna.2.2.1610
   Köchl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x
   Lee SK, 2012, CELL SIGNAL, V24, P2329, DOI 10.1016/j.cellsig.2012.07.022
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Mackenzie RM, 2013, CLIN SCI, V124, P403, DOI 10.1042/CS20120239
   Mariño G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4
   Meijer AJ, 2011, CURR BIOL, V21, PR227, DOI 10.1016/j.cub.2011.02.007
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Morán M, 2014, BBA-MOL BASIS DIS, V1842, P1059, DOI 10.1016/j.bbadis.2014.03.013
   MULLERHOCKER J, 1993, ARCH PATHOL LAB MED, V117, P202
   Narendra DP, 1900, V8, V0, P0
   Nisoli E, 2004, BIOCHEM PHARMACOL, V67, P1, DOI 10.1016/j.bcp.2003.10.015
   NOVAK I, 1900, V11, V0, P45
   Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522
   Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pessina S, 2010, CELL CYCLE, V9, P2189, DOI 10.4161/cc.9.11.11847
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Spinazzi M, 1900, V7, V0, P1235
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, PE341, DOI 10.1152/ajpendo.00400.2010
   Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002
   Tian G, 2014, ANTIOXID REDOX SIGN, V20, P2606, DOI 10.1089/ars.2013.5406
   TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tsai KL, 2011, MOL NUTR FOOD RES, V55, PS227, DOI 10.1002/mnfr.201100147
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625
   Wu SB, 2014, BBA-GEN SUBJECTS, V1840, P1331, DOI 10.1016/j.bbagen.2013.10.034
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   YONEDA M, 1989, J NEUROL SCI, V92, P143, DOI 10.1016/0022-510X(89)90132-9
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang J, 1900, V6, V0, P405
NR 84
TC 42
Z9 43
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 0006-3002
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD NOV 15
PY 2015
VL 1852
IS 11
BP 2535
EP 2553
DI 10.1016/j.bbadis.2015.08.027
PG 19
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA CS5QJ
UT WOS:000362132700020
PM 26341273
DA 2024-11-01
ER

PT J
AU Bowen, TS
   Schuler, G
   Adams, V
AF Bowen, T. Scott
   Schuler, Gerhard
   Adams, Volker
TI Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Review
DE Muscle wasting; Sarcopenia; Cachexia; Exercise training; Molecular analysis
ID chronic heart-failure; growth-factor-i; ubiquitin-proteasome pathway; left-ventricular dysfunction; mitochondrial-dna-deletion; age-related-changes; cell self-renewal; cancer cachexia; protein breakdown; gene-expression
AB Skeletal muscle provides a fundamental basis for human function, enabling locomotion and respiration. Transmission of external stimuli to intracellular effector proteins via signalling pathways is a highly regulated and controlled process that determines muscle mass by balancing protein synthesis and protein degradation. An impaired balance between protein synthesis and breakdown leads to the development of specific myopathies. Sarcopenia and cachexia represent two distinct muscle wasting diseases characterized by inflammation and oxidative stress, where specific regulating molecules associated with wasting are either activated (e.g. members of the ubiquitin-proteasome system and myostatin) or repressed (e.g. insulin-like growth factor 1 and PGC-1). At present, no therapeutic interventions are established to successfully treat muscle wasting in sarcopenia and cachexia. Exercise training, however, represents an intervention that can attenuate or even reverse the process of muscle wasting, by exerting anti-inflammatory and anti-oxidative effects that are able to attenuate signalling pathways associated with protein degradation and activate molecules associated with protein synthesis. This review will therefore discuss the molecular mechanisms associated with the pathology of muscle wasting in both sarcopenia and cachexia, as well as highlighting the intracellular effects of exercise training in attenuating the debilitating loss of muscle mass in these specific conditions.
C1 [Bowen, T. Scott; Schuler, Gerhard; Adams, Volker] Univ Leipzig, Dept Cardiol, Heart Ctr Leipzig, D-04289 Leipzig, Germany.
C3 Leipzig University; Heart Center Leipzig GMBH
RP Adams, V (corresponding author), Univ Leipzig, Dept Cardiol, Heart Ctr Leipzig, Strumpellstr 39, D-04289 Leipzig, Germany.
EM adav@medizin.uni-leipzig.de
FU Alexander von Humboldt Foundation
CR Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174
   Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718
   Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8
   Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N
   Argilés JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829
   Atherton PJ, 2012, J PHYSIOL-LONDON, V590, P1049, DOI 10.1113/jphysiol.2011.225003
   Attaix D, 2005, INT J BIOCHEM CELL B, V37, P1962, DOI 10.1016/j.biocel.2005.04.009
   Aucello M, 2009, AUTOPHAGY, V5, P527, DOI 10.4161/auto.5.4.7962
   Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622
   Bearne LM, 2002, RHEUMATOLOGY, V41, P157, DOI 10.1093/rheumatology/41.2.157
   Belardinelli R, 2012, J AM COLL CARDIOL, V60, P1521, DOI 10.1016/j.jacc.2012.06.036
   Benatti FB, 2015, NAT REV RHEUMATOL, V11, P86, DOI 10.1038/nrrheum.2014.193
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Borst SE, 2004, AGE AGEING, V33, P548, DOI 10.1093/ageing/afh201
   Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burney BO, 2012, J CLIN ENDOCR METAB, V97, PE700, DOI 10.1210/jc.2011-2387
   Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247
   Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0
   Carosio S, 2011, AGEING RES REV, V10, P35, DOI 10.1016/j.arr.2009.08.001
   Cassano M, 2009, J MUSCLE RES CELL M, V30, P243, DOI 10.1007/s10974-010-9204-y
   Castaneda C, 2001, ANN INTERN MED, V135, P965, DOI 10.7326/0003-4819-135-11-200112040-00008
   Ceelen JJM, 2014, CURR OPIN SUPPORT PA, V8, P339, DOI 10.1097/SPC.0000000000000088
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chrysis D, 1999, ENDOCRINOLOGY, V140, P5635, DOI 10.1210/en.140.12.5635
   Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005
   Cobley JN, 2014, FREE RADICAL BIO MED, V70, P23, DOI 10.1016/j.freeradbiomed.2014.02.004
   Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467
   Collins CA, 2006, CURR OPIN PHARMACOL, V6, P301, DOI 10.1016/j.coph.2006.01.006
   Collins-Hooper H, 2012, STEM CELLS, V30, P1182, DOI 10.1002/stem.1088
   Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, PE693, DOI 10.1152/ajpendo.00281.2004
   Combaret L, 2009, CURR OPIN CLIN NUTR, V12, P37, DOI 10.1097/MCO.0b013e32831b9c31
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Cunha TF, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0041701
   Dargelos E, 2007, EXP GERONTOL, V42, P1088, DOI 10.1016/j.exger.2007.08.009
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   DeRuisseau KC, 2005, EXP GERONTOL, V40, P526, DOI 10.1016/j.exger.2005.04.005
   Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330
   Edström E, 2006, J GERONTOL A-BIOL, V61, P663, DOI 10.1093/gerona/61.7.663
   Evans WJ, 2010, AM J CLIN NUTR, V91, P1123S, DOI 10.3945/ajcn.2010.28608A
   Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013
   Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6
   Forman DE, 2014, J CARD FAIL, V20, P422, DOI 10.1016/j.cardfail.2014.03.007
   Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710
   Fujita J, 1996, EUR SURG RES, V28, P361, DOI 10.1159/000129477
   García-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221
   Gielen S, 2003, J AM COLL CARDIOL, V42, P861, DOI 10.1016/S0735-1097(03)00848-9
   Gielen S, 2012, CIRCULATION, V125, P2716, DOI 10.1161/CIRCULATIONAHA.111.047381
   Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959
   Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002
   Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X
   Gould DW, 2013, J CACHEXIA SARCOPENI, V4, P111, DOI 10.1007/s13539-012-0096-0
   Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147
   Gouspillou G, 2010, BBA-BIOENERGETICS, V1797, P143, DOI 10.1016/j.bbabio.2009.09.004
   Hambrecht R, 2005, EUR J CARDIOV PREV R, V12, P401, DOI 10.1097/01.hjr.0000173106.68485.b7
   Harber MP, 2012, J APPL PHYSIOL, V113, P1495, DOI 10.1152/japplphysiol.00786.2012
   Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068
   Höllriegel R, 2013, INT J CARDIOL, V167, P975, DOI 10.1016/j.ijcard.2012.03.083
   HONG DH, 1994, J ANIM SCI, V72, P2279, DOI 10.2527/1994.7292279x
   Husmann Irene, 1996, CYTOKINE AND GROWTH FACTOR REVIEWS, V7, P249, DOI 10.1016/S1359-6101(96)00029-9
   Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010
   Ikizler TA, 2011, J RENAL NUTR, V21, P52, DOI 10.1053/j.jrn.2010.10.012
   Kim Tae Nyun, 2013, J BONE METAB, V20, P1
   Konopka AR, 2010, J GERONTOL A-BIOL, V65, P1201, DOI 10.1093/gerona/glq109
   Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, PE7, DOI 10.1159/000286344
   Kragsbjerg P, 1996, SCAND J INFECT DIS, V28, P391, DOI 10.3109/00365549609037926
   Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200
   Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com
   Lecker SH, 1999, J NUTR, V129, P227S, DOI 10.1093/jn/129.1.227S
   Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098
   Lenk K, 2012, EUR J PREV CARDIOL, V19, P404, DOI 10.1177/1741826711402735
   Levine S, 2011, AM J RESP CRIT CARE, V183, P483, DOI 10.1164/rccm.200910-1487OC
   Li YP, 2003, AM J PHYSIOL-CELL PH, V285, PC806, DOI 10.1152/ajpcell.00129.2003
   Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5
   Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035
   Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Mangner N, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0052274
   Martone AM, 2015, CURR PHARM DESIGN, V21, P1715, DOI 10.2174/1381612821666150130122032
   Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056
   McMullen CA, 2009, EXP GERONTOL, V44, P420, DOI 10.1016/j.exger.2009.03.006
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Moore DR, 2011, ACTA PHYSIOL, V201, P365, DOI 10.1111/j.1748-1716.2010.02187.x
   Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012
   Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735
   Moses AWG, 2004, BRIT J CANCER, V90, P996, DOI 10.1038/sj.bjc.6601620
   Ogawa M, 2013, BRIT J NUTR, V109, P1349, DOI 10.1017/S0007114512003297
   Pasini E, 2012, EXP GERONTOL, V47, P23, DOI 10.1016/j.exger.2011.10.003
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Porter MM, 1995, SCANDINAVIAN JOURNAL OF MEDICINE AND SCIENCE IN SPORTS, V5, P129
   Prisby RD, 2007, J BONE MINER RES, V22, P1280, DOI 10.1359/JBMR.070415
   Puppa MJ, 2014, FASEB J, V28, P998, DOI 10.1096/fj.13-240580
   Puppa MJ, 2012, J CACHEXIA SARCOPENI, V3, P117, DOI 10.1007/s13539-011-0047-1
   Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje
   Raue U, 2009, J APPL PHYSIOL, V106, P1611, DOI 10.1152/japplphysiol.91587.2008
   Rice KM, 2006, MECH AGEING DEV, V127, P670, DOI 10.1016/j.mad.2006.03.005
   Rieu I, 2009, J PHYSIOL-LONDON, V587, P5483, DOI 10.1113/jphysiol.2009.178319
   Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739
   Roberts BM, 2013, FASEB J, V27, P2600, DOI 10.1096/fj.12-222844
   Roubenoff R, 2001, MED SCI SPORT EXER, V33, P1811, DOI 10.1097/00005768-200111000-00003
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   RUMSEY WL, 1987, EXP GERONTOL, V22, P271, DOI 10.1016/0531-5565(87)90006-4
   Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, PE591, DOI 10.1152/ajpendo.00073.2004
   Sakellariou GK, 2014, FASEB J, V28, P1666, DOI 10.1096/fj.13-240390
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023
   Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097
   SCHIAFFINO S, 1972, J ULTRA MOL STRUCT R, V39, P1, DOI 10.1016/S0022-5320(72)80002-9
   Schulze PC, 2005, CIRC RES, V97, P418, DOI 10.1161/01.RES.0000179580.72375.c2
   Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014
   Slivka D, 2008, AM J PHYSIOL-REG I, V295, PR273, DOI 10.1152/ajpregu.00093.2008
   Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Springer J, 2012, INT J CANCER, V131, P2187, DOI 10.1002/ijc.27494
   Stene GB, 2013, CRIT REV ONCOL HEMAT, V88, P573, DOI 10.1016/j.critrevonc.2013.07.001
   Sullivan-Gunn MJ, 2013, BMC GERIATR, V13, P0, DOI 10.1186/1471-2318-13-104
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   Timmerman KL, 2010, DIABETES, V59, P2764, DOI 10.2337/db10-0415
   Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008
   Tisdale MJ, 2005, PHYSIOLOGY, V20, P340, DOI 10.1152/physiol.00019.2005
   TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7
   Toth MJ, 2012, J PHYSIOL-LONDON, V590, P1243, DOI 10.1113/jphysiol.2011.219659
   Toth MJ, 2011, J APPL PHYSIOL, V110, P892, DOI 10.1152/japplphysiol.00545.2010
   Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398
   Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098
   Visser M, 2002, J GERONTOL A-BIOL, V57, PM326, DOI 10.1093/gerona/57.5.M326
   Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481
   von Haehling S, 2013, INT J BIOCHEM CELL B, V45, P2257, DOI 10.1016/j.biocel.2013.04.025
   vonsHaehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/S13539-014-0164-8
   Wadley GD, 2007, J PHYSIOL-LONDON, V585, P253, DOI 10.1113/jphysiol.2007.141309
   Wadley GD, 2007, J APPL PHYSIOL, V102, P314, DOI 10.1152/japplphysiol.00549.2006
   Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003
   Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019
   Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8
   Williams A, 1999, SURGERY, V126, P744, DOI 10.1067/msy.2099.99888
   Wing SS, 2013, INT J BIOCHEM CELL B, V45, P2130, DOI 10.1016/j.biocel.2013.05.002
   Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002
   Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011
NR 149
TC 283
Z9 318
U1 8
U2 142
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-6009
EI 
J9 J CACHEXIA SARCOPENI
JI J. Caxhexia Sarcopenia Muscle
PD SEP 15
PY 2015
VL 6
IS 3
BP 197
EP 207
DI 10.1002/jcsm.12043
PG 11
WC Geriatrics & Gerontology; Medicine, General & Internal
SC Geriatrics & Gerontology; General & Internal Medicine
GA CQ5EB
UT WOS:000360625000002
PM 26401465
DA 2024-11-01
ER

PT J
AU Diebold, I
   Hennigs, JK
   Miyagawa, K
   Li, CYG
   Nickel, NP
   Kaschwich, M
   Cao, AQ
   Wang, LL
   Reddy, S
   Chen, PI
   Nakahira, K
   Alcazar, MAA
   Hopper, RK
   Ji, LJ
   Feldman, BJ
   Rabinovitch, M
AF Diebold, Isabel
   Hennigs, Jan K.
   Miyagawa, Kazuya
   Li, Caiyun G.
   Nickel, Nils P.
   Kaschwich, Mark
   Cao, Aiqin
   Wang, Lingli
   Reddy, Sushma
   Chen, Pin-I
   Nakahira, Kiichi
   Alcazar, Miguel A. Alejandre
   Hopper, Rachel K.
   Ji, Lijuan
   Feldman, Brian J.
   Rabinovitch, Marlene
TI BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary Hypertension
SO CELL METABOLISM
LA English
DT Article
ID morphogenetic protein-receptor; smooth-muscle-cells; arterial-hypertension; germline mutations; gene-expression; up-regulation; tgf-beta; mice; dysfunction; apoptosis
AB Mitochondrial dysfunction, inflammation, and mutant bone morphogenetic protein receptor 2 (BMPR2) are associated with pulmonary arterial hypertension (PAH), an incurable disease characterized by pulmonary arterial (PA) endothelial cell (EC) apoptosis, decreased microvessels, and occlusive vascular remodeling. We hypothesized that reduced BMPR2 induces PAEC mitochondrial dysfunction, promoting a pro-inflammatory or pro-apoptotic state. Mice with EC deletion of BMPR2 develop hypoxia-induced pulmonary hypertension that, incontrast tonon-transgenic littermates, does not reverse upon reoxygenation and is associated with reduced PA microvessels and lung EC p53, PGC1 alpha and TFAM, regulators of mitochondrial biogenesis, and mitochondrial DNA. Decreasing PAEC BMPR2 by siRNA during reoxygenation represses p53, PGC1 alpha, NRF2, TFAM, mitochondrial membrane potential, and ATP and induces mitochondrial DNA deletion and apoptosis. Reducing PAEC BMPR2 in normoxia increases p53, PGC1 alpha, TFAM, mitochondrial membrane potential, ATP production, and glycolysis, and induces mitochondrial fission and a pro-inflammatory state. These features are recapitulated in PAECs from PAH patients with mutant BMPR2.
C1 [Diebold, Isabel; Hennigs, Jan K.; Miyagawa, Kazuya; Li, Caiyun G.; Nickel, Nils P.; Kaschwich, Mark; Cao, Aiqin; Wang, Lingli; Reddy, Sushma; Chen, Pin-I; Alcazar, Miguel A. Alejandre; Hopper, Rachel K.; Ji, Lijuan; Feldman, Brian J.; Rabinovitch, Marlene] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
   [Diebold, Isabel; Hennigs, Jan K.; Miyagawa, Kazuya; Li, Caiyun G.; Nickel, Nils P.; Kaschwich, Mark; Cao, Aiqin; Wang, Lingli; Reddy, Sushma; Chen, Pin-I; Alcazar, Miguel A. Alejandre; Hopper, Rachel K.; Ji, Lijuan; Feldman, Brian J.; Rabinovitch, Marlene] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA.
   [Diebold, Isabel; Hennigs, Jan K.; Miyagawa, Kazuya; Li, Caiyun G.; Nickel, Nils P.; Kaschwich, Mark; Cao, Aiqin; Wang, Lingli; Chen, Pin-I; Alcazar, Miguel A. Alejandre; Hopper, Rachel K.; Rabinovitch, Marlene] Stanford Univ, Sch Med, Vera Moulton Wall Ctr Pulm Vasc Dis, Stanford, CA 94305 USA.
   [Nakahira, Kiichi] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.
C3 Stanford University; Stanford University; Stanford University; Cornell University; Weill Cornell Medicine
RP Rabinovitch, M (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
EM marlener@stanford.edu
FU CMREF; NIH-NHLBI [R01 HL087118, R01 HL074186]; Deutsche Herzstiftung e.V [S/06/11]; German Research Foundation (DFG) [He 6855/1-1, Ni 1456/1-1, AL 1636/1-1]
CR Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382
   Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, PH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Cheng Y, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.254
   Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871
   Culic O, 1997, AM J PHYSIOL-CELL PH, V273, PC205, DOI 10.1152/ajpcell.1997.273.1.C205
   Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, PL604, DOI 10.1152/ajplung.00309.2011
   Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059
   Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Fessel JP, 2013, AM J RESP CELL MOL, V49, P778, DOI 10.1165/rcmb.2012-0463OC
   Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Gill SE, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0088501
   Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, PL1082, DOI 10.1152/ajplung.00199.2009
   Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503
   Heo KS, 2011, J CELL BIOL, V193, P867, DOI 10.1083/jcb.201010051
   Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919
   Jilwan FN, 2013, CHEST, V143, P47, DOI 10.1378/chest.11-3124
   Julian MW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072354
   Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040
   Kim YM, 2011, AM J PATHOL, V179, P1560, DOI 10.1016/j.ajpath.2011.05.051
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479
   Matuschak GM, 1998, AM J RESP CRIT CARE, V157, P629, DOI 10.1164/ajrccm.157.2.9707120
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2
   Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974
   Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, PL753, DOI 10.1152/ajplung.00286.2010
   Mouraret N, 2013, CIRCULATION, V127, P1664, DOI 10.1161/CIRCULATIONAHA.113.002434
   OPrey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872
   Park KH, 2013, J IMMUNOL, V190, P6550, DOI 10.4049/jimmunol.1202284
   Potus F, 2014, AM J RESP CRIT CARE, V190, P318, DOI 10.1164/rccm.201402-0383OC
   RABINOVITCH M, 1981, AM J PHYSIOL, V240, PH62, DOI 10.1152/ajpheart.1981.240.1.H62
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC
   Sakao S, 2009, RESP RES, V10, P0, DOI 10.1186/1465-9921-10-95
   Sawada H, 2014, J EXP MED, V211, P263, DOI 10.1084/jem.20111741
   Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Shimasaki Y, 2013, CIRC RES, V113, P891, DOI 10.1161/CIRCRESAHA.113.301319
   Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592
   Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004
   Sutendra G, 2011, J MOL MED, V89, P771, DOI 10.1007/s00109-011-0762-2
   Sutendra G, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001327
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6
   Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, PL401, DOI 10.1152/ajplung.00114.2010
   Villeneuve C, 2013, ANTIOXID REDOX SIGN, V18, P5, DOI 10.1089/ars.2011.4373
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 58
TC 170
Z9 179
U1 3
U2 35
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD APR 7
PY 2015
VL 21
IS 4
BP 596
EP 608
DI 10.1016/j.cmet.2015.03.010
PG 13
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA CF4EF
UT WOS:000352500800014
PM 25863249
DA 2024-11-01
ER

PT J
AU Durhuus, JA
   Desler, C
   Rasmussen, LJ
AF Durhuus, Jon Ambaek
   Desler, Claus
   Rasmussen, Lene Juel
TI Mitochondria in Health and Disease-3rd Annual Conference of Society for Mitochondrial Research and Medicine-19-20 December 2013-Bengaluru, India
SO MITOCHONDRION
LA English
DT Article
DE Mitochondria; Tumorigenesis; Premature aging; Metabolic regulation; Neurological degeneration; Current and future strategies for diagnosis and treatment
ID dna; cells; deletions; myopathy; muscle
AB The primary role of mitochondria was long considered to be production of cellular energy. However, as the understanding of mitochondria in disease is ever expanding, so is their additional function for a healthy organism. Mitochondrial dysfunction is linked to a range of pathologies, including cancer, neurodegenerative disorders, premature aging, diabetes and muscular diseases. Mitochondrial diseases can be hard to diagnose and treat and, therefore, interdisciplinary research and communication are important. The Third Annual Conference of Society for Mitochondrial Research and Medicine India (SMRM) was titled "Mitochondria in Health and Disease". The conference was organized by Gayathri N, K Thangaraj, and la Singh and was held at the National Institute of Mental Health 82 Neuro Sciences (NIMHANS) in Bangalore, India, from the 19th to 20th of December 2013. The meeting featured internationally renowned speakers within the field of mitochondrial research and medicine with the goal of bridging the gap between basic and clinical researchers. This review summarizes key outcomes of the conference. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Durhuus, Jon Ambaek; Desler, Claus; Rasmussen, Lene Juel] Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.
C3 University of Copenhagen
RP Rasmussen, LJ (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, Bldg 18-1,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.
EM lenera@sund.ku.dk
CR Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003
   Ande S, 2014, FASEB J, V28, P0
   Ayyasamy V, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0024792
   Bhalla S, 2009, BIOCHEM BIOPH RES CO, V385, P445, DOI 10.1016/j.bbrc.2009.05.083
   Chakrabarty S, 2014, MITOCHONDRION, V0, P0
   Chakrabarty S, 2012, GENE, V500, P186, DOI 10.1016/j.gene.2012.03.054
   Davidson MM, 2009, MITOCHONDRION, V9, P463, DOI 10.1016/j.mito.2009.08.006
   Desler Claus, 2011, J AGING RES, V2011, P407536, DOI 10.4061/2011/407536
   Finsterer J, 2010, EUR J PAEDIATR NEURO, V14, P29, DOI 10.1016/j.ejpn.2009.07.005
   Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jash S, 2012, FASEB J, V26, P4187, DOI 10.1096/fj.11-203232
   Jash S, 2011, MITOCHONDRION, V11, P607, DOI 10.1016/j.mito.2011.03.124
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729
   Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616
   Loyo-Berrios Nilsa I, 2007, WMJ, V106, P85
   Mahato B, 2011, MITOCHONDRION, V11, P564, DOI 10.1016/j.mito.2011.03.006
   Marrache S, 2013, P NATL ACAD SCI USA, V110, P9445, DOI 10.1073/pnas.1301929110
   Pesta D, 2011, AM J PHYSIOL-REG I, V301, PR1078, DOI 10.1152/ajpregu.00285.2011
   Piyathilake C, 2013, NUTR RES PRACT, V7, P315, DOI 10.4162/nrp.2013.7.4.315
   Piyathilake CJ, 2012, CANCER PREV RES, V5, P385, DOI 10.1158/1940-6207.CAPR-11-0387
   Prabhu V, 2013, MITOCHONDRION, V13, P493, DOI 10.1016/j.mito.2012.10.010
   Rai N, 2014, MITOCHONDRION, V14, P1, DOI 10.1016/j.mito.2013.12.002
   Singh PK, 2013, MOL BIOL CELL, V24, P3776, DOI 10.1091/mbc.E13-05-0261
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Uppin MS, 2008, NEUROL INDIA, V56, P391
   Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002
NR 30
TC 7
Z9 8
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2015
VL 20
IS 
BP 7
EP 12
DI 10.1016/j.mito.2014.10.004
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CA0UQ
UT WOS:000348632200002
PM 25446394
DA 2024-11-01
ER

PT J
AU Li, WW
   Zhang, W
   Li, F
   Wang, CL
AF Li, Weiwei
   Zhang, Wei
   Li, Fang
   Wang, Cailing
TI Mitochondrial genetic analysis in a Chinese family suffering from both mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes and diabetes
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
LA English
DT Article
DE Diabetes; A3243G mutation; MELAS; heteroplasmy; polymorphism; mitochondrial myopathy
ID mutation; melas; phenotype; a3243g
AB To investigate the mitochondrial mutations in patients suffering from both mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) and maternally inherited diabetes. MELAS was confirmed by muscle biopsy performed from the biceps muscle of the proband. Mitochondrial DNA (mtDNA) was isolated from peripheral blood mononuclear cells. The significant mtDNA loci of other 14 family members were further detected according to the sequencing results of the proband. Direct sequencing of PCR products was used to identify the mitochondrial mutations. The proband (III 1) and her brother (III 3) both harbored the tRNALeu (UUR) A3243G mutation, with heteroplasmic levels of 50% and 33% respectively. Moreover, another two mitochondrial variants, A8860G and A15326G, were also detected in the samples of all the family members. MELAS and diabetes can coexist in one patient, and the main cause for these diseases is the tRNALeu (UUR) A3243G mutation. However, other gene variants may contribute to its pathogenesis. This case also supports the concept that both syndromes can be regarded as two phenotypes of the same disease.
C1 [Li, Weiwei; Zhang, Wei; Li, Fang; Wang, Cailing] Shandong Univ, Qianfoshan Hosp, Dept Endocrinol, Jinan 250014, Peoples R China.
C3 Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University
RP Wang, CL (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Endocrinol, 66 Jingshi Rd, Jinan 250014, Peoples R China.
EM sdqy.wcl@163.com
FU Natural Science Foundation [ZR2009CQ023]; Medical Science Development Plan of Shandong Province, PR China [2009QZ025]
CR Craven L, 2011, HUM MOL GENET, V20, PR168, DOI 10.1093/hmg/ddr373
   de Wit HM, 2012, NETH J MED, V70, P460
   Joko T, 1997, ENDOCR J, V44, P805, DOI 10.1507/endocrj.44.805
   Kara B, 2012, MOL GENET METAB, V107, P389, DOI 10.1016/j.ymgme.2012.06.013
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Tzen CY, 2003, MUSCLE NERVE, V28, P575, DOI 10.1002/mus.10473
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Zhang W, 2009, J CELL MOL MED, V13, P4636, DOI 10.1111/j.1582-4934.2008.00670.x
NR 12
TC 8
Z9 9
U1 0
U2 1
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1936-2625
EI 
J9 INT J CLIN EXP PATHO
JI Int. J. Clin. Exp. Pathol.
PD JUN 15
PY 2015
VL 8
IS 6
BP 7022
EP 7027
DI 
PG 6
WC Oncology; Pathology
SC Oncology; Pathology
GA CO6PD
UT WOS:000359277700116
PM 26261593
DA 2024-11-01
ER

PT J
AU Liu, H
   Han, YC
   Wang, S
   Wang, HB
AF Liu, Hong
   Han, Yuechen
   Wang, Shuai
   Wang, Haibo
TI Association between the mitochondrial DNA 4977 common deletion in the hair shaft and hearing loss in presbycusis
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE presbycusis; human hair shaft; common deletion; mitochondria; 4977-bp deletion
ID psychiatric-disorders; mutations; age; quantification; increases; myopathy; patient; brain
AB The aim of the present study was to examine the role of the mitochondrial (mt) DNA (common) (deletion) ((CD)) (4977) ((mtDNACD4977)) in the hair shaft in patients with presbycusis. A total of 87 individuals with presbycusis and 95 normal-hearing controls were selected based on strict audiometric criteria. Nested polymerase chain reaction (PCR), sequencing and quantitative (q)PCR were used to examine the expression levels of mtDNA(CD4977) in the hair shaft in presbycusis. Nested PCR of the hair shaft demonstrated that 8/95 cases with normal hearing were found to be positive for mtDNA(CD4977), as compared with 59/87 cases in the presbycusis group. The mtDNA(CD4977) was positive in 22/43 cases with mild-to-moderate hearing loss, 25/31 cases with moderate-to-severe, severe hearing loss, and 12/13 cases with profound deafness. Statistically significant differences in mtDNA(CD4977) expression were identified among all of the groups (P<0.001). The sequencing and qPCR assays demonstrated a trend towards an increase in the mean CD level of mtDNA(CD4977) with a more severe hearing loss at 8 kHz (r=0.778, P<0.001) and all ranges of frequency (r=0.858, P<0.001). In conclusion, the present study demonstrates a correlation between mtDNA(CD4977) in the human hair shaft and the severity of hearing loss in presbycusis.
C1 [Liu, Hong; Han, Yuechen; Wang, Haibo] Shandong Univ, Dept Otorhinolaryngol Head & Neck Surg, Prov Hosp, Jinan 250000, Shandong, Peoples R China.
   [Wang, Shuai] Shandong Univ, Dept Thorac Surg, Prov Hosp, Jinan 250000, Shandong, Peoples R China.
C3 Shandong University; Shandong University
RP Wang, HB (corresponding author), Shandong Univ, Dept Otorhinolaryngol Head & Neck Surg, Prov Hosp, 4 Duanxingxilu Rd, Jinan 250000, Shandong, Peoples R China.
EM whbotologic797@163.com
FU Science and Technology Development Program of Shandong province, Provincial Hospital Affiliated to Shandong University (Shandong, China) [2012G0021838]
CR Bai UM, 2001, HEARING RES, V154, P73, DOI 10.1016/S0378-5955(01)00221-0
   Bekaert B, 2012, FORENSIC SCI INT-GEN, V6, P277, DOI 10.1016/j.fsigen.2011.04.009
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Dai P, 2004, ACTA OTO-LARYNGOL, V124, P130, DOI 10.1080/00016480410016586
   FischelGhodsian N, 1997, HEARING RES, V110, P147, DOI 10.1016/S0378-5955(97)00077-4
   Gendron SP, 2012, MECH AGEING DEV, V133, P68, DOI 10.1016/j.mad.2012.01.002
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Kim EJ, 2012, MUTAT RES-GEN TOX EN, V749, P53, DOI 10.1016/j.mrgentox.2012.08.005
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Love Rachelle L, 2013, COCHLEAR IMPLANTS INT, V14, P28
   Mao ZP, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065565
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Nie HR, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067953
   Niu R, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040572
   Obara-Moszynska M, 2013, BMC PEDIATR, V13, P0, DOI 10.1186/1471-2431-13-27
   Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0
   Sequeira Adolfo, 2012, FRONTIERS IN GENETICS, V3, P103, DOI 10.3389/fgene.2012.00103
   Sprinzl GM, 2010, GERONTOLOGY, V56, P351, DOI 10.1159/000275062
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Torrell H, 2013, AM J MED GENET B, V162B, P213, DOI 10.1002/ajmg.b.32134
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
   Yuan Yong-yi, 2009, ZHONGHUA ER BI YAN HOU TOU JING WAI KE ZA ZHI, V44, P292
   Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480
   Zhong Y, 2011, MUTAT RES-FUND MOL M, V712, P11, DOI 10.1016/j.mrfmmm.2011.03.013
NR 26
TC 4
Z9 4
U1 0
U2 2
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD FEB 15
PY 2015
VL 11
IS 2
BP 1127
EP 1131
DI 10.3892/mmr.2014.2877
PG 5
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA CB3CS
UT WOS:000349506400053
PM 25373716
DA 2024-11-01
ER

PT J
AU Sasarman, F
   Thiffault, I
   Weraarpachai, W
   Salomon, S
   Maftei, C
   Gauthier, J
   Ellazam, B
   Webb, N
   Antonicka, H
   Janer, A
   Brunel-Guitton, C
   Elpeleg, O
   Mitchell, G
   Shoubridge, EA
AF Sasarman, Florin
   Thiffault, Isabelle
   Weraarpachai, Woranontee
   Salomon, Steven
   Maftei, Catalina
   Gauthier, Julie
   Ellazam, Benjamin
   Webb, Neil
   Antonicka, Hana
   Janer, Alexandre
   Brunel-Guitton, Catherine
   Elpeleg, Orly
   Mitchell, Grant
   Shoubridge, Eric A.
TI The 3' addition of CCA to mitochondrial tRNA<SUP>Ser(AGY)</SUP> is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase <i>TRNT1</i>
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID sideroblastic anemia-mlasa; lactic-acidosis; adding enzyme; dna; polymerization; deletions; mechanism; template; myopathy; gene
AB Addition of the trinucleotide cytosine/cytosine/adenine (CCA) to the 3' end of transfer RNAs (tRNAs) is essential for translation and is catalyzed by the enzyme TRNT1 (tRNA nucleotidyl transferase), which functions in both the cytoplasm and mitochondria. Exome sequencing revealed TRNT1 mutations in two unrelated subjects with different clinical features. The first presented with acute lactic acidosis at 3 weeks of age and developed severe developmental delay, hypotonia, microcephaly, seizures, progressive cortical atrophy, neurosensorial deafness, sideroblastic anemia and renal Fanconi syndrome, dying at 21 months. The second presented at 3.5 years with gait ataxia, dysarthria, gross motor regression, hypotonia, ptosis and ophthalmoplegia and had abnormal signals in brainstem and dentate nucleus. In subject 1, muscle biopsy showed combined oxidative phosphorylation (OXPHOS) defects, but there was no OXPHOS deficiency in fibroblasts from either subject, despite a 10-fold-reduction in TRNT1 protein levels in fibroblasts of the first subject. Furthermore, in normal controls, TRNT1 protein levels are 10-fold lower in muscle than in fibroblasts. High resolution northern blots of subject fibroblast RNA suggested incomplete CCA addition to the non-canonical mitochondrial tRNA(Ser(AGY)), but no obvious qualitative differences in other mitochondrial or cytoplasmic tRNAs. Complete knockdown of TRNT1 in patient fibroblasts rendered mitochondrial tRNA(Ser(AGY)) undetectable, and markedly reduced mitochondrial translation, except polypeptides lacking Ser(AGY) codons. These data suggest that the clinical phenotypes associated with TRNT1 mutations are largely due to impaired mitochondrial translation, resulting from defective CCA addition to mitochondrial tRNA(Ser(AGY)), and that the severity of this biochemical phenotype determines the severity and tissue distribution of clinical features.
C1 [Sasarman, Florin; Weraarpachai, Woranontee; Salomon, Steven; Webb, Neil; Antonicka, Hana; Janer, Alexandre; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.
   [Sasarman, Florin; Weraarpachai, Woranontee; Salomon, Steven; Webb, Neil; Antonicka, Hana; Janer, Alexandre; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.
   [Sasarman, Florin; Thiffault, Isabelle; Maftei, Catalina; Gauthier, Julie; Webb, Neil; Brunel-Guitton, Catherine; Mitchell, Grant] CHU St Justine, Dept Pediat, Div Med Genet, Montreal, PQ, Canada.
   [Ellazam, Benjamin] CHU St Justine, Dept Pathol, Montreal, PQ, Canada.
   Univ Montreal, Montreal, PQ, Canada.
   [Thiffault, Isabelle] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA.
   [Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel.
C3 McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Children's Mercy Hospital; Hebrew University of Jerusalem
RP Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.
EM eric@ericpc.mni.mcgill.ca
FU CIHR [MT-15460, 178978]; Fondation GO
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Betat H, 2010, CELL MOL LIFE SCI, V67, P1447, DOI 10.1007/s00018-010-0271-4
   Bottomley SS, 2014, HEMATOL ONCOL CLIN N, V28, P653, DOI 10.1016/j.hoc.2014.04.008
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   CHEN JY, 1992, J BIOL CHEM, V267, P14879
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Toh Y, 2009, EMBO J, V28, P3353, DOI 10.1038/emboj.2009.260
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711
   Yarham JW, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004424
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 23
TC 57
Z9 61
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD MAY 15
PY 2015
VL 24
IS 10
BP 2841
EP 2847
DI 10.1093/hmg/ddv044
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CJ2PK
UT WOS:000355326800012
PM 25652405
DA 2024-11-01
ER

PT J
AU Rygiel, KA
   Miller, J
   Grady, JP
   Rocha, MC
   Taylor, RW
   Turnbull, DM
AF Rygiel, K. A.
   Miller, J.
   Grady, J. P.
   Rocha, M. C.
   Taylor, R. W.
   Turnbull, D. M.
TI Mitochondrial and inflammatory changes in sporadic inclusion body myositis
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Article
DE atrophy; complex I; inflammation; mitochondria; mitochondrial deletions; sIBM
ID real-time pcr; dna deletions; muscle-fibers; mutations; cells; quantification; myopathy; expression; single
AB AimsSporadic inclusion body myositis (sIBM) is the most common late onset muscle disease causing progressive weakness. In light of the lack of effective treatment, we investigated potential causes underlying muscle wasting. We hypothesized that accumulation of mitochondrial respiratory deficiency in muscle fibres may lead to fibre atrophy and degeneration, contributing to muscle mass reduction. MethodsHistochemical and immunohistochemical analyses were performed on muscle biopsies from 16 sIBM patients to detect activity of mitochondrial enzymes and expression of mitochondrial respiratory chain proteins along with inflammatory markers respectively. Mitochondrial DNA mutations were assessed in single muscle fibres using real-time PCR. ResultsWe identified respiratory-deficient fibres at different stages of mitochondrial dysfunction, with downregulated expression of complex I of mitochondrial respiratory chain being the initial feature. We detected mitochondrial DNA rearrangements in the majority of individual respiratory-deficient muscle fibres. There was a strong correlation between number of T lymphocytes and macrophages residing in muscle tissue and the abundance of respiratory-deficient fibres. Moreover, we found that respiratory-deficient muscle fibres were more likely to be atrophic compared with respiratory-normal counterparts. ConclusionsOur findings suggest that mitochondrial dysfunction has a role in sIBM progression. A strong correlation between the severity of inflammation, degree of mitochondrial changes and atrophy implicated existence of a mechanistic link between these three parameters. We propose a role for inflammatory cells in the initiation of mitochondrial DNA damage, which when accumulated, causes respiratory dysfunction, fibre atrophy and ultimately degeneration of muscle fibres.
C1 [Rygiel, K. A.; Grady, J. P.; Rocha, M. C.; Taylor, R. W.; Turnbull, D. M.] Newcastle Univ, Inst Ageing & Hlth, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Rygiel, K. A.; Turnbull, D. M.] Newcastle Univ, Inst Ageing & Hlth, Sch Med, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Miller, J.] Newcastle Upon Tyne Hosp NHS Fdn Trust Royal Vict, Dept Neurol, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU Newcastle University Centre for Brain Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0700718]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; MRC Centre for Neuromuscular Disease [G000608-1]; Wellcome Trust Centre for Mitochondrial Research [096919/Z/11/Z]; Lily Foundation; UK NHS Highly Specialised 'Rare Mitochondrial Disorders of Adults and Children' Service; MRC [G0700718, MR/K000608/1] Funding Source: UKRI
CR ARAHATA K, 1986, ANN NEUROL, V19, P112, DOI 10.1002/ana.410190203
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dalakas MC, 2011, NEUROPATH APPL NEURO, V37, P226, DOI 10.1111/j.1365-2990.2010.01153.x
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Engel WK, 1998, NEUROLOGY, V51, P655, DOI 10.1212/WNL.51.3.655
   Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI 10.1016/j.nmd.2010.07.087
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   McKiernan SH, 2009, EXP GERONTOL, V44, P170, DOI 10.1016/j.exger.2008.09.014
   Miró O, 1998, BRIT J RHEUMATOL, V37, P1047
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Tateyama M, 2006, J NEUROL SCI, V249, P158, DOI 10.1016/j.jns.2006.06.021
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   Taylor RW, 2000, METH MOLEC MED, V38, P265, DOI 10.1385/1-59259-070-5:265
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Waschbisch A, 2010, J NEUROIMMUNOL, V225, P137, DOI 10.1016/j.jneuroim.2010.03.013
NR 28
TC 71
Z9 77
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD APR 15
PY 2015
VL 41
IS 3
BP 288
EP 303
DI 10.1111/nan.12149
PG 16
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA CD2LY
UT WOS:000350911100002
PM 24750247
DA 2024-11-01
ER

PT J
AU Kodaira, M
   Hatakeyama, H
   Yuasa, S
   Seki, T
   Egashira, T
   Tohyama, S
   Kuroda, Y
   Tanaka, A
   Okata, S
   Hashimoto, H
   Kusumoto, D
   Kunitomi, A
   Takei, M
   Kashimura, S
   Suzuki, T
   Yozu, G
   Shimojima, M
   Motoda, C
   Hayashiji, N
   Saito, Y
   Goto, Y
   Fukuda, K
AF Kodaira, Masaki
   Hatakeyama, Hideyuki
   Yuasa, Shinsuke
   Seki, Tomohisa
   Egashira, Toru
   Tohyama, Shugo
   Kuroda, Yusuke
   Tanaka, Atsushi
   Okata, Shinichiro
   Hashimoto, Hisayuki
   Kusumoto, Dai
   Kunitomi, Akira
   Takei, Makoto
   Kashimura, Shin
   Suzuki, Tomoyuki
   Yozu, Gakuto
   Shimojima, Masaya
   Motoda, Chikaaki
   Hayashiji, Nozomi
   Saito, Yuki
   Goto, Yu-ichi
   Fukuda, Keiichi
TI Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels
SO FEBS OPEN BIO
LA English
DT Article
DE MELAS; iPS cell; Mitochondrial disease; Disease modeling
ID mitochondrial-dna mutations; point mutation; disease; mtdna; generation; gene
AB Mitochondrial diseases are heterogeneous disorders, caused by mitochondrial dysfunction. Mitochondria are not regulated solely by nuclear genomic DNA but by mitochondrial DNA. It is difficult to develop effective therapies for mitochondrial disease because of the lack of mitochondrial disease models. Mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is one of the major mitochondrial diseases. The aim of this study was to generate MELAS-specific induced pluripotent stem cells (iPSCs) and to demonstrate that MELAS-iPSCs can be models for mitochondrial disease. We successfully established iPSCs from the primary MELAS-fibroblasts carrying 77.7% of m.3243A>G heteroplasmy. MELAS-iPSC lines ranged from 3.6% to 99.4% of m.3243A>G heteroplasmy levels. The enzymatic activities of mitochondrial respiratory complexes indicated that MELAS-iPSC-derived fibroblasts with high heteroplasmy levels showed a deficiency of complex I activity but MELAS-iPSC-derived fibroblasts with low heteroplasmy levels showed normal complex I activity. Our data indicate that MELAS-iPSCs can be models for MELAS but we should carefully select MELAS-iPSCs with appropriate heteroplasmy levels and respiratory functions for mitochondrial disease modeling. (C) 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 [Kodaira, Masaki; Yuasa, Shinsuke; Seki, Tomohisa; Egashira, Toru; Tohyama, Shugo; Kuroda, Yusuke; Tanaka, Atsushi; Okata, Shinichiro; Hashimoto, Hisayuki; Kusumoto, Dai; Kunitomi, Akira; Takei, Makoto; Kashimura, Shin; Suzuki, Tomoyuki; Yozu, Gakuto; Shimojima, Masaya; Motoda, Chikaaki; Hayashiji, Nozomi; Saito, Yuki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan.
   [Hatakeyama, Hideyuki; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Hatakeyama, Hideyuki; Goto, Yu-ichi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Tokyo, Japan.
C3 Keio University; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST)
RP Yuasa, S (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
EM yuasa@keio.jp
FU Ministry of Education, Culture, Sports, Science, and Technology; Health Labour Sciences Research Grant; New Energy and Industrial Technology Development Organization, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; Japan Science and Technology Agency; Research Center Network for Realization of Regenerative Medicine "The Program for Intractable Diseases Research utilizing Disease-specific iPS cells"; Nakatomi Foundation; Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology SENSHIN Medical Research Foundation; Kimura Memorial Heart Foundation Research Grant; Japan Intractable Diseases Research Foundation, Japan; Cell Science Research Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan; Grants-in-Aid for Scientific Research [25860623] Funding Source: KAKEN
CR ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Egashira T, 2012, CARDIOVASC RES, V95, P419, DOI 10.1093/cvr/cvs206
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gropman A L, 2001, CURR NEUROL NEUROSCI REP, V1, P185
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015
   Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tanaka A, 2014, J AM HEART ASSOC, V3, P0, DOI 10.1161/JAHA.114.001263
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
NR 22
TC 46
Z9 49
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2211-5463
EI 
J9 FEBS OPEN BIO
JI FEBS Open Bio
PD JUN 15
PY 2015
VL 5
IS 
BP 219
EP 225
DI 10.1016/j.fob.2015.03.008
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CZ3JC
UT WOS:000366999300028
PM 25853038
DA 2024-11-01
ER

PT J
AU Gonzalez-Freire, M
   de Cabo, R
   Bernier, M
   Sollott, SJ
   Fabbri, E
   Navas, P
   Ferrucci, L
AF Gonzalez-Freire, Marta
   de Cabo, Rafael
   Bernier, Michel
   Sollott, Steven J.
   Fabbri, Elisa
   Navas, Placido
   Ferrucci, Luigi
TI Reconsidering the Role of Mitochondria in Aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
LA English
DT Article
DE Mitochondria; Aging; Lifespan
ID fatty-acid unsaturation; skeletal-muscle mitochondria; oxidative stress; electron-transport; deletion mutations; lon protease; permeability transition; endoplasmic-reticulum; aerobic capacity; coenzyme-q
AB Background: Mitochondrial dysfunction has long been considered a major contributor to aging and age-related diseases. Harman's Mitochondrial Free Radical Theory of Aging postulated that somatic mitochondrial DNA mutations that accumulate over the life span cause excessive production of reactive oxygen species that damage macromolecules and impair cell and tissue function. Indeed, studies have shown that maximal oxidative capacity declines with age while reactive oxygen species production increases. Harman's hypothesis has been seriously challenged by recent studies showing that reactive oxygen species evoke metabolic health and longevity, perhaps through hormetic mechanisms that include autophagy. The purpose of this review is to scan the ever-growing literature on mitochondria from the perspective of aging research and try to identify priority questions that should be addressed in future research.Methods: A systematic search of peer-reviewed studies was performed using PubMed. Search terms included (i) mitochondria or mitochondrial; (ii) aging, ageing, older adults or elderly; and (iii) reactive oxygen species, mitochondria dynamics, mitochondrial proteostasis, cytosol, mitochondrial-associated membranes, redox homeostasis, electron transport chain, electron transport chain efficiency, epigenetic regulation, DNA heteroplasmy.Results: The importance of mitochondrial biology as a trait d'union between the basic biology of aging and the pathogenesis of age-related diseases is stronger than ever, although the emphasis has moved from reactive oxygen species production to other aspects of mitochondrial physiology, including mitochondrial biogenesis and turnover, energy sensing, apoptosis, senescence, and calcium dynamics. Conclusions: Mitochondria could play a key role in the pathophysiology of aging or in the earlier stages of some events that lead to the aging phenotype. Therefore, mitochondria will increasingly be targeted to prevent and treat chronic diseases and to promote healthy aging.
C1 [Gonzalez-Freire, Marta; de Cabo, Rafael; Bernier, Michel; Fabbri, Elisa; Ferrucci, Luigi] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Sollott, Steven J.] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.
   [Fabbri, Elisa] Univ Bologna, Dept Med & Surg Sci, I-40126 Bologna, Italy.
   [Navas, Placido] Univ Pablo de Olavide, CSIC, Inst Salud Carlos 3, Ctr Andaluz Biol Desarrollo,CIBERER, Seville 41013, Spain.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bologna; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP Gonzalez-Freire, M (corresponding author), NIA, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.
EM marta.gonzalezfreire@nih.gov
FU Intramural Research Program of NIH, National Institute on Aging
CR Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   [Anonymous], 2011, COLD SPRING HARB PER, V0, P0, DOI DOI 10.1101/CSHPER-SPECT.A007559
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004
   Bernales S, 2012, FRONT AGING NEUROSCI, V4, P0, DOI 10.3389/fnagi.2012.00005
   Bhattacharya A, 2011, FREE RADICAL BIO MED, V50, P592, DOI 10.1016/j.freeradbiomed.2010.12.014
   Birk AV, 2014, BRIT J PHARMACOL, V171, P2017, DOI 10.1111/bph.12468
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen YN, 2012, J GERONTOL A-BIOL, V67, P1121, DOI 10.1093/gerona/gls113
   Coen PM, 2013, J GERONTOL A-BIOL, V68, P447, DOI 10.1093/gerona/gls196
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Crescenzo R, 2014, BMC GERIATR, V14, P0, DOI 10.1186/1471-2318-14-79
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010
   Fabbri E, 2015, J GERONTOL A-BIOL, V70, P1297, DOI 10.1093/gerona/glu209
   Fernandez-Sanz C, 2015, THROMB HAEMOSTASIS, V113, P441, DOI 10.1160/TH14-10-0901
   Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003
   Giuliani C, 2014, AGING-US, V6, P454, DOI 10.18632/aging.100661
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gómez A, 2014, AGING CELL, V13, P551, DOI 10.1111/acel.12205
   Gouspillou G, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103044
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Guarente L, 2014, CELL, V159, P15, DOI 10.1016/j.cell.2014.08.041
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hirota Yuko, 2012, INT J CELL BIOL, V2012, P354914, DOI 10.1155/2012/354914
   Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029
   Isaya G, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00029
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kitazoe Y, 2011, GENOME BIOL EVOL, V3, P1233, DOI 10.1093/gbe/evr079
   Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lawless C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032117
   Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5
   Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Liu SY, 2014, AM J PHYSIOL-RENAL, V306, PF970, DOI 10.1152/ajprenal.00697.2013
   López-Domínguez JA, 2015, J GERONTOL A-BIOL, V70, P1181, DOI 10.1093/gerona/glu177
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   López-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maharjan S, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep05896
   Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845
   Martin-Montalvo A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3192
   McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043
   Mendelsohn AR, 2014, REJUV RES, V17, P62, DOI 10.1089/rej.2014.1546
   Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Newgard CB, 2014, J GERONTOL A-BIOL, V69, PS21, DOI 10.1093/gerona/glu058
   Ngo JK, 2013, REDOX BIOL, V1, P258, DOI 10.1016/j.redox.2013.01.015
   Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024
   OLeary MF, 2013, AM J PHYSIOL-CELL PH, V304, PC422, DOI 10.1152/ajpcell.00240.2012
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Pak JW, 2004, ANN NY ACAD SCI, V1019, P289, DOI 10.1196/annals.1297.049
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 1996, MECH AGEING DEV, V86, P53, DOI 10.1016/0047-6374(95)01673-2
   Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Peterson Courtney M, 2012, J AGING RES, V2012, P194821, DOI 10.1155/2012/194821
   Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031
   Prolla TA, 2014, CELL METAB, V19, P178, DOI 10.1016/j.cmet.2014.01.005
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rambold Angelika S, 2011, COMMUN INTEGR BIOL, V4, P752
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Rodríguez-Hernández A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174
   Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184
   Rose G, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013395
   Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030
   Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   Shi Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0100834
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Takeuchi A, 2015, J PHYSIOL SCI, V65, P11, DOI 10.1007/s12576-014-0326-7
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Umanskaya A, 2014, P NATL ACAD SCI USA, V111, P15250, DOI 10.1073/pnas.1412754111
   van Vliet AR, 2014, BBA-MOL CELL RES, V1843, P2253, DOI 10.1016/j.bbamcr.2014.03.009
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Weiss N, 2010, PFLUG ARCH EUR J PHY, V459, P631, DOI 10.1007/s00424-009-0764-x
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004
NR 101
TC 165
Z9 182
U1 3
U2 107
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV 15
PY 2015
VL 70
IS 11
BP 1334
EP 1342
DI 10.1093/gerona/glv070
PG 9
WC Geriatrics & Gerontology; Gerontology
SC Geriatrics & Gerontology
GA CW1QF
UT WOS:000364765700006
PM 25995290
DA 2024-11-01
ER

PT J
AU Cadalbert, LC
   Ghaffar, FN
   Stevenson, D
   Bryson, S
   Vaz, FM
   Gottlieb, E
   Strathdee, D
AF Cadalbert, Laurence C.
   Ghaffar, Farah Naz
   Stevenson, David
   Bryson, Sheila
   Vaz, Frederic M.
   Gottlieb, Eyal
   Strathdee, Douglas
TI Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis
SO PLOS ONE
LA English
DT Article
ID barth-syndrome; pirna biogenesis; mitochondrial dynamics; nuage formation; expression; mice; gene; cardiolipin; model; mitopld
AB Barth syndrome is an X-linked mitochondrial disease, symptoms of which include neutropenia and cardiac myopathy. These symptoms are the most significant clinical consequences of a disease, which is increasingly recognised to have a variable presentation. Mutation in the Taz gene in Xq28 is thought to be responsible for the condition, by altering mitochondrial lipid content and mitochondrial function. Male chimeras carrying a targeted mutation of Taz on their X-chromosome were infertile. Testes from the Taz knockout chimeras were smaller than their control counterparts and this was associated with a disruption of the progression of spermatocytes through meiosis to spermiogenesis. Taz knockout ES cells also showed a defect when differentiated to germ cells in vitro. Mutant spermatocytes failed to progress past the pachytene stage of meiosis and had higher levels of DNA double strand damage and increased levels of endogenous retrotransposon activity. Altogether these data revealed a novel role for Taz in helping to maintain genome integrity in meiosis and facilitating germ cell differentiation. We have unravelled a novel function for the Taz protein, which should contribute to an understanding of how a disruption of the Taz gene results in the complex symptoms underlying Barth Syndrome.
C1 [Cadalbert, Laurence C.; Ghaffar, Farah Naz; Stevenson, David; Bryson, Sheila; Strathdee, Douglas] Canc Res UK Beatson Inst, Transgen Technol Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.
   [Gottlieb, Eyal] Canc Res UK Beatson Inst, Cell Death & Metab Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.
   [Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
C3 Beatson Institute; Beatson Institute; University of Amsterdam; Academic Medical Center Amsterdam
RP Strathdee, D (corresponding author), Canc Res UK Beatson Inst, Transgen Technol Lab, Garscube Estate, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.
EM d.strathdee@beatson.gla.ac.uk
FU Cancer Research UK; Barth Syndrome Foundation; Barth Syndrome Trust
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Aravin AA, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000764
   Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003
   Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001
   Castañeda J, 2014, EMBO J, V33, P1999, DOI 10.15252/embj.201386855
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X
   Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005
   Gao Q, 2012, BMB REP, V45, P7, DOI 10.5483/BMBRep.2012.45.1.7
   Gonzalez IL, 2005, AM J MED GENET A, V134A, P409, DOI 10.1002/ajmg.a.30661
   Ha H, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-545
   Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009
   Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032
   Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004
   Huhta J, 2013, SEMIN FETAL NEONAT M, V18, P245, DOI 10.1016/j.siny.2013.05.003
   Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502
   Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831
   Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562
   Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce
   Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728
   Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973
   Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011
   Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203
   Lucchinetti E, 2006, PHYSIOL GENOMICS, V25, P314, DOI 10.1152/physiolgenomics.00251.2005
   Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106
   McEwan C, 2003, TRANSGENIC RES, V12, P519, DOI 10.1023/A:1024273324890
   Neuwald AF, 1997, CURR BIOL, V7, P0
   Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509
   Phoon CKL, 2012, J AM HEART ASSOC, V1, P0, DOI 10.1161/JAHA.111.000455
   Powers C, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00074
   Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057
   Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53
   Reynolds N, 2005, REPROD BIOMED ONLINE, V10, P72, DOI 10.1016/S1472-6483(10)60806-1
   Saxena A, 2012, DIS MARKERS, V33, P261, DOI 10.1155/2012/396737
   Schachtner H, 2012, EUR J CELL BIOL, V91, P923, DOI 10.1016/j.ejcb.2012.04.002
   Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007
   Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064
   Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004
   SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756
   Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410
   Shiromoto Y, 2013, RNA, V19, P803, DOI 10.1261/rna.038521.113
   Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012
   Singh DK, 2012, RNA BIOL, V9, P1380, DOI 10.4161/rna.22402
   Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1
   Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199
   St Laurent G, 2010, MECH AGEING DEV, V131, P299, DOI 10.1016/j.mad.2010.03.008
   van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111
   Vangompel Michael J W, 2011, SPERMATOGENESIS, V1, P36
   Vinet L, 2008, AM J PHYSIOL-HEART C, V295, PH352, DOI 10.1152/ajpheart.01101.2007
   Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005
   Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447
   Xu MG, 2008, BIOL REPROD, V79, P51, DOI 10.1095/biolreprod.108.068072
   Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103
   Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200
   Yang XSW-X, 2010, ADV BIOSCIENCE BIOTE, V1, P97
   Yin DT, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027154
NR 62
TC 14
Z9 18
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2015
VL 10
IS 6
BP 
EP 
DI 10.1371/journal.pone.0131066
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1AM
UT WOS:000358147500124
PM 26114544
DA 2024-11-01
ER

PT J
AU Shaibani, A
   Wong, LJ
   Zhang, VW
   Lewis, RA
   Shinawi, M
AF Shaibani, Aziz
   Wong, Lee-Jun
   Zhang, Victor Wei
   Lewis, Richard Alan
   Shinawi, Marwan
TI Autosomal recessive posterior column ataxia with retinitis pigmentosa caused by novel mutations in the <i>FLVCR1</i> gene
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE posterior column ataxia; neuropathy; autosomal recessive; retinitis pigmentosa; FLVCR1
ID mitochondrial heme; differentiation; exporter
AB Posterior column ataxia with retinitis pigmentosa (PCARP) is an autosomal recessive disorder characterized by severe sensory ataxia, muscle weakness and atrophy, and progressive pigmentary retinopathy. Recently, mutations in the FLVCR1 gene were described in four families with this condition. We investigated the molecular basis and studied the phenotype of PCARP in a new family. The proband is a 33-year-old woman presented with sensory polyneuropathy and retinitis pigmentosa (RP). The constellation of clinical findings with normal metabolic and genetic evaluation, including mitochondrial DNA (mtDNA) analysis and normal levels of phytanic acid and vitamin E, prompted us to seek other causes of our patient's condition. Sequencing of FLVCR1 in the proband and targeted mutation testing in her two affected siblings revealed two novel variants, c.1547G>A (p.R516Q) and c.1593+5_+8delGTAA predicted, respectively, to be highly conserved throughout evolution and affecting the normal splicing, therefore, deleterious. This study supports the pathogenic role of FLVCR1 in PCARP and expands the molecular and clinical spectra of PCARP. We show for the first time that nontransmembrane domain (TMD) mutations in the FLVCR1 can cause PCARP, suggesting different mechanisms for pathogenicity. Our clinical data reveal that impaired sensation can be part of the phenotypic spectrum of PCARP. This study along with previously reported cases suggests that targeted sequencing of the FLVCR1 gene should be considered in patients with severe sensory ataxia, RP, and peripheral sensory neuropathy.
C1 [Shaibani, Aziz] Nerve & Muscle Ctr Texas, Houston, TX USA.
   [Wong, Lee-Jun; Zhang, Victor Wei; Lewis, Richard Alan] Baylor Coll Med, Dept Mol, Houston, TX 77030 USA.
   [Wong, Lee-Jun; Zhang, Victor Wei; Lewis, Richard Alan] Baylor Coll Med, Dept Human Genet, Houston, TX USA.
   [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA.
   [Shinawi, Marwan] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO 63110 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL)
RP Shinawi, M (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, One Childrens Pl,Northwest Tower 9132, St Louis, MO 63110 USA.
EM shinawi_m@kids.wustl.edu
FU Research to Prevent Blindness, New York, NY
CR Berciano J, 1998, NEUROLOGY, V51, P1772, DOI 10.1212/WNL.51.6.1772-a
   Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422
   Fleming MD, 2012, J CLIN INVEST, V122, P4328, DOI 10.1172/JCI66607
   Higgins JJ, 1997, NEUROLOGY, V49, P1717, DOI 10.1212/WNL.49.6.1717
   Higgins JJ, 1999, NEUROLOGY, V52, P146, DOI 10.1212/WNL.52.1.146
   Ishiura H, 2011, NEUROGENETICS, V12, P117, DOI 10.1007/s10048-010-0271-4
   Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133
   Khan AA, 2013, MOL ASPECTS MED, V34, P669, DOI 10.1016/j.mam.2012.07.013
   Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008
   Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0
   Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014
   Rajadhyaksha AM, 2010, AM J HUM GENET, V87, P643, DOI 10.1016/j.ajhg.2010.10.013
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999
   Yanatori I, 2012, BLOOD CELL MOL DIS, V49, P60, DOI 10.1016/j.bcmd.2012.03.004
NR 15
TC 23
Z9 24
U1 1
U2 3
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD JAN 15
PY 2015
VL 125
IS 1
BP 43
EP 49
DI 10.3109/00207454.2014.904858
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA AU8EA
UT WOS:000345828000007
PM 24628582
DA 2024-11-01
ER

PT J
AU Fujita, Y
   Ito, M
   Kojima, T
   Yatsuga, S
   Koga, Y
   Tanaka, M
AF Fujita, Yasunori
   Ito, Masafumi
   Kojima, Toshio
   Yatsuga, Shuichi
   Koga, Yasutoshi
   Tanaka, Masashi
TI GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases
SO MITOCHONDRION
LA English
DT Article
DE GDF15; Pyruvate; Mitochondrial diseases; Cybrid; Microarray; Biomarker
ID macrophage inhibitory cytokine-1; endoplasmic-reticulum stress; cells harboring melas; stroke-like episodes; lactic-acidosis; gene-expression; dna mutations; p53; myopathy; pathway
AB Pyruvate therapy is a promising approach for the treatment of mitochondrial diseases. To identify novel biomarkers for diagnosis and to evaluate therapeutic efficacy, we performed microarray analysis of 2SD cybrid cells harboring a MELAS-causing mutation and control cells treated with either lactate or pyruvate. We found that expression and secretion of growth differentiation factor 15 (GDF15) were increased in 2SD cells treated with lactate and that serum GDF15 levels were significantly higher in patients with mitochondrial diseases than in those with other diseases, suggesting that GDF15 could be a useful marker for diagnosis and evaluating the therapeutic efficacy of pyruvate. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Fujita, Yasunori; Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mechanism Aging, Tokyo, Tokyo 1730015, Japan.
   [Kojima, Toshio] Toyohashi Univ Technol, Hlth Support Ctr, Toyohashi, Aichi 4418580, Japan.
   [Yatsuga, Shuichi; Koga, Yasutoshi] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan.
   [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Tokyo, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Toyohashi University of Technology; Kurume University; Tokyo Metropolitan Institute of Gerontology
RP Tanaka, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, 35-2 Sakae Cho, Tokyo, Tokyo 1730015, Japan.
EM mtanaka@tmig.or.jp
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan; GMEXT/JSPS [A-25242062, A-22240072, B-21390459, C-26670481, C-21590411, CER-24650414, C-26350922, C-25461571, YSB-25860891]; Ministry of Health, Labor, and Welfare of Japan; Takeda Science Foundation;  [23-Nanchi-Ippan-016];  [23-Nanchi-Ippan-116];  [24-Nanchi-Ippan-005]; Grants-in-Aid for Scientific Research [25242062, 26350922, 21590411, 26670342, 25860891, 26670481, 25461571] Funding Source: KAKEN
CR Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425
   Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002
   Brüning A, 2012, TOXICOL APPL PHARM, V264, P300, DOI 10.1016/j.taap.2012.08.011
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Dombroski BA, 2010, AM J HUM GENET, V86, P719, DOI 10.1016/j.ajhg.2010.03.017
   Dostálová I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Fuchs T, 2013, AGING CELL, V12, P882, DOI 10.1111/acel.12116
   Fujita Y, 2007, MITOCHONDRION, V7, P80, DOI 10.1016/j.mito.2006.11.003
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Hashimoto O, 2009, LIFE SCI, V85, P534, DOI 10.1016/j.lfs.2009.08.007
   Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004
   Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200
   Kami K, 2012, MITOCHONDRION, V12, P644, DOI 10.1016/j.mito.2012.07.113
   Kempf T, 2007, CLIN CHEM, V53, P284, DOI 10.1373/clinchem.2006.076828
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Koga Y, 2012, BRAIN DEV-JPN, V34, P87, DOI 10.1016/j.braindev.2011.03.003
   Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007
   Li J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065549
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Martin SD, 2014, BBA-GEN SUBJECTS, V1840, P1303, DOI 10.1016/j.bbagen.2013.09.019
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027
   Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191
   Saito K, 2012, BBA-GEN SUBJECTS, V1820, P632, DOI 10.1016/j.bbagen.2011.08.006
   Sermeus A, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.48
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tanaka M, 2007, MITOCHONDRION, V7, P399, DOI 10.1016/j.mito.2007.07.002
   Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003
   Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100
   Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x
   Yang H, 2003, MOL CANCER THER, V2, P1023
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151
NR 42
TC 106
Z9 114
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2015
VL 20
IS 
BP 34
EP 42
DI 10.1016/j.mito.2014.10.006
PG 9
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CA0UQ
UT WOS:000348632200005
PM 25446397
DA 2024-11-01
ER

PT J
AU Rocha, MC
   Grady, JP
   Grünewald, A
   Vincent, A
   Dobson, PF
   Taylor, RW
   Turnbull, DM
   Rygiel, KA
AF Rocha, Mariana C.
   Grady, John P.
   Gruenewald, Anne
   Vincent, Amy
   Dobson, Philip F.
   Taylor, Robert W.
   Turnbull, Doug M.
   Rygiel, Karolina A.
TI A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID cytochrome-c-oxidase; complex i deficiency; digital image-analysis; real-time pcr; dna deletions; muscle-fibers; mutation; single; gene; mtdna
AB Oxidative phosphorylation defects in human tissues are often challenging to quantify due to a mosaic pattern of deficiency. Biochemical assays are difficult to interpret due to the varying enzyme deficiency levels found in individual cells. Histochemical analysis allows semi-quantitative assessment of complex II and complex IV activities, but there is no validated histochemical assay to assess complex I activity which is frequently affected in mitochondrial pathology. To help improve the diagnosis of mitochondrial disease and to study the mechanisms underlying mitochondrial abnormalities in disease, we have developed a quadruple immunofluorescent technique enabling the quantification of key respiratory chain subunits of complexes I and IV, together with an indicator of mitochondrial mass and a cell membrane marker. This assay gives precise and objective quantification of protein abundance in large numbers of individual muscle fibres. By assessing muscle biopsies from subjects with a range of different mitochondrial genetic defects we have demonstrated that specific genotypes exhibit distinct biochemical signatures in muscle, providing evidence for the diagnostic use of the technique, as well as insight into the underlying molecular pathology. Stringent testing for reproducibility and sensitivity confirms the potential value of the technique for mechanistic studies of disease and in the evaluation of therapeutic approaches.
C1 [Rocha, Mariana C.; Dobson, Philip F.; Turnbull, Doug M.; Rygiel, Karolina A.] Newcastle Univ, Sch Med, Inst Neurosci, Ctr Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Rocha, Mariana C.; Grady, John P.; Gruenewald, Anne; Vincent, Amy; Taylor, Robert W.; Turnbull, Doug M.; Rygiel, Karolina A.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Ctr Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk; karolina.rygiel@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [G906919]; Newcastle University Centre for Brain Ageing and Vitality - Biotechnology and Biological Sciences Research Council; Newcastle University Centre for Brain Ageing and Vitality - Engineering and Physical Sciences Research Council; Newcastle University Centre for Brain Ageing and Vitality - Economic and Social Research Council; Newcastle University Centre for Brain Ageing and Vitality - Medical Research Council [G0700718]; MRC Centre for Neuromuscular Disease [G0006081]; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre in Age and Age Related Diseases award; UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children" Service; Wellcome Trust Studentship [090194/Z/09/Z]; Wellcome Trust [090194/Z/09/Z] Funding Source: Wellcome Trust; MRC [MR/L016354/1, MR/K000608/1, G0700718, MC_G0802536, G0800674] Funding Source: UKRI
CR Alvarenga AW, 2013, J HISTOCHEM CYTOCHEM, V61, P272, DOI 10.1369/0022155413477661
   [Anonymous], 2014, A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, V0, P0
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x
   Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   Choudhury KR, 2010, J HISTOCHEM CYTOCHEM, V58, P95, DOI 10.1369/jhc.2009.953554
   De Paepe B, 2009, J CLIN PATHOL, V62, P172, DOI 10.1136/jcp.2008.061267
   EGGER J, 1981, ARCH DIS CHILD, V56, P741, DOI 10.1136/adc.56.10.741
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   Goedkoop AY, 2005, ARCH DERMATOL RES, V297, P51, DOI 10.1007/s00403-005-0578-4
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Grünewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Horváth R, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.015024
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Klöppel S, 2008, BRAIN, V131, P2969, DOI 10.1093/brain/awn239
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Mahad DJ, 2009, J NEUROSCI METH, V184, P310, DOI 10.1016/j.jneumeth.2009.08.020
   MATSUOKA T, 1992, MUSCLE NERVE, V15, P209, DOI 10.1002/mus.880150213
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   MERANTE F, 1993, AM J HUM GENET, V53, P481
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Mula J, 2013, J APPL PHYSIOL, V114, P148, DOI 10.1152/japplphysiol.01022.2012
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Perales-Clemente E, 2010, MOL CELL BIOL, V30, P3038, DOI 10.1128/MCB.00025-10
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rizzardi AE, 2012, DIAGN PATHOL, V7, P0, DOI 10.1186/1746-1596-7-42
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
NR 61
TC 90
Z9 96
U1 0
U2 16
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD OCT 15
PY 2015
VL 5
IS 
BP 
EP 
DI 10.1038/srep15037
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT4XV
UT WOS:000362811700001
PM 26469001
DA 2024-11-01
ER

PT J
AU Tower, J
AF Tower, John
TI Programmed cell death in aging
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE Apoptosis; Necrosis; Aging; Sarcopenia; Mitochondria; Senescence
ID mitochondrial-dna mutations; chronological life-span; nuclear serine-protease; smooth-muscle-cells; saccharomyces-cerevisiae; apoptosis resistance; immune-system; increased susceptibility; caenorhabditis-elegans; reduces susceptibility
AB Programmed cell death (PCD) pathways, including apoptosis and regulated necrosis, are required for normal cell turnover and tissue homeostasis. Mis-regulation of PCD is increasingly implicated in aging and aging-related disease. During aging the cell turnover rate declines for several highly-mitotic tissues. Aging-associated disruptions in systemic and inter-cell signaling combined with cell-autonomous damage and mitochondrial malfunction result in increased PCD in some cell types, and decreased PCD in other cell types. Increased PCD during aging is implicated in immune system decline, skeletal muscle wasting (sarcopenia), loss of cells in the heart, and neurodegenerative disease. In contrast, cancer cells and senescent cells are resistant to PCD, enabling them to increase in abundance during aging. PCD pathways limit life span in fungi, but whether PCD pathways normally limit adult metazoan life span is not yet clear. PCD is regulated by a balance of negative and positive factors, including the mitochondria, which are particularly subject to aging-associated malfunction. (C) 2015 Elsevier B.V. All rights reserved.
C1 Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.
C3 University of Southern California
RP Tower, J (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, 1050 Childs Way,RRI 201, Los Angeles, CA 90089 USA.
EM jtower@usc.edu
FU Department of Health and Human Services [AG011833]; Southern California Environmental Health Sciences Center [5P30ES007048]
CR Ahn SH, 2005, CELL CYCLE, V4, P780, DOI 10.4161/cc.4.6.1745
   Ahn SH, 2006, MOL CELL, V24, P211, DOI 10.1016/j.molcel.2006.09.008
   Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002
   Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884
   Andux S, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000295
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bernhardt D, 2014, CURR OPIN MICROBIOL, V22, P1, DOI 10.1016/j.mib.2014.09.007
   Bosserman L, 2012, CANCER RES, V72, P3901, DOI 10.1158/0008-5472.CAN-12-0681
   Brust D, 2010, AGING CELL, V9, P761, DOI 10.1111/j.1474-9726.2010.00609.x
   Brust D, 2010, CURR GENET, V56, P225, DOI 10.1007/s00294-010-0295-1
   Büttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021
   Büttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197
   Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x
   Camplejohn RS, 2003, BRIT J CANCER, V88, P487, DOI 10.1038/sj.bjc.6600767
   Carmona-Gutiérrez D, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.43
   Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219
   Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198
   Chihara T, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004437
   Childs BG, 2014, EMBO REP, V0, P0
   Chimal-Monroy J, 2011, IUBMB LIFE, V63, P922, DOI 10.1002/iub.563
   Chou JP, 2013, CURR PHARM DESIGN, V19, P1680
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Degterev A, 2014, METHOD ENZYMOL, V545, P1, DOI 10.1016/B978-0-12-801430-1.00001-9
   Delaney JR, 2011, AGING CELL, V10, P1089, DOI 10.1111/j.1474-9726.2011.00742.x
   Delavallée L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432
   Denton D, 2013, BBA-MOL CELL RES, V1833, P3499, DOI 10.1016/j.bbamcr.2013.06.014
   Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095
   Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010
   EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321
   Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7
   Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002
   Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x
   Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848
   Fahrenkrog B, 2011, BIOCHEM SOC T, V39, P1499, DOI 10.1042/BST0391499
   Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904
   Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/582849
   FUKAGAWA NK, 1990, AM J PHYSIOL, V259, PE233, DOI 10.1152/ajpendo.1990.259.2.E233
   Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137
   Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96
   Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007
   Garigan D, 2002, GENETICS, V161, P1101
   Gelino Sara, 2012, J CLIN EXP PATHOL, VSuppl 4, P0
   Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004
   Giannaris EL, 2012, J COMP NEUROL, V520, P3492, DOI 10.1002/cne.23101
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010
   Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986
   Günther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364
   Gumienny TL, 1999, DEVELOPMENT, V126, P1011
   Gupta S, 2005, IMMUNOL REV, V205, P114, DOI 10.1111/j.0105-2896.2005.00261.x
   Gupta S, 2006, IMMUN AGEING, VI & A 3, P5
   Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794
   Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   Hernández-Martínez R, 2011, DEV GROWTH DIFFER, V53, P245, DOI 10.1111/j.1440-169X.2010.01246.x
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   Hill SM, 2015, BIOESSAYS, V0, P0
   Hroudová J, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/175062
   Hua Y, 2015, AGING CELL, V0, P0
   Hur JH, 2014, J BIOENERG BIOMEMBR, V46, P329, DOI 10.1007/s10863-014-9553-0
   Jazwinski SM, 2014, PROG MOL BIOL TRANSL, V127, P133, DOI 10.1016/B978-0-12-394625-6.00005-2
   Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014
   Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, PH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Kapetanaki MG, 2013, J PATHOL, V229, P310, DOI 10.1002/path.4122
   Kavathia N, 2009, AGING-US, V1, P652, DOI 10.18632/aging.100069
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kile BT, 2014, BRIT J HAEMATOL, V165, P217, DOI 10.1111/bjh.12757
   Kinet MJ, 2014, METHOD ENZYMOL, V545, P157, DOI 10.1016/B978-0-12-801430-1.00007-X
   King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601
   KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206
   Kirchman PA, 1999, GENETICS, V152, P179
   Kirkland JL, 2014, EXP GERONTOL, V0, P0
   Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730
   Kwak HB, 2014, J GERONTOL A JUL, V0, P0
   Kwak HB, 2013, J EXERC REHABIL, V9, P212, DOI 10.12965/jer.130002
   Lanni C, 2012, FREE RADICAL BIO MED, V52, P1727, DOI 10.1016/j.freeradbiomed.2012.02.034
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1111/j.1365-2958.2001.02317.x
   Lee M, 2014, BMB REP, V47, P51, DOI 10.5483/BMBRep.2014.47.2.005
   Lee Y, 2014, BMB REP, V47, P424, DOI 10.5483/BMBRep.2014.47.8.119
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, PR1288, DOI 10.1152/ajpregu.00576.2004
   Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234
   Liu J, 2013, CELL METAB, V18, P392, DOI 10.1016/j.cmet.2013.08.007
   Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75
   Long JM, 1999, J GERONTOL A-BIOL, V54, PB407, DOI 10.1093/gerona/54.10.B407
   Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002
   Lu B, 2012, ADV BIOSCI BIOTECH, V3, P705, DOI 10.4236/ABB.2012.326091
   Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Maklakov AA, 2013, BIOESSAYS, V35, P717, DOI 10.1002/bies.201300021
   Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007
   Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Maurer CW, 2007, DEVELOPMENT, V134, P1357, DOI 10.1242/dev.02818
   McGee MD, 2012, AGING-US, V4, P256, DOI 10.18632/aging.100448
   Merrill DA, 2001, J COMP NEUROL, V438, P445, DOI 10.1002/cne.1327
   Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X
   Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371
   Misell LM, 2005, BREAST CANCER RES TR, V89, P257, DOI 10.1007/s10549-004-2228-5
   Nixon Ralph A, 2012, COLD SPRING HARB PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a008839
   Nolan LA, 1999, J NEUROENDOCRINOL, V11, P393
   Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Oshiro S, 2011, ADV PHARMACOL SCI, V2011, P0, DOI 10.1155/2011/378278
   Osiewacz HD, 2000, EXP GERONTOL, V35, P677, DOI 10.1016/S0531-5565(00)00142-X
   Osiewacz HD, 2010, ANN NY ACAD SCI, V1197, P54, DOI 10.1111/j.1749-6632.2010.05190.x
   Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002
   PANDEY S, 1995, J CELL BIOCHEM, V58, P135, DOI 10.1002/jcb.240580203
   Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026
   Papucci L, 2004, CELL TISSUE RES, V316, P197, DOI 10.1007/s00441-004-0872-z
   Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   Polyak K, 1997, CELL DEATH DIFFER, V4, P242, DOI 10.1038/sj.cdd.4400226
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145
   Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793
   Qian DH, 2011, INT J MOL MED, V28, P207, DOI 10.3892/ijmm.2011.671
   RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104
   Rai Nirendra K, 2005, INT J LOW EXTREM WOUNDS, V4, P138, DOI 10.1177/1534734605280018
   Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926
   Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619
   Refaat A, 2014, ONCOL LETT, V7, P1327, DOI 10.3892/ol.2014.1922
   Renehan AG, 2001, BMJ-BRIT MED J, V322, P1536, DOI 10.1136/bmj.322.7301.1536
   Rérole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16
   Richard VR, 2013, AGING-US, V5, P234, DOI 10.18632/aging.100547
   Richardson RB, 2014, EXP GERONTOL, V55, P80, DOI 10.1016/j.exger.2014.03.015
   Rinnerthaler M, 2014, EXP GERONTOL, V0, P0
   Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007
   Ryu SJ, 2007, CELL DEATH DIFFER, V14, P1020, DOI 10.1038/sj.cdd.4402091
   Sainz RM, 2003, MICROSC RES TECHNIQ, V62, P524, DOI 10.1002/jemt.10414
   Salminen A, 2011, CELL MOL LIFE SCI, V68, P1021, DOI 10.1007/s00018-010-0597-y
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seiberg M, 2013, INT J COSMETIC SCI, V35, P532, DOI 10.1111/ics.12090
   Severin FF, 2002, CURR BIOL, V12, PR233, DOI 10.1016/S0960-9822(02)00776-5
   Sevini F, 2014, EXP GERONTOL, V0, P0
   Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216
   Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003
   Shen Jie, 2009, DISCOV MED, V8, P223
   Shen J, 2009, AGING-US, V1, P191, DOI 10.18632/aging.100018
   Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x
   Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465
   Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355
   Stegh AH, 2012, EXPERT OPIN THER TAR, V16, P67, DOI 10.1517/14728222.2011.643299
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Suh Y, 2002, MECH AGEING DEV, V123, P881, DOI 10.1016/S0047-6374(02)00025-8
   Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000
   Tarnawski AS, 2014, WORLD J GASTROENTERO, V20, P4467, DOI 10.3748/wjg.v20.i16.4467
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tower J, 2014, ARCH BIOCH BIOPHYS, V0, P0
   Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001
   Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012
   Vasconsuelo A, 2011, STEROIDS, V76, P1223, DOI 10.1016/j.steroids.2011.08.001
   Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807
   Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656
   Vazquez-Padron RI, 2004, J VASC SURG, V40, P1199, DOI 10.1016/j.jvs.2004.08.034
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   WANG E, 1995, CANCER RES, V55, P2284
   Wang E, 1997, EXP GERONTOL, V32, P471, DOI 10.1016/S0531-5565(96)00156-8
   Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194
   Wang XH, 2014, INT J MOL SCI, V15, P15358, DOI 10.3390/ijms150915358
   Warner HR, 1997, CURR TOP CELL REGUL, V35, P107, DOI 10.1016/S0070-2137(97)80004-0
   Wei M, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.0040013
   Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139
   Wilson A, 2010, BMC GENOMICS, V11, P0, DOI 10.1186/1471-2164-11-229
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Yakovlev Alexander G, 2004, NEURORX, V1, P5, DOI 10.1602/neurorx.1.1.5
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yeo EJ, 2000, MOL CELLS, V10, P415
   Zhao J, 2012, CANCER LETT, V314, P8, DOI 10.1016/j.canlet.2011.09.040
   Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102
   Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005
   Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584
NR 193
TC 267
Z9 293
U1 9
U2 75
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD SEP 15
PY 2015
VL 23
IS 
BP 90
EP 100
DI 10.1016/j.arr.2015.04.002
PG 11
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA CN0HG
UT WOS:000358094100009
PM 25862945
DA 2024-11-01
ER

PT J
AU Donato, AJ
   Morgan, RG
   Walker, AE
   Lesniewski, LA
AF Donato, Anthony J.
   Morgan, R. Garrett
   Walker, Ashley E.
   Lesniewski, Lisa A.
TI Cellular and molecular biology of aging endothelial cells
SO JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
LA English
DT Review
DE Aging; Endothelium; Oxidative stress; Inflammation; Senescence; Genomic instability
ID activated protein-kinase; nf-kappa-b; nitric-oxide synthase; regular aerobic exercise; smooth-muscle-cells; extends life-span; mitochondrial oxidative stress; foxo transcription factors; improves vascular function; dna-deletion mutations
AB Cardiovascular disease (CVD) is the leading cause of death in the United States and aging is a major risk factor for CVD development. One of the major age-related arterial phenotypes thought to be responsible for the development of CVD in older adults is endothelial dysfunction. Endothelial function is modulated by traditional CVD risk factors in young adults, but advancing age is independently associated with the development of vascular endothelial dysfunction. This endothelial dysfunction results from a reduction in nitric oxide bioavailability downstream of endothelial oxidative stress and inflammation that can be further modulated by traditional CVD risk factors in older adults. Greater endothelial oxidative stress with aging is a result of augmented production from the intracellular enzymes NADPH oxidase and uncoupled eNOS, as well as from mitochondrial respiration in the absence of appropriate increases in antioxidant defenses as regulated by relevant transcription factors, such as FOXO. Interestingly, it appears that NFlcB, a critical inflammatory transcription factor, is sensitive to this age-related endothelial redox change and its activation induces transcription of pro-inflammatory cytokines that can further suppress endothelial function, thus creating a vicious feed-forward cycle. This review will discuss the two macro-mechanistic processes, oxidative stress and inflammation, that contribute to endothelial dysfunction with advancing age as well as the cellular and molecular events that lead to the vicious cycle of inflammation and oxidative stress in the aged endothelium. Other potential mediators of this pro-inflammatory endothelial phenotype are increases in immune or senescent cells in the vasculature. Of note, genomic instability, telomere dysfunction or DNA damage has been shown to trigger cell senescence via the p53/p21 pathway and result in increased inflammatory signaling in arteries from older adults. This review will discuss the current state of knowledge regarding the emerging concepts of senescence and genomic instability as mechanisms underlying oxidative stress and inflammation in the aged endothelium. Lastly, energy sensitive/stress resistance pathways (SIRT-1, AMPK, mTOR) are altered in endothelial cells and/or arteries with aging and these pathways may modulate endothelial function via key oxidative stress and inflammation-related transcription factors. This review will also discuss what is known about the role of "energy sensing" longevity pathways in modulating endothelial function with advancing age. With the growing population of older adults, elucidating the cellular and molecular mechanisms of endothelial dysfunction with age is critical to establishing appropriate and measured strategies to utilize pharmacological and lifestyle interventions aimed at alleviating CVD risk. This article is part of a Special Issue entitled "SI: CV Aging". Published by Elsevier Ltd.
C1 [Donato, Anthony J.; Walker, Ashley E.; Lesniewski, Lisa A.] Univ Utah, Div Geriatr, Dept Internal Med, Salt Lake City, UT 84148 USA.
   [Donato, Anthony J.; Lesniewski, Lisa A.] Vet Affairs Med Ctr Salt Lake City, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA.
   [Morgan, R. Garrett] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
C3 Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; University of Washington; University of Washington Seattle
RP Donato, AJ (corresponding author), Univ Utah, Div Geriatr, Dept Internal Med, 500 Foothill Dr, Salt Lake City, UT 84148 USA.
EM tony.donato@utah.edu
FU NIH [NIA R01 AG040297, R21 AG043952, K02 AG045339, K01 AG029337, NIEHS T32 ES007032]; VA [1I01BX002151]
CR Ahluwalia A, 2011, J PHYSIOL PHARMACOL, V62, P583
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6
   [Anonymous], 2006, HDB EXP PHARM, V176, P0
   Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200
   Arvanitis DA, 2005, J CELL MOL MED, V9, P153, DOI 10.1111/j.1582-4934.2005.tb00345.x
   Asai K, 2000, ARTERIOSCL THROM VAS, V20, P1493, DOI 10.1161/01.ATV.20.6.1493
   Baker CSR, 1999, ARTERIOSCL THROM VAS, V19, P646, DOI 10.1161/01.ATV.19.3.646
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   BELMIN J, 1995, AM J PHYSIOL-HEART C, V268, PH2288, DOI 10.1152/ajpheart.1995.268.6.H2288
   Blau CW, 2012, NEUROBIOL AGING, V33, P0, DOI 10.1016/j.neurobiolaging.2011.09.035
   Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027
   Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289
   Brown KA, 2007, ARTERIOSCL THROM VAS, V27, P1941, DOI 10.1161/ATVBAHA.107.146852
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447
   Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177
   Cafueri G, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035312
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cardillo CM, 2000, HYPERTENSION, V35, P1237, DOI 10.1161/01.HYP.35.6.1237
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0
   Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279
   Chakrabarti S, 2009, J STEROID BIOCHEM, V117, P99, DOI 10.1016/j.jsbmb.2009.07.007
   Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567
   Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Chou TC, 1998, HYPERTENSION, V31, P643, DOI 10.1161/01.HYP.31.2.643
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Cohen RA, 1997, P NATL ACAD SCI USA, V94, P4193, DOI 10.1073/pnas.94.8.4193
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06
   Croley AN, 2005, J APPL PHYSIOL, V99, P1872, DOI 10.1152/japplphysiol.00498.2005
   Csiszar A, 2007, AM J PATHOL, V170, P388, DOI 10.2353/ajpath.2007.060708
   Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, PH1694, DOI 10.1152/ajpheart.00340.2006
   Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   Das DK, 2006, MOL INTERV, V6, P36, DOI 10.1124/mi.6.1.7
   Davis B, 2012, EUR J PHARMACOL, V695, P88, DOI 10.1016/j.ejphar.2012.07.025
   Demaree SR, 1999, ACTA PHYSIOL SCAND, V166, P203
   DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351
   DeVan AE, 2013, CLIN SCI, V124, P325, DOI 10.1042/CS20120291
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013
   Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, PH1417, DOI 10.1152/ajpheart.00089.2013
   Donato AJ, 2008, J APPL PHYSIOL, V105, P1359, DOI 10.1152/japplphysiol.90629.2008
   Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8
   Donato AJ, 2013, AGING CELL, V12, P772, DOI 10.1111/acel.12103
   Donato AJ, 2012, AM J PHYSIOL-HEART C, V303, PH672, DOI 10.1152/ajpheart.00271.2012
   Donato AJ, 2011, J PHYSIOL-LONDON, V589, P4545, DOI 10.1113/jphysiol.2011.211219
   Donato AJ, 2010, AM J PHYSIOL-HEART C, V298, PH671, DOI 10.1152/ajpheart.00761.2009
   Donato AJ, 2009, AM J PHYSIOL-HEART C, V297, PH425, DOI 10.1152/ajpheart.00689.2008
   Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x
   Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380
   Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771
   Eskurza I, 2006, J PHYSIOL-LONDON, V571, P661, DOI 10.1113/jphysiol.2005.102566
   Eskurza I, 2005, J PHYSIOL-LONDON, V568, P1057, DOI 10.1113/jphysiol.2005.092734
   Eskurza I, 2004, J PHYSIOL-LONDON, V556, P315, DOI 10.1113/jphysiol.2003.057042
   Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102
   Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590
   Flouris George A, 2000, MOLECULAR CELL BIOLOGY RESEARCH COMMUNICATIONS, V4, P62, DOI 10.1006/mcbr.2000.0255
   Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D
   Franklin SS, 2001, CIRCULATION, V103, P1245
   Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354
   Franklin SS, 1997, CIRCULATION, V96, P308
   Franzoni F, 2005, AM J HYPERTENS, V18, P510, DOI 10.1016/j.amjhyper.2004.11.006
   Gano LB, 2010, CIRCULATION, V122, P0
   Gano LB, 2014, AM J PHYSIOL-HEART C, V307, PH1754, DOI 10.1152/ajpheart.00377.2014
   Ganz P, 2003, CIRCULATION, V108, P2049, DOI 10.1161/01.CIR.0000089507.19675.F9
   Gerhard M, 1996, HYPERTENSION, V27, P849, DOI 10.1161/01.HYP.27.4.849
   Gioscia-Ryan RA, 2014, J PHYSIOL-LONDON, V592, P2549, DOI 10.1113/jphysiol.2013.268680
   Goettsch W, 2001, BIOCHEM BIOPH RES CO, V280, P908, DOI 10.1006/bbrc.2000.4180
   Gong X, 2014, EXP GERONTOL, V52, P9, DOI 10.1016/j.exger.2014.01.015
   Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404
   Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Hamilton CA, 2001, HYPERTENSION, V37, P529, DOI 10.1161/01.HYP.37.2.529
   Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346
   Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   HAUDENSCHILD CC, 1981, HYPERTENSION, V3, P148, DOI 10.1161/01.HYP.3.3_Pt_2.I148
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Health United States, 2010, SPEC FEAT DEATH DYIN, V0, P0
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027
   Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102
   Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222
   Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Inafuku Masashi, 2004, RINSHO BYORI, V52, P961
   Issa Jaqueline Scholz, 2005, ARQ. BRAS. CARDIOL., V85, P15, DOI 10.1590/S0066-782X2005001400004
   Jablonski Kristen L, 2009, THER ADV CARDIOVASC DIS, V3, P347, DOI 10.1177/1753944709345790
   Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025
   Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004
   Janjetovic K, 2011, EUR J PHARMACOL, V651, P41, DOI 10.1016/j.ejphar.2010.11.005
   Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034
   Kang LS, 2009, AM J PHYSIOL-HEART C, V297, PH1087, DOI 10.1152/ajpheart.00356.2009
   Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kaplon RE, 2011, J APPL PHYSIOL, V111, P1416, DOI 10.1152/japplphysiol.00721.2011
   Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Katakam PVG, 2000, HYPERTENSION, V35, P108, DOI 10.1161/01.HYP.35.1.108
   Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44
   KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66
   Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8
   Kobayashi Y, 2005, INT J MOL MED, V16, P237
   Kovacic JC, 2011, CIRCULATION, V123, P1650, DOI 10.1161/CIRCULATIONAHA.110.007021
   Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009
   Krouwer VJD, 2012, VASC CELL, V4, P0, DOI 10.1186/2045-824X-4-12
   Kuwano Y, 2006, AM J PHYSIOL-CELL PH, V290, PC433, DOI 10.1152/ajpcell.00135.2005
   Kyng KJ, 2005, ONCOGENE, V24, P5026, DOI 10.1038/sj.onc.1208692
   Labinskyy N, 2006, CURR MED CHEM, V13, P989, DOI 10.2174/092986706776360987
   Lafontaine-Lacasse M, 2010, NEUROSCI LETT, V480, P1, DOI 10.1016/j.neulet.2010.01.008
   LAI JH, 1994, J BIOL CHEM, V269, P30077
   Lakatta EG, 2009, MED CLIN N AM, V93, P583, DOI 10.1016/j.mcna.2009.02.008
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Leiro J, 2004, J LEUKOCYTE BIOL, V75, P1156, DOI 10.1189/jlb.1103561
   Lesniewski LA, 2012, MECH AGEING DEV, V133, P368, DOI 10.1016/j.mad.2012.03.011
   Lesniewski LA, 2011, AM J PHYSIOL-HEART C, V301, PH1025, DOI 10.1152/ajpheart.01276.2010
   Lesniewski LA, 2011, J GERONTOL A-BIOL, V66, P409, DOI 10.1093/gerona/glq233
   Lesniewski LA, 2009, J GERONTOL A-BIOL, V64, P9, DOI 10.1093/gerona/gln049
   Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200
   Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452
   Li ZH, 1999, HYPERTENSION, V33, P116, DOI 10.1161/01.HYP.33.1.116
   Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491
   Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Luscher TF, 1997, CLIN CARDIOL, V20, P3
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b
   MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499
   Majithiya JB, 2006, LIFE SCI, V78, P2615, DOI 10.1016/j.lfs.2005.10.020
   Manea A, 2007, ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, V113, P163, DOI 10.1080/13813450701531235
   Mannell HK, 2012, CARDIOVASC RES, V93, P111, DOI 10.1093/cvr/cvr265
   Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x
   Marchesi S, 2000, ATHEROSCLEROSIS, V153, P397, DOI 10.1016/S0021-9150(00)00415-9
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje
   Mervaala EMA, 2001, HYPERTENSION, V37, P414, DOI 10.1161/01.HYP.37.2.414
   Mihm MJ, 2000, J CARDIOVASC PHARM, V36, P182, DOI 10.1097/00005344-200008000-00007
   Miller SJ, 2007, AM J PHYSIOL-HEART C, V293, PH2634, DOI 10.1152/ajpheart.00397.2007
   Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17
   Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68
   Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031
   Miura H, 2003, CIRC RES, V92, PE31, DOI 10.1161/01.RES.0000054200.44505.AB
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   Moreau KL, 2003, J PHYSIOL-LONDON, V547, P309, DOI 10.1113/jphysiol.2002.032524
   Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, PH251, DOI 10.1152/ajpheart.00197.2013
   Mortuza R, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054514
   Myatt L, 1996, HYPERTENSION, V28, P488, DOI 10.1161/01.HYP.28.3.488
   Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504
   Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Newby K, 1997, CLIN CARDIOL, V20, P11, DOI 10.1002/clc.4960201405
   Nicholson WT, 2009, HYPERTENSION, V53, P973, DOI 10.1161/HYPERTENSIONAHA.108.121483
   Noureddine H, 2011, CIRC RES, V109, P543, DOI 10.1161/CIRCRESAHA.111.241299
   Novella S, 2013, AGE, V35, P117, DOI 10.1007/s11357-011-9337-y
   Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114
   Oelze M, 2014, HYPERTENSION, V63, P390, DOI 10.1161/HYPERTENSIONAHA.113.01602
   Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g
   Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460
   Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Paik JH, 2006, BIOCHEM SOC T, V34, P731, DOI 10.1042/BST0340731
   Papanicolaou KN, 2008, CIRC RES, V102, P16, DOI 10.1161/CIRCRESAHA.107.164186
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pelegrí C, 2007, MECH AGEING DEV, V128, P522, DOI 10.1016/j.mad.2007.07.002
   PERSSON MG, 1990, BRIT J PHARMACOL, V100, P463, DOI 10.1111/j.1476-5381.1990.tb15829.x
   Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev
   Pierce GL, 2009, CIRCULATION, V119, P1284, DOI 10.1161/CIRCULATIONAHA.108.804294
   Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Price DT, 2000, ANTIOXID REDOX SIGN, V2, P919, DOI 10.1089/ars.2000.2.4-919
   Pu YF, 2013, CELL PHYSIOL BIOCHEM, V32, P1167, DOI 10.1159/000354516
   Quijano C, 2007, AM J PHYSIOL-HEART C, V293, PH3404, DOI 10.1152/ajpheart.00761.2007
   Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056
   READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503
   Reihl K, 2013, FASEB J, V27, P0
   Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017
   Rudolph TK, 2007, AM J CLIN NUTR, V86, P334, DOI 10.1093/ajcn/86.2.334
   Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7
   Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005
   Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, PH2497, DOI 10.1152/ajpheart.00873.2007
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0
   Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x
   Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254
   Sartoretto JL, 2005, LIFE SCI, V77, P2676, DOI 10.1016/j.lfs.2005.05.022
   SATO I, 1993, BIOCHEM BIOPH RES CO, V195, P1070, DOI 10.1006/bbrc.1993.2153
   Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168
   Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708
   Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, PL1094, DOI 10.1152/ajplung.2001.280.6.L1094
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476
   Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196
   Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Sindler AL, 2013, J APPL PHYSIOL, V114, P681, DOI 10.1152/japplphysiol.00341.2012
   Sindler AL, 2009, J PHYSIOL-LONDON, V587, P3885, DOI 10.1113/jphysiol.2009.172221
   Singh NP, 2003, FERTIL STERIL, V80, P1420, DOI 10.1016/j.fertnstert.2003.04.002
   Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8
   Smith DT, 2003, J PHYSIOL-LONDON, V546, P289, DOI 10.1113/jphysiol.2002.027870
   Smith JJ, 2009, BMC SYST BIOL, V3, P0, DOI 10.1186/1752-0509-3-31
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Spier SA, 2004, J PHYSIOL-LONDON, V556, P947, DOI 10.1113/jphysiol.2003.060301
   Spier SA, 2007, AM J PHYSIOL-HEART C, V292, PH3119, DOI 10.1152/ajpheart.00588.2006
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5
   Stivala LA, 2001, J BIOL CHEM, V276, P22586, DOI 10.1074/jbc.M101846200
   TADDEI S, 1995, CIRCULATION, V91, P1981, DOI 10.1161/01.CIR.91.7.1981
   Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274
   Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Tang EHC, 2008, PHYSIOL GENOMICS, V32, P409, DOI 10.1152/physiolgenomics.00136.2007
   Tatchum-Talom R, 2004, CAN J PHYSIOL PHARM, V82, P200, DOI 10.1139/Y04-010
   Thoreen CC, 2005, CELL METAB, V1, P287, DOI 10.1016/j.cmet.2005.04.009
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Trott DW, 2011, J APPL PHYSIOL, V110, P1171, DOI 10.1152/japplphysiol.01037.2010
   Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703
   Tuñón MJ, 2003, BIOCHEM PHARMACOL, V66, P439, DOI 10.1016/S0006-2952(03)00288-0
   Uddin M, 2003, MECH AGEING DEV, V124, P811, DOI 10.1016/S0047-6374(03)00135-0
   Ungvari Z, 2008, AM J PHYSIOL-HEART C, V294, PH2121, DOI 10.1152/ajpheart.00012.2008
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092
   VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456
   van den Berg R, 2001, BRIT J NUTR, V86, PS121, DOI 10.1079/BJN2001340
   van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731
   van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, PC343, DOI 10.1152/ajpcell.00048.2003
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Veilai T, 2003, NATURE, V426, P0
   Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945
   Vgontzas AN, 2003, J CLIN ENDOCR METAB, V88, P2087, DOI 10.1210/jc.2002-021176
   Walker AE, 2014, CLIN SCI, V127, P645, DOI 10.1042/CS20140030
   Walker AE, 2014, AGE, V36, P559, DOI 10.1007/s11357-013-9585-0
   Walker AE, 2010, HYPERTENSION, V55, P363, DOI 10.1161/HYPERTENSIONAHA.109.145870
   Walker AE, 2009, AM J HYPERTENS, V22, P250, DOI 10.1038/ajh.2008.353
   Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409
   Westby CM, 2011, CLIN SCI, V120, P485, DOI 10.1042/CS20100475
   Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069
   Whittle JR, 2007, TRENDS ENDOCRIN MET, V18, P356, DOI 10.1016/j.tem.2007.07.007
   Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066
   Woodman CR, 2002, J APPL PHYSIOL, V93, P1685, DOI 10.1152/japplphysiol.00461.2002
   Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200
   Xiao J, 2013, J DIABETES RES, V2013, P0, DOI 10.1155/2013/185172
   Xin MG, 2003, MECH AGEING DEV, V124, P911, DOI 10.1016/S0047-6374(03)00163-5
   Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799
   Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002
   Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100
   Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603
   Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052
   Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483
NR 286
TC 351
Z9 376
U1 2
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0022-2828
EI 1095-8584
J9 J MOL CELL CARDIOL
JI J. Mol. Cell. Cardiol.
PD DEC 15
PY 2015
VL 89
IS 
BP 122
EP 135
DI 10.1016/j.yjmcc.2015.01.021
PG 14
WC Cardiac & Cardiovascular Systems; Cell Biology
SC Cardiovascular System & Cardiology; Cell Biology
GA CZ9KV
UT WOS:000367417400004
PM 25655936
DA 2024-11-01
ER

PT J
AU Tam, ZY
   Gruber, J
   Halliwell, B
   Gunawan, R
AF Tam, Zhi Yang
   Gruber, Jan
   Halliwell, Barry
   Gunawan, Rudiyanto
TI Context-Dependent Role of Mitochondrial Fusion-Fission in Clonal Expansion of mtDNA Mutations
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID dna deletion mutations; skeletal-muscle; copy number; in-vivo; organization; expression; turnover; dynamics; accumulation; autophagy
AB The accumulation of mutant mitochondrial DNA (mtDNA) molecules in aged cells has been associated with mitochondrial dysfunction, age-related diseases and the ageing process itself. This accumulation has been shown to often occur clonally, where mutant mtDNA grow in number and overpopulate the wild-type mtDNA. However, the cell possesses quality control (QC) mechanisms that maintain mitochondrial function, in which dysfunctional mitochondria are isolated and removed by selective fusion and mitochondrial autophagy (mitophagy), respectively. The aim of this study is to elucidate the circumstances related to mitochondrial QC that allow the expansion of mutant mtDNA molecules. For the purpose of the study, we have developed a mathematical model of mitochondrial QC process by extending our previous validated model of mitochondrial turnover and fusion-fission. A global sensitivity analysis of the model suggested that the selectivity of mitophagy and fusion is the most critical QC parameter for clearing de novo mutant mtDNA molecules. We further simulated several scenarios involving perturbations of key QC parameters to gain a better understanding of their dynamic and synergistic interactions. Our model simulations showed that a higher frequency of mitochondrial fusion-fission can provide a faster clearance of mutant mtDNA, but only when mutant-rich mitochondria that are transiently created are efficiently prevented from re-fusing with other mitochondria and selectively removed. Otherwise, faster fusion-fission quickens the accumulation of mutant mtDNA. Finally, we used the insights gained from model simulations and analysis to propose a possible circumstance involving deterioration of mitochondrial QC that permits mutant mtDNA to expand with age.
C1 [Tam, Zhi Yang] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Dept Biochem, Ctr Life Sci, Singapore 117548, Singapore.
   [Gruber, Jan] Natl Univ Singapore, Yale NUS Coll, Div Sci, Singapore 117548, Singapore.
   [Gunawan, Rudiyanto] Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.
   [Gunawan, Rudiyanto] Swiss Inst Bioinformat, Lausanne, Switzerland.
C3 Nanyang Technological University; National University of Singapore; National University of Singapore; Yale NUS College; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics
RP Tam, ZY (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
EM rudi.gunawan@chem.ethz.ch
FU ETH Zurich; Swiss National Science Foundation [150522]; Ministry of Education Singapore [MOE2010-T2-2-048, MOE2012-T2-2-003]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57
   Bess AS, 2012, NUCL ACIDS RES, V0, P0
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Doria E, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/830257
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971
   Figge MT, 2012, PLOS COMPUT BIOL, V8, P0, DOI 10.1371/journal.pcbi.1002576
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x
   Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Gruber J, 2013, BIOTECHNOL ADV, V31, P563, DOI 10.1016/j.biotechadv.2012.09.005
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274
   HUEMER RP, 1971, EXP GERONTOL, V6, P259, DOI 10.1016/0531-5565(71)90038-6
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kraytsberg Y, 2003, MECH AGEING DEV, V124, P49, DOI 10.1016/S0047-6374(02)00169-0
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Narendra D, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011338
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Patel PK, 2013, PLOS COMPUT BIOL, V9, P0, DOI 10.1371/journal.pcbi.1003108
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, P0, DOI 10.1371/journal.pcbi.1003728
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, P0, DOI 10.1371/journal.pcbi.1000572
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saltelli A, 2008, GLOBAL SENSITIVITY A, V0, P0
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Saunter CD, 2009, FEBS LETT, V583, P1267, DOI 10.1016/j.febslet.2009.02.041
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323
   Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433
   Struewing IT, 2007, FEBS J, V274, P2749, DOI 10.1111/j.1742-4658.2007.05809.x
   Tam ZY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076230
   Tam ZY, 2014, J GERONTOL A, V0, P0
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Turnbull DM, 1998, NAT GENET, V18, P199, DOI 10.1038/ng0398-199
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Ullah M, 2010, WIRES SYST BIOL MED, V2, P385, DOI 10.1002/wsbm.78
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Ziehn T, 2009, ENVIRON MODELL SOFTW, V24, P775, DOI 10.1016/j.envsoft.2008.12.002
NR 84
TC 42
Z9 49
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD MAY 15
PY 2015
VL 11
IS 5
BP 
EP 
DI 10.1371/journal.pcbi.1004183
PG 22
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA CL1KA
UT WOS:000356700200011
PM 25996936
DA 2024-11-01
ER

PT J
AU Catteruccia, M
   Sauchelli, D
   Della Marca, G
   Primiano, G
   Cuccagna, C
   Bernardo, D
   Leo, M
   Camporeale, A
   Sanna, T
   Cianfoni, A
   Servidei, S
AF Catteruccia, Michela
   Sauchelli, Donato
   Della Marca, Giacomo
   Primiano, Guido
   Cuccagna, Cristina
   Bernardo, Daniela
   Leo, Milena
   Camporeale, Antonella
   Sanna, Tommaso
   Cianfoni, Alessandro
   Servidei, Serenella
TI "Myo-cardiomyopathy" is commonly associated with the A8344G "MERRF" mutation
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial encephalomyopathies; MERRF syndrome; Cardiomyopathy; Respiratory insufficiency
ID ragged-red fibers; mitochondrial-dna; myoclonic epilepsy; lactic-acidosis; pulmonary-hypertension; cardiac involvement; oxidase deficiency; clinical-features; leigh-disease; disorders
AB The objective of the study was to better characterize the clinical phenotype associated with the A8344G "MERRF" mutation of mitochondrial DNA. Fifteen mutated patients were extensively investigated. The frequency of main clinical features was: exercise intolerance and/or muscle weakness 67 %, respiratory involvement 67 %, lactic acidosis 67 %, cardiac abnormalities 53 %, peripheral neuropathy 47 %, myoclonus 40 %, epilepsy 40 %, ataxia 13 %. A restrictive respiratory insufficiency requiring ventilatory support was observed in about half of our patients. One patient developed a severe and rapidly progressive cardiomyopathy requiring cardioverter-defibrillator implantation. Five patients died of overwhelming, intractable lactic acidosis. Serial muscle MRIs identified a consistent pattern of muscle involvement and progression. Cardiac MRI showed non-ischemic late gadolinium enhancement in the left ventricle inferolateral part as early sign of myocardial involvement. Brain spectroscopy demonstrated increased peak of choline and reduction of N-acetylaspartate. Lactate was never detected in brain areas, while it could be documented in ventricles. We confirm that muscle involvement is the most frequent clinical feature associated with A8443G mutation. In contrast with previous reports, however, about half of our patients did not develop signs of CNS involvement even in later stages of the disease. The difference may be related to the infrequent investigation of A8344G mutation in 'pure' mitochondrial myo-cardiomyopathy, representing a bias and a possible cause of syndrome's underestimation. Our study highlights the importance of lactic acidosis and respiratory muscle insufficiency as critical prognostic factors. Muscle and cardiac MRI and brain spectroscopy may be useful tools in diagnosis and follow-up of MERRF.
C1 [Catteruccia, Michela; Sauchelli, Donato; Della Marca, Giacomo; Primiano, Guido; Cuccagna, Cristina; Bernardo, Daniela; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dept Geriatr Neurosci & Orthoped, Inst Neurol, I-00168 Rome, Italy.
   [Catteruccia, Michela] Bambino Gesii Childrens Hosp, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, Dept Neurosci & Neurorehabil, Rome, Italy.
   [Leo, Milena; Camporeale, Antonella; Sanna, Tommaso] Univ Cattolica Sacro Cuore, Inst Cardiol, I-00168 Rome, Italy.
   [Cianfoni, Alessandro] Lugano Hosp, Neuroradiol, Neuroctr Southern Switzerland, Lugano, Switzerland.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Servidei, S (corresponding author), Univ Cattolica Sacro Cuore, Dept Geriatr Neurosci & Orthoped, Inst Neurol, Largo A Gemelli 8, I-00168 Rome, Italy.
EM s.servidei@rm.unicatt.it
FU Telethon [GUP09004]
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
   Chuang CS, 2007, NEUROL INDIA, V55, P385
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2013, BRAIN DEV-JPN, V35, P466, DOI 10.1016/j.braindev.2012.07.015
   FUKUHARA N, 1991, REV NEUROL, V147, P476
   FUKUHARA N, 1995, MUSCLE NERVE, V0, PS90
   Hirano M, 1994, CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   KENDALL BE, 1992, AM J NEURORADIOL, V13, P621
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Mancuso M, 2007, BIOCHEM BIOPH RES CO, V354, P1058, DOI 10.1016/j.bbrc.2007.01.099
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Sanger TD, 1996, PEDIATR NEUROL, V14, P57, DOI 10.1016/0887-8994(95)00226-X
   Scalais E, 2007, EUR J NEUROL, V14, Pe3, DOI 10.1111/j.1468-1331.2007.01926.x
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1996, BIOCHEM BIOPH RES CO, V20, P221
   SPROULE BJ, 1966, CAN MED ASSOC J, V94, P141
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   TEPLINSKY K, 1990, AM J PHYSIOL, V258, PH1193, DOI 10.1152/ajpheart.1990.258.4.H1193
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Yilmaz A, 2012, CLIN RES CARDIOL, V101, P255, DOI 10.1007/s00392-011-0387-z
   Zaganas I, 2009, J NEUROL, V256, P271, DOI 10.1007/s00415-009-0921-3
   ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D
NR 33
TC 40
Z9 44
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAR 15
PY 2015
VL 262
IS 3
BP 701
EP 710
DI 10.1007/s00415-014-7632-0
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA CE0BX
UT WOS:000351469200025
PM 25559684
DA 2024-11-01
ER

PT J
AU Lehmann, D
   Schubert, K
   Joshi, PR
   Hardy, SA
   Tuppen, HAL
   Baty, K
   Blakely, EL
   Bamberg, C
   Zierz, S
   Deschauer, M
   Taylor, RW
AF Lehmann, Diana
   Schubert, Kathrin
   Joshi, Pushpa R.
   Hardy, Steven A.
   Tuppen, Helen A. L.
   Baty, Karen
   Blakely, Emma L.
   Bamberg, Christian
   Zierz, Stephan
   Deschauer, Marcus
   Taylor, Robert W.
TI Pathogenic mitochondrial mt-tRNA<SUP>Ala</SUP> variants are uniquely associated with isolated myopathy
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID rna point mutations; external ophthalmoplegia; trna(ala) gene; pure myopathy; dna mutations; human-disease; patient
AB Pathogenic mitochondrial DNA (mtDNA) point mutations are associated with a wide range of clinical phenotypes, often involving multiple organ systems. We report two patients with isolated myopathy owing to novel mt-tRNA(Ala) variants. Muscle biopsy revealed extensive histopathological findings including cytochrome c oxidase (COX)-deficient fibres. Pyrosequencing confirmed mtDNA heteroplasmy for both mutations (m.5631G>A and m.5610G>A) whilst single-muscle fibre segregation studies (revealing statistically significant higher mutation loads in COX-deficient fibres than in COX-positive fibres), hierarchical mutation segregation within patient tissues and decreased steady-state mt-tRNAAla levels all provide compelling evidence of pathogenicity. Interestingly, both patients showed very high-mutation levels in all tissues, inferring that the threshold for impairment of oxidative phosphorylation, as evidenced by COX deficiency, appears to be extremely high for these mt-tRNAAla variants. Previously described mt-tRNAAla mutations are also associated with a pure myopathic phenotype and demonstrate very high mtDNA heteroplasmy thresholds, inferring at least some genotype: phenotype correlation for mutations within this particular mt-tRNA gene.
C1 [Lehmann, Diana; Schubert, Kathrin; Joshi, Pushpa R.; Zierz, Stephan; Deschauer, Marcus] Univ Halle Wittenberg, Dept Neurol, D-06108 Halle, Saale, Germany.
   [Hardy, Steven A.; Tuppen, Helen A. L.; Baty, Karen; Blakely, Emma L.; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Bamberg, Christian] Rhein Mosel Fachklin, Dept Neurol, Andernach, Germany.
C3 Martin Luther University Halle Wittenberg; Newcastle University - UK
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU German Ministry of Education and Research; Wellcome Trust [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; Lily Foundation; UK NHS Specialist Commissioners funds the 'Rare Mitochondrial Disorders of Adults and Children' Diagnostic Service in Newcastle upon Tyne; MRC [G0601943, MR/K000608/1] Funding Source: UKRI
CR Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Pinós T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 17
TC 19
Z9 20
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD DEC 15
PY 2015
VL 23
IS 12
BP 1735
EP 1738
DI 10.1038/ejhg.2015.73
PG 4
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CW6TC
UT WOS:000365129700025
PM 25873012
DA 2024-11-01
ER

PT J
AU Zhang, J
   Guo, JH
   Fang, WH
   Jun, QL
   Shi, KL
AF Zhang, Jin
   Guo, Junhong
   Fang, Wanghui
   Jun, Qili
   Shi, Kaili
TI Clinical features of MELAS and its relation with A3243G gene point mutation
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
LA English
DT Article
DE MELAS; point mutation; mitochondrial DNA; maternal inheritance
ID parkinsons-disease; mitochondrial; prevalence; family; adults
AB Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) mostly occur in children. The point mutation A3243G of mitochondrial DNA (mtDNA) may work as a specific bio-marker for mitochondrial disorders. The related clinical features, however, may vary among individuals. This study therefore investigated the relation between MELAS clinical features and point mutation A3243G of mtDNA, in an attempt to provide further evidences for genetic diagnosis of MELAS. Children with MELAS-like syndromes were tested for both blood lactate level and point mutation A3243G of mtDNA. Further family study was performed by mtDNA mutation screening at the same loci for those who had positive gene mutation at A3243G loci. Those who were negative for A3243G point mutation were examined by muscle biopsy and genetic screening. Both clinical and genetic features were analyzed. In all 40 cases with positive A3243G mutation, 36 children fitted clinical diagnosis of MELAS. In other 484 cases with negative mutation, only 8 children were clinically diagnosed with MELAS. Blood lactate levels in both groups were all elevated (P>O. 05). In a further genetic screening of 28 families, 10 biological mothers and 8 silbings of MELAS children had positive A3243G point mutations but without any clinical symptoms. Certain difference existed in the clinical manifestations between children who were positive and negative for A3243G mutation of mtDNA but without statistical significance. MELAS showed maternal inheritance under most circumstances.
C1 [Zhang, Jin; Guo, Junhong; Fang, Wanghui; Jun, Qili] Shanxi Med Univ, Hosp 1, Dept Internal Med Neurol, Taiyuan 030001, Shanxi, Peoples R China.
   [Shi, Kaili] Shanxi Prov Childrens Hosp, Dept Neurol, Taiyuan 030001, Shanxi, Peoples R China.
C3 Shanxi Medical University
RP Zhang, J (corresponding author), Shanxi Med Univ, Hosp 1, Dept Internal Med Neurol, 85 Jiefang South Rd, Taiyuan 030001, Shanxi, Peoples R China.
EM zhangjindoctor88@126.com
FU Department of science research project in Shanxi Province [20130313022]; Yuan funds The first hospital of ShanXi medical university [YJ1402]
CR Abeliovich A, 2010, NATURE, V463, P744, DOI 10.1038/463744a
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Clark J, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-69
   Cwerman-Thibault H, 2011, J INHERIT METAB DIS, V34, P327, DOI 10.1007/s10545-010-9131-5
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Kim HK, 2010, ANN NY ACAD SCI, V1201, P177, DOI 10.1111/j.1749-6632.2010.05623.x
   Lembke A, 2013, PSYCHONEUROENDOCRINO, V38, P115, DOI 10.1016/j.psyneuen.2012.05.006
   Lim ST, 2011, NEUROPHARMACOLOGY, V60, P1160, DOI 10.1016/j.neuropharm.2010.10.012
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Prasad M, 2014, CAN J NEUROL SCI, V41, P210, DOI 10.1017/S0317167100016607
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Zhang Yong-Mei, 2010, YICHUAN, V32, P353, DOI 10.3724/SP.J.1005.2010.00353
NR 20
TC 15
Z9 19
U1 0
U2 4
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1936-2625
EI 
J9 INT J CLIN EXP PATHO
JI Int. J. Clin. Exp. Pathol.
PD JUN 15
PY 2015
VL 8
IS 10
BP 13411
EP 13415
DI 
PG 5
WC Oncology; Pathology
SC Oncology; Pathology
GA DA5AJ
UT WOS:000367814200169
PM 26722549
DA 2024-11-01
ER

PT J
AU Di Marco, LY
   Venneri, A
   Farkas, E
   Evans, PC
   Marzo, A
   Frangi, AF
AF Di Marco, Luigi Yuri
   Venneri, Annalena
   Farkas, Eszter
   Evans, Paul C.
   Marzo, Alberto
   Frangi, Alejandro F.
TI Vascular dysfunction in the pathogenesis of Alzheimer's disease - A review of endothelium-mediated mechanisms and ensuing vicious circles
SO NEUROBIOLOGY OF DISEASE
LA English
DT Review
DE Alzheimer's disease; Blood-brain barrier permeability; Cerebral hypoperfusion; Endothelial dysfunction; Mitochondrial dysfunction; Ultrastructural damage
ID blood-brain-barrier; protein-kinase-c; amyloid-beta protein; nitric-oxide synthase; smooth-muscle-cells; chronic cerebral hypoperfusion; positron emission tomography; mitochondria dna deletions; receptor-related protein-1; central-nervous-system
AB Late-onset dementia is a major health concern in the ageing population. Alzheimer's disease (AD) accounts for the largest proportion (65-70%) of dementia cases in the older population. Despite considerable research effort, the pathogenesis of late-onset AD remains unclear. Substantial evidence suggests that the neurodegenerative process is initiated by chronic cerebral hypoperfusion (CCH) caused by ageing and cardiovascular conditions. CCH causes reduced oxygen, glucose and other nutrient supply to the brain, with direct damage not only to the parenchymal cells, but also to the blood-brain barrier (BBB), a key mediator of cerebral homeostasis. BBB dysfunction mediates the indirect neurotoxic effects of CCH by promoting oxidative stress, inflammation, paracellular permeability, and dysregulation of nitric oxide, a key regulator of regional blood flow. As such, BBB dysfunction mediates a vicious circle in which cerebral perfusion is reduced further and the neurodegenerative process is accelerated. Endothelial interaction with pericytes and astrocytes could also play a role in the process. Reciprocal interactions between vascular dysfunction and neurodegeneration could further contribute to the development of the disease. A comprehensive overview of the complex scenario of interacting endothelium-mediated processes is currently lacking, and could prospectively contribute to the identification of adequate therapeutic interventions. This study reviews the current literature of in vitro and ex vivo studies on endothelium-mediated mechanisms underlying vascular dysfunction in AD pathogenesis, with the aim of presenting a comprehensive overview of the complex network of causative relationships. Particular emphasis is given to vicious circles which can accelerate the process of neurovascular degeneration. (C) 2015 Published by Elsevier Inc.
C1 [Di Marco, Luigi Yuri; Frangi, Alejandro F.] Univ Sheffield, Dept Elect & Elect Engn, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield S1 3JD, S Yorkshire, England.
   [Venneri, Annalena] Univ Sheffield, Sch Med, Dept Neurosci, Sheffield S1 3JD, S Yorkshire, England.
   [Venneri, Annalena] IRCCS San Camillo Fdn Hosp, Venice, Italy.
   [Farkas, Eszter] Univ Szeged, Fac Med, Dept Med Phys & Informat, Szeged, Hungary.
   [Farkas, Eszter] Univ Szeged, Fac Sci & Informat, Szeged, Hungary.
   [Evans, Paul C.] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield S1 3JD, S Yorkshire, England.
   [Marzo, Alberto] Univ Sheffield, Dept Mech Engn, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield S1 3JD, S Yorkshire, England.
C3 University of Sheffield; University of Sheffield; IRCCS Ospedale San Camillo; Szeged University; Szeged University; University of Sheffield; University of Sheffield
RP Di Marco, LY (corresponding author), Univ Sheffield, Dept Elect & Elect Engn, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield S1 3JD, S Yorkshire, England.
EM luigiyuri.dimarco@gmail.com
FU European Union's Seventh Framework Programme (FP7) as part of the project VPH-DARE@IT [601055]; Engineering and Physical Sciences Research Council (EPSRC) (OCEAN Project) [EP/M006328/1]; Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences [BO/00327/14/5]; EPSRC [EP/M006328/1] Funding Source: UKRI
CR Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030
   Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x
   Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772
   Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668
   Abete P, 2014, AGEING RES REV, V18, P41, DOI 10.1016/j.arr.2014.07.003
   AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F
   Aliev G, 2014, CURR MED CHEM, V21, P2208, DOI 10.2174/0929867321666131227161303
   Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159
   Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x
   Aliev G, 2002, BRAIN PATHOL, V12, P21
   Aliev Gjumrakch, 2011, RECENT PAT CARDIOVASC DRUG DISCOV, V6, P222
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aliev G, 2009, NEUROTOX RES, V16, P293, DOI 10.1007/s12640-009-9066-5
   Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040
   Alonso A, 2009, J NEUROL SCI, V280, P79, DOI 10.1016/j.jns.2009.02.004
   Andjelkovic AV, 1998, J NEUROSCI RES, V51, P423, DOI 10.1002/(SICI)1097-4547(19980215)51:4<423::AID-JNR2>3.0.CO;2-E
   Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001
   Austin SA, 2013, J NEUROCHEM, V127, P691, DOI 10.1111/jnc.12334
   Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080
   Bamji-Mirza M, 2014, J ALZHEIMERS DIS, V40, P105, DOI 10.3233/JAD-131949
   Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612
   Bauer HC, 2000, CELL MOL NEUROBIOL, V20, P13, DOI 10.1023/A:1006939825857
   Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043
   Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3
   Bennett SAL, 2000, NEUROBIOL AGING, V21, P207, DOI 10.1016/S0197-4580(00)00131-7
   Bennett S, 2009, J ALZHEIMERS DIS, V17, P245, DOI 10.3233/JAD-2009-1041
   BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003
   BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B
   Blanc EM, 1997, J NEUROCHEM, V68, P1870
   Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14
   BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698
   BROADWELL RD, 1981, P NATL ACAD SCI-BIOL, V78, P7820, DOI 10.1073/pnas.78.12.7820
   Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001
   Brown RC, 2005, BIOCHEM BIOPH RES CO, V327, P1114, DOI 10.1016/j.bbrc.2004.12.123
   Bürger S, 2009, INT J DEV NEUROSCI, V27, P517, DOI 10.1016/j.ijdevneu.2009.06.011
   Bulbarelli A, 2012, MOL CELL NEUROSCI, V49, P415, DOI 10.1016/j.mcn.2012.01.007
   Burgmans S, 2013, J ALZHEIMERS DIS, V35, P859, DOI 10.3233/JAD-122155
   BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U
   Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9
   Calderone V, 2010, BIOCHEM PHARMACOL, V79, P39, DOI 10.1016/j.bcp.2009.07.017
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje
   Chaitanya GV, 2014, CELL COMMUN SIGNAL, V12, P0, DOI 10.1186/1478-811X-12-7
   Ciallella JR, 1999, THROMB HAEMOSTASIS, V81, P630
   Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247
   Claudio L, 1996, ACTA NEUROPATHOL, V91, P6
   COLE G, 1988, BRAIN RES, V452, P165, DOI 10.1016/0006-8993(88)90021-2
   Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009
   Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321
   Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005
   Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021
   De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001
   de la Torre JC, 2002, J ALZHEIMERS DIS, V4, P497, DOI 10.3233/jad-2002-4606
   de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793
   de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002
   de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057
   de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0
   de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6
   Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890
   Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663
   DEHOUCK B, 1994, J CELL BIOL, V126, P465, DOI 10.1083/jcb.126.2.465
   DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x
   Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8
   Deli MA, 2010, J ALZHEIMERS DIS, V22, P777, DOI 10.3233/JAD-2010-100759
   Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3
   Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469
   DORHEIM MA, 1994, BIOCHEM BIOPH RES CO, V205, P659, DOI 10.1006/bbrc.1994.2716
   DUARA R, 1986, NEUROLOGY, V36, P879, DOI 10.1212/WNL.36.7.879
   Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080
   Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544
   Farkas E, 2000, ACTA NEUROPATHOL, V100, P395, DOI 10.1007/s004010000195
   Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X
   Farkas E, 2006, VASC DIS PREV, V3, P253, DOI 10.2174/156727006778019167
   Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003
   Farkas IG, 2003, ACTA HISTOCHEM, V105, P115, DOI 10.1078/0065-1281-00696
   FAULSTICH ME, 1991, INT J NEUROSCI, V57, P39, DOI 10.3109/00207459109150345
   FERRARIDILEO G, 1985, J CEREBR BLOOD F MET, V5, P458, DOI 10.1038/jcbfm.1985.62
   Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367
   Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, P0
   Folin M, 2005, INT J MOL MED, V15, P929
   Fonseca AC, 2014, MOL NEUROBIOL, V0, P0
   Fonseca ACRG, 2013, BBA-MOL BASIS DIS, V1832, P2191, DOI 10.1016/j.bbadis.2013.08.007
   Fossati S, 2012, NEURODEGENER DIS, V10, P324, DOI 10.1159/000332821
   FOSTER NL, 1984, ANN NEUROL, V16, P649, DOI 10.1002/ana.410160605
   FRIEDLAND RP, 1989, NEUROLOGY, V39, P1427, DOI 10.1212/WNL.39.11.1427
   FROHMAN EM, 1991, J NEUROL SCI, V106, P105, DOI 10.1016/0022-510X(91)90202-I
   Garcia-Escudero V, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/162152
   Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9
   Gentile MT, 2004, J BIOL CHEM, V279, P48135, DOI 10.1074/jbc.M407358200
   Giri R, 2002, AM J PHYSIOL-CELL PH, V283, PC895, DOI 10.1152/ajpcell.00293.2001
   Giri R, 2000, AM J PHYSIOL-CELL PH, V279, PC1772, DOI 10.1152/ajpcell.2000.279.6.C1772
   Gonzalez-Velasquez FJ, 2008, J NEUROCHEM, V104, P500, DOI 10.1111/j.1471-4159.2007.04988.x
   Gonzalez-Velasquez FJ, 2011, CURR ALZHEIMER RES, V8, P81
   GRAMMAS P, 1995, DEMENTIA, V6, P126, DOI 10.1159/000106934
   Grammas P, 2004, J ALZHEIMERS DIS, V6, P275
   GRAMMAS P, 1995, NEUROBIOL AGING, V16, P563, DOI 10.1016/0197-4580(95)00048-J
   Grammas P, 2002, J ALZHEIMERS DIS, V4, P217, DOI 10.3233/JAD-2002-4311
   Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7
   Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4
   Grammas P, 2006, J ALZHEIMERS DIS, V9, P51
   Grammas Paula, 2011, CLEVE CLIN J MED, V78 Suppl 1, PS50, DOI 10.3949/ccjm.78.s1.09
   Grammas P, 2011, INT J CLIN EXP PATHO, V4, P616
   Grammas P, 2011, EXPERT REV MOL MED, V13, P0, DOI 10.1017/S1462399411001918
   Grammas P, 2011, J NEUROINFLAMM, V8, P0, DOI 10.1186/1742-2094-8-26
   Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x
   Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165
   Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7
   Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   HARIK SI, 1981, J CEREBR BLOOD F MET, V1, P329, DOI 10.1038/jcbfm.1981.36
   HARIK SI, 1986, P NATL ACAD SCI USA, V83, P4067, DOI 10.1073/pnas.83.11.4067
   HARIK SI, 1992, CAN J PHYSIOL PHARM, V70, PS113, DOI 10.1139/y92-252
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516
   HEISS WD, 1991, J NEURAL TRANSM-GEN, V0, P13
   Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008
   Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295
   Hughes TF, 2010, AM J ALZHEIMERS DIS, V25, P432, DOI 10.1177/1533317510368399
   Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6
   Itoh Y, 2006, CLIN HEMORHEOL MICRO, V34, P163
   JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65
   Jellinger KA, 2005, J NEUROL SCI, V229, P37, DOI 10.1016/j.jns.2004.11.018
   Jeynes B, 2008, CURR ALZHEIMER RES, V5, P432, DOI 10.2174/156720508785908937
   Jeynes B, 2009, NEUROSCI LETT, V463, P244, DOI 10.1016/j.neulet.2009.07.091
   JOHSHITA H, 1993, ADV EXP MED BIOL, V331, P61
   Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032
   Kalaria RN, 1995, BRAIN RES, V705, P349, DOI 10.1016/0006-8993(95)01250-8
   KALARIA RN, 1995, NEUROREPORT, V6, P477, DOI 10.1097/00001756-199502000-00018
   KALARIA RN, 1989, NEUROSCI LETT, V106, P233, DOI 10.1016/0304-3940(89)90231-0
   KALARIA RN, 1989, NEUROSCI LETT, V97, P203, DOI 10.1016/0304-3940(89)90164-X
   KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x
   Kalaria RN, 2003, INT PSYCHOGERIATR, V15, P47, DOI 10.1017/S1041610203008950
   Kalaria RN, 1996, MOL BRAIN RES, V35, P58, DOI 10.1016/0169-328X(95)00180-Z
   Kalaria RN, 1997, ANN NY ACAD SCI, V826, P263, DOI 10.1111/j.1749-6632.1997.tb48478.x
   Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1
   Kamouchi M, 2004, MOL BRAIN RES, V126, P114, DOI 10.1016/j.molbrainres.2004.03.008
   Katusic ZS, 2014, EUR HEART J, V35, P888, DOI 10.1093/eurheartj/eht544
   Kelleher RJ, 2013, AM J CARDIOVASC DIS, V3, P197
   KOBAYASHI H, 1982, NEUROLOGY, V32, P1384, DOI 10.1212/WNL.32.12.1384
   Kook SY, 2013, TISSUE BARRIERS, V1, P0, DOI 10.4161/tisb.23993
   Kook SY, 2012, J NEUROSCI, V32, P8845, DOI 10.1523/JNEUROSCI.6102-11.2012
   Krizbai IA, 2005, CELL MOL NEUROBIOL, V25, P129, DOI 10.1007/s10571-004-1378-7
   Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x
   Latta CH, 2014, NEUROSCIENCE, V0, P0
   Lenzsér G, 2005, BRAIN RES, V1051, P72, DOI 10.1016/j.brainres.2005.05.064
   Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007
   Lucke-Wold BP, 2015, J ALZHEIMERS DIS, V43, P711, DOI 10.3233/JAD-141422
   Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072
   Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, P0, DOI 10.1186/2045-8118-9-23
   Lyros E, 2014, CURR ALZHEIMER RES, V11, P18, DOI 10.2174/1567205010666131119235254
   Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029
   Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066
   Mark KS, 2002, AM J PHYSIOL-HEART C, V282, PH1485, DOI 10.1152/ajpheart.00645.2001
   MARTINEZ M, 1994, NEUROSCI LETT, V170, P121, DOI 10.1016/0304-3940(94)90254-2
   MASLIAH E, 1991, J NEUROSCI, V11, P2759
   Matsushima H, 1996, J NEUROCHEM, V67, P317
   Maxwell AJ, 2002, NITRIC OXIDE-BIOL CH, V6, P101, DOI 10.1006/niox.2001.0394
   McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8
   Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001
   Miller MC, 2008, BRAIN RES, V1230, P273, DOI 10.1016/j.brainres.2008.06.124
   Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   Moore P, 1998, NEUROSCI LETT, V254, P29, DOI 10.1016/S0304-3940(98)00653-3
   MORRIS SM, 1994, AM J PHYSIOL, V266, PE829, DOI 10.1152/ajpendo.1994.266.6.E829
   Müller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5
   MUTISYA EM, 1994, J NEUROCHEM, V63, P2179
   Niewiadomska G, 2011, BEHAV BRAIN RES, V221, P515, DOI 10.1016/j.bbr.2010.02.024
   Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532
   Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759
   Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf
   Oishi K, 2007, MICROVASC RES, V73, P20, DOI 10.1016/j.mvr.2006.08.004
   Owen JB, 2010, FREE RADICAL BIO MED, V49, P1798, DOI 10.1016/j.freeradbiomed.2010.09.013
   Pakaski M, 2002, NEUROCHEM INT, V41, P409, DOI 10.1016/S0197-0186(02)00026-8
   Palmer JC, 2013, J ALZHEIMERS DIS, V36, P577, DOI 10.3233/JAD-130383
   Paris Daniel, 2004, ANGIOGENESIS, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf
   Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005
   Park R, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.258
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x
   Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193
   Perluigi M, 2014, AGEING RES REV, V13, P75, DOI 10.1016/j.arr.2013.12.005
   PEROUTKA SJ, 1980, SCIENCE, V208, P610, DOI 10.1126/science.6102801
   Perry G, 2000, INT J DEV NEUROSCI, V18, P417, DOI 10.1016/S0736-5748(00)00006-X
   Placido AI, 2014, MOLECULAR NEUROBIOLOGY, V0, P0
   Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998
   Provias J, 2014, INT J ALZHEIMERS DIS, V2014, P191863, DOI 10.1155/2014/191863
   Provias J, 2008, CURR NEUROVASC RES, V5, P199, DOI 10.2174/156720208785425729
   Reinhardt CA, 1997, TOXICOL IN VITRO, V11, P513, DOI 10.1016/S0887-2333(97)00039-8
   Roberts KF, 2014, ANN NEUROL, V76, P837, DOI 10.1002/ana.24270
   Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44
   Roher AE, 2011, ALZHEIMERS DEMENT, V7, P436, DOI 10.1016/j.jalz.2010.08.228
   Rosengarten B, 2006, J NEUROL, V253, P58, DOI 10.1007/s00415-005-0926-5
   RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725
   Ruzali WAW, 2013, J ALZHEIMERS DIS, V33, P95, DOI 10.3233/JAD-2012-121336
   Sagare AP, 2012, COLD SPRING HARB PER, V0, P0
   Sagare AP, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3932
   Sanchez A, 2013, J ALZHEIMERS DIS, V34, P281, DOI 10.3233/JAD-121636
   Sanchez A, 2012, J ALZHEIMERS DIS, V32, P587, DOI 10.3233/JAD-2012-120829
   SATO A, 1995, ALZ DIS ASSOC DIS, V9, P28, DOI 10.1097/00002093-199505000-00007
   Schini-Kerth VB, 1999, TRANSFUS CLIN BIOL, V6, P355, DOI 10.1016/S1246-7820(00)88980-6
   Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629
   Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P1034, DOI 10.1097/NEN.0b013e3181f46e25
   Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P98, DOI 10.1097/NEN.0b013e3181c8ad2f
   SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507
   Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5
   Smith MA, 1997, J NEUROSCI, V17, P2653
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   STEWART PA, 1992, LAB INVEST, V67, P734
   Strasser A, 1997, ACT NEUR S, V70, P8
   Suhara T, 2003, NEUROBIOL AGING, V24, P437, DOI 10.1016/S0197-4580(02)00135-5
   Sun MK, 2004, J ALZHEIMERS DIS, V6, P355
   Suo ZM, 1998, BRAIN RES, V807, P110, DOI 10.1016/S0006-8993(98)00780-X
   Toda N, 2012, J ALZHEIMERS DIS, V32, P569, DOI 10.3233/JAD-2012-120670
   Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547
   Tong XK, 1999, NEUROSCIENCE, V92, P163, DOI 10.1016/S0306-4522(98)00750-7
   Tripathy D, 2013, FRONT AGING NEUROSCI, V5, P0, DOI 10.3389/fnagi.2013.00019
   Uchihara T, 1997, STROKE, V28, P1948, DOI 10.1161/01.STR.28.10.1948
   Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van Assema DME, 2012, BRAIN, V135, P181, DOI 10.1093/brain/awr298
   Van Beek AHEA, 2011, BEHAV BRAIN RES, V221, P537, DOI 10.1016/j.bbr.2009.12.047
   van Norden AGW, 2012, BBA-MOL BASIS DIS, V1822, P340, DOI 10.1016/j.bbadis.2011.07.003
   Vogelgesang S, 2002, PHARMACOGENETICS, V12, P535, DOI 10.1097/00008571-200210000-00005
   Vromman A, 2013, AGING CELL, V12, P358, DOI 10.1111/acel.12056
   Vukic V, 2009, NEUROBIOL DIS, V34, P95, DOI 10.1016/j.nbd.2008.12.007
   Walsh T, 2009, J AM GERIATR SOC, V57, P140, DOI 10.1111/j.1532-5415.2008.02051.x
   WANG HY, 1994, NEUROBIOL AGING, V15, P293, DOI 10.1016/0197-4580(94)90023-X
   Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109
   Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004
   Whitehouse PJ, 1997, PSYCHOPHARMACOL BULL, V33, P129
   Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050
   Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006
   Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152
   Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008
   Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287
   Xu J, 2001, J CEREBR BLOOD F MET, V21, P702, DOI 10.1097/00004647-200106000-00008
   Yamagata K, 2004, NEUROBIOL DIS, V17, P491, DOI 10.1016/j.nbd.2004.08.001
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200
   Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039
   Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003
   Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114
   Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x
NR 245
TC 194
Z9 215
U1 0
U2 44
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD OCT 15
PY 2015
VL 82
IS 
BP 593
EP 606
DI 10.1016/j.nbd.2015.08.014
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA CW4RO
UT WOS:000364980000056
PM 26311408
DA 2024-11-01
ER

PT J
AU Peralta, S
   Torraco, A
   Iommarini, L
   Diaz, F
AF Peralta, Susana
   Torraco, Alessandra
   Iommarini, Luisa
   Diaz, Francisca
TI Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies
SO MITOCHONDRION
LA English
DT Review
DE Mitochondria; Oxidative phosphorylation; OXPHOS; Mouse models; Mitochondrial diseases
ID gene-therapy; mtdna heteroplasmy; respiratory-chain; deoxynucleotide pools; nicotinamide riboside; allotopic expression; skeletal-muscle; dna mutations; murine model; bezafibrate
AB Mitochondrial defects are the cause of numerous disorders affecting the oxidative phosphorylation system (OXPHOS) in humans leading predominantly to neurological and muscular degeneration. The molecular origin, manifestations, and progression of mitochondrial diseases have a broad spectrum, which makes very challenging to find a globally effective therapy. The study of the molecular mechanisms underlying the mitochondrial dysfunction indicates that there is a wide range of pathways, enzymes and molecules that can be potentially targeted for therapeutic purposes. Therefore, focusing on the pathology of the disease is essential to design new treatments. In this review, we will summarize and discuss the different therapeutic interventions tested in some mouse models of mitochondrial diseases emphasizing the molecular mechanisms of action and their potential applications. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All tights reserved.
C1 [Peralta, Susana; Diaz, Francisca] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.
   [Torraco, Alessandra] IRCCS, Bambino Gesu Childrens Hosp, Mol Med Lab, Neuromuscular & Neurodegenerat Disorders, I-00146 Rome, Italy.
   [Iommarini, Luisa] Univ Bologna, Dept Pharm & Biotechnol FABIT, I-40126 Bologna, Italy.
C3 University of Miami; IRCCS Bambino Gesu; University of Bologna
RP Diaz, F (corresponding author), Two Story Labs, 1420 NW 9th Ave,Room 230B, Miami, FL 33136 USA.
EM SPeralta@med.miami.edu; alessandra.torraco@opbg.net; luisa.iommarini2@unibo.it; fdiaz1@med.miami.edu
FU James and Esther King Research Program Florida Department of Health [08KN-01]; National Institute of Health [GM101225]; United Mitochondrial Disease Foundation [14050R]
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023
   Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074
   Bonnefont JP, 2009, NEW ENGL J MED, V360, P838, DOI 10.1056/NEJMc0806334
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bouaita A, 2012, BRAIN, V135, P35, DOI 10.1093/brain/awr290
   Bundred N, 2013, INVEST NEW DRUG, V31, P949, DOI 10.1007/s10637-012-9922-7
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Dillon LM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044335
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Djouadi F, 2011, CELL METAB, V14, P715, DOI 10.1016/j.cmet.2011.11.003
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   El-Khoury R, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003182
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Hirano M, 2004, NUCLEOS NUCLEOT NUCL, V23, P1217, DOI 10.1081/NCN-200027485
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kakizaki Y, 2010, BBA-BIOENERGETICS, V1797, P20, DOI 10.1016/j.bbabio.2009.07.006
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339
   Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769
   Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923
   Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Saada A, 2011, MOL GENET METAB, V104, P39, DOI 10.1016/j.ymgme.2011.07.016
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schiff M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028823
   Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tenenbaum A, 2005, ARCH INTERN MED, V165, P1154, DOI 10.1001/archinte.165.10.1154
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 86
TC 9
Z9 9
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2015
VL 23
IS 
BP 71
EP 80
DI 10.1016/j.mito.2015.01.007
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CO0EV
UT WOS:000358823800009
PM 25638392
DA 2024-11-01
ER

PT J
AU Lorenzoni, PJ
   Werneck, LC
   Kay, CSK
   Silvado, CES
   Scola, RH
AF Lorenzoni, Paulo Jose
   Werneck, Lineu Cesar
   Kamoi Kay, Claudia Suemi
   Soares Silvado, Carlos Eduardo
   Scola, Rosana Herminia
TI When should MELAS (<i>Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes</i>) be the diagnosis?
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE MELAS; mitochondria; myopathy; stroke; encephalopathy; genetics
ID transfer rnaleu(uur) gene; muscle-fiber analysis; c-oxidase deficiency; ragged-red fibers; point mutation; clinical-features; blood-vessels; vascular involvement; molecular-genetics; dna mutation
AB Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) is a rare mitochondrial disorder. Diagnostic criteria for MELAS include typical manifestations of the disease: stroke-like episodes, encephalopathy, evidence of mitochondrial dysfunction ( laboratorial or histological) and known mitochondrial DNA gene mutations. Clinical features of MELAS are not necessarily uniform in the early stages of the disease, and correlations between clinical manifestations and physiopathology have not been fully elucidated. It is estimated that point mutations in the tRNA(Leu(UUR)) gene of the DNAmt, mainly A3243G, are responsible for more of 80% of MELAS cases. Morphological changes seen upon muscle biopsy in MELAS include a substantive proportion of ragged red fibers (RRF) and the presence of vessels with a strong reaction for succinate dehydrogenase. In this review, we discuss mainly diagnostic criterion, clinical and laboratory manifestations, brain images, histology and molecular findings as well as some differential diagnoses and current treatments.
C1 [Lorenzoni, Paulo Jose; Werneck, Lineu Cesar; Kamoi Kay, Claudia Suemi; Soares Silvado, Carlos Eduardo; Scola, Rosana Herminia] Univ Fed Parana, Hosp Clin, Dept Clin Med, Serv Neurol & Doencas Neuromusculares, BR-80060000 Curitiba, Parana, Brazil.
C3 Universidade Federal do Parana
RP Scola, RH (corresponding author), Hosp Clin UFPR, Serv Doencas Neuromusculares, Rua Gen Carneiro,181-3 Andar, BR-80060900 Curitiba, Parana, Brazil.
EM rosana.scola@hc.ufpr.br
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Conforto AB, 2007, ARQ NEURO-PSIQUIAT, V65, P371, DOI 10.1590/S0004-282X2007000300001
   DiMauro S, 2013, GENEREVIEWS, V0, P0
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1178, DOI 10.1111/j.1468-1331.2009.02789.x
   Finsterer Josef, 2012, OPEN NEUROL J, V6, P26, DOI 10.2174/1874205X01206010026
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Gilchrist JM, 1996, STROKE, V27, P1420, DOI 10.1161/01.STR.27.8.1420
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7
   Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   KOBAYASHI M, 1986, J INHERIT METAB DIS, V9, P301, DOI 10.1007/BF01799670
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koenigsberger MR, 1976, 5 ANN M CHILD NEUR S, V0, P0
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   MATSUOKA T, 1992, MUSCLE NERVE, V15, P209, DOI 10.1002/mus.880150213
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Richardson J, 2015, STEM CELLS, V33, P639, DOI 10.1002/stem.1887
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHAPIRA Y, 1975, NEUROLOGY, V25, P614, DOI 10.1212/WNL.25.7.614
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Tanji K, 2008, J NEUROL SCI, V270, P23, DOI 10.1016/j.jns.2008.01.016
   TOKUNAGA M, 1993, ANN NEUROL, V33, P275, DOI 10.1002/ana.410330308
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Vanderver Adeline, 2005, CURR NEUROL NEUROSCI REP, V5, P110
   Werneck L C, 1987, ARQ NEUROPSIQUIATR, V45, P288
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 60
TC 45
Z9 57
U1 0
U2 15
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD NOV 15
PY 2015
VL 73
IS 11
BP 959
EP 967
DI 10.1590/0004-282X20150154
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA CV5SR
UT WOS:000364331900014
PM 26517220
DA 2024-11-01
ER

PT J
AU Moteki, H
   Azaiez, H
   Booth, KT
   Hattori, M
   Sato, A
   Sato, Y
   Motobayashi, M
   Sloan, CM
   Kolbe, DL
   Shearer, AE
   Smith, RJH
   Usami, S
AF Moteki, Hideaki
   Azaiez, Hela
   Booth, Kevin T.
   Hattori, Mitsuru
   Sato, Ai
   Sato, Yoshihiko
   Motobayashi, Mitsuo
   Sloan, Christina M.
   Kolbe, Diana L.
   Shearer, A. Eliot
   Smith, Richard J. H.
   Usami, Shin-ichi
TI Hearing Loss Caused by a <i>P2RX2</i> Mutation Identified in a MELAS Family With a Coexisting Mitochondrial 3243AG Mutation
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE hearing loss; genetics; P2X2; MELAS; massively parallel sequencing
ID dna mutations; deafness; enrichment; cochlea; locus
AB Objectives: We present a family with a mitochondrial DNA 3243A>G mutation resulting in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), of which some members have hearing loss in which a novel mutation in the P2RX2 gene was identified. Methods: One hundred ninety-four (194) Japanese subjects from unrelated families were enrolled in the study. Targeted genomic enrichment and massively parallel sequencing of all known nonsyndromic hearing loss genes were performed to identify the genetic causes of hearing loss. Results: A novel mutation in the P2RX2 gene that corresponded to c.601G>A (p.Asp201Tyr) was identified. Two patients carried the mutation and had severe sensorineural hearing loss, while other members with MELAS (who did not carry the P2RX2 mutation) had normal hearing. Conclusion: This is the first case report of a diagnosis of hearing loss caused by P2RX2 mutation in patients with MELAS. A potential explanation is that a decrease in adenosine triphosphate (ATP) production due to MELAS with a mitochondrial 3243A>G mutation might suppress activation of P2X2 receptors. We also suggest that hearing loss caused by the P2RX2 mutation might be influenced by the decrease in ATP production due to MELAS.
C1 [Moteki, Hideaki; Hattori, Mitsuru; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 3908621, Japan.
   [Moteki, Hideaki; Azaiez, Hela; Booth, Kevin T.; Sloan, Christina M.; Kolbe, Diana L.; Shearer, A. Eliot; Smith, Richard J. H.] Univ Iowa Hosp & Clin, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol & Renal Res Labs, Iowa City, IA 52242 USA.
   [Moteki, Hideaki; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 3908621, Japan.
   [Sato, Ai; Sato, Yoshihiko] Shinshu Univ, Sch Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Matsumoto, Nagano 3908621, Japan.
   [Motobayashi, Mitsuo] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan.
C3 Shinshu University; University of Iowa; Shinshu University; Shinshu University; Shinshu University
RP Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.
EM usami@shinshu-u.ac.jp
FU NIDCD [RO1s DC003544, DC002842, DC012049]
CR Blanton SH, 2002, J MED GENET, V39, P567, DOI 10.1136/jmg.39.8.567
   Faletra F, 2014, GENE, V534, P236, DOI 10.1016/j.gene.2013.10.052
   Frommolt P, 2012, HUM MUTAT, V33, P635, DOI 10.1002/humu.22036
   Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110
   Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001
   Housley GD, 1999, J NEUROSCI, V19, P8377
   Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Petersen MB, 2002, CLIN GENET, V62, P1, DOI 10.1034/j.1399-0004.2002.620101.x
   Scuderi C, 2010, MITOCHONDRION, V10, P548, DOI 10.1016/j.mito.2010.04.004
   Shearer AE, 2013, J MED GENET, V50, P627, DOI 10.1136/jmedgenet-2013-101749
   Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107
   Shearer AE, 2012, BMC BIOTECHNOL, V12, P0, DOI 10.1186/1472-6750-12-20
   Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3
   Telang RS, 2010, PURINERG SIGNAL, V6, P263, DOI 10.1007/s11302-010-9195-6
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Yan D, 2005, J HUM GENET, V50, P516, DOI 10.1007/s10038-005-0286-0
   Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110
   Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102
   Zhu Y, 2010, PURINERG SIGNAL, V6, P221, DOI 10.1007/s11302-010-9184-9
NR 22
TC 14
Z9 17
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-4894
EI 1943-572X
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD MAY 15
PY 2015
VL 124
IS 
BP 177S
EP 183S
DI 10.1177/0003489415575045
PG 7
WC Otorhinolaryngology
SC Otorhinolaryngology
GA CG6PA
UT WOS:000353422900018
PM 25788561
DA 2024-11-01
ER

PT J
AU Tranah, GJ
   Yaffe, K
   Katzman, SM
   Lam, ET
   Pawlikowska, L
   Kwok, PY
   Schork, NJ
   Manini, TM
   Kritchevsky, S
   Thomas, F
   Newman, AB
   Harris, TB
   Coleman, AL
   Gorin, MB
   Helzner, EP
   Rowbotham, MC
   Browner, WS
   Cummings, SR
AF Tranah, Gregory J.
   Yaffe, Kristine
   Katzman, Shana M.
   Lam, Ernest T.
   Pawlikowska, Ludmila
   Kwok, Pui-Yan
   Schork, Nicholas J.
   Manini, Todd M.
   Kritchevsky, Stephen
   Thomas, Fridtjof
   Newman, Anne B.
   Harris, Tamara B.
   Coleman, Anne L.
   Gorin, Michael B.
   Helzner, Elizabeth P.
   Rowbotham, Michael C.
   Browner, Warren S.
   Cummings, Steven R.
TI Mitochondrial DNA Heteroplasmy Associations With Neurosensory and Mobility Function in Elderly Adults
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
LA English
DT Article
DE Mitochondrial DNA; Heteroplasmy; Cognition; Vision; Hearing; Mobility
ID hereditary optic neuropathy; complex-i deficiency; skeletal-muscle; clonal expansion; mtdna mutations; nd3 gene; disease; cells; selection; dysfunction
AB Background. Mitochondrial DNA ( mtDNA) heteroplasmy is a mixture of normal and mutated mtDNA molecules in a cell. High levels of heteroplasmy at specific mtDNA sites lead to inherited mitochondrial diseases with neurological, sensory, and movement impairments. Here we test the hypothesis that heteroplasmy levels in elderly adults are associated with impaired function resembling mild forms of mitochondrial disease. Methods. We examined platelet mtDNA heteroplasmy at 20 disease-causing sites for associations with neurosensory and mobility function among 137 participants from the community-based Health, Aging, and Body Composition Study. Results. Elevated mtDNA heteroplasmy at four mtDNA sites in complex I and tRNA genes was nominally associated with reduced cognition, vision, hearing, and mobility: m. 10158T> C with Modified Mini-Mental State Examination score ( p =.009); m. 11778G> A with contrast sensitivity ( p =.02); m. 7445A> G with high-frequency hearing ( p =.047); and m. 5703G> A with 400 m walking speed ( p =.007). Conclusions. These results indicate that increased mtDNA heteroplasmy at disease-causing sites is associated with neurosensory and mobility function in older persons. We propose the novel use of mtDNA heteroplasmy as a simple, noninvasive predictor of age-related neurologic, sensory, and movement impairments.
C1 [Tranah, Gregory J.; Rowbotham, Michael C.; Browner, Warren S.; Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
   [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA.
   [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA.
   [Katzman, Shana M.] LA Eye Ctr & Clin, Los Angeles, CA USA.
   [Lam, Ernest T.] BioNano Genom Inc, San Diego, CA USA.
   [Pawlikowska, Ludmila] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.
   [Pawlikowska, Ludmila; Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.
   [Schork, Nicholas J.] J Craig Venter Inst, San Francisco, CA USA.
   [Schork, Nicholas J.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
   [Kritchevsky, Stephen] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA.
   [Thomas, Fridtjof] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA.
   [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA.
   [Coleman, Anne L.; Gorin, Michael B.] Jules Stein Eye Inst, Los Angeles, CA 90024 USA.
   [Coleman, Anne L.; Gorin, Michael B.] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA.
   [Helzner, Elizabeth P.] Suny Downstate Med Ctr, Dept Epidemiol & Biostat, Brooklyn, NY 11203 USA.
C3 California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; J. Craig Venter Institute; University of California System; University of California San Francisco; State University System of Florida; University of Florida; Wake Forest University; University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; State University of New York (SUNY) System; SUNY Downstate Health Sciences University
RP Tranah, GJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Mission Hall Global Hlth & Clin Sci Bldg,550 16th, San Francisco, CA 94143 USA.
EM gtranah@sfcc-cpmc.net
FU NIH, National Institute on Aging [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Institutes of Health [R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932, R01-HL121023]; Research and Education Leadership Committee of the CPMC Foundation
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Catricala S, 2012, IMMUN AGEING, V9, P0, DOI 10.1186/1742-4933-9-20
   Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965
   Coon KD, 2006, MITOCHONDRION, V6, P194, DOI 10.1016/j.mito.2006.07.002
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Durham SE, 2006, NEUROMUSCULAR DISORD, V16, P381, DOI 10.1016/j.nmd.2006.03.012
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868
   Guy J, 2014, INVEST OPHTH VIS SCI, V55, P841, DOI 10.1167/iovs.13-13365
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Naviaux RK, 2000, EUR J PEDIATR, V159, PS219, DOI 10.1007/PL00014407
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Tranah GJ, 2012, BBA-BIOENERGETICS, V1817, P1691, DOI 10.1016/j.bbabio.2012.05.012
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyrrell DJ, 2015, J GERONTOL A-BIOL, V70, P1394, DOI 10.1093/gerona/glu096
   Van Remmen H, 2009, J GERONTOL A-BIOL, V64, P171, DOI 10.1093/gerona/gln058
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zanna C, 2003, ANN NY ACAD SCI, V1010, P213, DOI 10.1196/annals.1299.037
   Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548
NR 53
TC 21
Z9 22
U1 3
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV 15
PY 2015
VL 70
IS 11
BP 1418
EP 1424
DI 10.1093/gerona/glv097
PG 7
WC Geriatrics & Gerontology; Gerontology
SC Geriatrics & Gerontology
GA CW1QF
UT WOS:000364765700016
PM 26328603
DA 2024-11-01
ER

PT J
AU Sazonova, MA
   Chicheva, MM
   Zhelankin, AV
   Sobenin, IA
   Bobryshev, YV
   Orekhov, AN
AF Sazonova, Margarita A.
   Chicheva, Mariya M.
   Zhelankin, Andrey V.
   Sobenin, Igor A.
   Bobryshev, Yuri V.
   Orekhov, Alexander N.
TI Association of mutations in the mitochondrial genome with the subclinical carotid atherosclerosis in women
SO EXPERIMENTAL AND MOLECULAR PATHOLOGY
LA English
DT Article
DE Mitochondria; Atherosclerosis; Heteroplasmy level; Mitochondrial genome; Mutations
ID cytochrome-b gene; somatic mutations; skeletal-muscle; point mutation; late-onset; mtdna; dna; polymorphisms; frequent; patient
AB The importance of the study of an association of mitochondrial DNA mutations with asymptomatic atherosclerosis in women is undeniable. In the present study, a series of PCR with primers for mutation region and further amplificate pyrosequencing were carried out to identify point substitutions or microdeletions of the mitochondrial genome. The results obtained were processed using the original method of estimating the level of heteroplasmy. Five mutations in the mitochondrial genome, namely C3256T, G14709A, G12315A, G13513A and G14846A, in which the heteroplasmy level was associated with the degree of preclinical atherosclerosis in women, were identified. The data obtained in the study showed that C3256T, G14709A and G12315A mutations have a positive correlation with atherosclerosis while G13513A and G14846A mutations have a negative correlation with atherosclerotic lesions. Total mutational load of the mitochondrial genome for C3256T, G14709A, G12315A, G13513A and G14846A mutations explains 68% of the variability of thickness of the carotid intimamedial layer, while the complex of traditional risk factors for cardiovascular diseases explains only 8% of the IMT variability. Data on the correlation between heteroplasmy levels of 0256T, G14709A, G12315A, G13513A and G14846A mutations prompt a suggestion that these mutations may be present on the same haplotypes of mitochondrial genome, associated with atherosclerosis. (C) 2015 Elsevier Inc All rights reserved.
C1 [Sazonova, Margarita A.; Chicheva, Mariya M.; Zhelankin, Andrey V.; Sobenin, Igor A.] Med Genet Lab, Moscow, Russia.
   [Sazonova, Margarita A.; Sobenin, Igor A.; Bobryshev, Yuri V.; Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia.
   [Bobryshev, Yuri V.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia.
   [Orekhov, Alexander N.] Moscow MV Lomonosov State Univ, Dept Biophys, Fac Biol, Moscow, Russia.
C3 Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; University of New South Wales Sydney; Western Sydney University; Lomonosov Moscow State University
RP Bobryshev, YV (corresponding author), Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia.
EM y.bobryshev@unsw.edu.au
FU Russian Scientific Foundation [14-14-01038]; Russian Science Foundation [14-14-01038] Funding Source: Russian Science Foundation
CR Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M
   Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Arvanitis DA, 2005, J CELL MOL MED, V9, P153, DOI 10.1111/j.1582-4934.2005.tb00345.x
   Ben Assayag E, 2009, THROMB RES, V124, P458, DOI 10.1016/j.thromres.2009.04.008
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chen SN, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-111
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Chu NF, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-136
   Finsterer J, 2007, VASA-J VASCULAR DIS, V36, P229, DOI 10.1024/0301-1526.36.4.229
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kawamoto R, 2001, J HUM GENET, V46, P506, DOI 10.1007/s100380170031
   Mancuso M, 2005, J NEUROL SCI, V228, P93, DOI 10.1016/j.jns.2004.10.018
   Marian A J, 1997, J CARDIOVASC RISK, V4, P333, DOI 10.1097/00043798-199710000-00003
   Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Saukko M, 2010, METAB SYNDR RELAT D, V8, P425, DOI 10.1089/met.2010.0004
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Sazonova MA, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00111
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Sobenin IA, 2011, PROBLEMS PROSPECTS M, V3, P108
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046573
   Szabó GV, 2013, INTERV MED APPL SCI, V5, P46, DOI 10.1556/IMAS.5.2013.1.10
NR 30
TC 14
Z9 16
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4800
EI 1096-0945
J9 EXP MOL PATHOL
JI Exp. Mol. Pathol.
PD AUG 15
PY 2015
VL 99
IS 1
BP 25
EP 32
DI 10.1016/j.yexmp.2015.04.003
PG 8
WC Pathology
SC Pathology
GA CO0BD
UT WOS:000358814200005
PM 25910413
DA 2024-11-01
ER

PT J
AU Khan, NA
   Govindaraj, P
   Meena, AK
   Thangaraj, K
AF Khan, Nahid Akhtar
   Govindaraj, Periyasamy
   Meena, Angamuthu Kannan
   Thangaraj, Kumarasamy
TI Mitochondrial disorders: Challenges in diagnosis & treatment
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Review
DE Diagnosis; diseases; mitochondrial DNA; mutation; treatment
ID hereditary optic neuropathy; cytochrome-c-oxidase; complex-i deficiency; progressive external ophthalmoplegia; human embryofetal development; dna mutations; leigh-syndrome; prenatal-diagnosis; lactic-acidosis; ketogenic diet
AB Mitochondrial dysfunctions are known to be responsible for a number of heterogenous clinical presentations with multi-systemic involvement. Impaired oxidative phosphorylation leading to a decrease in cellular energy (ATP) production is the most important cause underlying these disorders. Despite significant progress made in the field of mitochondrial medicine during the last two decades, the molecular mechanisms underlying these disorders are not fully understood. Since the identification of first mitochondrial DNA (mtDNA) mutation in 1988, there has been an exponential rise in the identification of mtDNA and nuclear DNA mutations that are responsible for mitochondrial dysfunction and disease. Genetic complexity together with ever widening clinical spectrum associated with mitochondrial dysfunction poses a major challenge in diagnosis and treatment. Effective therapy has remained elusive till date and is mostly efficient in relieving symptoms. In this review, we discuss the important clinical and genetic features of mitochondrials disorders with special emphasis on diagnosis and treatment.
C1 [Khan, Nahid Akhtar; Govindaraj, Periyasamy; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Telangana, India.
   [Meena, Angamuthu Kannan] Nizams Inst Med Sci, Dept Neurol, Hyderabad, Andhra Pradesh, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences
RP Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Telangana, India.
EM thangs@ccmb.res.in
FU Department of Biotechnology (DBT), Government of India, New Delhi; Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [BioAge-BSC0208]
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angebault Claire, 2011, BMC RES NOTES, V4, P557, DOI 10.1186/1756-0500-4-557
   Barshop BA, 2004, MOL GENET METAB, V83, P138, DOI 10.1016/j.ymgme.2004.06.009
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1999, J MED GENET, V36, P425
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   Deschauer M, 2006, ARCH NEUROL-CHICAGO, V63, P902, DOI 10.1001/archneur.63.6.902
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Govindaraj P, 2011, MITOCHONDRION, V11, P504, DOI 10.1016/j.mito.2011.01.009
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065
   Marchington D, 2010, J MED GENET, V47, P257, DOI 10.1136/jmg.2009.072900
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Masino SA, 2008, TRENDS NEUROSCI, V31, P273, DOI 10.1016/j.tins.2008.02.009
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   MORAES CT, 1995, MUSCLE NERVE, V0, PS150
   Morava E, 2006, J INHERIT METAB DIS, V29, P589, DOI 10.1007/s10545-006-0227-x
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811
   Poulton J, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001066
   Poulton J, 2009, BMJ-BRIT MED J, V338, P0, DOI 10.1136/bmj.b94
   Prietsch V, 2002, J INHERIT METAB DIS, V25, P531, DOI 10.1023/A:1022040422590
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6
   Steenweg ME, 2011, BRAIN, V134, P3333, DOI 10.1093/brain/awr254
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vanniarajan A, 2006, ACTA NEUROL SCAND, V114, P350, DOI 10.1111/j.1600-0404.2006.00673.x
   Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 121
TC 58
Z9 67
U1 0
U2 14
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0971-5916
EI 
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD JAN 15
PY 2015
VL 141
IS 
BP 13
EP 26
DI 
PG 14
WC Immunology; Medicine, General & Internal; Medicine, Research & Experimental
SC Immunology; General & Internal Medicine; Research & Experimental Medicine
GA CF9RU
UT WOS:000352904600005
PM 25857492
DA 2024-11-01
ER

PT J
AU Ding, L
   Liu, YL
AF Ding, Lin
   Liu, Yilun
TI Borrowing Nuclear DNA Helicases to Protect Mitochondrial DNA
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial DNA; DNA replication; DNA repair; RECQ4; Twinkle; PIF1; DNA2; SUV3
ID human pif1 helicase; progressive external ophthalmoplegia; g-quadruplex dna; copy number; saccharomyces-cerevisiae; polynucleotide phosphorylase; biochemical-analysis; twinkle-helicase; polymerase-alpha; rna/dna helicase
AB In normal cells, mitochondria are the primary organelles that generate energy, which is critical for cellular metabolism. Mitochondrial dysfunction, caused by mitochondrial DNA (mtDNA) mutations or an abnormal mtDNA copy number, is linked to a range of human diseases, including Alzheimer's disease, premature aging and cancer. mtDNA resides in the mitochondrial lumen, and its duplication requires the mtDNA replicative helicase, Twinkle. In addition to Twinkle, many DNA helicases, which are encoded by the nuclear genome and are crucial for nuclear genome integrity, are transported into the mitochondrion to also function in mtDNA replication and repair. To date, these helicases include RecQ-like helicase 4 (RECQ4), petite integration frequency 1 (PIF1), DNA replication helicase/nuclease 2 (DNA2) and suppressor of var1 3-like protein 1 (SUV3). Although the nuclear functions of some of these DNA helicases have been extensively studied, the regulation of their mitochondrial transport and the mechanisms by which they contribute to mtDNA synthesis and maintenance remain largely unknown. In this review, we attempt to summarize recent research progress on the role of mammalian DNA helicases in mitochondrial genome maintenance and the effects on mitochondria-associated diseases.
C1 [Ding, Lin; Liu, Yilun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, Duarte, CA 91010 USA.
C3 City of Hope; Beckman Research Institute of City of Hope
RP Liu, YL (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, Duarte, CA 91010 USA.
EM lding@coh.org; yiliu@coh.org
FU National Cancer Institute [R01 CA151245]
CR Akiyama T, 2008, MOL CANCER THER, V7, P3461, DOI 10.1158/1535-7163.MCT-08-0530
   ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348
   Almeida M, 2010, INT BONE MINERAL DEN, V7, P340, DOI 10.1138/20100467
   Arenas J, 2003, ANN NEUROL, V53, P278, DOI 10.1002/ana.10430
   Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200
   Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006
   BUTOW RA, 1989, GENOME, V31, P757, DOI 10.1139/g89-134
   Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749
   Carew JS, 2004, LEUKEMIA, V18, P1934, DOI 10.1038/sj.leu.2403545
   Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120
   Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023
   Cheng X, 2010, EUR J CELL BIOL, V89, P742, DOI 10.1016/j.ejcb.2010.06.008
   Chi ZF, 2012, INT J BIOCHEM CELL B, V44, P1942, DOI 10.1016/j.biocel.2012.07.016
   Crawford DR, 1997, FREE RADICAL BIO MED, V22, P551, DOI 10.1016/S0891-5849(96)00380-2
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   DSouza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001
   Daley JM, 2014, NUCLEIC ACIDS RES, V42, P11083, DOI 10.1093/nar/gku803
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   Desler Claus, 2011, J AGING RES, V2011, P407536, DOI 10.4061/2011/407536
   Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736
   Dmochowska A, 1999, ACTA BIOCHIM POL, V46, P155, DOI 10.18388/abp.1999_4193
   Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008
   DUMAS LB, 1982, MOL GEN GENET, V187, P42, DOI 10.1007/BF00384381
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Eki T, 1996, GENOMICS, V37, P408, DOI 10.1006/geno.1996.0581
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09
   Formosa T, 1999, GENETICS, V151, P1459
   FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Gagou ME, 2014, ONCOTARGET, V5, P11381, DOI 10.18632/oncotarget.2501
   Gagou ME, 2011, CANCER RES, V71, P4998, DOI 10.1158/0008-5472.CAN-10-4404
   Gebert N, 2011, BBA-BIOMEMBRANES, V1808, P1002, DOI 10.1016/j.bbamem.2010.08.003
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011080
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Gu YQ, 2008, NUCLEIC ACIDS RES, V36, P6295, DOI 10.1093/nar/gkn609
   Gu YQ, 2013, PRION, V7, P341, DOI 10.4161/pri.26022
   Gupta S, 2014, CARCINOGENESIS, V35, P34, DOI 10.1093/carcin/bgt315
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997
   Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Ichikawa K, 2002, NIHON YAKURIGAKU ZAS, V119, P219, DOI 10.1254/fpj.119.21911979727
   Im JS, 2015, CELL CYCLE, V14, P1001, DOI 10.1080/15384101.2015.1007001
   Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106
   Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100
   Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010
   Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102
   Karanja KK, 2012, CELL CYCLE, V11, P3983, DOI 10.4161/cc.22215
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102
   Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595
   Kohzaki M, 2012, CARCINOGENESIS, V33, P1203, DOI 10.1093/carcin/bgs149
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974
   Lee CH, 2013, J BIOL CHEM, V288, P9468, DOI 10.1074/jbc.M112.418715
   Li FY, 1999, NEUROLOGY, V53, P1265, DOI 10.1212/WNL.53.6.1265
   Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88
   Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031
   Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075
   Marino F, 2013, BIOPHYS CHEM, V177, P34, DOI 10.1016/j.bpc.2013.02.009
   Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070
   Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524
   Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647
   Miyazaki T, 2012, ARTHRITIS RES THER, V14, P0
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363
   Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152
   Pereira M, 2007, MECH AGEING DEV, V128, P609, DOI 10.1016/j.mad.2007.09.001
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092
   Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sturzenegger A, 2014, J BIOL CHEM, V289, P27314, DOI 10.1074/jbc.M114.578823
   Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074
   Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108
   Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903
   Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Veno ST, 2011, BIOCHEM J, V440, P293, DOI 10.1042/BJ20100991
   Wang DDH, 2014, J BIOL CHEM, V289, P16727, DOI 10.1074/jbc.M113.536540
   Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605
   Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Westermann B, 2014, BBA-BIOENERGETICS, V1837, P1039, DOI 10.1016/j.bbabio.2013.10.005
   Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235
   Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zhou RB, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02190
NR 121
TC 30
Z9 33
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
EI 
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY 15
PY 2015
VL 16
IS 5
BP 10870
EP 10887
DI 10.3390/ijms160510870
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CK5DC
UT WOS:000356241400104
PM 25984607
DA 2024-11-01
ER

PT J
AU Lam, CW
   Law, CY
   Siu, WK
   Fung, CW
   Yau, MM
   Huen, KF
   Lee, HHC
   Mak, CM
AF Lam, Ching-Wan
   Law, Chun-Yiu
   Siu, Wai-Kwan
   Fung, Cheuk-Wing
   Yau, Man-Mut
   Huen, Kwai-Fun
   Lee, Hencher Han-Chih
   Mak, Chloe Miu
TI Novel <i>POLG</i> mutation in a patient with sensory ataxia, neuropathy, ophthalmoparesis and stroke
SO CLINICA CHIMICA ACTA
LA English
DT Article
DE POLG; Stroke; Sensory ataxia; Neuropathy; Ophthalmoparesis
ID dna-polymerase-gamma; mitochondrial; ophthalmoplegia; disorders; sando
AB Background: Clinical diagnosis of POLG-related disorders can be challenging because the phenotypic spectrums are heterogeneous which can mimic different types of mitochondrial disorders. Case: We report a case of POLG-related disorder in an 18 y Chinese girl who had been diagnosed as MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) for the past 8 y. She first presented at 10 y with sudden onset of headache, repeated focal seizures and visual loss, complicated with residual sensory and motor neuropathy, ophthalmoparesis and cortical blindness. MRI brain showed extensive cytotoxic edema and ischemia in bilateral parietal-occipital lobes. Mutation analysis for common point mutations in the mitochondrial DNA and muscle biopsy was negative. She was referred to us for mitochondrial whole genome analysis. However, no pathogenic variants can be determined. We initiated further genetic analysis for POLG which confirmed compound heterozygous mutations NM_002693.2:c.925C>T (p.Arg309Cys) and a novel mutation c.2244G>T (p.Trp748Cys). Both were determined to be pathogenic using in silico analysis. Conclusions: The novel mutation contributes to the expanding spectrum of disease-causing mutations. A definitive diagnosis can benefit our patient and also the relatives by avoiding sodium valproate induced liver toxicity in POLG patients and also the heterozygotes. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Lam, Ching-Wan; Law, Chun-Yiu] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Siu, Wai-Kwan; Lee, Hencher Han-Chih; Mak, Chloe Miu] Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Fung, Cheuk-Wing] Queen Mary Hosp, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.
   [Yau, Man-Mut; Huen, Kwai-Fun] Tseung Kwan O Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China.
C3 University of Hong Kong; University of Hong Kong
RP Lam, CW (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
EM ching-wanlam@pathology.hku.hk
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Chinnery PF, 1997, MITOCHONDRIAL DISORD, V0, P0
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Lam CW, 2015, CLIN CHIM ACTA, V440, P201, DOI 10.1016/j.cca.2014.10.030
   Lam CW, 2014, CLIN CHIM ACTA, V436, P217, DOI 10.1016/j.cca.2014.05.014
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   LESTIENNE P, 1987, BIOCHEM BIOPH RES CO, V146, P1146, DOI 10.1016/0006-291X(87)90767-4
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Siu WK, 2011, FAM CANCER, V10, P695, DOI 10.1007/s10689-011-9466-6
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 29
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD AUG 25
PY 2015
VL 448
IS 
BP 211
EP 214
DI 10.1016/j.cca.2015.06.028
PG 4
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA CQ8OZ
UT WOS:000360869300034
PM 26169155
DA 2024-11-01
ER

PT J
AU Broomfield, A
   Sweeney, M
   Woodward, C
   Fratter, C
   Morris, A
   Leonard, J
   Abulhoul, L
   Grunewald, S
   Clayton, P
   Hanna, M
   Poulton, J
   Rahman, S
AF Broomfield, Alexander
   Sweeney, Mary G.
   Woodward, Cathy E.
   Fratter, Carl
   Morris, Andrew M.
   Leonard, James V.
   Abulhoul, Lara
   Grunewald, Stephanie
   Clayton, Peter T.
   Hanna, Michael G.
   Poulton, Joanna
   Rahman, Shamima
TI Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID complete heart-block; pearson-syndrome; external ophthalmoplegia; plus; rearrangements; duplications; dysfunction; evolution; anemia
AB Background Single large-scale mitochondrial DNA (mtDNA) deletions (SLSMDs) are amongst the most frequently diagnosed mtDNA disorders in childhood, yet their natural history remains poorly understood. We report the natural history of a large multicentre cohort of such children. Methods We reviewed case notes from three different UK centres to determine the clinical course of 34 patients (16 female, 18 male) with childhood-onset mitochondrial disease caused by SLSMDs. Kaplan-Meier analysis was used to compare survival of patients presenting with haematological features (Pearson syndrome) and those with nonhaematological presentations. Results The most frequent initial presentation was with isolated ptosis (16/34, 47 %). Eleven (32 %) patients presented with transfusion-dependent anaemia soon after birth and were diagnosed with Pearson syndrome, whilst ten were classified as having Kearns-Sayre syndrome, three as having progressive external ophthalmoplegia (PEO) and seven as having PEO-plus. Three patients did not conform to any specific mitochondrial syndrome. The most frequently affected organ during the disease course was the kidney, with documented tubular or glomerular dysfunction in 17 of 20 (85 %) cases who had detailed investigations. SLSMDs were present in blood and/or urine cells in all cases tested, indicating that muscle biopsy is not necessary for diagnosis in the paediatric age range. Kaplan-Meier survival analysis revealed significantly worse mortality in patients with Pearson syndrome compared with the rest of the cohort. Conclusions Mitochondrial disease caused by SLSMDs is clinically heterogeneous, and not all cases conform to a classical mitochondrial syndrome. Multisystem disease is the norm, with anaemia, renal impairment and endocrine disturbance being the most frequent extraneurological features. SLSMDs should be considered in the differential diagnosis of all children presenting with ptosis.
C1 [Broomfield, Alexander; Morris, Andrew M.] Cent Manchester Univ, Hosp NHS Fdn trust, St Marys Hosp, Genet Med, Manchester M13 9WL, Lancs, England.
   [Sweeney, Mary G.; Woodward, Cathy E.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Fratter, Carl] Univ Oxford, Hosp NHS Trust, Churchill Hosp, Oxford Med Genet Labs, Oxford OX3 7LE, England.
   [Abulhoul, Lara; Grunewald, Stephanie; Rahman, Shamima] Hosp NHS Fdn Trust, Inst Child Hlth, Metab Unit, London WC1N 3JH, England.
   [Grunewald, Stephanie; Clayton, Peter T.; Rahman, Shamima] UCL Inst Child Hlth, Genet & Genom Med, London WC1N 1EH, England.
   [Hanna, Michael G.] UCL Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Poulton, Joanna] John Radcliffe Hosp, Womens Ctr, NDOG, Oxford OX3 9DU, Oxon, England.
   [Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, London WC1N 3JH, England.
C3 University of Manchester; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Oxford; University of London; University College London
RP Rahman, S (corresponding author), UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, 30 Guilford St, London WC1N 3JH, England.
EM shamima.rahman@ucl.ac.uk
FU Great Ormond Street Hospital Children's Charity; MRC [MR/K000608/1, G0800674] Funding Source: UKRI
CR Akaike M, 1997, CLIN CARDIOL, V20, P239, DOI 10.1002/clc.4960200310
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   BERNARD AM, 1987, CLIN CHEM, V33, P775
   Biousse V, 2001, SEMIN NEUROL, V21, P275, DOI 10.1055/s-2001-17945
   Di Mauro S, 1993, GENEREVIEW, V0, P0
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Herget-Rosenthal S, 2004, CLIN CHEM, V50, P552, DOI 10.1373/clinchem.2003.027763
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Krauch G, 2002, AM J MED GENET, V110, P57, DOI 10.1002/ajmg.10410
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Morel AS, 2009, EUR J PEDIATR, V168, P311, DOI 10.1007/s00431-008-0756-4
   Morris AAM, 1997, ARCH DIS CHILD, V77, P56, DOI 10.1136/adc.77.1.56
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Riera ARP, 2008, J ELECTROCARDIOL, V41, P675, DOI 10.1016/j.jelectrocard.2008.04.001
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   Rahman S, 2000, J INHERIT METAB DIS, V23, P753, DOI 10.1023/A:1005611803306
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 37
TC 76
Z9 80
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD MAY 15
PY 2015
VL 38
IS 3
BP 445
EP 457
DI 10.1007/s10545-014-9778-4
PG 13
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA CI1JJ
UT WOS:000354500000008
PM 25352051
DA 2024-11-01
ER

PT J
AU Yis, U
   Ezgü, FS
   Karakaya, P
   Polat, I
   Arslan, N
   Çankaya, T
   Bozkaya, ÖG
   Kurul, SH
AF Yis, Uluc
   Ezgu, Fatih Suheyl
   Karakaya, Pakize
   Polat, Ipek
   Arslan, Nur
   Cankaya, Tufan
   Bozkaya, Ozlem Giray
   Kurul, Semra Hiz
TI A Novel Mutation in the Mitochondrial DNA Cytochrome b Gene (<i>MTCYB</i>) in a Patient with Prader Willi Syndrome
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Prader-Willi syndrome; mitochondria disease; mitochondrial cytochrome b gene
ID sudden-death; dysfunction; duplication; deletion
AB In recent years, it has been suggested that defects in energy metabolism may accompany Prader Willi syndrome. Mutations in the mitochondrial cytochrome b gene have been commonly associated isolated mitochondrial myopathy and exercise intolerance, rarely with multisystem disorders. The authors describe a novel mutation (mt. 15209T>C) in mitochondrial cytochrome b gene in a 2-year-old girl with Prader-Willi syndrome with a clinical history of lactic acidosis attacks, renal sodium loss, hepatopathy, progressive cerebral atrophy, and sudden death. The authors suggest that atypical clinical findings in patients with Prader-Willi syndrome should direct the physician to search for a mitochondrial disease.
C1 [Yis, Uluc; Karakaya, Pakize; Polat, Ipek; Kurul, Semra Hiz] Dokuz Eylul Univ, Sch Med, Dept Pediat, Div Child Neurol, Izmir, Turkey.
   [Ezgu, Fatih Suheyl] Gazi Univ, Sch Med, Div Pediat Metab & Nutr, Dept Pediat, Ankara, Turkey.
   [Arslan, Nur] Dokuz Eylul Univ, Dept Pediat, Div Pediat Metab & Nutr, Sch Med, Ankara, Turkey.
   [Cankaya, Tufan; Bozkaya, Ozlem Giray] Dokuz Eylul Univ, Sch Med, Div Genet, Dept Pediat, Ankara, Turkey.
C3 Dokuz Eylul University; Gazi University; Dokuz Eylul University; Dokuz Eylul University
RP Yis, U (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Pediat, Div Child Neurol, Izmir, Turkey.
EM ulyis@yahoo.com
CR Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   Frye RE, 2009, J CHILD NEUROL, V24, P1316, DOI 10.1177/0883073809333531
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Nagai T, 2005, AM J MED GENET A, V136A, P45, DOI 10.1002/ajmg.a.30777
   Rodriguez-Jato S, 2005, NUCLEIC ACIDS RES, V33, P4740, DOI 10.1093/nar/gki786
   Sacco M, 2005, HORM RES, V63, P29, DOI 10.1159/000082525
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   Van Vliet G, 2004, J PEDIATR-US, V144, P129, DOI 10.1016/j.jpeds.2003.09.049
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Yazdi PG, 2013, CTS-CLIN TRANSL SCI, V6, P347, DOI 10.1111/cts.12083
NR 16
TC 2
Z9 2
U1 1
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR 15
PY 2015
VL 30
IS 3
BP 378
EP 381
DI 10.1177/0883073814530499
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA CB9VY
UT WOS:000349982900017
PM 24771578
DA 2024-11-01
ER

PT J
AU Yasuzaki, Y
   Yamada, Y
   Ishikawa, T
   Harashima, H
AF Yasuzaki, Yukari
   Yamada, Yuma
   Ishikawa, Takuya
   Harashima, Hideyoshi
TI Validation of Mitochondrial Gene Delivery in Liver and Skeletal Muscle via Hydrodynamic Injection Using an Artificial Mitochondrial Reporter DNA Vector
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE mitochondria; transgene expression; gene delivery; hydrodynamic injection; gene therapy
ID plasmid dna; secondary structure; vein injections; inner membrane; disease; transcription; expression; promoters; proteins; mutation
AB For successful mitochondrial transgene expression, two independent processes, i.e., developing a mitochondrial gene delivery system and construction of DNA vector to achieve mitochondrial gene expression, are required. To date, very few studies dealing with mitochondrial gene delivery have been reported and, in most cases, transgene expression was not validated, because the construction of a reporter DNA vector for mitochondrial gene expression is the bottleneck. In this study, mitochondrial transgene expression by the in vivo mitochondrial gene delivery of an artificial mitochondrial reporter DNA vector via hydrodynamic injection is demonstrated. In the procedure, a large volume of naked plasmid DNA (pDNA) is rapidly injected. We designed and constructed pHSP-mtLuc (CGG) as a mitochondrial reporter DNA vector that possesses a mitochondrial heavy strand promoter (HSP) and an artificial mitochondrial genome with the reporter NanoLuc (Nluc) luciferase gene that records adjustments to the mitochondrial codon system. We delivered the pDNA into mouse liver mitochondria by hydrodynamic injection, and detected exogenous mRNA in the liver using reverse transcription PCR analysis. The hydrodynamic injection of pHSP-mtLuc (CGG) resulted in the expression of the Nluc luciferase protein in liver and skeletal muscle. Our mitochondrial transgene expression reporter system would contribute to mitochondrial gene therapy and further studies directed at mitochondrial molecular biology.
C1 [Yasuzaki, Yukari; Yamada, Yuma; Ishikawa, Takuya; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Sapporo, Hokkaido 060, Japan.
C3 Hokkaido University
RP Harashima, H (corresponding author), Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.
EM harasima@pharm.hokudai.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (MEXT) [23680053, 25560219, 26282131]; Grants-in-Aid for Scientific Research [25560219, 23680053, 26282131] Funding Source: KAKEN
CR Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9
   Cardoso AM, 2015, MOL PHARMACEUT, V12, P716, DOI 10.1021/mp5005349
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X
   DSouza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   FISHER RP, 1985, J BIOL CHEM, V260, P1330
   Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hagstrom JE, 2004, MOL THER, V10, P386, DOI 10.1016/j.ymthe.2004.05.004
   Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478
   Hegge JO, 2010, HUM GENE THER, V21, P829, DOI 10.1089/hum.2009.172
   Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jackson CB, 2014, MITOCHONDRION, V17, P67, DOI 10.1016/j.mito.2014.05.011
   Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624
   Jones CN, 2008, RNA, V14, P862, DOI 10.1261/rna.909208
   Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294
   Kobayashi N, 2005, ADV DRUG DELIVER REV, V57, P713, DOI 10.1016/j.addr.2004.12.006
   Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947
   Lyrawati D, 2011, PHARM RES-DORDR, V28, P2848, DOI 10.1007/s11095-011-0544-0
   Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101
   Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490
   Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314
   Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623
   Toumi H, 2006, MOL THER, V13, P229, DOI 10.1016/j.ymthe.2005.07.699
   Vigen KK, 2007, HUM GENE THER, V18, P257, DOI 10.1089/hum.2006.115
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Weissig V, 2011, PHARM RES-DORDR, V28, P2657, DOI 10.1007/s11095-011-0556-9
   Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249
   Wooddell CI, 2011, HUM GENE THER, V22, P889, DOI 10.1089/hum.2010.160
   Yamada Y, 2012, METHOD ENZYMOL, V509, P301, DOI 10.1016/B978-0-12-391858-1.00015-0
   Yasuzaki Y, 2014, PHARMACEUTICALS, V7, P881, DOI 10.3390/ph7080881
   Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029
   Yokoo T, 2013, GENE THER, V20, P816, DOI 10.1038/gt.2013.2
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734
NR 44
TC 36
Z9 38
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
EI 
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD DEC 15
PY 2015
VL 12
IS 12
BP 4311
EP 4320
DI 10.1021/acs.molpharmaceut.5b00511
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA CY1FG
UT WOS:000366151500013
PM 26567847
DA 2024-11-01
ER

PT J
AU Powel, CA
   Kopajtich, R
   D'Souza, AR
   Rorbach, J
   Kremer, LS
   Husain, RA
   Dallabona, C
   Donnini, C
   Alston, CL
   Griffin, H
   Pyle, A
   Chinnery, PF
   Strom, TM
   Meitinger, T
   Rodenburg, RJ
   Schottmann, G
   Schuelke, M
   Romain, N
   Haller, RG
   Ferrero, I
   Haack, TB
   Taylor, RW
   Prokisch, H
   Minczukl, M
AF Powel, Christopher A.
   Kopajtich, Robert
   D'Souza, Aaron R.
   Rorbach, Joanna
   Kremer, Laura S.
   Husain, Ralf A.
   Dallabona, Cristina
   Donnini, Claudia
   Alston, Charlotte L.
   Griffin, Helen
   Pyle, Angela
   Chinnery, Patrick F.
   Strom, Tim M.
   Meitinger, Thomas
   Rodenburg, Richard J.
   Schottmann, Gudrun
   Schuelke, Markus
   Romain, Nadine
   Haller, Ronald G.
   Ferrero, Ileana
   Haack, Tobias B.
   Taylor, Robert W.
   Prokisch, Holger
   Minczukl, Michal
TI <i>TRMT5</i> Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID hypertrophic cardiomyopathy; sideroblastic anemia; lactic-acidosis; translation; anticodon; myopathy
AB Deficiencies in respiratory-chain complexes lead to a variety of clinical phenotypes resulting from inadequate energy production by the mitochondrial oxidative phosphorylation system. Defective expression of mtDNA-encoded genes, caused by mutations in either the mitochondrial or nuclear genome, represents a rapidly growing group of human disorders. By whole-exome sequencing, we identified two unrelated individuals carrying compound heterozygous variants in TRMT5 (tRNA methyltransferase 5). TRMT5 encodes a mitochondrial protein with strong homology to members of the class I-like methyltransferase superfamily. Both affected individuals presented with lactic acidosis and evidence of multiple mitochondrial respiratory-chain-complex deficiencies in skeletal muscle, although the clinical presentation of the two affected subjects was remarkably different; one presented in childhood with failure to thrive and hypertrophic cardiomyopathy, and the other was an adult with a life-long history of exercise intolerance. Mutations in TRMT5 were associated with the hypomodification of a guanosine residue at position 37 (G37) of mitochondrial tRNA; this hypomodification was particularly prominent in skeletal muscle. Deficiency of the G37 modification was also detected in human cells subjected to TRMT5 RNAi. The pathogenicity of the detected variants was further confirmed in a heterologous yeast model and by the rescue of the molecular phenotype after re-expression of wild-type TRMT5 cDNA in cells derived from the affected individuals. Our study highlights the importance of post-transcriptional modification of mitochondrial tRNAs for faithful mitochondrial function.
C1 [Powel, Christopher A.; D'Souza, Aaron R.; Rorbach, Joanna; Minczukl, Michal] MRC, Mitochondrial Biol Unit, Cambridge CB2 OXY, England.
   [Kopajtich, Robert; Kremer, Laura S.; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.; Prokisch, Holger] German Res Ctr Environm Hlth, Inst Human Genet Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.
   [Kopajtich, Robert; Kremer, Laura S.; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Husain, Ralf A.] Jena Univ Hosp, Dept Neuropediatr, D-07740 Jena, Germany.
   [Dallabona, Cristina; Donnini, Claudia; Ferrero, Ileana] Univ Parma, Dept Life Sci, I-43124 Parma, Italy.
   [Alston, Charlotte L.; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Griffin, Helen; Pyle, Angela; Chinnery, Patrick F.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Meitinger, Thomas] German Ctr Cardiovasc Res, Munich Heart Alliance, D-81675 Munich, Germany.
   [Rodenburg, Richard J.] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500HB Nijmegen, Netherlands.
   [Schottmann, Gudrun; Schuelke, Markus] Charite, Dept Neuropediatr, D-13353 Berlin, Germany.
   [Schottmann, Gudrun; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.
   [Romain, Nadine; Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75231 USA.
   [Romain, Nadine; Haller, Ronald G.] Neuromuscular Ctr, Inst Exercise & Environm Med, Texas Hlth Presbyterian Hosp Dallas, Dallas, TX 75231 USA.
C3 Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Friedrich Schiller University of Jena; University of Parma; Newcastle University - UK; Newcastle University - UK; German Centre for Cardiovascular Research; Munich Heart Alliance; Radboud University Nijmegen; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Texas System; University of Texas Southwestern Medical Center Dallas
RP Prokisch, H (corresponding author), German Res Ctr Environm Hlth, Inst Human Genet Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.
EM prokisch@helmholtz-muenchen.de; michal.minczuk@mrc-mbu.cam.ac.uk
FU Medical Research Council UK [MC_U105697135]; German Bundesministerium fur Bildung und Forschung through E-Rare project GENOMIT [01GM1207]; German Network or Mitochondrial Disorders [01GM1113C, 01GM0866]; Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; German Center for Heart Research [Z76010017300, Z56010015300]; Wellcome Trust Strategic Award [096919/Z/11/Z]; Medical Research Council Centre for Neuromuscular Diseases [G0601943]; UK National Health Service Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; Lily Foundation; National Institute for Health Research doctoral fellowship [NIHR-HCS-D12-03-04]; Telethon Italy [GGP11011]; MRC [G0601943, MC_U105697135] Funding Source: UKRI
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Becker L, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114918
   BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265
   Björk GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Brulé H, 1998, NUCLEIC ACIDS RES, V26, P537, DOI 10.1093/nar/26.2.537
   Brulé H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010
   Christian T, 2013, RNA, V19, P1192, DOI 10.1261/rna.039503.113
   Christian T, 2010, RNA, V16, P2484, DOI 10.1261/rna.2376210
   Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072
   Euro L, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00021
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   HAGERVALL TG, 1990, BIOCHIM BIOPHYS ACTA, V1050, P263, DOI 10.1016/0167-4781(90)90178-5
   HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135
   Helm M, 2014, CHEM BIOL, V21, P174, DOI 10.1016/j.chembiol.2013.10.015
   Kirino Y, 2006, HUM MOL GENET, V15, P897, DOI 10.1093/hmg/ddl007
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lee C, 2007, J BIOL CHEM, V282, P27744, DOI 10.1074/jbc.M704572200
   Li JN, 1997, J MOL BIOL, V271, P209, DOI 10.1006/jmbi.1997.1176
   Mayr JA, 2015, J INHERIT METAB DIS, V0, P0
   Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005
   Paris Z, 2013, RNA, V19, P649, DOI 10.1261/rna.036665.112
   Powell CA, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00079
   PUTZ J, 1994, NAT STRUCT BIOL, V1, P580, DOI 10.1038/nsb0994-580
   Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014
   Sasarman F, 2015, HUM MOL GENET, V24, P2841, DOI 10.1093/hmg/ddv044
   Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390
   Synofzik M, 2014, AM J HUM GENET, V95, P689, DOI 10.1016/j.ajhg.2014.10.013
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743
   Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863
   Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z
   Wei FY, 2015, CELL METAB, V21, P428, DOI 10.1016/j.cmet.2015.01.019
   Yarham JW, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004424
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 46
TC 74
Z9 82
U1 2
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD AUG 6
PY 2015
VL 97
IS 2
BP 319
EP 328
DI 10.1016/j.ajhg.2015.06.011
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA CO7GY
UT WOS:000359328800012
PM 26189817
DA 2024-11-01
ER

PT J
AU Duff, RM
   Shearwood, AMJ
   Ermer, J
   Rossetti, G
   Gooding, R
   Richman, TR
   Balasubramaniam, S
   Thorburn, DR
   Rackham, O
   Lamont, PJ
   Filipovska, A
AF Duff, Rachael M.
   Shearwood, Anne-Marie J.
   Ermer, Judith
   Rossetti, Giulia
   Gooding, Rebecca
   Richman, Tara R.
   Balasubramaniam, Shanti
   Thorburn, David R.
   Rackham, Oliver
   Lamont, Phillipa J.
   Filipovska, Aleksandra
TI A mutation in <i>MT</i>-<i>TW</i> causes a tRNA processing defect and reduced mitochondrial function in a family with Leigh syndrome
SO MITOCHONDRION
LA English
DT Article
DE Leigh syndrome; Multi-organ mitochondrial disease; tRNA; MT-TW; tRNA tryptophan; Mitochondrial disease; OXPHOS
ID dna; trna(trp); disorders; myopathy; features; disease
AB Leigh syndrome (LS) is a progressive mitochondrial neurodegenerative disorder, whose symptoms most commonly include psychomotor delay with regression, lactic acidosis and a failure to thrive. Here we describe three siblings with LS, but with additional manifestations including hypertrophic cardiomyopathy, hepatosplenomegaly, cholestatic hepatitis, and seizures. All three affected siblings were found to be homoplasmic for an m. 5559A>G mutation in the T stem of the mitochondrial DNA-encoded MT-TW by next generation sequencing. The m.5559A>G mutation causes a reduction in the steady state levels of tRNA(TrP) and this decrease likely affects the stability of other mitochondrial RNAs in the patient fibroblasts. We observe accumulation of an unprocessed transcript containing tRNA(TrP), decreased de novo protein synthesis and consequently lowered steady state levels of mitochondrial DNA-encoded proteins that compromise mitochondrial respiration. Our results show that the m.5559A>G mutation at homoplasmic levels causes LS in association with severe multi-organ disease (LS-plus) as a consequence of dysfunctional mitochondrial RNA metabolism. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Duff, Rachael M.; Shearwood, Anne-Marie J.; Ermer, Judith; Rossetti, Giulia; Richman, Tara R.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA 6009, Australia.
   [Duff, Rachael M.; Shearwood, Anne-Marie J.; Ermer, Judith; Rossetti, Giulia; Richman, Tara R.; Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia.
   [Gooding, Rebecca] QEII Med Ctr, PathWest Lab Med, Diagnost Genom, Nedlands, WA 6009, Australia.
   [Balasubramaniam, Shanti] Princess Margaret Hosp, Dept Pediat & Adolescent Med, Metab Unit, Perth, WA 6008, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Rackham, Oliver; Filipovska, Aleksandra] Univ Western Australia, Sch Chem & Biochem, Nedlands, WA 6009, Australia.
   [Lamont, Phillipa J.] Royal Perth Hosp, Dept Neurol, Neurogenet unit, Perth, WA, Australia.
C3 University of Western Australia; Harry Perkins Institute of Medical Research; University of Western Australia; Pathwest Laboratory Medicine; Queen Elizabeth II Medical Centre; University of Western Australia; Princess Margaret Hospital for Children; University of Western Australia; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; Royal Children's Hospital Melbourne; University of Melbourne; University of Western Australia; East Metropolitan Health Service; Royal Perth Hospital; University of Western Australia
RP Filipovska, A (corresponding author), Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA 6009, Australia.
EM aleksandra.filipovska@uwa.edu.au
FU National Health and Medical Research Council [APP1058442, APP1045677, APP1041582, APP1023460, APP1005030]; Australian Mitochondrial Disease Foundation (AMDF); AMDF; NHMRC Dora Lush Scholarship
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   BINDOFF LA, 1993, J BIOL CHEM, V268, P19559
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Gardner JL, 2007, BIOSCIENCE REP, V27, P139, DOI 10.1007/s10540-007-9042-3
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0
   Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128
   Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Richman TR, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005089
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tang S, 2010, MITOCHONDRION, V10, P350, DOI 10.1016/j.mito.2010.02.003
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2014, MITOCHONDRIAL DNA AS, V0, P0
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 32
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2015
VL 25
IS 
BP 113
EP 119
DI 10.1016/j.mito.2015.10.008
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CX8DW
UT WOS:000365933800014
PM 26524491
DA 2024-11-01
ER

PT J
AU Liu, SF
   Kuo, HC
   Tseng, CW
   Huang, HT
   Chen, YC
   Tseng, CC
   Lin, MC
AF Liu, Shih-Feng
   Kuo, Ho-Chang
   Tseng, Ching-Wan
   Huang, Hung-Tu
   Chen, Yung-Che
   Tseng, Chia-Cheng
   Lin, Meng-Chih
TI Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease
SO PLOS ONE
LA English
DT Article
ID oxidative stress; skeletal-muscle; quadriceps; endurance
AB Background Oxidative stress is known to be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). Evidence suggests that leukocytes mitochondria DNA (mtDNA) is susceptible to undergo mutations, insertions, or depletion in response to reactive oxidative stress (ROS). We hypothesize that mtDNA copy number is associated with the development of COPD. Methodology/Principal Findings Relative mtDNA copy number was measured by a quantitative realtime PCR assay using DNA extracted from peripheral leukocytes. MtDNA copy number of peripheral leukocytes in the COPD group (n = 86) is significantly decreased compared with nonsmoker group (n = 77) (250.3 +/- 21.5 VS. 464.2 +/- 49.9, P<0.001). MtDNA copy number in the COPD group was less than that in the healthy smoking group, but P value nearly achieved significance (250.3 +/- 21.5 VS. 404.0 +/- 76.7, P = 0.08) MtDNA copy number has no significance with age, gender, body mass index, current smoking, and pack-years in COPD group, healthy smoker group and no smoker group, respectively. Serum glutathione level in the COPD group is significantly decreased compared with healthy smoker and nonsmoker groups (4.5 +/- 1.3 VS. 6.2 +/- 1.9 and 4.5 +/- 1.3 VS. 7.1 +/- 1.1 mU/mL; P<0.001 respectively). Pearson correlation test shows a significant liner correlation between mtDNA copy number and serum glutathione level (R = 0.2, P = 0.009). Conclusions/Significance COPD is associated with decreased leukocyte mtDNA copy number and serum glutathione. COPD is a regulatory disorder of leukocytes mitochondria. However, further studies are needed to determine the real mechanisms about the gene and the function of mitochondria.
C1 [Liu, Shih-Feng; Chen, Yung-Che; Tseng, Chia-Cheng; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan.
   [Liu, Shih-Feng; Kuo, Ho-Chang; Tseng, Ching-Wan; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan.
   [Liu, Shih-Feng; Kuo, Ho-Chang; Chen, Yung-Che; Tseng, Chia-Cheng; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.
   [Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.
   [Huang, Hung-Tu] Kaohsiung Med Univ, Sch Med, Dept Anat, Coll Med, Kaohsiung, Taiwan.
C3 Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University
RP Liu, SF (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan.
EM liuphysico@yahoo.com.tw; mengchih@adm.cgmh.org.tw
FU Chang Gung Memorial Hospital [CMRPG891051]
CR Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002
   Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636
   Barnes PJ, 1999, THORAX, V54, P245, DOI 10.1136/thx.54.3.245
   Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Engelen MPKJ, 2000, AM J RESP CRIT CARE, V161, P98, DOI 10.1164/ajrccm.161.1.9901031
   Falk Jeremy A, 2008, PROC AM THORAC SOC, V5, P543, DOI 10.1513/pats.200708-142ET
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Hoffmann RF, 2013, RESP RES, V14, P0, DOI 10.1186/1465-9921-14-97
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Kim JH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067227
   Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC
   Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4
   Langen RCJ, 2003, FREE RADICAL BIO MED, V35, P226, DOI 10.1016/S0891-5849(03)00316-2
   Lee JW, 2012, EURASIP J IMAGE VIDE, V0, P0, DOI DOI 10.1186/1687-5281-2012-7
   Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440
   Meissner C, 2007, Z GERONTOL GERIATR, V40, P325, DOI 10.1007/s00391-007-0481-z
   Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468
   Peng H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082739
   Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408
   Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031
   Rahman I, 1996, FREE RADICAL BIO MED, V21, P669, DOI 10.1016/0891-5849(96)00155-4
   Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607
   Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106
   Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013
   Sandri M, 2002, CURR OPIN CLIN NUTR, V5, P249, DOI 10.1097/00075197-200205000-00003
   Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260
   Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Yamagata T, 2007, CHEST, V132, P890, DOI 10.1378/chest.07-0569
NR 34
TC 38
Z9 43
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD SEP 22
PY 2015
VL 10
IS 9
BP 
EP 
DI 10.1371/journal.pone.0138716
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS0ZW
UT WOS:000361792100091
PM 26394041
DA 2024-11-01
ER

PT J
AU Franzke, B
   Neubauer, O
   Wagner, KH
AF Franzke, Bernhard
   Neubauer, Oliver
   Wagner, Karl-Heinz
TI Super DNAging-New insights into DNA integrity, genome stability and telomeres in the oldest old
SO MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
LA English
DT Review
DE Genome stability; Centenarians; Nonagenarians; Longevity; Healthy aging; Maximum lifespan
ID peripheral-blood lymphocytes; age-related diseases; mitochondrial-dna; oxidative stress; skeletal-muscle; point mutations; life-style; micronucleus frequency; chromosomal damage; physical-exercise
AB Reductions in DNA integrity, genome stability, and telomere length are strongly associated with the aging process, age-related diseases as well as the age-related loss of muscle mass. However, in people reaching an age far beyond their statistical life expectancy the prevalence of diseases, such as cancer, cardiovascular disease, diabetes or dementia, is much lower compared to "averagely" aged humans. These inverse observations in nonagenarians (90-99 years), centenarians (100-109 years) and super-centenarians (110 years and older) require a closer look into dynamics underlying DNA damage within the oldest old of our society. Available data indicate improved DNA repair and antioxidant defense mechanisms in "super old" humans, which are comparable with much younger cohorts. Partly as a result of these enhanced endogenous repair and protective mechanisms, the oldest old humans appear to cope better with risk factors for DNA damage over their lifetime compared to subjects whose lifespan coincides with the statistical life expectancy. This model is supported by study results demonstrating superior chromosomal stability, telomere dynamics and DNA integrity in "successful agers". There is also compelling evidence suggesting that life-style related factors including regular physical activity, a well-balanced diet and minimized psycho-social stress can reduce DNA damage and improve chromosomal stability. The most conclusive picture that emerges from reviewing the literature is that reaching "super old" age appears to be primarily determined by hereditary/genetic factors, while a healthy lifestyle additionally contributes to achieving the individual maximum lifespan in humans. More research is required in this rapidly growing population of super old people. In particular, there is need for more comprehensive investigations including short- and long-term lifestyle interventions as well as investigations focusing on the mechanisms causing DNA damage, mutations, and telomere shortening. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Franzke, Bernhard; Neubauer, Oliver; Wagner, Karl-Heinz] Univ Vienna, Res Platform Act Ageing, A-1090 Vienna, Austria.
   [Neubauer, Oliver] Queensland Univ Technol, Tissue Repair & Regenerat Grp, Fac Hlth, Sch Biomed Sci,IHBI, Brisbane, Qld 4059, Australia.
   [Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci, Fac Life Sci, A-1090 Vienna, Austria.
C3 University of Vienna; Queensland University of Technology (QUT); University of Vienna
RP Wagner, KH (corresponding author), Univ Vienna, Dept Nutr Sci, Althanstr 14, A-1090 Vienna, Austria.
EM karl-heinz.wagner@univie.ac.at
FU University of Vienna; Austrian National Bank [14541]
CR Ames Bruce N, 2010, J NUCLEIC ACIDS, V2010, P0, DOI 10.4061/2010/725071
   Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223
   ARNETZ BB, 1983, PSYCHOSOM MED, V45, P395, DOI 10.1097/00006842-198310000-00003
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Battershill JM, 2008, MUTAGENESIS, V23, P423, DOI 10.1093/mutage/gen040
   Bendix L, 2011, MECH AGEING DEV, V132, P568, DOI 10.1016/j.mad.2011.10.003
   Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10
   BONASSI S, 1995, CANCER EPIDEM BIOMAR, V4, P671
   Bori Z, 2012, EXP GERONTOL, V47, P417, DOI 10.1016/j.exger.2012.03.004
   Borup MT, 2008, J THEOR BIOL, V250, P66, DOI 10.1016/j.jtbi.2007.09.016
   Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Chevanne M, 2003, BIOGERONTOLOGY, V4, P97, DOI 10.1023/A:1023399820770
   Chevanne M, 2007, REJUV RES, V10, P191, DOI 10.1089/rej.2006.0514
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Erceg P, 2007, J GENET, V86, P277, DOI 10.1007/s12041-007-0035-6
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fenech M, 1998, MUTAT RES-FUND MOL M, V404, P155, DOI 10.1016/S0027-5107(98)00109-2
   Fenech M, 2002, FOOD CHEM TOXICOL, V40, P1113, DOI 10.1016/S0278-6915(02)00028-5
   Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003
   Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050
   Fenech MF, 2010, AM J CLIN NUTR, V91, P1438S, DOI 10.3945/ajcn.2010.28674D
   Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224
   FRANCESCHI C, 1992, ANN NY ACAD SCI, V663, P4, DOI 10.1111/j.1749-6632.1992.tb38643.x
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franzke B, 2014, MUTAGENESIS, V0, P0
   Franzke B, 2015, EXP GERONTOL, V65, P16, DOI 10.1016/j.exger.2015.03.001
   Franzke B, 2015, MUTAGENESIS, V30, P147, DOI 10.1093/mutage/geu074
   Garagnani P, 2013, AGING-US, V5, P373, DOI 10.18632/aging.100562
   Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011
   Halaschek-Wiener J, 2008, MECH AGEING DEV, V129, P638, DOI 10.1016/j.mad.2008.07.004
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hazane F, 2006, J PHOTOCH PHOTOBIO B, V82, P214, DOI 10.1016/j.jphotobiol.2005.10.004
   He YH, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.01.015
   Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164
   Humphreys V, 2007, AGE AGEING, V36, P521, DOI 10.1093/ageing/afm107
   Hyland P, 2002, EXP GERONTOL, V37, P465, DOI 10.1016/S0531-5565(01)00216-9
   Ishikawa N, 2012, AGE, V34, P795, DOI 10.1007/s11357-011-9280-y
   Joyner MJ, 2013, J APPL PHYSIOL, V114, P1, DOI 10.1152/japplphysiol.01313.2012
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kimura M, 2007, AM J PHYSIOL-REG I, V293, PR2210, DOI 10.1152/ajpregu.00615.2007
   King CM, 1997, MUTAT RES-FUND MOL M, V377, P137, DOI 10.1016/S0027-5107(97)00072-9
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kirkwood TBL, 1997, EXP GERONTOL, V32, P395, DOI 10.1016/S0531-5565(96)00171-4
   Klement K, 2014, EXP CELL RES, V329, P42, DOI 10.1016/j.yexcr.2014.09.003
   Koltai E, 2012, AM J PHYSIOL-REG I, V303, PR127, DOI 10.1152/ajpregu.00337.2011
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821
   Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869
   Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x
   Maugeri D, 2004, ARCH GERONTOL GERIAT, V0, P271
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Moller P, 1996, CHEM-BIOL INTERACT, V102, P17, DOI 10.1016/0009-2797(96)03729-5
   Müezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003
   Müllner E, 2014, MUTAGENESIS, V29, P1, DOI 10.1093/mutage/get056
   Müllner E, 2013, MUTAGENESIS, V28, P205, DOI 10.1093/mutage/ges073
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Nakamura KI, 2007, EXP GERONTOL, V42, P944, DOI 10.1016/j.exger.2007.05.003
   Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008
   Neubauer O, 2008, EXERC IMMUNOL REV, V14, P51
   Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Park Dong Choon, 2013, KOREAN J AUDIOL, V17, P39, DOI 10.7874/kja.2013.17.2.39
   Paul L, 2011, J NUTR BIOCHEM, V22, P895, DOI 10.1016/j.jnutbio.2010.12.001
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002
   Ponsot E, 2008, MUSCLE NERVE, V37, P467, DOI 10.1002/mus.20964
   Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526
   Radák Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6
   Radak Z, 2007, J APPL PHYSIOL, V102, P1696, DOI 10.1152/japplphysiol.01051.2006
   Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498
   Radak Z, 2011, FREE RADICAL BIO MED, V51, P417, DOI 10.1016/j.freeradbiomed.2011.04.018
   Reichhold S, 2009, MUTAT RES-REV MUTAT, V682, P28, DOI 10.1016/j.mrrev.2009.02.002
   Reichhold S, 2009, FREE RADICAL RES, V43, P753, DOI 10.1080/10715760903040628
   Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Siu PM, 2011, EXP PHYSIOL, V96, P889, DOI 10.1113/expphysiol.2011.058396
   Slijepcevic P, 2008, MECH AGEING DEV, V129, P11, DOI 10.1016/j.mad.2007.10.012
   Smoliner C, 2009, BRIT J NUTR, V102, P1663, DOI 10.1017/S0007114509990900
   Starr JM, 2007, EXP GERONTOL, V42, P571, DOI 10.1016/j.exger.2006.12.002
   Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011
   Tedone E, 2014, EXP GERONTOL, V58, P90, DOI 10.1016/j.exger.2014.06.018
   Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809
   Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009
   Trappe S, 2013, J APPL PHYSIOL, V114, P3, DOI 10.1152/japplphysiol.01107.2012
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyson J, 2007, P NUTR SOC, V66, P42, DOI 10.1017/S0029665107005289
   Volkert D, 2011, Z GERONTOL GERIATR, V44, P91, DOI 10.1007/s00391-011-0174-5
   von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5
   W.H. Organisation N.I.o. Aging N.I.o. Health U.S.D.o.H.a.H. Services, 2011, GLOBAL HLTH AGING, V0, P0
   Wallner M, 2012, MUTAGENESIS, V27, P731, DOI 10.1093/mutage/ges039
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   WHO, 2014, WORLD HLTH STAT 2014, V0, P0
   Wojda A, 2007, MUTAGENESIS, V22, P195, DOI 10.1093/mutage/gem002
   Wojda A, 2006, J GERONTOL A-BIOL, V61, P763, DOI 10.1093/gerona/61.8.763
   Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 118
TC 30
Z9 36
U1 0
U2 24
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1383-5742
EI 1388-2139
J9 MUTAT RES-REV MUTAT
JI Mutat. Res.-Rev. Mutat. Res.
PD OCT-DEC 15
PY 2015
VL 766
IS 
BP 48
EP 57
DI 10.1016/j.mrrev.2015.08.001
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA CZ9HA
UT WOS:000367407400005
PM 26596548
DA 2024-11-01
ER

PT J
AU Lehmann, D
   Schubert, K
   Joshi, PR
   Baty, K
   Blakely, EL
   Zierz, S
   Taylor, RW
   Deschauer, M
AF Lehmann, Diana
   Schubert, Kathrin
   Joshi, Pushpa R.
   Baty, Karen
   Blakely, Emma L.
   Zierz, Stephan
   Taylor, Robert W.
   Deschauer, Marcus
TI A novel m.7539C&gt;T point mutation in the mt-tRNA<SUP>Asp</SUP> gene associated with multisystemic mitochondrial disease
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondria; Multisystemic disease; tRNA(Asp)
ID transfer-rna mutations; dna mutations
AB Mitochondrial transfer RNA (mt-tRNA) mutations are the commonest sub-type of mitochondrial (mtDNA) mutations associated with human disease. We report a patient with multisytemic disease characterised by myopathy, spinal ataxia, sensorineural hearing loss, cataract and cognitive impairment in whom a novel m.7539C>T mt-tRNA(Asp) transition was identified. Muscle biopsy revealed extensive histopathological findings including cytochrome c oxidase (COX)-deficient fibres. Pyrosequencing confirmed mtDNA heteroplasmy for the mutation whilst single muscle fibre segregation studies revealed statistically significant higher mutation loads in COX-deficient fibres than in COX-positive fibres. Absence from control databases, hierarchical mt-tRNA mutation segregation within tissues, and occurrence at conserved sequence positions, further confirm this novel mt-tRNA mutation to be pathogenic. To date only three mt-tRNA(Asp) gene mutations have been described with clear evidence of pathogenicity. The novel m.7539C>T mt-tRNA(Asp) gene mutation extends the spectrum of pathogenic mutations in this gene, further supporting the notion that mt-tRNA(Asp) gene mutations are associated with multisystemic disease presentations. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Lehmann, Diana; Schubert, Kathrin; Joshi, Pushpa R.; Zierz, Stephan; Deschauer, Marcus] Univ Halle Wittenberg, Dept Neurol, D-06097 Halle, Germany.
   [Baty, Karen; Blakely, Emma L.; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Martin Luther University Halle Wittenberg; Newcastle University - UK
RP Deschauer, M (corresponding author), Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06097 Halle, Germany.
EM marcus.deschauer@uk-halle.de
FU German Ministry of Education and Research; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service; MRC [G0601943] Funding Source: UKRI
CR Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Lax NZ, 2013, J NEUROPATH EXP NEUR, V72, P164, DOI 10.1097/NEN.0b013e31828129c5
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   ZIERZ S, 1989, NERVENARZT, V60, P545
NR 17
TC 8
Z9 8
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JAN 15
PY 2015
VL 25
IS 1
BP 81
EP 84
DI 10.1016/j.nmd.2014.09.008
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CB4AR
UT WOS:000349571100012
PM 25447692
DA 2024-11-01
ER

PT J
AU Ahmed, N
   Ronchi, D
   Comi, GP
AF Ahmed, Naghia
   Ronchi, Dario
   Comi, Giacomo Pietro
TI Genes and Pathways Involved in Adult Onset Disorders Featuring Muscle Mitochondrial DNA Instability
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mtDNA maintenance; multiple mtDNA deletions; adult mitochondrial disorders; progressive external ophthalmoplegia; mitochondrial myopathy
ID progressive external ophthalmoplegia; dominant optic atrophy; polymerase-gamma mutation; base excision-repair; thymidine kinase; saccharomyces-cerevisiae; familial parkinsonism; spastic paraplegia; twinkle helicase; mpv17 encodes
AB Replication and maintenance of mtDNA entirely relies on a set of proteins encoded by the nuclear genome, which include members of the core replicative machinery, proteins involved in the homeostasis of mitochondrial dNTPs pools or deputed to the control of mitochondrial dynamics and morphology. Mutations in their coding genes have been observed in familial and sporadic forms of pediatric and adult-onset clinical phenotypes featuring mtDNA instability. The list of defects involved in these disorders has recently expanded, including mutations in the exo-/endo-nuclease flap-processing proteins MGME1 and DNA2, supporting the notion that an enzymatic DNA repair system actively takes place in mitochondria. The results obtained in the last few years acknowledge the contribution of next-generation sequencing methods in the identification of new disease loci in small groups of patients and even single probands. Although heterogeneous, these genes can be conveniently classified according to the pathway to which they belong. The definition of the molecular and biochemical features of these pathways might be helpful for fundamental knowledge of these disorders, to accelerate genetic diagnosis of patients and the development of rational therapies. In this review, we discuss the molecular findings disclosed in adult patients with muscle pathology hallmarked by mtDNA instability.
C1 [Ahmed, Naghia; Ronchi, Dario; Comi, Giacomo Pietro] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat,Neurol Unit, I-20122 Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Ronchi, D (corresponding author), Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat,Neurol Unit, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM naghia.ahmed89@gmail.com; dario.ronchi@gmail.com; giacomo.comi@unimi.it
FU Fondazione Cariplo [2014-1010]
CR Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Akbari M, 2015, DNA REPAIR, V32, P172, DOI 10.1016/j.dnarep.2015.04.029
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012641
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Belenguer P, 2013, BBA-MOL CELL RES, V1833, P176, DOI 10.1016/j.bbamcr.2012.08.004
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bonnen PE, 2013, AM J HUM GENET, V93, P773, DOI 10.1016/j.ajhg.2013.09.003
   Boschetti E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096692
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Budd ME, 2013, J BIOL CHEM, V288, P29414, DOI 10.1074/jbc.M113.472456
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Dörner A, 2007, TRENDS CARDIOVAS MED, V17, P284, DOI 10.1016/j.tcm.2007.10.001
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gloor JW, 2012, NUCLEIC ACIDS RES, V40, P6774, DOI 10.1093/nar/gks388
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   IEEE, 2013, 2013 IEEE INT, V0, P0, DOI DOI 10.1155/2013/146860
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006
   Jahani-Asl A, 2011, J BIOL CHEM, V286, P4772, DOI 10.1074/jbc.M110.167155
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Löllgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mendelsohn BA, 2014, JIMD REP, V13, P37, DOI 10.1007/8904_2013_267
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nguyen D, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.117
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishino I, 2000, ANN NEUROL, V47, P792
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200
   Ranieri M, 2013, NEUROL RES INT, V2013, P0, DOI 10.1155/2013/293893
   Ronchi D, 2015, BRAIN, V138, PE372, DOI 10.1093/brain/awu384
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scarpelli M, 2013, NEURORADIOL J, V26, P520, DOI 10.1177/197140091302600505
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, ADV EXP MED BIOL, V652, P69, DOI 10.1007/978-90-481-2813-6_6
   Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   Synofzik M, 2012, NEUROLOGY, V78, P0, DOI 10.1007/s12311-012-0378-2
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075048
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 116
TC 22
Z9 24
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG 15
PY 2015
VL 16
IS 8
BP 18054
EP 18076
DI 10.3390/ijms160818054
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CZ0WE
UT WOS:000366826100073
PM 26251896
DA 2024-11-01
ER

PT J
AU de Laat, P
   Fleuren, LHJ
   Bekker, MN
   Smeitink, JAM
   Janssen, MCH
AF de Laat, Paul
   Fleuren, Leanne H. J.
   Bekker, Mireille N.
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
TI Obstetric complications in carriers of the m.3243A&gt;G mutation, a retrospective cohort study on maternal and fetal outcome
SO MITOCHONDRION
LA English
DT Article
DE m.3243A>G mutation; Mitochondrial myopathy; Encephalomyopathy; Lactic acidosis and stroke-like episodes (MELAS syndrome); Maternally inherited diabetes deafness (MIDD); Mitochondrial medicine; Preeclampsia; Diabetes gravidarum; Prematurity; Dysmaturity; Obstetric complications
ID stroke-like episodes; preimplantation genetic diagnosis; lactic-acidosis; mitochondrial encephalopathy; clinical presentations; diabetes-mellitus; pregnancy; melas; epidemiology; a3243g
AB Introduction: The mitochondrial DNA m.3243A>G mutation is the most prevalent mutation causing mitochondrial disease in adult patients. Aside from some case reports, there are no studies on obstetric complications in a cohort of m.3243A>G carriers. We aimed to identify the prevalence of obstetric complications in a cohort of women carrying the m.3243A>G mutation. Methods: All female carriers of the m.3243A>G mutation known from our previous national inventory were sent a questionnaire regarding their obstetric history. Data were compared to national references. Data from the national inventory, including NMDAS (disease severity) scores and heteroplasmy levels in urinary epithelial cells (UEC) were used to stratify women. Results: Sixty women participated, the mean age was 47 years (range 20-70), mean NMDAS was 14.6 (range 0-46), and mean heteroplasmy percentage in UEC was 19.9% (range 5-85%). Ninety-eight pregnancies in 46 women were reported. Twenty-three (25.3%) had a premature delivery and five of them (5.5%) had a gestation of <= 32 weeks and eleven of the women (12%) suffered from preeclampsia. No different heteroplasmy level was found in the women with preeclampsia. Nine pregnancies (11%) were complicated by gestational diabetes. Discussion: Obstetric complications occur frequently in carriers of the m.3243A>G mutation. Proper guidance during pregnancies and early detection of possible obstetric complications are needed. As techniques to prevent transmission of mitochondrial mutations are studied it is important to know the possible complications patients may experience from the ensuing pregnancy. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [de Laat, Paul; Fleuren, Leanne H. J.; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboudumc Amalia Childrens Hosp, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Bekker, Mireille N.] Radboudumc, Dept Obstet & Gynecol, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboudumc, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen
RP de Laat, P (corresponding author), Radboudumc Amalia Childrens Hosp, Nijmegen Ctr Mitochondrial Disorders, Huispost 804,Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM paul.delaat@radboudumc.nl
FU Energy4All Foundation
CR Annaiah TK, 2007, J OBSTET GYNAECOL, V27, P618, DOI 10.1080/01443610701546318
   [Anonymous], 2002, OBSTET GYNECOL, V99, P159
   Burton GJ, 2009, PLACENTA, V30, PS43, DOI 10.1016/j.placenta.2008.11.003
   Butte NF, 1999, AM J CLIN NUTR, V69, P299
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   CUNNINGHAM FG, 1975, OBSTET GYNECOL, V46, P581
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Durand-Dubief F, 2004, REV NEUROL-FRANCE, V160, P824, DOI 10.1016/S0035-3787(04)71038-3
   GANT NF, 1974, OBSTET GYNECOL, V43, P854
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, PS1, DOI 10.1067/mob.2000.107928
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA
   JovanovicPeterson L, 1996, DIABETES METAB REV, V12, P287, DOI 10.1002/(SICI)1099-0895(199612)12:4<287::AID-DMR170>3.0.CO;2-E
   Kovilam OP, 1999, OBSTET GYNECOL, V93, P853, DOI 10.1016/S0029-7844(98)00457-8
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moriarty KT, 2008, J OBSTET GYNAECOL, V28, P349, DOI 10.1080/01443610802048545
   Nesbitt V, 2013, J NEUROL NEUROSURG P, V0, P0
   Padmini E, 2009, CLIN CHEM LAB MED, V47, P1073, DOI 10.1515/CCLM.2009.247
   Penney GC, 2003, BJOG-INT J OBSTET GY, V110, P315, DOI 10.1016/S1470-0328(03)02967-7
   Perinatale Zorg in Nederland, 2011, PER ZORG NED 2011, V0, P0
   Poulton J, 2009, BMJ-BRIT MED J, V338, P0, DOI 10.1136/bmj.b94
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shi ZH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064351
   Shibata E, 2003, PLACENTA, V24, P698, DOI 10.1016/S0143-4004(03)00083-3
   Stark R, 2007, EUR J CLIN INVEST, V37, P236, DOI 10.1111/j.1365-2362.2007.01773.x
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078
   Temple R, 2002, BRIT MED J, V325, P1275, DOI 10.1136/bmj.325.7375.1275
   TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vollebregt KC, 2010, ACTA OBSTET GYN SCAN, V89, P261, DOI 10.3109/00016340903433982
NR 43
TC 28
Z9 31
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2015
VL 25
IS 
BP 98
EP 103
DI 10.1016/j.mito.2015.10.005
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CX8DW
UT WOS:000365933800012
PM 26455484
DA 2024-11-01
ER

PT J
AU Delgado-Alvarado, M
   de la Riva, P
   Jiménez-Urbieta, H
   Gago, B
   Gabilondo, A
   Bornstein, B
   Rodríguez-Oroz, MC
AF Delgado-Alvarado, Manuel
   de la Riva, Patricia
   Jimenez-Urbieta, Haritz
   Gago, Belen
   Gabilondo, Alazne
   Bornstein, Belen
   Cruz Rodriguez-Oroz, Maria
TI Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE POLG; Parkinsonism; Progressive external ophthalmoplegia; Ptosis; Cognitive impairment; Obsessive disorder
ID progressive external ophthalmoplegia; mitochondrial-dna mutations; polg1 gene; disease; family; association; inheritance; variants; patient
AB Polymerase gamma (POLG) is the enzyme responsible for the replication and maintenance of mitochondrial DNA (mtDNA). Mutations in the POLG1 gene can lead to mitochondrial dysfunction, producing a wide range of neurological and non-neurological phenotypes. Neurological manifestations include ataxia, muscular weakness, epilepsy, progressive external ophthalmoplegia (PEO), ptosis, neuropathy, psychiatric disorders and, more rarely, parkinsonism. We present the case of an 80-year old female patient with a history of PEO, ptosis, childish behaviour, obsessive disorder, cognitive decline, and parldnsonism. A comprehensive study showed striatal dopamine deficiency on DaT Scan and ragged red fibres as evidenced by Gomori staining in a biopsy of the biceps brachii. Multiple deletions of mtDNA were detected, and sequencing of the POLG1 gene identified a novel substitution, 2834A>T, in exon 18, changing the p.His945Leu amino acid. In silico analysis using PolyPhen-2 (http://genetics.bwh.hardvard.edu/pph2/) predicted that this change is probably damaging, with a score of 1.0 (0-1). (C) 2015 Elsevier B.V. All rights reserved.
C1 [Delgado-Alvarado, Manuel; Jimenez-Urbieta, Haritz; Gago, Belen; Cruz Rodriguez-Oroz, Maria] Biodonostia Res Inst, Neurosci Area, San Sebastian 200014, Spain.
   [de la Riva, Patricia; Gabilondo, Alazne; Cruz Rodriguez-Oroz, Maria] Univ Hosp Donostia, San Sebastian, Spain.
   [Delgado-Alvarado, Manuel; Gago, Belen; Cruz Rodriguez-Oroz, Maria] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.
   [Bornstein, Belen] Hosp Univ Puerta de Hierro, Serv Bioquim, Madrid, Spain.
   [Bornstein, Belen] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [Cruz Rodriguez-Oroz, Maria] Basque Fdn Sci, Ikerbasque, Bilbao, Spain.
C3 University Hospital Donostia; CIBERNED; Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Basque Foundation for Science
RP Rodríguez-Oroz, MC (corresponding author), Biodonostia Res Inst, Neurosci Area, Paseo Dr Beguiristain S-N, San Sebastian 200014, Spain.
EM maria.rodriguezoroz@biodonostia.org
CR Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Büeler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   Dolhun R, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-92
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Famum GA, 2014, BIOCHIM BIOPHYS ACTA, V1837, P1113
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Gui YX, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050086
   Gurgel-Giannetti J, 2012, MUSCLE NERVE, V45, P453, DOI 10.1002/mus.22330
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Inczedy-Farkas G, 2014, ARCH CLIN NEUROPSYCH, V29, P315, DOI 10.1093/arclin/acu016
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Mukai M, 2013, PARKINSONISM RELAT D, V19, P821, DOI 10.1016/j.parkreldis.2013.04.011
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Posada IJ, 2010, MED CLIN-BARCELONA, V135, P452, DOI 10.1016/j.medcli.2010.03.031
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
NR 30
TC 12
Z9 12
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2015
VL 350
IS 1-2
BP 93
EP 97
DI 10.1016/j.jns.2015.02.011
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CH0UN
UT WOS:000353738000016
PM 25724872
DA 2024-11-01
ER

PT J
AU Venter, L
   Lindeque, Z
   van Rensburg, PJ
   van der Westhuizen, F
   Smuts, I
   Louw, R
AF Venter, Leonie
   Lindeque, Zander
   van Rensburg, Peet Jansen
   van der Westhuizen, Francois
   Smuts, Izelle
   Louw, Roan
TI Untargeted urine metabolomics reveals a biosignature for muscle respiratory chain deficiencies
SO METABOLOMICS
LA English
DT Article
DE Respiratory chain deficiency; Metabolomics; Urinary biomarker; LC-MS
ID mitochondrial disorders; diagnostic-criteria; biomarker discovery; monitor progression; disease; adults; scale
AB Mitochondrial diseases are a heterogeneous group of disorders characterised by impaired mitochondrial oxidative phosphorylation system. Most often for mitochondrial disease, where no metabolic diagnostic biomarkers exist, a deficiency is diagnosed after analysing the respiratory chain enzymes (complexes I-IV) in affected tissues or by identifying one of an ever expanding number of DNA mutations. This presents a great challenge to identify cases to undergo the invasive diagnostic procedures required. An untargeted liquid chromatography mass spectrometry metabolomics approach was used to search for a metabolic biosignature that can distinguish respiratory chain deficient (RCD) patients from clinical controls (CC). A cohort of 37 ethnically diverse cases was used. Sample preparation, liquid chromatography time-of-flight mass spectrometry methods and data processing methods were standardised. Furthermore the developed methodology used reverse phase chromatography in conjunction with positive electrospray ionisation and hydrophilic interaction chromatography with negative electrospray ionisation. Urine samples of 37 patients representing two different experimental groups were analysed. The two experimental groups comprised of patients with confirmed RCDs and CC. After a variety of data mining steps and statistical analyses a list of 12 features were compiled with the ability to distinguish between patients with RCDs and CC. Although the features of the biosignature needs to be identified and the biosignature validated, this study demonstrates the value of untargeted metabolomics to identify a metabolic biosignature to possibly be applied in the selection criteria for RCDs.
C1 [Venter, Leonie; Lindeque, Zander; van Rensburg, Peet Jansen; van der Westhuizen, Francois; Louw, Roan] North West Univ, Ctr Human Metabon, Potchefstroom, South Africa.
   [Smuts, Izelle] Univ Pretoria, Dept Paediat & Child Hlth, Steve Biko Acad Hosp, ZA-0002 Pretoria, South Africa.
C3 North West University - South Africa; University of Pretoria
RP Louw, R (corresponding author), North West Univ, Ctr Human Metabon, Potchefstroom Campus, Potchefstroom, South Africa.
EM Roan.Louw@nwu.ac.za
FU North-West University, Potchefstroom Campus
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Christin C, 2013, MOL CELL PROTEOMICS, V12, P263, DOI 10.1074/mcp.M112.022566
   Ellis SM, 2003, MANAGEMENT DYNAMICS, V12, P51, DOI 10.10520/EJC69666
   Hrydziuszko O, 2012, METABOLOMICS, V8, PS161, DOI 10.1007/s11306-011-0366-4
   Munnich A, 2011, ONLINE METABOLIC MOL, V10, P0
   Pewsner D, 2004, BMJ-BRIT MED J, V329, P209, DOI 10.1136/bmj.329.7459.209
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Smuts I, 2010, J INHERIT METAB DIS, V33, PS95, DOI 10.1007/s10545-009-9031-8
   Smuts I, 2013, METABOLOMICS, V9, P379, DOI 10.1007/s11306-012-0455-z
   Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, PW652, DOI 10.1093/nar/gkp356
NR 17
TC 22
Z9 22
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD FEB 15
PY 2015
VL 11
IS 1
BP 111
EP 121
DI 10.1007/s11306-014-0675-5
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AZ6QH
UT WOS:000348343300011
DA 2024-11-01
ER

PT J
AU Gal, A
   Inczedy-Farkas, G
   Pal, E
   Remenyi, V
   Bereznai, B
   Geller, L
   Szelid, Z
   Merkely, B
   Molnar, MJ
AF Gal, Aniko
   Inczedy-Farkas, Gabriella
   Pal, Endre
   Remenyi, Viktoria
   Bereznai, Benjamin
   Geller, Laszlo
   Szelid, Zsolt
   Merkely, Bela
   Molnar, Maria Judit
TI The coexistence of <i>dynamin 2</i> mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy
SO CLINICAL NEUROPATHOLOGY
LA English
DT Article
DE centronuclear myopathy; repetitive discharge; dynamin 2 mutation; cardiomyopathy; mitochondrial DNA (mtDNA) deletion
ID marie-tooth disease; neonatal onset; muscle; neuropathy; phenotype; features; fission; patient; gene
AB Dynamin2 (DNM2) gene mutations may result in Charcot-Marie-Tooth disease and centronuclear myopathy. Here, we present a patient suffering from cardiomyopathy and centronuclear myopathy with repetitive discharges and mild axonal neuropathy due to DNM2 mutation. Detailed cardiological and neurological examinations, electrophysiological tests, muscle biopsy, and molecular genetic analysis were performed. The patient developed left bundle branch block at age 40 and was fitted with a pacemaker at the age of 43. The patient has severe heart failure, ptosis, strabism, facial and proximal muscle weakness. Electrophysiological investigations found myopathy, complex repetitive discharges, and axonal neuropathy. Skeletal muscle biopsy detected centronuclear myopathy and cytochrome C oxidase (COX) negative fibers. Genetic analysis detected a pathogenic c.1105C>T (p.R369W) DNM2 gene mutation and heteroplasmic multiple mitochondrial DNA (mtDNA) deletion. Our data broadens the phenotypic spectrum of DNM2 mutations. The presence of the multiple mtDNA deletions may provide new aspects to understanding the pathogenesis of multisystemic symptoms in patients with DNM2 mutations.
C1 [Gal, Aniko; Inczedy-Farkas, Gabriella; Remenyi, Viktoria; Bereznai, Benjamin; Molnar, Maria Judit] Semmelweis Univ, Inst Genom Med & Rare Disorders, H-1083 Budapest, Hungary.
   [Pal, Endre] Univ Pecs, Dept Neurol, Pecs, Hungary.
   [Geller, Laszlo; Szelid, Zsolt; Merkely, Bela] Semmelweis Univ, Ctr Heart, H-1083 Budapest, Hungary.
C3 Semmelweis University; University of Pecs; Semmelweis University
RP Molnar, MJ (corresponding author), Semmelweis Univ, Inst Genom Med & Rare Disorders, Tomostr 25-29, H-1083 Budapest, Hungary.
EM molnarmj@gmail.com
FU Hungarian Brain Research Program;  [BIOINF09 TET_10-1-2011-0058]
CR Al-Rinvaishid A, 2003, BRAIN DEV, V25, P62
   Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253
   Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657
   Bitoun M, 2009, NEUROLOGY, V72, P93, DOI 10.1212/01.wnl.0000338624.25852.12
   Bitoun M, 2008, NEUROMUSCULAR DISORD, V18, P334, DOI 10.1016/j.nmd.2008.01.005
   Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235
   Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595
   Catteruccia M, 2013, NEUROMUSCULAR DISORD, V23, P229, DOI 10.1016/j.nmd.2012.12.009
   Claeys KG, 2009, BRAIN, V132, P1741, DOI 10.1093/brain/awp115
   Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4
   Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61
   Hanisch F, 2011, J NEUROL, V258, P1085, DOI 10.1007/s00415-010-5889-5
   Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714
   Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573
   Jungbluth H, 2008, ORPHANET J RARE DIS, V3, P0, DOI 10.1186/1750-1172-3-26
   Kierdaszuk B, 2013, NEUROMUSCULAR DISORD, V23, P219, DOI 10.1016/j.nmd.2012.12.007
   Koutsopoulos OS, 2013, EUR J HUM GENET, V21, P637, DOI 10.1038/ejhg.2012.226
   Krishnan KJ, 2012, NEUROMUSCULAR DISORD, V22, P839, DOI 10.1016/j.nmd.2012.06.124
   Li J, 2013, INT J CARDIOL, V168, P2109, DOI 10.1016/j.ijcard.2013.01.006
   Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267
   Melberg A, 2010, NEUROMUSCULAR DISORD, V20, P53, DOI 10.1016/j.nmd.2009.10.006
   Nomura S, 2011, INT J CARDIOL, V150, P213, DOI 10.1016/j.ijcard.2011.05.009
   Park YE, 2014, J CLIN NEUROL, V10, P24
   Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313
   Susman RD, 2010, NEUROMUSCULAR DISORD, V20, P229, DOI 10.1016/j.nmd.2010.02.016
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tinelli E, 2013, HUM MOL GENET, V22, P4417, DOI 10.1093/hmg/ddt292
   Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250
   VERHIEST W, 1976, BRIT HEART J, V38, P504
   Zanoteli E, 2009, ARQ NEURO-PSIQUIAT, V67, P102, DOI 10.1590/S0004-282X2009000100023
   Züchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514
NR 31
TC 9
Z9 9
U1 0
U2 7
PU DUSTRI-VERLAG DR KARL FEISTLE
PI DEISENHOFEN-MUENCHEN
PA BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY
SN 0722-5091
EI 
J9 CLIN NEUROPATHOL
JI Clin. Neuropathol.
PD MAR-APR 15
PY 2015
VL 34
IS 2
BP 89
EP 95
DI 10.5414/NP300789
PG 7
WC Clinical Neurology; Pathology
SC Neurosciences & Neurology; Pathology
GA CE0KE
UT WOS:000351492100006
PM 25492887
DA 2024-11-01
ER

PT J
AU Korzeniewski, B
AF Korzeniewski, Bernard
TI Effects of OXPHOS complex deficiencies and ESA dysfunction in working intact skeletal muscle: implications for mitochondrial myopathies
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE Mitochondrial diseases; mtDNA mutations; Oxidative phosphorylation; Inborn enzyme deficiencies; Computer model
ID oxidative-phosphorylation; oxygen-consumption; atp synthesis; threshold; fatigue; heteroplasmy; transitions; efficiency; kinetics; diseases
AB The effects of inborn oxidative phosphorylation (OXPHOS) complex deficiencies or possible each-step activation (ESA) dysfunction on the bioenergetic system in working intact skeletal muscle are studied using a computer model of OXPHOS published previously. The curves representing the dependencies of (V) over dot O-2 and metabolite concentrations on single complex activity, entire OXPHOS activity or ESA intensity exhibit a characteristic threshold at some OXPHOS complex activity/ESA intensity. This threshold for (V) over dot O-2 of single complex activities is significantly lower in intact muscle during moderate and heavy work, than in isolated mitochondria in state 3. Metabolite concentrations and pH in working muscle start to change significantly at much higher OXPHOS complex activities/ESA intensities than (V) over dot O-2. The effect of entire OXPHOS deficiency or ESA dysfunction is potentially much stronger than the effect of a single complex deficiency. Implications of these findings for the genesis of mitochondrial myopathies are discussed. It is concluded that (V) over dot O-2 in state 3 and its dependence on complex activity in isolated mitochondria is not a universal quantitative determinant of the effect of mitochondrial dysfunctions in vivo. Moderate and severe mitochondria dysfunctions are defined: the former affect significantly only metabolite concentrations and pH, while the latter also decrease significantly (V) over dot O-2 in intact skeletal muscle during work. The dysfunction-caused decrease in (V) over dot O-2/oxidative ATP synthesis flux, disturbance of metabolite homeostasis, elevated ROS production and anaerobic glycolysis recruitment can account for such mitochondrial myopathy symptoms as muscle weakness, exercise intolerance (exertional fatigue) and lactic acidosis. (C) 2015 Elsevier B.V. All rights reserved.
C1 Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland.
C3 Jagiellonian University
RP Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.
EM bernard.korzeniewski@gmail.com
CR Alam MT, 2015, BBA-BIOENERGETICS, V1847, P526, DOI 10.1016/j.bbabio.2015.02.006
   Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983
   Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043
   GROEN AK, 1982, J BIOL CHEM, V257, P2754
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   KATZ LA, 1989, AM J PHYSIOL, V256, PH265, DOI 10.1152/ajpheart.1989.256.1.H265
   Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Korzeniewski B, 2006, J BIOL CHEM, V281, P3057, DOI 10.1074/jbc.M510418200
   Korzeniewski B, 2005, BIOPHYS CHEM, V116, P145, DOI 10.1016/j.bpc.2005.04.001
   Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882
   Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   Korzeniewski B, 2001, BIOCHEM J, V357, P835, DOI 10.1042/0264-6021:3570835
   Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011
   Korzeniewski B, 1996, BIOCHEM J, V319, P143, DOI 10.1042/bj3190143
   Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013
   Korzeniewski B, 2006, AM J PHYSIOL-HEART C, V291, PH1466, DOI 10.1152/ajpheart.00004.2006
   Korzeniewski B, 2015, J APPL PHYSIOL, V118, P1240, DOI 10.1152/japplphysiol.00027.2015
   Korzeniewski B, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0117145
   Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013
   Korzeniewski B, 2013, J APPL PHYSIOL, V115, P605, DOI 10.1152/japplphysiol.00469.2013
   Korzeniewski B, 2011, PROG BIOPHYS MOL BIO, V107, P274, DOI 10.1016/j.pbiomolbio.2011.08.003
   LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171
   LETELLIER T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P58, DOI 10.1016/0005-2728(93)90189-M
   Liguzinski P, 2006, AM J PHYSIOL-CELL PH, V291, PC1213, DOI 10.1152/ajpcell.00078.2006
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Woledge RC, 1998, ACTA PHYSIOL SCAND, V162, P267, DOI 10.1046/j.1365-201X.1998.0294e.x
   Wu F, 2007, AM J PHYSIOL-CELL PH, V292, PC115, DOI 10.1152/ajpcell.00237.2006
NR 41
TC 11
Z9 12
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD OCT 15
PY 2015
VL 1847
IS 10
BP 1310
EP 1319
DI 10.1016/j.bbabio.2015.07.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ8PY
UT WOS:000360872100030
PM 26188374
DA 2024-11-01
ER

PT J
AU McCormick, EM
   Kenyon, L
   Falk, MJ
AF McCormick, Elizabeth M.
   Kenyon, Lawrence
   Falk, Marni J.
TI Desmin common mutation is associated with multi-systemic disease manifestations and depletion of mitochondria and mitochondria! DNA
SO FRONTIERS IN GENETICS
LA English
DT Article
ID cytoskeleton; myopathy
AB Desmin (DES) is a major muscle scaffolding protein that also functions to anchor mitochondria. Pathogenic DES mutations, however, have not previously been recognized as a cause of multi-systemic mitochondrial disease. Here, we describe a 45-year-old man who presented to The Children's Hospital of Philadelphia Mitochondrial-Genetics Diagnostic Clinic for evaluation of progressive cardiac, neuromuscular, gastrointestinal, and mood disorders. Muscle biopsy at age 45 was remarkable for cytoplasmic bodies, as well as ragged red fibers and SDH positive/COX negative fibers that were suggestive of a mitochondrial myopathy. Muscle also showed significant reductions in mitochondrial content (16% of control mean for citrate synthase activity) and mitochondrial DNA (35% of control mean). His family history was significant for cardiac conduction defects and myopathy in multiple maternal relatives. Multiple single gene and panel-based sequencing studies were unrevealing. Whole exome sequencing identified a known pathogenic p.S13F mutation in DES that had previously been associated with desmin-related myopathy. Desmin-related myopathy is an autosomal dominant disorder characterized by right ventricular hypertrophic cardiomyopathy, myopathy, and arrhythmias. However, neuropathy, gastrointestinal dysfunction, and depletion of both mitochondria and mitochondrial DNA have not previously been widely recognized in this disorder. Recognition that mitochondrial dysfunction occurs in desmin-related myopathy clarifies the basis for the multi-systemic manifestations, as are typical of primary mitochondrial disorders. Understanding the mitochondrial pathophysiology of desmin-related myopathy highlights the possibility of new therapies for this otherwise untreatable and often fatal class of disease. We postulate that drug treatments aimed at improving mitochondrial biogenesis or reducing oxidative stress may be effective therapies to ameliorate the effects of desmin-related disease.
C1 [McCormick, Elizabeth M.; Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA.
   [Kenyon, Lawrence] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA.
   [Falk, Marni J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jefferson University; University of Pennsylvania
RP Falk, MJ (corresponding author), Childrens Hosp Philadelphia, ARC 1002C,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM falkm@email.chop.edu
FU NICHD NIH HHS [U54 HD086984] Funding Source: Medline
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Bergman JEH, 2007, EUR J MED GENET, V50, P355, DOI 10.1016/j.ejmg.2007.06.003
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Henderson M, 2013, ACTA NEUROPATHOL, V125, P917, DOI 10.1007/s00401-013-1113-x
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Schröder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   STROMER MH, 1988, CELL MOTIL CYTOSKEL, V11, P117, DOI 10.1002/cm.970110205
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   van Spaendonck-Zwarts KY, 2012, NETH HEART J, V20, P219, DOI 10.1007/s12471-011-0233-y
   Venegas Victor, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1907s68
   Vigelso Andreas, 2014, INT J PHYSIOL PATHOPHYSIOL PHARMACOL, V6, P84
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010
NR 23
TC 17
Z9 17
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JUN 5
PY 2015
VL 6
IS 
BP 
EP 
DI 10.3389/fgene.2015.00199
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA CP1NR
UT WOS:000359643000002
PM 26097489
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Wakil, S
AF Finsterer, Josef
   Wakil, Salma
TI Abnormalities of Skin and Cutaneous Appendages in Neuromuscular Disorders
SO PEDIATRIC NEUROLOGY
LA English
DT Review
DE cutaneous; dermis; sweat glands; hairs; dermatological; myopathy; neuropathy; neuromuscular transmission
ID epidermolysis-bullosa simplex; muscular-dystrophy; mitochondrial-dna; congenital insensitivity; lactic-acidosis; plec mutations; fabry-disease; patient; neuropathy; hair
AB OBJECTIVES: A thorough evaluation of the skin and its appendages is frequently outside the area of expertise of the neurologist who deals with neuromuscular disorders. However, the skin is more frequently affected in neuromuscular disorders and deserves more attention than so far acknowledged. METHODS: Review of publications by searching Medline dealing with skin disorders in neuromuscular disorders. RESULTS: Skin abnormalities are most frequently found in patients with dermatomyositis, myotonic dystrophies, mitochondrial disorders, muscular dystrophies, and neuropathies. The hairs and the sweat glands are the appendages most frequently affected in neuromuscular disorders. In myotonic dystrophies and mitochondrial disorders there are indications that the rate of skin neoplasms is increased compared with the general population. CONCLUSIONS: Skin lesions in neuromuscular disorders are not unusual. Neurologists should be aware of the cutaneous implications of neuromuscular disorders and should take a thorough history relative to cutaneous manifestations and complete a comprehensive investigation of the skin and its appendages. If there is evidence of a dermatological problem in a neuromuscular disorder, a dermatologist should be consulted. Dermatological involvement in neuromuscular disorders may contribute to the diagnosis of neuromuscular disorders and may help to differentiate between various entities. The skin should become a focus of the neurologist as well.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Wakil, Salma] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
C3 Rudolfstiftung Hospital; King Faisal Specialist Hospital & Research Center
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Aghaei Shahin, 2006, DERMATOL ONLINE J, V12, P5
   Artuch R, 1998, HORM RES, V50, P99, DOI 10.1159/000023243
   Baertling F, 2013, J INHERIT METAB DIS, V36, P1081, DOI 10.1007/s10545-013-9593-3
   Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428
   Born AP, 2010, NEUROMUSCULAR DISORD, V20, P136, DOI 10.1016/j.nmd.2009.11.009
   CABLE WJL, 1982, NEUROLOGY, V32, P347, DOI 10.1212/WNL.32.4.347
   Carmi E, 2001, ANN DERMATOL VENER, V128, P1031
   Cassano N, 2014, GIORN ITAL DERMAT V, V149, P555
   Chakrabarty B, 2014, J CHILD NEUROL, V29, PNP5, DOI 10.1177/0883073813488662
   Chakrabarty B, 2014, J CHILD NEUROL, V29, P469, DOI 10.1177/0883073813482769
   Charlesworth A, 2013, BRIT J DERMATOL, V168, P808, DOI 10.1111/bjd.12202
   CHARROW J, 1986, J PEDIATR-US, V108, P729, DOI 10.1016/S0022-3476(86)81054-X
   Chong P Siao Tick, 2003, J CLIN NEUROMUSCUL DIS, V5, P1, DOI 10.1097/00131402-200309000-00001
   CLANCY RR, 1980, J NEUROL SCI, V46, P257, DOI 10.1016/0022-510X(80)90050-7
   Dimachkie MM, 2012, SEMIN NEUROL, V32, P227, DOI 10.1055/s-0032-1329201
   Du-Thanh A, 2006, ANN DERMATOL VENER, V133, P991, DOI 10.1016/S0151-9638(06)71085-7
   Esteban-García A, 2004, REV NEUROLOGIA, V39, P525, DOI 10.33588/rn.3906.2004237
   Finsterer J, 2005, ACTA OPHTHALMOL SCAN, V83, P628, DOI 10.1111/j.1600-0420.2005.00518.x
   Finsterer J, 2013, J MED LIFE, V6, P477
   Finsterer J, 2011, REV INVEST CLIN, V63, P322
   Fiorentino D, 2011, J AM ACAD DERMATOL, V65, P25, DOI 10.1016/j.jaad.2010.09.016
   Fujita T, 1974, NIHON RINSHO, V32, P554
   Graells J, 1996, INT J DERMATOL, V35, P732, DOI 10.1111/j.1365-4362.1996.tb00651.x
   HAYASAKA S, 1989, GRAEF ARCH CLIN EXP, V227, P209, DOI 10.1007/BF02172750
   Hermanns-Lê T, 2014, ULTRASTRUCT PATHOL, V38, P164, DOI 10.3109/01913123.2013.829151
   Iaccarino L, 2014, J AUTOIMMUN, V48-49, P122, DOI 10.1016/j.jaut.2013.11.005
   Itin PH, 2001, HAUTARZT, V52, P244, DOI 10.1007/s001050051298
   Karvonen SL, 1999, BRIT J DERMATOL, V140, P634
   Katirji B, 2014, NEUROMUSCULAR DISORD, VXXV, P476
   Katona I, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-17
   Kefala-Agoropoulou K, 2008, PEDIATR BLOOD CANCER, V50, P939, DOI 10.1002/pbc.21379
   Kim JE, 2011, J CLIN NEUROL, V7, P233, DOI 10.3988/jcn.2011.7.4.233
   Kim W, 2013, ORTHOP TRAUMATOL-SUR, V99, P881, DOI 10.1016/j.otsr.2013.05.006
   King ICC, 2015, PEDIATR DERMATOL, V32, P97, DOI 10.1111/pde.12353
   KUNTZER T, 1991, REV NEUROL, V147, P819
   Kwok T, 2013, J CUTAN MED SURG, V17, PS1, DOI 10.2310/7750.2013.WOUND3
   Latronico N, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075696
   Marque M, 2010, BRIT J DERMATOL, V163, P1337, DOI 10.1111/j.1365-2133.2010.09912.x
   Mehta SG, 2006, AM J MED GENET A, V140A, P322, DOI 10.1002/ajmg.a.31008
   Moghadam-Kia S, 2013, DERMATOL CLIN, V31, P75, DOI 10.1016/j.det.2012.08.008
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   Nakai K, 2009, EUR J DERMATOL, V19, P507, DOI 10.1684/ejd.2009.0713
   Nance CS, 2006, ARCH NEUROL-CHICAGO, V63, P453, DOI 10.1001/archneur.63.3.453
   Oaklander AL, 2013, PEDIATRICS, V131, PE1091, DOI 10.1542/peds.2012-2597
   Ortonne N, 2002, ANN PATHOL, V22, P39
   Park Y, 2014, ANN REHABIL MED-ARM, V38, P292, DOI 10.5535/arm.2014.38.2.292
   Parodi A, 2014, GIORN ITAL DERMAT V, V149, P79
   Pellegrini C, 2013, J CELL PHYSIOL, V228, P1323, DOI 10.1002/jcp.24290
   Reichart B, 2004, BMC CELL BIOL, V5, P0, DOI 10.1186/1471-2121-5-12
   Requena L, 1997, BRIT J DERMATOL, V136, P768, DOI 10.1111/j.1365-2133.1997.tb03668.x
   Rocha N, 2005, J EUR ACAD DERMATOL, V19, P605, DOI 10.1111/j.1468-3083.2005.01222.x
   Sagnelli A, 2014, NEUROMUSCULAR DISORD, V24, P272, DOI 10.1016/j.nmd.2013.11.006
   Santos G, 2013, AN BRAS DERMATOL, V88, P1009, DOI 10.1590/abd1806-4841.20132266
   Sayyahfar S, 2013, PEDIATR DERMATOL, V30, P754, DOI 10.1111/j.1525-1470.2012.01833.x
   Sharma RC, 2002, DERMATOLOGY, V205, P305, DOI 10.1159/000065852
   Sherrod Quyn J, 2008, DERMATOL ONLINE J, V14, P22
   Sidhu A, 2014, J PEDIATR-US, V165, P1060, DOI 10.1016/j.jpeds.2014.06.016
   Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556
   Stagi S, 2010, HORM RES PAEDIAT, V73, P409, DOI 10.1159/000308176
   Steggink Lars C, 2013, NED TIJDSCHR GENEESKD, V157, P0
   Teive HAG, 2008, MOVEMENT DISORD, V23, P1191, DOI 10.1002/mds.21990
   TULINIUS MH, 1995, EUR J PEDIATR, V154, P35, DOI 10.1007/BF01972970
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   WEISS BJ, 1991, ANN NEUROL, V30, P419, DOI 10.1002/ana.410300316
   Winter L, 2013, ACTA NEUROPATHOL, V125, P77, DOI 10.1007/s00401-012-1026-0
   Yin JH, 2015, INT J DERMATOL, V54, P185, DOI 10.1111/ijd.12655
   Zemtsov A, 2010, ARCH DERMATOL RES, V302, P169, DOI 10.1007/s00403-009-0997-8
NR 68
TC 8
Z9 9
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD OCT 15
PY 2015
VL 53
IS 4
BP 301
EP 308
DI 10.1016/j.pediatrneurol.2015.03.005
PG 8
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA CS4OX
UT WOS:000362056500004
PM 26385056
DA 2024-11-01
ER

PT J
AU Pulliero, A
   Godschalk, R
   Andreassi, MG
   Curfs, D
   Van Schooten, FJ
   Izzotti, A
AF Pulliero, A.
   Godschalk, R.
   Andreassi, M. G.
   Curfs, D.
   Van Schooten, F. J.
   Izzotti, A.
TI Environmental carcinogens and mutational pathways in atherosclerosis
SO INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
LA English
DT Review
DE Carcinogens; DNA damage; Atherosclerosis; Cardiovascular diseases; Polycyclic aromatic hydrocarbons; Radiation
ID smooth-muscle-cells; polycyclic aromatic-hydrocarbons; coronary-heart-disease; persistent organic pollutants; nucleotide excision-repair; activated protein-kinases; low-density-lipoprotein; age-dependent changes; induced dna-damage; cigarette-smoke
AB Atherosclerosis is associated with DNA damage in both circulating and vessel-wall cells and DNA adducts derived from exposure to environmental mutagens are abundant in atherosclerotic vessels. Environmental chemical carcinogens identified as risk factor for atherosclerosis include polycyclic aromatic hydrocarbons (benzo(a)pyrene, dimethylbenz(a)anthracene, beta-naphthoflavone, pyrene, 3methylcolanthrene), arsenic, cadmium, 1,3-butadiene, cigarette smoke. Accordingly, polymorphisms of genes encoding for phase I/II metabolic reaction and DNA repair are risk factor for cardiovascular diseases, although their role is negligible as compared to other risk factors. The pathogenic relevance of mutation-related molecular damage in atherosclerosis has been demonstrated in experimental animal models involving the exposure to chemical mutagens. The relevance of mutation-related events in worsening atherosclerosis prognosis has been demonstrated in human clinical studies mainly as referred to mitochondrial DNA damage. Atherosclerosis is characterized by the occurrence of high level of oxidative damage in blood vessel resulting from both endogenous and exogenous sources. Mitochondrial damage is a main endogenous source of oxidative stress whose accumulation causes activation of intrinsic apoptosis through BIRC2 inhibition and cell loss contributing to plaque development and instability. Environmental physical mutagens, including ionizing radiation, are a risk factor for atherosclerosis even at the low exposure dose occurring in case of occupational exposure or the high exposure doses occurring during radiotherapy. Conversely, the role of exciting UV radiation in atherosclerosis is still uncertain. This review summarizes the experimental and clinical evidence supporting the pathogenic role of mutation-related pathway in atherosclerosis examining the underlying molecular mechanisms. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Pulliero, A.; Izzotti, A.] Univ Genoa, Dept Hlth Sci, I-16126 Genoa, Italy.
   [Godschalk, R.; Curfs, D.; Van Schooten, F. J.] Maastricht Univ, Maastricht UMC, Sch Nutr Toxicol & Metab NUTRIM, Dept Toxicol, NL-6200 MD Maastricht, Netherlands.
   [Andreassi, M. G.] CNR, Inst Clin Physiol, I-56124 Pisa, Italy.
   [Izzotti, A.] IRCCS AOU San Martino IST, Genoa, Italy.
C3 University of Genoa; Maastricht University; Maastricht University Medical Centre (MUMC); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Genoa; IRCCS AOU San Martino IST
RP Izzotti, A (corresponding author), Univ Genoa, Dept Hlth Sci, I-16126 Genoa, Italy.
EM izzotti@unige.it
CR Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
   AGIR (Advisory Group on Ionising Radiation), 2010, REPORT OF THE INDEPE, V0, P0
   Akbas HS, 2010, LIPIDS HEALTH DIS, V9, P0, DOI 10.1186/1476-511X-9-92
   ALBERT RE, 1977, CANCER RES, V37, P2232
   Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047
   Ammit AJ, 2001, J APPL PHYSIOL, V91, P1431, DOI 10.1152/jappl.2001.91.3.1431
   Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Annas A, 2000, MUTAT RES-GEN TOX EN, V471, P145, DOI 10.1016/S1383-5718(00)00127-3
   Arroyo LH, 1999, CARDIOVASC RES, V41, P369, DOI 10.1016/S0008-6363(98)00308-3
   AUGE N, 1995, BIOCHEM J, V309, P1015, DOI 10.1042/bj3091015
   Aviram M, 2005, HANDB EXP PHARM, V170, P263
   Bäckhed F, 2013, NAT MED, V19, P533, DOI 10.1038/nm.3178
   Bakhru A, 2005, PLOS MED, V2, P528, DOI 10.1371/journal.pmed.0020160
   Balansky R, 1996, CANCER RES, V56, P1642
   BATASTINI G, 1984, AM J PATHOL, V114, P403
   Bazo AP, 2001, CARDIOVASC PATHOL, V20, P0
   Becker AE, 2001, ANNU REV MED, V52, P289, DOI 10.1146/annurev.med.52.1.289
   BEIR, 2006, HEALTH RISKS FROM EX, V0, P0
   Bernhard D, 2003, FASEB J, V17, P2302, DOI 10.1096/fj.03-0312fje
   Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Binková B, 2001, INT J HYG ENVIR HEAL, V204, P49, DOI 10.1078/1438-4639-00072
   Bjorkerud B, 1996, ARTERIOSCL THROM VAS, V16, P416, DOI 10.1161/01.ATV.16.3.416
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   BOLOTNIKOVA MG, 1994, SCI TOTAL ENVIRON, V142, P29, DOI 10.1016/0048-9697(94)90070-1
   BOND JA, 1981, J TOXICOL ENV HEALTH, V7, P327, DOI 10.1080/15287398109529983
   BOND JA, 1980, TOXICOL APPL PHARM, V52, P323, DOI 10.1016/0041-008X(80)90119-2
   BOND JA, 1979, LIFE SCI, V25, P425, DOI 10.1016/0024-3205(79)90574-5
   Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010
   Briedé JJ, 2004, FREE RADICAL RES, V38, P995, DOI 10.1080/10715760400000976
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brunnemann KD, 1994, CARCINOGENESIS, V10, P1863
   BUCALA R, 1993, P NATL ACAD SCI USA, V90, P6434, DOI 10.1073/pnas.90.14.6434
   BUENING MK, 1978, P NATL ACAD SCI USA, V75, P5358, DOI 10.1073/pnas.75.11.5358
   California Air Resources Board, 1991, PROPOSED IDENTIFICAT, V0, P0
   CARDIS E, 1995, RADIAT RES, V142, P117, DOI 10.2307/3579020
   Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708
   Centers for Disease Control and Prevention (CDC), 2003, MMWR MORB MORTAL WKLY REP, V52, P131
   Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801
   Curfs DMJ, 2005, FASEB J, V19, P1290, DOI 10.1096/fj.04-2269fje
   Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X
   Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1
   Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825
   DARBY SC, 1987, BRIT J CANCER, V55, P179, DOI 10.1038/bjc.1987.35
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7
   Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938
   den Hartigh LJ, 2010, TOXICOL IN VITRO, V24, P1993, DOI 10.1016/j.tiv.2010.08.017
   Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430
   DIPPLE A, 1976, ACS MONOGR SER, V173, P245
   Djoussé L, 2002, STROKE, V33, P1357, DOI 10.1161/01.STR.0000014325.54063.1A
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Dumrese C, 2005, BMC MICROBIOL, V5, P0, DOI 10.1186/1471-2180-5-2
   Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380
   FRIBERG L, 1983, ANNU REV PUBL HEALTH, V4, P367, DOI 10.1146/annurev.pu.04.050183.002055
   Fukagawa NK, 2008, ENVIRON HEALTH PERSP, V116, P1218, DOI 10.1289/ehp.11172
   Gairola CG, 2001, ATHEROSCLEROSIS, V156, P49, DOI 10.1016/S0021-9150(00)00621-3
   Galper SL, 2011, BLOOD, V117, P412, DOI 10.1182/blood-2010-06-291328
   Gepner AD, 2011, AM HEART J, V161, P0, DOI 10.1016/j.ahj.2010.09.023
   Gianicolo ME, 2010, CARDIOVASC ULTRASOUN, V8, P0, DOI 10.1186/1476-7120-8-8
   GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047
   Godschalk R, 2003, FREE RADICAL RES, V37, P1299, DOI 10.1080/10715760310001621333
   Godschalk RWL, 2007, MUTAT RES-FUND MOL M, V621, P87, DOI 10.1016/j.mrfmmm.2007.02.012
   Gong Z, 2006, TOXICOL LETT, V166, P229, DOI 10.1016/j.toxlet.2006.07.307
   Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004
   Gorog P, 1997, ATHEROSCLEROSIS, V129, P1, DOI 10.1016/S0021-9150(96)06000-5
   Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835
   Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585
   Güngör N, 2007, FASEB J, V21, P2359, DOI 10.1096/fj.07-8163com
   Güngör N, 2010, MUTAGENESIS, V25, P149, DOI 10.1093/mutage/gep053
   Güngör N, 2010, MUTAGENESIS, V25, P77, DOI 10.1093/mutage/gep049
   Haegens A, 2007, J IMMUNOL, V178, P1800, DOI 10.4049/jimmunol.178.3.1800
   Hall M, 1990, CHEM CARCINOGENESIS, V0, P327
   HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307
   HATTEMERFREY HA, 1991, TOXICOL IND HEALTH, V7, P141, DOI 10.1177/074823379100700303
   Hauptmann M, 2003, AM J EPIDEMIOL, V157, P239, DOI 10.1093/aje/kwf189
   Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662
   Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379
   Hendry JH, 2008, RADIAT ENVIRON BIOPH, V47, P189, DOI 10.1007/s00411-007-0155-7
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   HOWARD G, 1994, ARCH INTERN MED, V154, P1277
   IACOPETTA B, 1995, INT J ONCOL, V7, P399
   INOUE T, 1995, CARDIOLOGY, V86, P374, DOI 10.1159/000176904
   Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x
   Itsara LS, 2014, PLOS GENET, V610, P0
   Ivanov VK, 2011, RADIATSIONNAYA BIOLOGIYA RADIOEKOLOGIYA, V51, P41
   IZZOTTI A, 1994, CANCER RES, V54, P0
   Izzotti A, 2001, MUTAT RES-GEN TOX EN, V494, P97, DOI 10.1016/S1383-5718(01)00183-8
   Izzotti A, 2001, FASEB J, V15, P752, DOI 10.1096/fj.00-0312com
   IZZOTTI A, 1995, CANCER EPIDEM BIOMAR, V4, P105
   Izzotti A, 2008, MUTAT RES-FUND MOL M, V644, P38, DOI 10.1016/j.mrfmmm.2008.06.012
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   Izzotti A, 2011, ANN NY ACAD SCI, V1229, P103, DOI 10.1111/j.1749-6632.2011.06091.x
   Izzotti A, 2009, MUTAT RES-FUND MOL M, V667, P1, DOI 10.1016/j.mrfmmm.2009.06.001
   Jakovljevic I, 2011, ARH HIG RADA TOKSIKO, V62, P357, DOI 10.2478/10004-1254-62-2011-2095
   Järup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032
   Jaworski C, 2013, J AM COLL CARDIOL, V13, P01405
   Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149
   JELINSKY SA, 1995, BIOCHEMISTRY-US, V34, P13545, DOI 10.1021/bi00041a034
   Ji KT, 2013, INT J MOL MED, V31, P922, DOI 10.3892/ijmm.2013.1288
   Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59
   Kalayoglu MV, 1998, INFECT IMMUN, V66, P5067, DOI 10.1128/IAI.66.11.5067-5072.1998
   Karlsson FH, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2266
   Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374
   Kerley-Hamilton JS, 2012, TOXICOL SCI, V126, P391, DOI 10.1093/toxsci/kfs002
   Kerzee JK, 2000, MOL PHARMACOL, V58, P152, DOI 10.1124/mol.58.1.152
   Kim EJ, 2011, J INVEST DERMATOL, V131, P1720, DOI 10.1038/jid.2011.106
   Kitchin KT, 2001, TOXICOL APPL PHARM, V172, P249, DOI 10.1006/taap.2001.9157
   Knaapen AM, 2007, MUTAT RES-FUND MOL M, V621, P31, DOI 10.1016/j.mrfmmm.2006.12.010
   Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032
   Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977
   Kowalski M, 2001, J PHYSIOL PHARMACOL, V52, P3
   Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f
   Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085
   Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137
   Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x
   Lind PM, 2012, ENVIRON HEALTH PERSP, V120, P38, DOI 10.1289/ehp.1103563
   Lind YS, 2013, ENVIRON RES, V123, P39, DOI 10.1016/j.envres.2013.02.007
   Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982
   Lu KP, 2000, MUTAT RES-FUND MOL M, V454, P35, DOI 10.1016/S0027-5107(00)00095-6
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Lynn S, 2000, CIRC RES, V86, P514, DOI 10.1161/01.RES.86.5.514
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Magalhaes MCF, 2002, PURE APPL CHEM, V74, P1843, DOI 10.1351/pac200274101843
   MAJESKY MW, 1985, P NATL ACAD SCI USA, V82, P3450, DOI 10.1073/pnas.82.10.3450
   MAJESKY MW, 1983, CARCINOGENESIS, V4, P647, DOI 10.1093/carcin/4.6.647
   Mali VR, 2014, FREE RADICAL RES, V48, P251, DOI 10.3109/10715762.2013.864761
   Malik Q, 2012, FREE RADICAL RES, V46, P554, DOI 10.3109/10715762.2012.663913
   Marinkovic N, 2013, BIOCHEM MEDICA, V23, P255
   Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024
   Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361
   McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018
   Meng D, 2009, TOXICOL LETT, V184, P44, DOI 10.1016/j.toxlet.2008.10.016
   Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082
   Miller KP, 2001, DRUG METAB REV, V33, P1, DOI 10.1081/DMR-100000138
   Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200
   Moorthy B, 2003, J PHARMACOL EXP THER, V305, P394, DOI 10.1124/jpet.102.044271
   Moorthy B, 2002, CARDIOVASC RES, V53, P1002, DOI 10.1016/S0008-6363(01)00536-3
   Moran AE, 2012, GLOB HEART, V7, P315, DOI 10.1016/j.gheart.2012.10.004
   Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0
   Mossman BT, 2000, INHAL TOXICOL, V12, P307, DOI 10.1080/08958378.2000.11463240
   Mulrooney DA, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.b4606
   Naira J, 2007, MUTAT RES-FUND MOL M, V621, P95, DOI 10.1016/j.mrfmmm.2007.02.013
   Narne P, 2013, GENET TEST MOL BIOMA, V17, P236, DOI 10.1089/gtmb.2012.0330
   Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752
   Ng D, 1998, J IMMUNOL, V161, P942
   Nishio E, 1998, LIFE SCI, V62, P1339, DOI 10.1016/S0024-3205(98)00068-X
   Oesterling E, 2008, TOXICOL APPL PHARM, V232, P309, DOI 10.1016/j.taap.2008.07.001
   Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, PH130, DOI 10.1152/ajpheart.00599.2006
   OU XL, 1994, CHEM-BIOL INTERACT, V93, P29, DOI 10.1016/0009-2797(94)90083-3
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   OWENS GK, 1995, PHYSIOL REV, V75, P487
   PAIGEN B, 1986, CANCER RES, V46, P3321
   Park JH, 2005, CHEM RES TOXICOL, V18, P1026, DOI 10.1021/tx050001a
   PENN A, 1993, CIRCULATION, V88, P1820, DOI 10.1161/01.CIR.88.4.1820
   PENN A, 1981, CANCER RES, V41, P588
   PENN A, 1991, ARTERIOSCLER THROMB, V11, P1053, DOI 10.1161/01.ATV.11.4.1053
   Penn A, 1996, CIRCULATION, V93, P552, DOI 10.1161/01.CIR.93.3.552
   PENN A, 1988, CARCINOGENESIS, V9, P2185, DOI 10.1093/carcin/9.12.2185
   PENN AL, 1981, ARTERY, V9, P382
   PESSAHRASMUSSEN H, 1991, ARTERY, V18, P240
   Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736
   Pluder F, 2011, RADIAT ENVIRON BIOPH, V50, P155, DOI 10.1007/s00411-010-0342-9
   Podechard N, 2009, CARDIOVASC RES, V82, P361, DOI 10.1093/cvr/cvp007
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Prozialeck WC, 2006, LIFE SCI, V79, P1493, DOI 10.1016/j.lfs.2006.05.007
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   REVIS NW, 1984, TOXICOLOGY, V32, P215, DOI 10.1016/0300-483X(84)90075-1
   Riccioni G, 2012, J GERIATR CARDIOL, V9, P305, DOI 10.3724/SP.J.1263.2012.02132
   Richardson RB, 2008, INT J RADIAT BIOL, V84, P838, DOI 10.1080/09553000802392748
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Rozankovic PB, 2011, J NEUROL, V258, P753, DOI 10.1007/s00415-010-5824-9
   SADHU DN, 1993, ARCH BIOCHEM BIOPHYS, V300, P124, DOI 10.1006/abbi.1993.1017
   SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6
   Salama SA, 2002, ENVIRON MOL MUTAGEN, V40, P153, DOI 10.1002/em.10106
   Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8
   Sasaki H, 2002, J CLIN EPIDEMIOL, V55, P974, DOI 10.1016/S0895-4356(02)00439-0
   Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071
   Sempos CT, 1998, ANN EPIDEMIOL, V8, P289, DOI 10.1016/S1047-2797(97)00233-0
   Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130
   Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779
   Shimizu Y, 2010, BMJ-BRIT MED J, V34, P0
   Shyu HY, 2012, J ATHEROSCLER THROMB, V19, P316, DOI 10.5551/jat.10967
   Siasos G, 2009, AM J HYPERTENS, V22, P586, DOI 10.1038/ajh.2009.57
   Simonelli V, 2012, MUTAT RES-FUND MOL M, V731, P1, DOI 10.1016/j.mrfmmm.2011.10.012
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   Sjögren B, 2001, SCAND J WORK ENV HEA, V27, P420
   SLAGA TJ, 1980, CANCER RES, V40, P1981
   Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P371, DOI 10.1016/S0278-6915(99)00156-8
   Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803
   Speir E, 1998, CIRC RES, V83, P210, DOI 10.1161/01.RES.83.2.210
   Sram RJ, 2011, AIR QUAL ATMOS HLTH, V4, P161, DOI 10.1007/s11869-011-0133-8
   Starke RM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071954
   STAVENOW L, 1988, ARTERY, V15, P94
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414
   Tiirola T, 2007, ATHEROSCLEROSIS, V194, P403, DOI 10.1016/j.atherosclerosis.2006.08.013
   Topinka J, 2011, TOXICOL LETT, V202, P186, DOI 10.1016/j.toxlet.2011.02.005
   Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167
   Tribble DL, 1999, ARTERIOSCL THROM VAS, V19, P1387, DOI 10.1161/01.ATV.19.6.1387
   Uno S, 2014, TOXICOLOGY, V316, P34, DOI 10.1016/j.tox.2013.12.005
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   van Grevenynghe J, 2006, BIOCHEM BIOPH RES CO, V341, P763, DOI 10.1016/j.bbrc.2006.01.028
   van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374
   Van Schooten FJ, 1998, FASEB J, V12, P1409, DOI 10.1096/fasebj.12.13.1409
   Vayssier-Taussat M, 2001, AM J PHYSIOL-HEART C, V280, PH1293, DOI 10.1152/ajpheart.2001.280.3.H1293
   Verschuren JJW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0056262
   VLADIMIROV YA, 1980, ADV LIPID RES, V17, P173
   Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001
   WHO, 2006, ALMOST A QUARTER OF, V0, P0
   Winczura A, 2012, FREE RADICAL RES, V46, P442, DOI 10.3109/10715762.2012.658516
   Winkelmann BR, 2001, CURR MED RES OPIN, V17, P132, DOI 10.1185/0300799039117049
   Yalin S, 2007, CELL BIOCHEM FUNCT, V25, P509, DOI 10.1002/cbf.1339
   Yamaguchi H, 2004, TRANSFUSION, V44, P1072, DOI 10.1111/j.1537-2995.2004.04005.x
   Yamaguchi H, 2002, INFECT IMMUN, V70, P2392, DOI 10.1128/IAI.70.5.2392-2398.2002
   Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949
   Yang H, 2009, ATHEROSCLEROSIS, V207, P51, DOI 10.1016/j.atherosclerosis.2009.03.052
   Yang Z, 2004, ANNU MEETING SOC FRE, V0, P0
   Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111
   Yu XH, 2014, THROMB RES, V133, P229, DOI 10.1016/j.thromres.2013.11.017
   Yung Lai Ming, 2006, CARDIOVASCULAR & HEMATOLOGICAL DISORDERS - DRUG TARGETS, V6, P1
   ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094
   Zielinski JM, 2009, INT J OCCUP MED ENV, V22, P27, DOI 10.2478/v10001-009-0001-z
   ZWIJSEN RML, 1990, ATHEROSCLEROSIS, V85, P71, DOI 10.1016/0021-9150(90)90184-K
NR 229
TC 27
Z9 32
U1 1
U2 29
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 1438-4639
EI 1618-131X
J9 INT J HYG ENVIR HEAL
JI Int. J. Hyg. Environ. Health.
PD MAY 15
PY 2015
VL 218
IS 3
BP 293
EP 312
DI 10.1016/j.ijheh.2015.01.007
PG 20
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CG2IF
UT WOS:000353097400002
PM 25704189
DA 2024-11-01
ER

PT J
AU Garcia-Diaz, B
   Barca, E
   Balreira, A
   Lopez, LC
   Tadesse, S
   Krishna, S
   Naini, A
   Mariotti, C
   Castellotti, B
   Quinzii, CM
AF Garcia-Diaz, Beatriz
   Barca, Emanuele
   Balreira, Andrea
   Lopez, Luis C.
   Tadesse, Saba
   Krishna, Sindhu
   Naini, Ali
   Mariotti, Caterina
   Castellotti, Barbara
   Quinzii, Catarina M.
TI Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID strand-break repair; oculomotor apraxia type-1; coenzyme q(10) deficiency; ocular motor apraxia; early-onset ataxia; cerebellar-ataxia; oxidative stress; coq(10) deficiency; protein aprataxin; mammalian-cells
AB Ataxia oculomotor apraxia type 1 (AOA1) is an autosomal recessive disease caused by mutations in APTX, which encodes the DNA strand-break repair protein aprataxin (APTX). CoQ10 deficiency has been identified in fibroblasts and muscle of AOA1 patients carrying the common W279X mutation, and aprataxin has been localized to mitochondria in neuroblastoma cells, where it enhances preservation of mitochondrial function. In this study, we show that aprataxin deficiency impairs mitochondrial function, independent of its role in mitochondrial DNA repair. The bioenergetics defect in AOA1-mutant fibroblasts and APTX-depleted Hela cells is caused by decreased expression of SDHA and genes encoding CoQ biosynthetic enzymes, in association with reductions of APE1, NRF1 and NRF2. The biochemical and molecular abnormalities in APTX-depleted cells are recapitulated by knockdown of APE1 in Hela cells and are rescued by overexpression of NRF1/2. Importantly, pharmacological upregulation of NRF1 alone by 5-aminoimidazone-4-carboxamide ribonucleotide does not rescue the phenotype, which, in contrast, is reversed by the upregulation of NRF2 by rosiglitazone. Accordingly, we propose that the lack of aprataxin causes reduction of the pathway APE1/NRF1/NRF2 and their target genes. Our findings demonstrate a critical role of APTX in transcription regulation of mitochondrial function and the pathogenesis of AOA1 via a novel pathomechanistic pathway, which may be relevant to other neurodegenerative diseases.
C1 [Garcia-Diaz, Beatriz; Barca, Emanuele; Balreira, Andrea; Lopez, Luis C.; Tadesse, Saba; Quinzii, Catarina M.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Krishna, Sindhu; Naini, Ali] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.
   [Barca, Emanuele] Univ Messina, Dept Neurosci, UOC Neurol & Neuromuscular Disorders, I-98100 Messina, Italy.
   [Lopez, Luis C.] Univ Granada, Hlth Sci Technol Pk PTS, Biomed Res Ctr CIBM, Inst Biotechnol, Granada 18100, Spain.
   [Mariotti, Caterina; Castellotti, Barbara] Fdn IRCCS Ist Neurol Carlo Besta, Unite Genet Malattie Neurodegenerat & Metabol, I-20126 Milan, Italy.
C3 Columbia University; Columbia University; University of Messina; University of Granada; Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Quinzii, CM (corresponding author), Columbia Univ, Med Ctr, 630 W 168th St,P&S 4-431, New York, NY 10032 USA.
EM cmq2101@cumc.columbia.edu
FU NIH [P01 HD080642-01]; 'Fundacion Alfonso Martin Escudero', Spain; 'Ramon y Cajal' National Programme, Ministerio de Economia y Competitividad, Spain [RYC-2011-07643]; NICHD [5K23 HD065871]; Muscle Dystrophy Association (MDA)
CR Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164
   Becherel OJ, 2006, HUM MOL GENET, V15, P2239, DOI 10.1093/hmg/ddl149
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Castellotti B, 2011, NEUROGENETICS, V12, P193, DOI 10.1007/s10048-011-0281-x
   Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017
   DArrigo S, 2008, J CHILD NEUROL, V23, P895, DOI 10.1177/0883073808314959
   Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184
   El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002
   Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   García-Corzo L, 2013, HUM MOL GENET, V22, P1233, DOI 10.1093/hmg/dds530
   González-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243
   Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hirano M, 2007, ANN NEUROL, V61, P162, DOI 10.1002/ana.21078
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Inoue N, 1971, RINSHO SHINKEIGAKU, V11, P855
   Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Le Ber I, 2007, NEUROLOGY, V68, P295, DOI 10.1212/01.wnl.0000252366.10731.43
   Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283
   Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492
   Li MX, 2012, FREE RADICAL BIO MED, V53, P237, DOI 10.1016/j.freeradbiomed.2012.04.002
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Martin J, 2013, HEPATOLOGY, V57, P2037, DOI 10.1002/hep.26060
   Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, PE1107, DOI 10.1152/ajpendo.1997.273.6.E1107
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Palau F, 2006, ORPHANET J RARE DIS, V1, P0, DOI 10.1186/1750-1172-1-47
   Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2013, FASEB J, V27, P612, DOI 10.1096/fj.12-209361
   Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200
   Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08
   Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808
   Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6
   Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108
   Tranchant C, 2003, NEUROLOGY, V60, P868, DOI 10.1212/01.WNL.0000048562.88536.A4
   Uekawa K, 1992, RINSHO SHINKEIGAKU, V32, P1067
   Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026
   Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638
   Yokoseki A, 2011, BRAIN, V134, P1387, DOI 10.1093/brain/awr069
NR 51
TC 19
Z9 20
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 15
PY 2015
VL 24
IS 16
BP 4516
EP 4529
DI 10.1093/hmg/ddv183
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CR4OU
UT WOS:000361315400004
PM 25976310
DA 2024-11-01
ER

PT J
AU Gorman, GS
   Pfeffer, G
   Griffin, H
   Blakely, EL
   Kurzawa-Akanbi, M
   Gabriel, J
   Sitarz, K
   Roberts, M
   Schoser, B
   Pyle, A
   Schaefer, AM
   McFarland, R
   Turnbull, DM
   Horvath, R
   Chinnery, PF
   Taylor, RW
AF Gorman, Grainne S.
   Pfeffer, Gerald
   Griffin, Helen
   Blakely, Emma L.
   Kurzawa-Akanbi, Marzena
   Gabriel, Jessica
   Sitarz, Kamil
   Roberts, Mark
   Schoser, Benedikt
   Pyle, Angela
   Schaefer, Andrew M.
   McFarland, Robert
   Turnbull, Douglass M.
   Horvath, Rita
   Chinnery, Patrick F.
   Taylor, Robert W.
TI Clonal Expansion of Secondary Mitochondrial DNA Deletions Associated With Spinocerebellar Ataxia Type 28
SO JAMA NEUROLOGY
LA English
DT Article
ID spastic paraplegia; mutations; afg3l2; degeneration; impairment; sca28
AB IMPORTANCE Progressive external ophthalmoplegia (PEO) is a common feature in adults with mitochondrial (mt) DNA maintenance disorders associated with somatic mtDNA deletions in muscle, yet the causal genetic defect in many patients remains undetermined. OBSERVATIONS Whole-exome sequencing identified a novel, heterozygous p.(Gly671Trp) mutation in the AFG3L2 gene encoding anmt protease-previously associated with dominant spinocerebellar ataxia type 28 disease-in a patient with indolent ataxia and PEO. Targeted analysis of a larger, genetically undetermined cohort of patients with PEO with suspected mtDNA maintenance abnormalities identified a second unrelated patient with a similar phenotype and a novel, heterozygous p.(Tyr689His) AFG3L2 mutation. Analysis of patient fibroblasts revealed mt fragmentation and decreased AFG3L2 transcript expression. Western blotting of patient fibroblast and muscle showed decreased AFG3L2 protein levels. CONCLUSIONS AND RELEVANCE Our observations suggest that AFG3L2 mutations are another important cause, albeit rare, of a late-onset ataxic PEO phenotype due to a disturbance of mtDNA maintenance.
C1 [Gorman, Grainne S.; Pfeffer, Gerald; Griffin, Helen; Blakely, Emma L.; Kurzawa-Akanbi, Marzena; Gabriel, Jessica; Sitarz, Kamil; Pyle, Angela; Schaefer, Andrew M.; McFarland, Robert; Turnbull, Douglass M.; Horvath, Rita; Chinnery, Patrick F.; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gorman, Grainne S.; Blakely, Emma L.; McFarland, Robert; Turnbull, Douglass M.; Taylor, Robert W.] Newcastle Univ, Inst Ageing & Hlth, Natl Inst Hlth Res Biomed Res Ctr Ageing, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Pfeffer, Gerald; Griffin, Helen; Kurzawa-Akanbi, Marzena; Sitarz, Kamil; Pyle, Angela; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Roberts, Mark] Hope Hosp, Dept Neurol, Salford M6 8HD, Lancs, England.
   [Schoser, Benedikt] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Munich
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU UK National Health Service (NHS) Specialised Service for Rare Mitochondrial Diseases of Adults and Children, Newcastle; National Institute for Health Research (NIHR) Biomedical Research Centre funding scheme based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; Medical Research Council (UK) Mitochondrial Disease Patient Cohort [G0800674]; UK NHS Highly Specialised Rare Mitochondrial Disorders of Adults and Children Service; Canadian Institutes of Health Research; EU FP7 TIRCON; NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; MRC [MR/K006312/1, G0601943, G0800674] Funding Source: UKRI
CR Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Maltecca F, 2008, J NEUROSCI, V28, P2827, DOI 10.1523/JNEUROSCI.4677-07.2008
   Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
NR 12
TC 33
Z9 33
U1 1
U2 7
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD JAN 15
PY 2015
VL 72
IS 1
BP 106
EP 111
DI 10.1001/jamaneurol.2014.1753
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA AY8PI
UT WOS:000347815300017
PM 25420100
DA 2024-11-01
ER

PT J
AU Fernández-Millán, P
   Lázaro, M
   Cansiz-Arda, S
   Gerhold, JM
   Rajala, N
   Schmitz, CA
   Silva-Espiña, C
   Gil, D
   Bernadó, P
   Valle, M
   Spelbrink, JN
   Solà, M
AF Fernandez-Millan, Pablo
   Lazaro, Melisa
   Cansiz-Arda, Sirin
   Gerhold, Joachim M.
   Rajala, Nina
   Schmitz, Claus-A.
   Silva-Espina, Cristina
   Gil, David
   Bernado, Pau
   Valle, Mikel
   Spelbrink, Johannes N.
   Sola, Maria
TI The hexameric structure of the human mitochondrial replicative helicase Twinkle
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID single-particle analysis; stranded-dna-binding; crystal-structure; electron-microscopy; modular architecture; molecular-dynamics; primase-helicase; primer synthesis; protein; domain
AB The mitochondrial replicative helicase Twinkle is involved in strand separation at the replication fork of mitochondrial DNA (mtDNA). Twinkle malfunction is associated with rare diseases that include late onset mitochondrial myopathies, neuromuscular disorders and fatal infantile mtDNA depletion syndrome. We examined its 3D structure by electron microscopy (EM) and small angle X-ray scattering (SAXS) and built the corresponding atomic models, which gave insight into the first molecular architecture of a full-length SF4 helicase that includes an N-terminal zinc-binding domain (ZBD), an intermediate RNA polymerase domain (RPD) and a RecA-like hexamerization C-terminal domain (CTD). The EM model of Twinkle reveals a hexameric two-layered ring comprising the ZBDs and RPDs in one layer and the CTDs in another. In the hexamer, contacts in trans with adjacent subunits occur between ZBDs and RPDs, and between RPDs and CTDs. The ZBDs show important structural heterogeneity. In solution, the scattering data are compatible with a mixture of extended hexa- and heptameric models in variable conformations. Overall, our structural data show a complex network of dynamic interactions that reconciles with the structural flexibility required for helicase activity.
C1 [Fernandez-Millan, Pablo; Schmitz, Claus-A.; Silva-Espina, Cristina; Sola, Maria] Struct MitoLab, E-08028 Barcelona, Spain.
   [Fernandez-Millan, Pablo; Schmitz, Claus-A.; Silva-Espina, Cristina; Sola, Maria] CSIC, Mol Biol Inst Barcelona IBMB, Dept Biol Struct, E-08028 Barcelona, Spain.
   [Lazaro, Melisa; Gil, David; Valle, Mikel] CICbioGUNE, Ctr Cooperat Res Biosci, Struct Biol Unit, E-48160 Derio, Spain.
   [Cansiz-Arda, Sirin; Gerhold, Joachim M.; Spelbrink, Johannes N.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6525 GA Nijmegen, Netherlands.
   [Rajala, Nina; Spelbrink, Johannes N.] Univ Tampere, BioMediTech, Mitochondrial DNA Maintenance Grp, FI-33014 Tampere, Finland.
   [Bernado, Pau] Univ Montpellier I&II, CNRS UMR 5048, INSERM U1054, Ctr Biochim Struct, F-34090 Montpellier, France.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); CIC bioGUNE; Radboud University Nijmegen; Tampere University; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier
RP Solà, M (corresponding author), Struct MitoLab, E-08028 Barcelona, Spain.
EM mvalle@cicbiogune.es; hans.spelbrink@radboudumc.nl; maria.sola@ibmb.csic.es
FU MINECO [BFU2009-07134, BFU2012-33516, BFU2012-34873, BES-2008-005384REF]; Generalitat de Catalunya [SGR2009-1366, 2014 SGR 997]; EU [FP7-HEALTH-2010-261460, FP7-PEOPLE-2011-290246, FP7-HEALTH-2012-306029-2]; Academy of Finland [CoE]; Tampere University Hospital Medical Research Fund [9J119, 9K126, 9L097]; Netherlands Organization for Scientific Research [NWO: VICI] [865.10.004]; European Molecular Biology Organization [EMBO LTF]; Marie Curie Actions [EMBO LTF 1066 2011, MCA-EMBOCOFUND2010, GA-2010-267146]; Agence Nationale de la Recherche SPIN-HD [CHEX-2011]; ATIP-Avenir
CR Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418
   Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205
   Baxter WT, 2007, J STRUCT BIOL, V157, P56, DOI 10.1016/j.jsb.2006.07.019
   Bernadó P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bernadó P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, PW349, DOI 10.1093/nar/gkt381
   Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373
   Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004
   Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943
   Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243
   Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139
   Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3
   Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011
   Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499
   Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107
   Leipe DD, 2000, GENOME RES, V10, P5
   Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Morinière J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   OShea VL, 2014, CURR OPIN STRUC BIOL, V25, P16, DOI 10.1016/j.sbi.2013.11.006
   Pan H, 2000, STRUCTURE, V8, P231, DOI 10.1016/S0969-2126(00)00101-5
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Podobnik M, 2000, J MOL BIOL, V300, P353, DOI 10.1006/jmbi.2000.3844
   Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Tanner DE, 2011, J CHEM THEORY COMPUT, V7, P3635, DOI 10.1021/ct200563j
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Webb Benjamin, 2016, CURR PROTOC PROTEIN SCI, V86, P0, DOI 10.1002/cpbi.3
   Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 57
TC 33
Z9 39
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 30
PY 2015
VL 43
IS 8
BP 4284
EP 4295
DI 10.1093/nar/gkv189
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CJ2LV
UT WOS:000355317200040
PM 25824949
DA 2024-11-01
ER

PT J
AU Naue, J
   Hörer, S
   Sänger, T
   Strobl, C
   Hatzer-Grubwieser, P
   Parson, W
   Lutz-Bonengel, S
AF Naue, Jana
   Horer, Steffen
   Sanger, Timo
   Strobl, Christina
   Hatzer-Grubwieser, Petra
   Parson, Walther
   Lutz-Bonengel, Sabine
TI Evidence for frequent and tissue-specific sequence heteroplasmy in human mitochondrial DNA
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Point heteroplasmy; Control region; Sanger sequencing
ID mtdna control-region; substitution rate variation; hypervariable region; point mutations; nucleotide substitution; healthy-subjects; genes; sites; age; inheritance
AB Mitochondrial point heteroplasmy is a common event observed not only in patients with mitochondrial diseases but also in healthy individuals. We here report a comprehensive investigation of heteroplasmy occurrence in human including the whole mitochondrial control region from nine different tissue types of 100 individuals. Sanger sequencing was used as a standard method and results were supported by cloning, minisequencing, and massively parallel sequencing. Only 12% of all individuals showed no heteroplasmy, whereas 88% showed at least one heteroplasmic position within the investigated tissues. In 66% of individuals up to 8 positions were affected. The highest relative number of heteroplasmies was detected in muscle and liver (79%, 69%), followed by brain, hair, and heart (36.7%-30.2%). Lower percentages were observed in bone, blood, lung, and buccal cells (19.8%-16.2%). Accumulation of position-specific heteroplasmies was found in muscle (positions 64, 72, 73,189, and 408), liver (position 72) and brain (partial deletion at position 71). Deeper analysis of these specific positions in muscle revealed a non-random appearance and position-specific dependency on age. MtDNA heteroplasmy frequency and its potential functional importance have been underestimated in the past and its occurrence is ubiquitous and dependent at least on age, tissue, and position-specific mutation rates. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Naue, Jana; Horer, Steffen; Sanger, Timo; Lutz-Bonengel, Sabine] Univ Freiburg, Med Ctr, Inst Legal Med, D-79104 Freiburg, Germany.
   [Naue, Jana] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.
   [Strobl, Christina; Hatzer-Grubwieser, Petra; Parson, Walther] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria.
   [Parson, Walther] Penn State Eberly Coll Sci, University Pk, PA USA.
C3 University of Freiburg; University of Freiburg; Medical University of Innsbruck; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park
RP Naue, J (corresponding author), Univ Freiburg, Med Ctr, Inst Legal Med, Albertstr 9, D-79104 Freiburg, Germany.
EM jana.naue@uniklinik-freiburg.de; steffen.hoerer@uniklinik-freiburg.de; timo.saenger@uniklinik-freiburg.de; christina.strobl@i-med.ac.at; petra.hatzer-grubwieser@i-med.ac.at; walther.parson@i-med.ac.at; sabinedutz-bonengel@uniklinilc-freiburg.de
FU state of Baden-Wurttemberg (Competence Centre "Legal Medicine"); Wissenschaftliche Gesellschaft Freiburg
CR Alaeddini R, 2010, FORENSIC SCI INT-GEN, V4, P148, DOI 10.1016/j.fsigen.2009.09.007
   Alonso A, 2002, FORENSIC SCI INT, V125, P1, DOI 10.1016/S0379-0738(01)00602-8
   Andrew T, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022332
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5
   Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397
   Bauer CM, 2013, FORENSIC SCI INT-GEN, V7, P313, DOI 10.1016/j.fsigen.2012.10.012
   Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231
   BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331
   Brandstätter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Cormio A, 2005, NEUROBIOL AGING, V26, P655, DOI 10.1016/j.neurobiolaging.2004.06.014
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   de Camargo MA, 2011, MOL BIOL REP, V38, P1219, DOI 10.1007/s11033-010-0220-1
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Diroma MA, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-S3-S2
   Marinho AND, 2011, GENET MOL BIOL, V34, P31, DOI 10.1590/S1415-47572010005000106
   Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004
   Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046
   Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499
   Goto H, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-6-r59
   HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   HUTCHISOCA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0
   Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4
   Jakupciak JP, 2008, BMC CANCER, V8, P0, DOI 10.1186/1471-2407-8-285
   Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109
   Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382
   KRJUTSKOV K, 2013, CURR GENET, V0, P1
   Lacan M, 2009, INT J LEGAL MED, V123, P161, DOI 10.1007/s00414-008-0266-y
   Lagerström-Fermér M, 2001, AM J HUM GENET, V68, P1299, DOI 10.1086/320115
   Lee HY, 2006, ANN HUM GENET, V70, P59, DOI 10.1111/j.1529-8817.2005.00217.x
   Lo MC, 2005, ANN NY ACAD SCI, V1042, P130, DOI 10.1196/annals.1338.013
   Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161
   Melton T, 2004, FORENSIC SCI REV, V16, P1
   Meyer S, 1999, GENETICS, V152, P1103
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221
   MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8
   MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895
   Naue J, 2011, INT J LEGAL MED, V125, P427, DOI 10.1007/s00414-011-0549-6
   Niederstätter H, 2007, FORENSIC SCI INT-GEN, V1, P29, DOI 10.1016/j.fsigen.2006.10.007
   Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018
   Parson W, 2013, FORENSIC SCI INT-GEN, V7, P632, DOI 10.1016/j.fsigen.2013.09.007
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487
   Ramos A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074636
   Röck AW, 2013, FORENSIC SCI INT-GEN, V7, P601, DOI 10.1016/j.fsigen.2013.07.005
   Rose G, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013395
   Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161
   Salas A, 2001, INT J LEGAL MED, V114, P186, DOI 10.1007/s004140000164
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Sekiguchi K, 2003, MITOCHONDRION, V2, P401, DOI 10.1016/S1567-7249(03)00028-X
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Tan DJ, 2004, ANN NY ACAD SCI, V1011, P310, DOI 10.1196/annals.1293.030
   Thèves C, 2006, J FORENSIC SCI, V51, P865, DOI 10.1111/j.1556-4029.2006.00163.x
   Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702
   WAKELEY J, 1993, J MOL EVOL, V37, P613
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wiegand P, 2006, INT J LEGAL MED, V120, P160, DOI 10.1007/s00414-005-0048-8
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 71
TC 81
Z9 98
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2015
VL 20
IS 
BP 82
EP 94
DI 10.1016/j.mito.2014.12.002
PG 13
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CA0UQ
UT WOS:000348632200011
PM 25526677
DA 2024-11-01
ER

PT J
AU Cagin, U
   Enriquez, JA
AF Cagin, Umut
   Antonio Enriquez, Jose
TI Mitochondrial DNA-related disorders: emphasis on mechanisms and heterogeneity
SO TURKISH JOURNAL OF BIOLOGY
LA English
DT Review
DE Mitochondria; oxidative phosphorylation; mitochondrial DNA; mitochondrial DNA disorders; mitochondrial DNA mutations
ID hereditary optic neuropathy; progressive external ophthalmoplegia; respiratory-chain disorders; substantia-nigra neurons; kearns-sayre syndrome; complex-i deficiency; cytochrome-c-oxidase; paternal inheritance; replication bubble; oxidative stress
AB Mitochondrial diseases are a heterogeneous group of disorders that are currently the focus of intense research. The many cell functions performed by mitochondria include ATP production, calcium homeostasis, and apoptosis. One of the unique properties of mitochondria is the existence of a separate mitochondrial genome (mitochondrial DNA, mtDNA) found in varying copy numbers and containing 37 genes, 13 of them encoding proteins. All 13 mitochondrially encoded proteins form part of oxidative phosphorylation complexes through combination with approximately 100 nuclear DNA-encoded proteins. Coregulation of nDNA and mtDNA is therefore essential for mitochondrial function, and this coregulation contributes to the heterogeneity and complexity observed in mitochondrial disorders. In recent times, significant advances have been made in our understanding of mtDNA-related disorders. A comprehensive review of these studies will benefit both current and new researchers and clinicians involved in the field. This review examines the major types of mtDNA-related defects and their pathogenic mechanisms, with a special emphasis on the heterogeneity of mitochondrial disorders. Potential treatment strategies specialized for each of the disorders, including the hormone melatonin and the recent advances in gene therapy, related to their potential applications for the management of the primary mtDNA disorders are also discussed.
C1 [Cagin, Umut; Antonio Enriquez, Jose] Natl Ctr Cardiovasc Res CNIC, Cardiovasc Dev & Repair Dept, Madrid, Spain.
   [Antonio Enriquez, Jose] Univ Zaragoza, Fac Sci, Dept Biochem & Mol & Cellular Biol, Zaragoza, Spain.
C3 Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza
RP Cagin, U (corresponding author), Natl Ctr Cardiovasc Res CNIC, Cardiovasc Dev & Repair Dept, Madrid, Spain.
EM ucagin@cnic.es
FU Ministerio de Economia y Competitividad [SAF2012-1207, CSD2007-00020]; Comunidad de Madrid [CAM/API1009]; EU (Mitochondrial European Educational Training, MEET: European Commission Seventh Framework Programme, FP7-PEOPLE-ITN MARIE CURIE) [317433]; Instituto de Salud Carlos III (FIS) [PI11-00078]; Ministerio de Economia y Competitividad; Pro-CNIC Foundation
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Alavi MV, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-32
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4
   Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P404, DOI 10.1016/S0968-0004(03)00165-8
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   Bonnefont JP, 2010, CLIN PHARMACOL THER, V88, P101, DOI 10.1038/clpt.2010.55
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001
   Cagin U, 2015, INT J BIOCHEM CELL B, V63, P10, DOI 10.1016/j.biocel.2015.01.026
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484
   Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Dogan SA, 2011, PHYSIOL RES, V60, PS61, DOI 10.33549/physiolres.932179
   Dragicevic N, 2011, J PINEAL RES, V51, P75, DOI 10.1111/j.1600-079X.2011.00864.x
   Dunn DA, 2012, BBA-GEN SUBJECTS, V1820, P601, DOI 10.1016/j.bbagen.2011.08.005
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Golubitzky A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026883
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hashimoto M, 2015, MOL THER IN PRESS, V0, P0
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Holt IJ, 2003, TRENDS BIOCHEM SCI, V28, P355, DOI 10.1016/S0968-0004(03)00133-6
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   Huang WY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0081546
   Iommarini L, 2012, NEUROLOGY, V79, P1517, DOI 10.1212/WNL.0b013e31826d5f72
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W
   Li J, 2008, GENET MOL RES, V7, P1054, DOI 10.4238/vol7-4gmr480
   Libri V, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0051395
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   MARIOTTI C, 1994, J CLIN INVEST, V93, P1102, DOI 10.1172/JCI117061
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Moraes CT, 2014, TRENDS CELL BIOL, V24, P209, DOI 10.1016/j.tcb.2014.02.002
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Naviaux RK, 2004, MITOCHONDRION, V4, P351, DOI 10.1016/j.mito.2004.07.002
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Palladino MJ, 2010, NEUROBIOL DIS, V40, P40, DOI 10.1016/j.nbd.2010.05.009
   Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204
   Pandi-Perumal SR, 2013, NEUROTOX RES, V23, P267, DOI 10.1007/s12640-012-9337-4
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Poulton J, 2009, BMJ-BRIT MED J, V338, P0, DOI 10.1136/bmj.b94
   Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schwartz M, 2004, J NEUROL SCI, V218, P99, DOI 10.1016/j.jns.2003.11.008
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sitarz KS, 2012, NEUROLOGY, V79, P1515, DOI 10.1212/WNL.0b013e31826d5f60
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szklarczyk R, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0439
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Temperley RJ, 2003, HUM MOL GENET, V12, P2341, DOI 10.1093/hmg/ddg238
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   VILKKI J, 1990, AM J HUM GENET, V47, P95
   Villa-Cuesta E, 2014, J CELL SCI, V127, P2282, DOI 10.1242/jcs.142026
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 166
TC 1
Z9 1
U1 0
U2 14
PU Tubitak Scientific & Technological Research Council Turkey
PI ANKARA
PA ATATURK BULVARI NO 221, KAVAKLIDERE, TR-06100 ANKARA, TURKIYE
SN 1300-0152
EI 1303-6092
J9 TURK J BIOL
JI Turk. J. Biol.
PD JUN 15
PY 2015
VL 39
IS 6
BP 840
EP 855
DI 10.3906/biy-1505-20
PG 16
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA CX2DM
UT WOS:000365505600006
DA 2024-11-01
ER

PT J
AU Wang, YX
   Le, WD
AF Wang, Ying-Xin
   Le, Wei-Dong
TI Progress in Diagnosing Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes
SO CHINESE MEDICAL JOURNAL
LA English
DT Review
ID point mutation; dna mutation; late-onset; melas; gene; ophthalmoplegia; adults
C1 [Wang, Ying-Xin; Le, Wei-Dong] Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Dalian 116011, Liaoning, Peoples R China.
   [Le, Wei-Dong] Dalian Med Univ, Affiliated Hosp 1, Ctr Translat Res Neurol Dis, Dalian 116011, Liaoning, Peoples R China.
C3 Dalian Medical University; Dalian Medical University
RP Le, WD (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Ctr Translat Res Neurol Dis, Dalian 116011, Liaoning, Peoples R China.
EM wdle@sibs.ac.cn
CR Amornvit Jakkrit, 2014, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V97, P467
   [Anonymous], 2014, GENE REV, V0, P0
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Dindyal S, 2014, ANN R COLL SURG ENGL, V96, P101, DOI 10.1308/003588414
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Goto M, 2014, BRAIN DEV-JPN, V36, P180, DOI 10.1016/j.braindev.2013.03.001
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hoptasz M, 2014, NEUROL NEUROCHIR POL, V48, P150, DOI 10.1016/j.pjnns.2013.12.007
   Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Magner M, 2011, EUR J PAEDIATR NEURO, V15, P101, DOI 10.1016/j.ejpn.2010.10.001
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Motoda Atsuko, 2013, RINSHO SHINKEIGAKU, V53, P446
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   SATO W, 1994, BIOCHEM MOL BIOL INT, V33, P1055
   Schaefer AM, 2005, MUSCLE NERVE, V32, P104, DOI 10.1002/mus.20319
   Stenqvist L, 2005, PEDIATR RES, V58, P258, DOI 10.1203/01.PDR.0000169966.82325.1A
   SWEENEY MG, 1993, Q J MED, V86, P709
   van Adel Brian A, 2009, J CLIN NEUROMUSCUL DIS, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Wang SJ, 2013, GENE, V531, P472, DOI 10.1016/j.gene.2013.09.019
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0079859
NR 32
TC 33
Z9 40
U1 0
U2 16
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA
SN 0366-6999
EI 
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUL 5
PY 2015
VL 128
IS 13
BP 1820
EP 1825
DI 10.4103/0366-6999.159360
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA CL6RY
UT WOS:000357096100020
PM 26112726
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Orsucci, D
   Angelini, C
   Bertini, E
   Carelli, V
   Comi, GP
   Donati, MA
   Federico, A
   Minetti, C
   Moggio, M
   Mongini, T
   Santorelli, FM
   Servidei, S
   Tonin, P
   Toscano, A
   Bruno, C
   Bello, L
   Ienco, EC
   Cardaioli, E
   Catteruccia, M
   Da Pozzo, P
   Filosto, M
   Lamperti, C
   Moroni, I
   Musumeci, O
   Pegoraro, E
   Ronchi, D
   Sauchelli, D
   Scarpelli, M
   Sciacco, M
   Valentino, ML
   Vercelli, L
   Zeviani, M
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Angelini, Corrado
   Bertini, Enrico
   Carelli, Valerio
   Comi, Giacomo Pietro
   Donati, Maria Alice
   Federico, Antonio
   Minetti, Carlo
   Moggio, Maurizio
   Mongini, Tiziana
   Santorelli, Filippo Maria
   Servidei, Serenella
   Tonin, Paola
   Toscano, Antonio
   Bruno, Claudio
   Bello, Luca
   Ienco, Elena Caldarazzo
   Cardaioli, Elena
   Catteruccia, Michela
   Da Pozzo, Paola
   Filosto, Massimiliano
   Lamperti, Costanza
   Moroni, Isabella
   Musumeci, Olimpia
   Pegoraro, Elena
   Ronchi, Dario
   Sauchelli, Donato
   Scarpelli, Mauro
   Sciacco, Monica
   Valentino, Maria Lucia
   Vercelli, Liliana
   Zeviani, Massimo
   Siciliano, Gabriele
TI Redefining phenotypes associated with mitochondrial DNA single deletion
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE CPEO; KSS; Mitochondrial disorders; mtDNA; Pearson syndrome; Single deletion
ID ocular myopathy; disease; ophthalmoplegia; neuropathology; mechanisms; disorders; mutation; patient; adults; muscle
AB Progressive external ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS) and Pearson syndrome are the three sporadic clinical syndromes classically associated with single large-scale deletions of mitochondrial DNA (mtDNA). PEO plus is a term frequently utilized in the clinical setting to identify patients with PEO and some degree of multisystem involvement, but a precise definition is not available. The purpose of the present study is to better define the clinical phenotypes associated with a single mtDNA deletion, by a retrospective study on a large cohort of 228 patients from the database of the "Nation-wide Italian Collaborative Network of Mitochondrial Diseases". In our database, single deletions account for about a third of all patients with mtDNA-related disease, more than previously recognized. We elaborated new criteria for the definition of PEO and "KSS spectrum" (a category of which classic KSS represents the most severe extreme). The criteria for "KSS spectrum" include the resulting multisystem clinical features associated with the KSS features, and which therefore can predict their presence or subsequent development. With the new criteria, we were able to classify nearly all our single-deletion patients: 64.5 % PEO, 31.6 % KSS spectrum (including classic KSS 6.6 %) and 2.6 % Pearson syndrome. The deletion length was greater in KSS spectrum than in PEO, whereas heteroplasmy was inversely related with age at onset. We believe that the new phenotype definitions implemented here may contribute to a more homogeneous patient categorization, which will be useful in future cohort studies of natural history and clinical trials.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Ienco, Elena Caldarazzo; Siciliano, Gabriele] Univ Pisa, Neurol Clin, I-56126 Pisa, Italy.
   [Angelini, Corrado; Bello, Luca; Pegoraro, Elena] Univ Padua, Neurol Clin, Padua, Italy.
   [Bertini, Enrico; Catteruccia, Michela] Bambino Gesu Pediat Hosp, IRCCS, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia] Univ Bologna, IRCCS Ist Sci Neurol Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.
   [Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurosci Sect,Neurol Unit,Dino Ferrari Ctr, Milan, Italy.
   [Donati, Maria Alice] Univ Florence, Meyer Childrens Hosp, Florence, Italy.
   [Federico, Antonio; Cardaioli, Elena; Da Pozzo, Paola] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy.
   [Minetti, Carlo; Bruno, Claudio] Ist Giannina Gaslini, Neuropediat, I-16148 Genoa, Italy.
   [Minetti, Carlo; Bruno, Claudio] Ist Giannina Gaslini, Ctr Myol & Neurodegnerat Disorders, I-16148 Genoa, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular Unit, Dino Ferrari Ctr, Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Turin, Dept Neurosci, Turin, Italy.
   [Santorelli, Filippo Maria] IRCCS Stella Maris, Pisa, Italy.
   [Servidei, Serenella; Sauchelli, Donato] Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy.
   [Tonin, Paola; Scarpelli, Mauro] Univ Verona, Neurol Clin, I-37100 Verona, Italy.
   [Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Dept Neurosci, Messina, Italy.
   [Moroni, Isabella] Fdn Carlo Besta Inst Neurol IRCCS, Child Neurol Unit, Milan, Italy.
   [Lamperti, Costanza; Zeviani, Massimo] Fdn Carlo Besta Inst Neurol IRCCS, Unit Mol Neurogenet, Milan, Italy.
   [Filosto, Massimiliano] Univ Hosp Spedali Civili, Neurol Clin, Brescia, Italy.
C3 University of Pisa; University of Padua; IRCCS Bambino Gesu; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Siena; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Turin; IRCCS Fondazione Stella Maris; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona; University of Messina; Fondazione IRCCS Istituto Neurologico Carlo Besta; Fondazione IRCCS Istituto Neurologico Carlo Besta; Hospital Spedali Civili Brescia
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Via Roma 67, I-56126 Pisa, Italy.
EM mancusomichelangelo@gmail.com
FU Telethon [GUP09004]; MITOCON
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Campos Y, 1996, NEUROLOGY, V47, P1012, DOI 10.1212/WNL.47.4.1012
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Kiyomoto BH, 1997, J NEUROL SCI, V152, P160, DOI 10.1016/S0022-510X(97)00158-5
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Magalhaes PJ, 1996, ACTA OPHTHALMOL SCAN, V74, P29
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2008, MOVEMENT DISORD, V23, P2098, DOI 10.1002/mds.22050
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   MORIKAWA Y, 1993, VIRCHOWS ARCH A, V423, P227, DOI 10.1007/BF01614775
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Vilarinho L, 1998, EUR NEUROL, V39, P148, DOI 10.1159/000007925
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 24
TC 65
Z9 65
U1 0
U2 11
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAY 15
PY 2015
VL 262
IS 5
BP 1301
EP 1309
DI 10.1007/s00415-015-7710-y
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA CI7NN
UT WOS:000354950500024
PM 25808502
DA 2024-11-01
ER

PT J
AU Van Driessche, K
   Ducatelle, R
   Chiers, K
   Van Coster, R
   van der Kolk, JH
AF Van Driessche, K.
   Ducatelle, R.
   Chiers, K.
   Van Coster, R.
   van der Kolk, J. H.
TI Ultrastructural mitochondrial alterations in Equine myopathies of unknown origin
SO VETERINARY QUARTERLY
LA English
DT Article
DE Musculus quadriceps femoris; myopathy; ultrastructure; mitochondrion; equine; horse
ID atypical myopathy; skeletal-muscle; disease; disorders; horses; dna; mutations; diagnosis; dynamics; fusion
AB Background: Very few mitochondrial myopathies have been described in horses. Objective: To examine the ultrastructure of muscle mitochondria in equine cases of myopathy of unknown origin. Materials & methods: Biopsies of vastus lateralis of the Musculus quadriceps femoris were taken predominantly immediately post mortem and processed for transmission electron microscopy. As a result, electron micrographs of 90 horses in total were available for analysis comprising 4 control horses, 16 horses suffering from myopathy and 70 otherwise diseased horses. Results: Following a thorough clinical and laboratory work-up, four out of five patients that did not fit into the usual algorithm to detect known causes of myopathy showed ultrastructural mitochondrial alterations. Small mitochondria with zones with complete disruption of cristae associated with lactic acidemia were detected in a 17-year-old pony mare, extremely long and slender mitochondria with longitudinal cristae in a 5-year-old Quarter horse stallion, a mixture of irregular extremely large mitochondria (measuring 2500 by 800nm) next to smaller ones in an 8-year-old Hanoverian mare and round mitochondria with only few cristae in a 11-year-old pony gelding. It remains uncertain whether the subsarcolemmal mitochondrial accumulations observed in the fifth patient have any pathological significance. Conclusions: Ultrastructural alterations in mitochondria were detected in at least four horses. To conclude that these are due to mitochondrial dysfuntions, biochemical tests should be performed. Practical applications: The possibility of a mitochondrial myopathy should be included in the differential diagnosis of muscle weakness.
C1 [Van Driessche, K.; Ducatelle, R.; Chiers, K.] Univ Ghent, Dept Pathol Bacteriol & Avian Med, Fac Vet Med, Merelbeke, Belgium.
   [Van Coster, R.] Univ Ghent, Div Child Neurol & Metab, Dept Pediat & Genet, Fac Med, B-9000 Ghent, Belgium.
   [Van Coster, R.] Univ Ghent, Neuromuscular Reference Ctr, Fac Med, B-9000 Ghent, Belgium.
   [van der Kolk, J. H.] Univ Bern, Swiss Inst Equine Med ISME, Vetsuisse Fac, Div Clin Vet Med, Bern, Switzerland.
   [van der Kolk, J. H.] Euregio Lab Serv, Sect Equine Metab & Genet Dis, Maastricht, Netherlands.
C3 Ghent University; Ghent University; Ghent University; University of Bern; Maastricht University
RP Van Driessche, K (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Med, Fac Vet Med, Merelbeke, Belgium.
EM Karolien.VanDriessche@UGent.be
CR Aleman M, 2008, NEUROMUSCULAR DISORD, V18, P277, DOI 10.1016/j.nmd.2008.01.001
   Aleman M, 2006, NEUROMUSCULAR DISORD, V16, P737, DOI 10.1016/j.nmd.2006.07.019
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Cassart D, 2007, EQUINE VET J, V39, P26, DOI 10.2746/042516407X157765
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cheville FN, 1994, ULTRASTRUCT PATHOL, V0, P51
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   DEVIVO DC, 1990, BIOL NEONATE, V58, P54
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Harrison SP, 2006, MITOCHONDRION, V6, P53, DOI 10.1016/j.mito.2006.01.002
   Jiang QY, 2011, MOL BIOL REP, V38, P593, DOI 10.1007/s11033-010-0145-8
   Kanzaki Y, 2010, CIRCULATION, V121, P831, DOI 10.1161/CIR.0b013e3181d22e2d
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Son Z, 2009, MOL BIOL CELL, V20, P3525
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   VALBERG SJ, 1994, MUSCLE NERVE, V17, P305, DOI 10.1002/mus.880170308
   van Galen G, 2012, EQUINE VET J, V44, P621, DOI 10.1111/j.2042-3306.2012.00555.x
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Westermann CM, 2011, MOL GENET METAB, V104, P273, DOI 10.1016/j.ymgme.2011.07.022
NR 27
TC 2
Z9 2
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0165-2176
EI 1875-5941
J9 VET QUART
JI Vet. Q.
PD JAN 2
PY 2015
VL 35
IS 1
BP 2
EP 8
DI 10.1080/01652176.2015.983681
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA CB1PZ
UT WOS:000349401400002
PM 25365353
DA 2024-11-01
ER

PT J
AU An, WB
   Zhang, JL
   Chang, LX
   Zhang, YC
   Wan, Y
   Ren, YY
   Niu, DY
   Wu, J
   Zhu, XF
   Guo, Y
AF An, Wenbin
   Zhang, Jingliao
   Chang, Lixian
   Zhang, Yingchi
   Wan, Yang
   Ren, Yuanyuan
   Niu, Deyun
   Wu, Jian
   Zhu, Xiaofan
   Guo, Ye
TI Mutation analysis of Chinese sporadic congenital sideroblastic anemia by targeted capture sequencing
SO JOURNAL OF HEMATOLOGY & ONCOLOGY
LA English
DT Article
DE Congenital sideroblastic anemia; Targeted capture sequencing; Molecular genetics; Clinical characteristics
ID gene; iron; immunodeficiency; identification; transporter; myopathy; fevers; ataxia; abc7
AB Background: Congenital sideroblastic anemias (CSAs) comprise a group of heterogenous genetic diseases that are caused by the mutation of various genes involved in heme biosynthesis, iron-sulfur cluster biogenesis, or mitochondrial solute transport or metabolism. However, approximately 40 % of patients with CSA have not been found to have pathogenic gene mutations. In this study, we systematically analyzed the mutation profile in 10 Chinese patients with sporadic CSA. Findings: We performed targeted deep sequencing analysis in ten patients with CSA using a panel of 417 genes that included known CSA-related genes. Mitochondrial genomes were analyzed using next-generation sequencing with a mitochondria enrichment kit and the HiSeq2000 sequencing platform. The results were confirmed by Sanger sequencing. The ALAS2 mutation was detected in one patient. SLC25A38 mutations were detected in three patients, including three novel mutations. Mitochondrial DNA deletions were detected in two patients. No disease-causing mutations were detected in four patients. Conclusion: To our knowledge, the pyridoxine-effective mutation C471Y of ALAS2, the compound heterozygous mutation W87X, I143Pfs146X, and the homozygous mutation R134C of SLC25A38 were found for the first time. Our findings add to the number of reported cases of this rare disease and to the CSA pathogenic mutation database. Our findings expand the phenotypic profile of mitochondrial DNA deletion mutations. This work also demonstrates the application of a congenital blood disease assay and targeted capture sequencing for the genetic screening analysis and diagnosis of heterogenous genetic CSA.
C1 [An, Wenbin; Zhang, Jingliao; Chang, Lixian; Wan, Yang; Ren, Yuanyuan; Zhu, Xiaofan; Guo, Ye] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Blood Dis Ctr, Div Pediat, Tianjin 300020, Peoples R China.
   [An, Wenbin; Zhang, Jingliao; Chang, Lixian; Zhang, Yingchi; Wan, Yang; Ren, Yuanyuan; Zhu, Xiaofan; Guo, Ye] Peking Union Med Coll, Tianjin 300020, Peoples R China.
   [Niu, Deyun; Wu, Jian] MyGenostics Inc, Baltimore, MD USA.
   [Zhang, Yingchi; Zhu, Xiaofan; Guo, Ye] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS
RP Guo, Y (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Blood Dis Ctr, Div Pediat, 288 Nanjing Rd, Tianjin 300020, Peoples R China.
EM guoyanr@126.com
FU National Natural Science Foundation of China [81270651]; Ministry of Education [20121106110036]
CR Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743
   Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792
   Bekri S, 2000, BLOOD, V96, P3256
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, V0, PP525, DOI 10.1182/asheducation-2011.1.525
   Fujiwara T, 2013, PEDIATR INT, V55, P675, DOI 10.1111/ped.12217
   Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Kaneko K, 2014, HAEMATOLOGICA, V99, P252, DOI 10.3324/haematol.2013.085449
   Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021
   Liu G, 2013, HAEMATOLOGICA, V98, PE158, DOI 10.3324/haematol.2013.095513
   Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283
   Ricketts CJ, 2006, ACTA PAEDIATR, V95, P99, DOI 10.1080/08035250500323715
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008
   Visconte V, 2014, J HEMATOL ONCOL, V7, P0, DOI 10.1186/s13045-014-0089-x
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Wiseman DH, 2013, BLOOD, V122, P112, DOI 10.1182/blood-2012-08-439083
   Wu J, 2011, SCI TRANSL MED, V3, P0, DOI 10.1126/scitranslmed.3002543
NR 25
TC 13
Z9 16
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1756-8722
J9 J HEMATOL ONCOL
JI J. Hematol. Oncol.
PD MAY 20
PY 2015
VL 8
IS 
BP 
EP 
DI 10.1186/s13045-015-0154-0
PG 7
WC Oncology; Hematology
SC Oncology; Hematology
GA CI7EZ
UT WOS:000354927000001
PM 25985931
DA 2024-11-01
ER

PT J
AU Hatakeyama, H
   Katayama, A
   Komaki, H
   Nishino, I
   Goto, Y
AF Hatakeyama, Hideyuki
   Katayama, Ayako
   Komaki, Hirofumi
   Nishino, Ichizo
   Goto, Yu-ichi
TI Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA<SUP>Trp</SUP>
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE Mitochondrial myopathy; encephalopathy; lactic acidosis; stroke-like episodes (MELAS); Mutant mitochondrial tRNA(Trp); Mitochondrial respiratory dysfunction; Induced pluripotent stem cells (iPSCs); in vitro cellular disease models
ID pluripotent stem-cells; cytochrome-c-oxidase; wobble modification deficiency; mtdna mutation; point mutation; transfer-rnas; dna; encephalopathy; pathway; genome
AB Introduction: Numerous pathogenic mutations responsible for mitochondrial diseases have been identified in mitochondrial DNA (mtDNA)-encoded tRNA genes. In most cases, however, the detailed molecular pathomechanisms and cellular pathophysiology of these mtDNA mutations - how such genetic defects determine the variation and the severity of clinical symptoms in affected individuals-remain unclear. To investigate the molecular pathomechanisms and to realize in vitro recapitulation of mitochondrial diseases, intracellular mutant mtDNA proportions must always be considered. Results: We found a disease-causative mutation, m.5541C>T heteroplasmy in MT-TW gene, in a patient exhibiting mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with multiple organ involvement. We identified the intrinsic molecular pathomechanisms of m.5541C>T. This mutation firstly disturbed the translation machinery of mitochondrial tRNA(Trp) and induced mitochondrial respiratory dysfunction, followed by severely injured mitochondrial homeostasis. We also demonstrated cell-type-specific disease phenotypes using patient-derived induced pluripotent stem cells (iPSCs) carrying similar to 100 % mutant m.5541C>T. Significant loss of terminally differentiated iPSC-derived neurons, but not their stem/progenitor cells, was detected most likely due to serious mitochondrial dysfunction triggered by m.5541C>T; in contrast, m.5541C>T did not apparently affect skeletal muscle development. Conclusions: Our iPSC-based disease models would be widely available for understanding the "definite" genotype-phenotype relationship of affected tissues and organs in various mitochondrial diseases caused by heteroplasmic mtDNA mutations, as well as for further drug discovery applications.
C1 [Hatakeyama, Hideyuki; Komaki, Hirofumi; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan.
   [Hatakeyama, Hideyuki; Goto, Yu-ichi] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan.
   [Katayama, Ayako; Komaki, Hirofumi; Goto, Yu-ichi] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo 1878551, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan.
   [Nishino, Ichizo; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Kodaira, Tokyo 1878551, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Hatakeyama, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan.
EM hideyuki@ncnp.go.jp; goto@ncnp.go.jp
FU Ministry of Health, Labour, and Welfare, Japan; AMED-CREST from the Japan Agency for Medical Research and Development
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002
   Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Okita K, 2011, NAT METHODS, V8, P409, DOI 10.1038/NMETH.1591
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Schägger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Silvestri G, 1998, NEUROMUSCULAR DISORD, V8, P291, DOI 10.1016/S0960-8966(98)00037-6
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 37
TC 32
Z9 32
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
EI 
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD AUG 22
PY 2015
VL 3
IS 
BP 
EP 
DI 10.1186/s40478-015-0227-x
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA CP9XE
UT WOS:000360247900001
PM 26297375
DA 2024-11-01
ER

PT J
AU Thomas, M
   Salpietro, V
   Canham, N
   Ruggieri, M
   Phadke, R
   Kinali, M
AF Thomas, Mark
   Salpietro, Vincenzo
   Canham, Natalie
   Ruggieri, Martino
   Phadke, Rahul
   Kinali, Maria
TI Mitochondria DNA Depletion Syndrome in a Infant with Multiple Congenital Malformations, Severe Myopathy, and Prolonged Postoperative Paralysis
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE mitochondrial depletion syndrome; congenital malformation; anaesthesia; curare; VACTERL
ID respiratory-chain deficiency; mtdna depletion; vater association; anesthesia; disorders; defects; kinase
AB Mitochondrial DNA depletion syndromes are an important cause of mitochondrial cytopathies in both children and adults. We describe a newborn with multiple congenital malformations including a right aberrant subclavian artery and a trachea-oesophageal fistula in whom mitochondrial depletion syndrome was unmasked by perioperative muscle relaxation. After vecuronium infusion, the infant developed an irreversible postoperative paralysis, leading to death 32 days after surgery. The present case highlights (a) the clinical heterogeneity of mitochondrial depletion syndrome; (b) the importance of rigorous antemortem and postmortem investigations when the cause of a severe myopathy is uncertain; (c) the possible coexistence of mitochondrial depletion syndrome and congenital malformations as a result of a likely abnormal antenatal embryofetal development and (d) the importance of a careful anaesthetic management of children with mitochondrial depletion syndrome, which could be prone to complications related to the possible depressive effects on mitochondrial electron transport chain mediated by some anaesthetic agents.
C1 [Thomas, Mark] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Neonatal Med, London SW10 9NH, England.
   [Salpietro, Vincenzo; Kinali, Maria] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Paediat Neurol, London SW10 9NH, England.
   [Salpietro, Vincenzo] Univ Messina, Dept Pediat, Messina, Italy.
   [Canham, Natalie] Northwick Pk Hosp & Clin Res Ctr, North West London Hosp NHS Trust, North West Thames Reg Genet Serv, Kennedy Galton Ctr, London, England.
   [Ruggieri, Martino] Univ Catania, Dept Educ Sci, Catania, Italy.
   [Phadke, Rahul] UCLH, Dubowitz Neuromuscular Ctr, London, England.
C3 Imperial College London; Imperial College London; University of Messina; Imperial College London; University of Catania; University College London Hospitals NHS Foundation Trust; University of London; University College London
RP Thomas, M (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, Dept Neonatal Med, 369 Fulham Rd, London SW10 9NH, England.
EM mark.thomas@chelwest.nhs.uk
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Damian MS, 1996, AM J MED GENET, V62, P398, DOI 10.1002/(SICI)1096-8628(19960424)62:4<398::AID-AJMG13>3.0.CO;2-J
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Finsterer J, 1998, CAN J ANAESTH, V45, P781, DOI 10.1007/BF03012149
   Footitt EJ, 2008, BRIT J ANAESTH, V100, P436, DOI 10.1093/bja/aen014
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   KOCH JH, 1960, BIOCHEM PHARMACOL, V3, P231, DOI 10.1016/0006-2952(60)90111-8
   Lee IC, 2013, J CHILD NEUROL, V28, P404, DOI 10.1177/0883073812469722
   LU C, 1994, CLIN CARDIOL, V17, P503, DOI 10.1002/clc.4960170909
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367
   Rafique MB, 2013, J ANESTH, V27, P186, DOI 10.1007/s00540-012-1488-1
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Thauvin-Robinet C, 2006, EUR J MED GENET, V49, P71, DOI 10.1016/j.ejmg.2005.04.001
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   WIESEL S, 1991, ANESTH ANALG, V72, P696
NR 19
TC 3
Z9 4
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD APR 15
PY 2015
VL 30
IS 5
BP 654
EP 658
DI 10.1177/0883073814532546
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA CE7IR
UT WOS:000352013100026
PM 24789116
DA 2024-11-01
ER

PT J
AU Akhmedov, AT
   Marín-García, J
AF Akhmedov, Alexander T.
   Marin-Garcia, Jose
TI Mitochondrial DNA maintenance: an appraisal
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE CVD; mtDNA; Nucleoid; mtDNA replication; mtDNA repair
ID base-excision-repair; progressive external ophthalmoplegia; single-stranded-dna; rothmund-thomson-syndrome; transcription factor-a; human pif1 helicase; structure-function defects; recessive twinkle mutations; polymerase-gamma mutations; oxidatively damaged dna
AB Mitochondria play a crucial role in a variety of cellular processes ranging from energy metabolism, generation of reactive oxygen species (ROS), and Ca2+ handling to stress responses, cell survival, and death. Malfunction of the organelle may contribute to the pathogenesis of neuromuscular disorders, cancer, premature aging, and cardiovascular diseases, including myocardial ischemia, cardiomyopathy, and heart failure. Mitochondria are unique as they contain their own genome organized into DNA-protein complexes, so-called mitochondrial nucleoids, along with multiprotein machineries, which promote mitochondrial DNA (mtDNA) replication, transcription, and repair. Although the organelle possesses almost all known nuclear DNA repair pathways, including base excision repair, mismatch repair, and recombinational repair, the proximity of mtDNA to the main sites of ROS production and the lack of protective histones may result in increased susceptibility to oxidative stress and other types of mtDNA damage. Defects in the components of these highly organized machineries, which mediate mtDNA maintenance (replication and repair), may result in accumulation of point mutations and/or deletions in mtDNA and decreased mtDNA copy number impairing mitochondrial function. This review will focus on the mechanisms of mtDNA maintenance with emphasis on the proteins implicated in these processes and their functional role in various disease conditions and aging.
C1 [Akhmedov, Alexander T.; Marin-Garcia, Jose] Mol Cardiol & Neuromuscular Inst, Highland Pk, NJ 08904 USA.
RP Marín-García, J (corresponding author), Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
EM tmci@att.net
CR Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991
   Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418
   Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012641
   Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON CTM, 1980, NUCLEIC ACIDS RES, V8, P875
   Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686
   Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4
   Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200
   Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609
   Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602
   Bochman ML, 2011, MOL BIOL CELL, V22, P1955, DOI 10.1091/mbc.E11-01-0045
   Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003
   Boulé JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200
   BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642
   Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5
   Burks LM, 2007, GENE, V391, P26, DOI 10.1016/j.gene.2006.11.019
   Cadenas S, 2010, CARDIOVASC RES, V88, P219, DOI 10.1093/cvr/cvq256
   Cadet Jean, 2011, MUTAT RES, V711, P3, DOI 10.1016/j.mrfmmm.2011.02.004
   Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Caradonna S, 1996, EXP CELL RES, V222, P345, DOI 10.1006/excr.1996.0044
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177
   Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712
   Chisholm KM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030748
   Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682
   Clayton D A, 1975, BASIC LIFE SCI, V5B, P589
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Cohen BH, 2010, GENEREVIEWS GENETEST, V0, P0
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x
   Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169
   DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004
   Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413
   Diray-Arce J, 2013, BMC PLANT BIOL, V13, P0, DOI 10.1186/1471-2229-13-36
   Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033
   Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Duxin JP, 2012, J BIOL CHEM, V287, P21980, DOI 10.1074/jbc.M112.359018
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869
   Eki T, 1996, GENOMICS, V37, P408, DOI 10.1006/geno.1996.0581
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   FANNING E, 1992, ANNU REV BIOCHEM, V61, P55
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Farge G, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2001
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   FISHER RP, 1992, J BIOL CHEM, V267, P3358
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527
   Fung H, 1998, CANCER RES, V58, P189
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Garcia CCM, 2010, CHEM RES TOXICOL, V23, P1245, DOI 10.1021/tx1001018
   Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301
   Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gaston D, 2009, METHOD ENZYMOL, V457, P21, DOI 10.1016/S0076-6879(09)05002-2
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213
   Gredilla R, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/282438
   Gu YQ, 2008, NUCLEIC ACIDS RES, V36, P6295, DOI 10.1093/nar/gkn609
   Gu YQ, 2013, PRION, V7, P341, DOI 10.4161/pri.26022
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HALLIWELL B, 1984, LANCET, V2, P1095
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799
   Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Houshmand M, 2006, NEUROL INDIA, V54, P182
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Huang Y, 2006, ACTA BIOCH BIOPH SIN, V38, P335, DOI 10.1111/j.1745-7270.2006.00165.x
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Huebscher Ulrich, 2009, V521, V0, PP19, DOI 10.1007/978-1-60327-815-7_2
   Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012
   Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033
   Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106
   Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2
   Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Karahalil B, 2003, J BIOL CHEM, V278, P33701, DOI 10.1074/jbc.M301617200
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852
   Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   KEIL RL, 1993, GENETICS, V135, P711
   Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   LEcuyer T, 2006, AM J PHYSIOL-HEART C, V291, PH1273, DOI 10.1152/ajpheart.00738.2005
   LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x
   Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880
   Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   Lee KH, 2003, MOL CELLS, V15, P81
   Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283
   Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2003, AM J PHYSIOL-HEART C, V284, PH1, DOI 10.1152/ajpheart.00814.2002
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Liu QQ, 2000, J BIOL CHEM, V275, P1615, DOI 10.1074/jbc.275.3.1615
   Lloyd DR, 2000, CANCER RES, V60, P517
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200
   Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Marin-Garcia J, 2000, J CHILD NEUROL, V15, P555, DOI 10.1177/088307380001500812
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   MarinGarcia J, 1997, J INHERIT METAB DIS, V20, P674, DOI 10.1023/A:1005322409330
   Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070
   Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200
   Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524
   Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618
   Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269
   Nair J, 2011, METHODS MOL BIOL, V682, P189, DOI 10.1007/978-1-60327-409-8_14
   Nakamura J, 1999, CANCER RES, V59, P2522
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355
   OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598
   Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2
   Osenbroch PO, 2009, FEBS J, V276, P2811, DOI 10.1111/j.1742-4658.2009.07004.x
   Ouyang KJ, 2008, MECH AGEING DEV, V129, P425, DOI 10.1016/j.mad.2008.03.003
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268
   Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152
   Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556
   Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pohjoismäki JLO, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1082
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   Sharma NK, 2014, DNA REPAIR, V13, P22, DOI 10.1016/j.dnarep.2013.11.002
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   Singh DK, 2012, MUTAT RES-FUND MOL M, V736, P15, DOI 10.1016/j.mrfmmm.2011.06.002
   Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074
   Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466
   Swenberg JA, 2008, CHEM RES TOXICOL, V21, P253, DOI 10.1021/tx700408t
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119
   Tahbaz N, 2012, NUCLEIC ACIDS RES, V40, P3484, DOI 10.1093/nar/gkr1245
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Tanaka A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067642
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5
   Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023
   Wu Y, 2012, J NUCL ACIDS, V2012, P0, DOI 10.1155/2012/140601
   Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235
   Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843
   Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269
   Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
NR 310
TC 59
Z9 63
U1 0
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD NOV 15
PY 2015
VL 409
IS 1-2
BP 283
EP 305
DI 10.1007/s11010-015-2532-x
PG 23
WC Cell Biology
SC Cell Biology
GA CS4IX
UT WOS:000362040600027
PM 26286847
DA 2024-11-01
ER

PT J
AU Keogh, MJ
   Chinnery, PF
AF Keogh, Michael J.
   Chinnery, Patrick F.
TI Mitochondrial DNA mutations in neurodegeneration
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE DNA; Mitochondrial; Aging; Parkinson disease; Alzheimer disease; Lewy body disease
ID substantia-nigra-neurons; mtdna control-region; respiratory-chain function; alzheimers-disease brain; onset parkinsons-disease; kearns-sayre syndrome; human skeletal-muscle; oxidase subunit-i; point mutations; complex-i
AB Mitochondrial dysfunction is observed in both the aging brain, and as a core feature of several neurodegenerative diseases. A central mechanism mediating this dysfunction is acquired molecular damage to mitochondrial DNA (mtDNA). In addition, inherited stable mtDNA variation (mitochondrial haplogroups), and inherited low level variants (heteroplasmy) have also been associated with the development of neurodegenerative disease and premature neural aging respectively. Herein we review the evidence for both inherited and acquired mtDNA mutations contributing to neural aging and neurodegenerative disease. This article is part of a Special Issue entitled: Mitochondrial Dysfunction in Aging. (c) 2015 Elsevier B.V. All rights reserved.
C1 [Keogh, Michael J.; Chinnery, Patrick F.] Newcastle Univ, Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
C3 Newcastle University - UK
EM p.f.chinnery@ncl.ac.uk
FU Wellcome Trust [103396/Z/13/Z, 101876/Z/13/Z, 096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University; Wellcome Trust [103396/Z/13/Z] Funding Source: Wellcome Trust; MRC [G0601943] Funding Source: UKRI
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Campbell GR, 2012, CNS NEUROL DISORD-DR, V11, P589
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021
   Chang SW, 2000, BIOCHEM BIOPH RES CO, V273, P203, DOI 10.1006/bbrc.2000.2885
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   Chinnery PF, 2001, AM J HUM GENET, V68, P529, DOI 10.1086/318204
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260
   DAurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   DELEON MJ, 1983, AM J NEURORADIOL, V4, P568
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Grazina M, 2004, NEUROBIOL DIS, V15, P306, DOI 10.1016/j.nbd.2003.11.004
   Gredilla R, 2010, NEUROBIOL AGING, V31, P993, DOI 10.1016/j.neurobiolaging.2008.07.004
   Hamblet NS, 1997, MUTAT RES-FUND MOL M, V379, P253, DOI 10.1016/S0027-5107(97)00158-9
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Ingram CJE, 2012, AMYOTROPH LATERAL SC, V13, P341, DOI 10.3109/17482968.2012.654394
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031
   Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Lücking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Molina JA, 1997, NEUROLOGY, V48, P636, DOI 10.1212/WNL.48.3.636
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Müller SK, 2013, NEUROBIOL AGING, V34, P2231, DOI 10.1016/j.neurobiolaging.2013.03.016
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MYTILINEOU C, 1994, J NEURAL TRANSM-PARK, V8, P223, DOI 10.1007/BF02260943
   NAKASE H, 1990, AM J HUM GENET, V46, P418
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Nishigaki Y, 2007, MITOCHONDRION, V7, P72, DOI 10.1016/j.mito.2006.11.002
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675
   Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x
   Ridge PG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045134
   Rosa A, 2008, BMC MED GENET, V9, P0, DOI 10.1186/1471-2350-9-57
   Rose G, 2008, EUR J NEUROL, V15, P1006, DOI 10.1111/j.1468-1331.2008.02222.x
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Santoro A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012037
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   Schleicher E, 2007, KIDNEY INT, V72, PS17, DOI 10.1038/sj.ki.5002382
   Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Siguroardóttir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902
   Simon DK, 2001, GENOMICS, V73, P113, DOI 10.1006/geno.2001.6515
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797
   SOONG NW, 1992, NAT GENET, V2, P318
   SPELBRINK JN, 1994, HUM MOL GENET, V3, P1989, DOI 10.1093/hmg/3.11.1989
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   SWERDLOW RH, 2000, MOL MECH NEURODEGENE, V0, P233
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674
   TORRONI A, 1993, AM J HUM GENET, V53, P563
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tysoe C, 1996, J MED GENET, V33, P1002, DOI 10.1136/jmg.33.12.1002
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Yang DZ, 2014, MOL GENET GENOMICS, V289, P1241, DOI 10.1007/s00438-014-0884-7
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zoccolella S, 2012, EUR J NEUROL, V19, Pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 142
TC 113
Z9 125
U1 0
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD NOV 15
PY 2015
VL 1847
IS 11
BP 1401
EP 1411
DI 10.1016/j.bbabio.2015.05.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS1XH
UT WOS:000361861700008
PM 26014345
DA 2024-11-01
ER

PT J
AU Hebert, SL
   Marquet-de Rougé, P
   Lanza, IR
   McCrady-Spitzer, SK
   Levine, JA
   Middha, S
   Carter, RE
   Klaus, KA
   Therneau, TM
   Highsmith, EW
   Nair, KS
AF Hebert, Sadie L.
   Marquet-de Rouge, Perrine
   Lanza, Ian R.
   McCrady-Spitzer, Shelly K.
   Levine, James A.
   Middha, Sumit
   Carter, Rickey E.
   Klaus, Katherine A.
   Therneau, Terry M.
   Highsmith, Edward W.
   Nair, K. Sreekumaran
TI Mitochondrial Aging and Physical Decline: Insights From Three Generations of Women
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
LA English
DT Article
DE Mitochondrial DNA; Aging; SIRT3; Oxidative capacity; Acetylated protein; Skeletal muscle
ID dna-deletion mutations; human skeletal-muscle; all-cause mortality; oxidative stress; degenerative diseases; insulin-resistance; elderly-women; sirt3; men; exercise
AB Decline in mitochondrial DNA (mtDNA) copy number, function, and accumulation of mutations and deletions have been proposed to contribute to age-related physical decline, based on cross sectional studies in genetically unrelated individuals. There is wide variability of mtDNA and functional measurements in many population studies and therefore we assessed mitochondrial function and physical function in 18 families of grandmothers, mothers, and daughters who share the same maternally inherited mtDNA sequence. A significant age-related decline in mtDNA copy number, mitochondrial protein expression, citrate synthase activity, cytochrome c oxidase content, and VO2 peak were observed. Also, a lower abundance of SIRT3, accompanied by an increase in acetylated skeletal muscle proteins, was observed in grandmothers. Muscle tissue-based full sequencing of mtDNA showed greater than 5% change in minor allele frequency over a lifetime in two locations, position 189 and 408 in the noncoding D-loop region but no changes were noted in blood cells mtDNA. The decline in oxidative capacity and muscle function with age in three generations of women who share the same mtDNA sequence are associated with a decline in muscle mtDNA copy number and reduced protein deacetylase activity of SIRT3.
C1 [Hebert, Sadie L.; Marquet-de Rouge, Perrine; Lanza, Ian R.; McCrady-Spitzer, Shelly K.; Levine, James A.; Klaus, Katherine A.; Highsmith, Edward W.; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA.
   [Middha, Sumit; Carter, Rickey E.; Therneau, Terry M.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic
RP Nair, KS (corresponding author), Mayo Clin, Div Endocrinol, 200 First St SW,Joseph 5-194, Rochester, MN 55905 USA.
EM nair.sree@mayo.edu
FU National Institutes of Health [R01 AG09531]; CTSA from the National Center for Advancing Translational Science (NCATS) [UL1 TR000135]; Mayo Clinic Metabolomics Resource Core from the National Institute of Diabetes and Digestive and Kidney Diseases [U24DK100469]
CR Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, PE790, DOI 10.1152/ajpendo.1997.273.4.E790
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j
   Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Harris AM, 2007, AM J PHYSIOL-ENDOC M, V292, PE1207, DOI 10.1152/ajpendo.00509.2006
   HEATH GW, 1981, J APPL PHYSIOL, V51, P634, DOI 10.1152/jappl.1981.51.3.634
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Johnson ML, 2015, J GERONTOL A-BIOL, V70, P1386, DOI 10.1093/gerona/glu221
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x
   LEE CM, 1993, J GERONTOL, V48, PB201, DOI 10.1093/geronj/48.6.B201
   Levine J, 2001, AM J PHYSIOL-ENDOC M, V281, PE670, DOI 10.1152/ajpendo.2001.281.4.E670
   Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561
   Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lutz S, 2000, INT J LEGAL MED, V113, P155, DOI 10.1007/s004140050288
   Mitchell P, 2014, DIABETES, V63, P3569, DOI 10.2337/db14-1059
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629
   NAIR KS, 1988, AM J PHYSIOL, V254, PE208, DOI 10.1152/ajpendo.1988.254.2.E208
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Nicklett EJ, 2012, J AM GERIATR SOC, V60, P862, DOI 10.1111/j.1532-5415.2012.03924.x
   PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Proctor DN, 1996, J APPL PHYSIOL, V81, P2495, DOI 10.1152/jappl.1996.81.6.2495
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Robinson JB, 1987, MITOCHONDRIA: A PRACTICAL APPROACH, V0, P153
   Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shokolenko IN, 2013, DNA REPAIR, V12, P488, DOI 10.1016/j.dnarep.2013.04.023
   Short K, 2003, DIABETES, V52, P0
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Talbot LA, 2007, PREV MED, V45, P169, DOI 10.1016/j.ypmed.2007.05.014
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP AG, V207, P1950
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Villareal DT, 2006, AM J PHYSIOL-ENDOC M, V291, PE1003, DOI 10.1152/ajpendo.00100.2006
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
NR 58
TC 41
Z9 45
U1 1
U2 16
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV 15
PY 2015
VL 70
IS 11
BP 1409
EP 1417
DI 10.1093/gerona/glv086
PG 9
WC Geriatrics & Gerontology; Gerontology
SC Geriatrics & Gerontology
GA CW1QF
UT WOS:000364765700015
PM 26297939
DA 2024-11-01
ER

PT J
AU Carelli, V
   Maresca, A
   Caporali, L
   Trifunov, S
   Zanna, C
   Rugolo, M
AF Carelli, Valerio
   Maresca, Alessandra
   Caporali, Leonardo
   Trifunov, Selena
   Zanna, Claudia
   Rugolo, Michela
TI Mitochondria: Biogenesis and mitophagy balance in segregation and clonal expansion of mitochondrial DNA mutations
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Mitochondrial DNA; Mitochondrial DNA mutations; Clonal expansion; Mitophagy; Nucleoids
ID optic atrophy; rapid segregation; genetic autonomy; skeletal-muscle; human-cells; mtdna; complementation; deletions; selection; explains
AB Mitochondria are cytoplasmic organelles containing their own multi-copy genome. They are organized in a highly dynamic network, resulting from balance between fission and fusion, which maintains homeostasis of mitochondrial mass through mitochondrial biogenesis and mitophagy. Mitochondrial DNA (mtDNA) mutates much faster than nuclear DNA. In particular, mtDNA point mutations and deletions may occur somatically and accumulate with aging, coexisting with the wild type, a condition known as heteroplasmy. Under specific circumstances, clonal expansion of mutant mtDNA may occur within single cells, causing a wide range of severe human diseases when mutant overcomes wild type. Furthermore, mtDNA deletions accumulate and clonally expand as a consequence of deleterious mutations in nuclear genes involved in mtDNA replication and maintenance, as well as in mitochondrial fusion genes (mitofusin-2 and OPA1), possibly implicating mtDNA nucleoids segregation. We here discuss how the intricacies of mitochondrial homeostasis impinge on the intracellular propagation of mutant mtDNA. This article is part of a Directed Issue entitled: Energy Metabolism Disorders and Therapies. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Carelli, Valerio; Maresca, Alessandra; Caporali, Leonardo; Zanna, Claudia] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Carelli, Valerio; Maresca, Alessandra; Caporali, Leonardo; Trifunov, Selena] Univ Bologna, Neurol Unit, Dept Biomed & NeuroMotor Sci DiBiNeM, I-40139 Bologna, Italy.
   [Trifunov, Selena; Zanna, Claudia; Rugolo, Michela] Univ Bologna, Dept Pharm & Biotechnol, Unit Cellular Biochem, I-40139 Bologna, Italy.
C3 AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna
RP Carelli, V (corresponding author), Univ Bologna, Bellaria Hosp, Dept Biomed & NeuroMotor Sci DiBiNeM, IRCCS Inst Neurol Sci Bologna, Via Altura 3, I-40139 Bologna, Italy.
EM valerio.carelli@unibo.it
FU Marie Curie Project: Mitochondrial European Educational Training (MEET) MEET; Futuro in Ricerca-FIRB; Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) PRIN; Telethon Grants [GGP06233, GPP10005, GGP11182]; Emilia-Romagna regional program ER-MITO; Fondazione Galletti
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Attardi G, 2002, NAT GENET, V30, P360, DOI 10.1038/ng0402-360
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bukowiecki R, 2014, GERONTOLOGY, V60, P174, DOI 10.1159/000355050
   Busch KB, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0442
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Carlson EA, 2013, MUTAT RES-REV MUTAT, V752, P1, DOI 10.1016/j.mrrev.2012.08.003
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   DAurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Enríquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howell N, 2000, HUM REPROD, V15 Suppl 2, P235
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Khrapko K, 2014, PROG MOL BIOL TRANSL, V127, P29, DOI 10.1016/B978-0-12-394625-6.00002-7
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014
   Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Murley A, 2013, ELIFE, V2, P0, DOI 10.7554/eLife.00422
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Popadin K, 2014, AGING CELL, V13, P579, DOI 10.1111/acel.12231
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Takai D, 1999, J BIOL CHEM, V274, P11199, DOI 10.1074/jbc.274.16.11199
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2013, COLD SPRING HARB PER, V5, P0
   Wallace DC, 2013, PHILOS T R SOC B, V368, P0, DOI 10.1098/rstb.2012.0267
   Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
NR 64
TC 57
Z9 61
U1 0
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JUN 15
PY 2015
VL 63
IS 
BP 21
EP 24
DI 10.1016/j.biocel.2015.01.023
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CJ7WJ
UT WOS:000355710800005
PM 25666555
DA 2024-11-01
ER

PT J
AU Gang, Q
   Bettencourt, C
   Houlden, H
   Hanna, MG
   Machado, PM
AF Gang, Qiang
   Bettencourt, Conceicao
   Houlden, Henry
   Hanna, Michael G.
   Machado, Pedro M.
TI Genetic advances in sporadic inclusion body myositis
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE genetics; inclusion body myopathies; inclusion body myositis
ID mitochondrial-dna deletions; valosin-containing protein; onset alzheimers-disease; frontotemporal dementia; paget-disease; polymorphism; variants; myopathy; japanese; tomm40
AB Purpose of review To describe recent developments in the genetics of sporadic inclusion body myositis (sIBM). Recent findings Genes located within major histocompatibility complex regions remain the strongest genetic association with sIBM. The rs10527454 polymorphism in the TOMM40 gene seems to have a disease modifying effect on sIBM by delaying the onset of symptoms, and this effect may be enhanced by the APOE epsilon 3/epsilon 3 genotype. Rare variants in the VCP and SQSTM1 genes have been identified in sIBM patients in two studies using targeted next-generation sequencing and whole-exome sequencing. Two studies have confirmed the correlation between the amount of cytochrome c oxidase - deficient fibres and the proportion of mitochondrial DNA (mtDNA) deletions in sIBM. Some rare variants in mtDNA-related nuclear genes have also been reported. Summary There have been advances in the genetics of sIBM over the past 2 years facilitated by the use of next-generation sequencing. Genes that cause hereditary IBM, which has clinical or pathological features resembling sIBM, have provided clues to the genetic basis of sIBM. To date, genes located in major histocompatibility complex regions and genes involved in protein homeostasis or mtDNA maintenance have been implicated in sIBM. Whole-exome sequencing-association studies, RNA sequencing, and whole-genome sequencing in large sIBM cohorts will be key tools to unravel the genetics of sIBM and its contribution to disease aetiopathogenesis.
C1 [Gang, Qiang; Bettencourt, Conceicao; Houlden, Henry; Hanna, Michael G.; Machado, Pedro M.] UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, Dept Mol Neurosci, London, England.
C3 University of London; University College London
RP Machado, PM (corresponding author), MRC Ctr Neuromuscular Dis, Box 102,8-11 Queen Sq, London WC1N 3BG, England.
EM p.machado@ucl.ac.uk
FU University College London (UCL) Impact Studentship; Chinese Scholarship Council; National Institute for Health Research (NIHR); MRC Centre grant [MR/K000608/01]; MRC [MR/J004758/1]; National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC); UCLH Biomedical Research Centre (BRC); MRC [G0802760, MR/K000608/1, G1001253, G108/638, MR/J004758/1] Funding Source: UKRI
CR Amato AA, 1998, NEUROLOGY, V51, P598, DOI 10.1212/WNL.51.2.598
   [Anonymous], 2008, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, V0, P0, DOI DOI 10.1073/PNAS.0806192105
   Badrising UA, 2004, NEUROLOGY, V63, P2396, DOI 10.1212/01.WNL.0000148588.15052.4C
   Brady S, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2013-004552
   Broccolini A, 2015, BBA-MOL BASIS DIS, V1852, P644, DOI 10.1016/j.bbadis.2014.08.007
   Cai HY, 2012, J NEUROL, V259, P1913, DOI 10.1007/s00415-012-6439-0
   Cortese A, 2014, NEUROBIOL AGING, V35, P1491, DOI 10.1016/j.neurobiolaging.2013.12.029
   Di Blasi C, 2000, ANN NEUROL, V47, P811, DOI 10.1002/1531-8249(200006)47:6<811::AID-ANA16>3.3.CO;2-0
   Gang Q, 2015, NEUROMUSCULAR DISORD, V25, P1
   Gang Q, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2014.12.039
   Gang Q, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-88
   GARLEPP MJ, 1994, CLIN EXP IMMUNOL, V98, P40
   Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851
   Kaleem M, 2007, NEURODEGENER DIS, V4, P376, DOI 10.1159/000105158
   Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
   Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003
   Koffman BM, 1998, J NEUROIMMUNOL, V84, P139, DOI 10.1016/S0165-5728(97)00245-2
   Kok CC, 2000, NEUROMUSCULAR DISORD, V10, P604, DOI 10.1016/S0960-8966(00)00144-9
   Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004
   Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Machado PM, 2014, CURR OPIN NEUROL, V27, P591, DOI 10.1097/WCO.0000000000000129
   Mastaglia FL, 2013, NEUROMUSCULAR DISORD, V23, P969, DOI 10.1016/j.nmd.2013.09.008
   Mastaglia FL, 2009, NEUROMUSCULAR DISORD, V19, P763, DOI 10.1016/j.nmd.2009.07.015
   Median AG, 2012, TRENDS GENET, V28, P487, DOI 10.1016/j.tig.2012.06.008
   Needham M, 2008, J NEUROL NEUROSUR PS, V79, P1056, DOI 10.1136/jnnp.2007.138891
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Newman WG, 2014, GENES-BASEL, V5, P1001, DOI 10.3390/genes5041001
   OHanlon TP, 2005, MEDICINE, V84, P338, DOI 10.1097/01.md.0000189818.63141.8c
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pinkus JL, 2014, NEUROMUSCULAR DISORD, V24, P611, DOI 10.1016/j.nmd.2014.04.012
   Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x
   Ranque-Francois B, 2005, ANN RHEUM DIS, V64, P634, DOI 10.1136/ard.2004.025494
   Rohrer JD, 2011, J NEUROL, V258, P1494, DOI 10.1007/s00415-011-5966-4
   Rojana-udomsart A, 2013, J NEUROIMMUNOL, V254, P174, DOI 10.1016/j.jneuroim.2012.09.003
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69
   Roses AD, 2010, ARCH NEUROL-CHICAGO, V67, P536, DOI 10.1001/archneurol.2010.88
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Scott AP, 2012, J NEUROIMMUNOL, V250, P66, DOI 10.1016/j.jneuroim.2012.04.021
   Scott AP, 2006, NEUROMUSCULAR DISORD, V16, P311, DOI 10.1016/j.nmd.2006.02.002
   Seelen M, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.01.152
   Sivakumar K, 1997, BRAIN, V120, P653, DOI 10.1093/brain/120.4.653
   Tateyama M, 2003, INTERNAL MED, V42, P1035, DOI 10.2169/internalmedicine.42.1035
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
NR 48
TC 8
Z9 9
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD NOV 15
PY 2015
VL 27
IS 6
BP 586
EP 594
DI 10.1097/BOR.0000000000000213
PG 9
WC Rheumatology
SC Rheumatology
GA DD0PX
UT WOS:000369623000011
PM 26335925
DA 2024-11-01
ER

PT J
AU Holmbeck, MA
   Donner, JR
   Villa-Cuesta, E
   Rand, DM
AF Holmbeck, Marissa A.
   Donner, Julia R.
   Villa-Cuesta, Eugenia
   Rand, David M.
TI A <i>Drosophila</i> model for mito-nuclear diseases generated by an incompatible interaction between tRNA and tRNA synthetase
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Disease; Epistasis; Mitochondria
ID mitochondrial protein-synthesis; hereditary optic neuropathy; sideroblastic anemia; lactic-acidosis; muscle degeneration; energy-metabolism; yars2 mutations; parkin mutants; inner-membrane; flight-muscle
AB Communication between the mitochondrial and nuclear genomes is vital for cellular function. The assembly of mitochondrial enzyme complexes, which produce the majority of cellular energy, requires the coordinated expression and translation of both mitochondrially and nuclear-encoded proteins. The joint genetic architecture of this system complicates the basis of mitochondrial diseases, and mutations both in mitochondrial DNA (mtDNA)- and nuclear-encoded genes have been implicated in mitochondrial dysfunction. Previously, in a set of mitochondrial-nuclear introgression strains, we characterized a dual genome epistasis in which a naturally occurring mutation in the Drosophila simulans simw(501) mtDNA-encoded transfer RNA (tRNA) for tyrosine (tRNA(Tyr)) interacts with a mutation in the nuclear-encoded mitochondrially localized tyrosyl-tRNA synthetase from Drosophila melanogaster. Here, we show that the incompatible mitochondrial-nuclear combination results in locomotor defects, reduced mitochondrial respiratory capacity, decreased oxidative phosphorylation (OXPHOS) enzyme activity and severe alterations in mitochondrial morphology. Transgenic rescue strains containing nuclear variants of the tyrosyl-tRNA synthetase are sufficient to rescue many of the deleterious phenotypes identified when paired with the simw(501) mtDNA. However, the severity of this defective mito-nuclear interaction varies across traits and genetic backgrounds, suggesting that the impact of mitochondrial dysfunction might be tissue specific. Because mutations in mitochondrial tRNA(Tyr) are associated with exercise intolerance in humans, this mitochondrial-nuclear introgression model in Drosophila provides a means to dissect the molecular basis of these, and other, mitochondrial diseases that are a consequence of the joint genetic architecture of mitochondrial function.
C1 [Holmbeck, Marissa A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.
   [Donner, Julia R.; Rand, David M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
   [Villa-Cuesta, Eugenia] Adelphi Univ, Dept Biol, Garden City, NY 11530 USA.
C3 Brown University; Brown University; Adelphi University
RP Rand, DM (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
EM David_Rand@Brown.edu
FU NIGMS awarded [R15GM113156]; NIGMS [R01GM067862]; NIA [R01AG027849];  [1F31AG040925-02]
CR Arnqvist G, 2010, EVOLUTION, V64, P3354, DOI 10.1111/j.1558-5646.2010.01135.x
   Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X
   BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Chae S, 2013, SCI SIGNAL, V6, P0, DOI 10.1126/scisignal.2003266
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110
   DEAK II, 1977, J MORPHOL, V153, P307, DOI 10.1002/jmor.1051530209
   Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011
   Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Klein P, 2014, EMBO J, V33, P341, DOI 10.1002/embj.201284290
   Klose J, 1999, ELECTROPHORESIS, V20, P643
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Meiklejohn CD, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003238
   Montooth KL, 2010, EVOLUTION, V64, P3364, DOI 10.1111/j.1558-5646.2010.01077.x
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1001379
   ODONNELL PT, 1989, GENE DEV, V3, P1233, DOI 10.1101/gad.3.8.1233
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   PECKHAM M, 1990, J MUSCLE RES CELL M, V11, P203, DOI 10.1007/BF01843574
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Pulkes T, 2000, NEUROLOGY, V55, P1210, DOI 10.1212/WNL.55.8.1210
   Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003
   Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698
   Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146
   Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Sacktor B, 1976, BIOCHEM SOC SYMP, V0, P111
   Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schriner SE, 2009, FREE RADICAL RES, V43, P836, DOI 10.1080/10715760903089724
   SHAFIQ SA, 1963, J CELL BIOL, V17, P351, DOI 10.1083/jcb.17.2.351
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Suarez RK, 1996, P NATL ACAD SCI USA, V93, P12616, DOI 10.1073/pnas.93.22.12616
   Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112
   Sugiyama S, 2007, GENETICS, V176, P927, DOI 10.1534/genetics.107.072074
   Toivonen JM, 2001, GENETICS, V159, P241
   Tran Hornig-Do H, 2014, EMBO MOL MED, V6, P183
   Vartiainen S, 2014, DIS MODEL MECH, V7, P635, DOI 10.1242/dmm.016527
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhu CT, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004354
NR 61
TC 30
Z9 36
U1 1
U2 15
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD AUG 15
PY 2015
VL 8
IS 8
BP 843
EP U530
DI 10.1242/dmm.019323
PG 23
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA CN3DD
UT WOS:000358303200008
PM 26035388
DA 2024-11-01
ER

PT J
AU Chinnery, PF
AF Chinnery, Patrick F.
TI Mitochondrial disease in adults: what's old and what's new?
SO EMBO MOLECULAR MEDICINE
LA English
DT Review
DE mitochondrial disease; mitochondrial DNA; mitochondrial encephalomyopathy; myopathy; neurometabolic
ID progressive external ophthalmoplegia; dominant optic atrophy; cytochrome-c-oxidase; lactic-acidosis; dna deletions; m.3243a-greater-than-g mutation; spinocerebellar ataxia; thymidine kinase; gene-mutations; common-cause
AB Ten years ago, there was an emerging view that the molecular basis for adult mitochondrial disorders was largely known and that the clinical phenotypes had been well described. Nothing could have been further from the truth. The establishment of large cohorts of patients has revealed new aspects of the clinical presentation that were not previously appreciated. Over time, this approach is starting to provide an accurate understanding of the natural history of mitochondrial disease in adults. Advances in molecular diagnostics, underpinned by next generation sequencing technology, have identified novel molecular mechanisms. Recently described mitochondrial disease phenotypes have disparate causes, and yet share common mechanistic themes. In particular, disorders of mtDNA maintenance have emerged as a major cause of mitochondrial disease in adults. Progressive mtDNA depletion and the accumulation of mtDNA mutations explain some of the clinical features, but the genetic and cellular processes responsible for the mtDNA abnormalities are not entirely clear in each instance. Unfortunately, apart from a few specific examples, treatments for adult mitochondrial disease have not been forthcoming. However, the establishment of international consortia, and the first multinational randomised controlled trial, have paved the way for major progress in the near future, underpinned by growing interest from the pharmaceutical industry. Adult mitochondrial medicine is, therefore, in its infancy, and the challenge is to harness the new understanding of its molecular and cellular basis to develop treatments of real benefit to patients.
C1 [Chinnery, Patrick F.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 University of Cambridge
RP Chinnery, PF (corresponding author), Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
EM pfc25@medschl.cam.ac.uk
FU Medical Research Council (UK) Mitochondrial Biology Unit [MC_UP_1501/2]; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; EU FP7 TIRCON; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; MRC [MR/K000608/1, G0601943] Funding Source: UKRI
CR Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Dieteren CEJ, 2012, J BIOL CHEM, V287, P41851, DOI 10.1074/jbc.M112.391151
   Dindyal S, 2014, ANN R COLL SURG ENGL, V96, P101, DOI 10.1308/003588414
   Elguindy MM, 2015, J BIOL CHEM, V290, P20815, DOI 10.1074/jbc.M115.641498
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fernández-Vizarra E, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00134
   Foley AR, 2014, BRAIN, V137, P44, DOI 10.1093/brain/awt315
   Fujikawa M, 2015, FEBS LETT, V589, P2707, DOI 10.1016/j.febslet.2015.08.006
   García-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Gardner K, 2015, EUR J HUM GENET, V23, P413, DOI 10.1038/ejhg.2014.96
   Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howell N, 1998, AM J HUM GENET, V63, P1220, DOI 10.1086/302049
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kornblum C, 2001, NEUROLOGY, V56, P1409, DOI 10.1212/WNL.56.10.1409
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Nemes A, 2008, EUR J OPHTHALMOL, V18, P309, DOI 10.1177/112067210801800225
   Nemes A, 2009, SWISS MED WKLY, V139, P117, DOI smw-12390
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   NIKOSKELAINEN EK, 1994, LANCET, V344, P857, DOI 10.1016/S0140-6736(94)92830-4
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Poulton J, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001066
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rötig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Skladal D, 2000, J INHERIT METAB DIS, V23, P513, DOI 10.1023/A:1005620515996
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 85
TC 94
Z9 109
U1 1
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD DEC 15
PY 2015
VL 7
IS 12
BP 1503
EP 1512
DI 10.15252/emmm.201505079
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DA9NF
UT WOS:000368135400001
PM 26612854
DA 2024-11-01
ER

PT J
AU Zierz, CM
   Joshi, PR
   Zierz, S
AF Zierz, Charlotte Maria
   Joshi, Pushpa Raj
   Zierz, Stephan
TI Frequencies of myohistological mitochondrial changes in patients with mitochondrial DNA deletions and the common m.3243A&gt;G point mutation
SO NEUROPATHOLOGY
LA English
DT Article
DE COX-deficient; ragged-red fibers; mtDNA; myohistological changes; point mutation; single; multiple deletions
ID progressive external ophthalmoplegia; ragged-red fibers; skeletal-muscle; diseases; pathology; myopathy; neuropathy; disorders; features; melas
AB Frequencies of typical myohistological changes such as ragged red fibers (RRF) and cytochrome c oxidase (COX)-deficient fibers have been suggested to be dependent on underlying mitochondrial DNA (mtDNA) defect. However, there are no systematic studies comparing frequencies of myohistological changes and underlying genotypes. The histopathological changes were analysed in 29 patients with genetically confirmed mitochondrial myopathies. Genotypes included multiple mtDNA deletions due to POLG1 mutations (n=11), single mtDNA deletion (n=10) and mtDNA point mutation m.3243A>G (n=8). Histochemical reactions, including Gomori-trichome, COX/SDH (succinate dehydrogenase) and SDH as well as immunohistological reaction with COX-antibody against subunit I (COI) were carried out in muscle biopsy sections of all patients. The COX-deficient fibers were observed most frequently in all three patient groups. The frequencies of myopathological changes were not significantly different in the different genotypes in all three histochemical stains. However, there was a tendency to lower means and variations in patients with point mutation. Only COI-negative fibers were histochemically negative for COX activity in all patient groups. Frequency of COI-negative fibers was significantly lower in patients with mtDNA point mutation than in patients with deletions. This suggests that impact of point mutation on protein synthesis is less than that of deletions.
C1 [Zierz, Charlotte Maria; Joshi, Pushpa Raj; Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany.
C3 Martin Luther University Halle Wittenberg
RP Joshi, PR (corresponding author), Univ Halle Wittenberg, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
EM pushpa.joshi@medizin.uni-halle.de
FU German Federal Ministry of Education and Research (BMBF)
CR Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   CHARIOT P, 1993, ANN NEUROL, V34, P561, DOI 10.1002/ana.410340409
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   COLLINS S, 1995, ACTA NEUROL SCAND, V91, P287, DOI 10.1111/j.1600-0404.1995.tb07007.x
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KAWAI H, 1995, MUSCLE NERVE, V18, P753, DOI 10.1002/mus.880180712
   Koga Y, 2000, ACTA NEUROPATHOL, V99, P186, DOI 10.1007/PL00007423
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Possekel S, 1996, NEUROMUSCULAR DISORD, V6, P215, DOI 10.1016/0960-8966(96)00002-8
   POULTON J, 1995, NEUROMUSCULAR DISORD, V5, P345, DOI 10.1016/0960-8966(95)00073-V
   Reichmann H, 1996, EUR NEUROL, V36, P98, DOI 10.1159/000117217
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   YAMAMOTO M, 1988, ACTA NEUROPATHOL, V76, P558, DOI 10.1007/BF00689593
   YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822
NR 23
TC 10
Z9 13
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD APR 15
PY 2015
VL 35
IS 2
BP 130
EP 136
DI 10.1111/neup.12173
PG 7
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA CF5WV
UT WOS:000352628900004
PM 25378026
DA 2024-11-01
ER

PT J
AU Remenyi, V
   Inczedy-Farkas, G
   Komlosi, K
   Horvath, R
   Maasz, A
   Janicsek, I
   Pentelenyi, K
   Gal, A
   Karcagi, V
   Melegh, B
   Molnar, MJ
AF Remenyi, Viktoria
   Inczedy-Farkas, Gabriella
   Komlosi, Katalin
   Horvath, Rita
   Maasz, Anita
   Janicsek, Ingrid
   Pentelenyi, Klara
   Gal, Aniko
   Karcagi, Veronika
   Melegh, Bela
   Molnar, Maria Judit
TI Retrospective assessment of the most common mitochondrial DNA mutations in a large Hungarian cohort of suspect mitochondrial cases
SO MITOCHONDRIAL DNA
LA English
DT Article
DE LHON; MELAS; MERRF; mitochondrial deletions; mutation frequency; NARP
ID hereditary optic neuropathy; progressive external ophthalmoplegia; stroke-like episodes; diabetes-mellitus; clinical-features; chinese patients; lactic-acidosis; a3243g mutation; a8344g mutation; mtdna mutations
AB Prevalence estimations for mitochondrial disorders still vary widely and only few epidemiologic studies have been carried out so far. With the present work we aim to give a comprehensive overview about frequencies of the most common mitochondrial mutations in Hungarian patients. A total of 1328 patients were tested between 1999 and 2012. Among them, 882 were screened for the m.3243A>G, m.8344A>G, m.8993T>C/G mutations and deletions, 446 for LHON primary mutations. The mutation frequency in our cohort was 2.61% for the m.3243A>G, 1.47% for the m.8344A>G, 17.94% for Leber's Hereditary Optic Neuropathy (m.3460G>A, m.11778G>A, m.14484T>C) and 0.45% for the m.8993T>C/G substitutions. Single mtDNA deletions were detected in 14.97%, while multiple deletions in 6.01% of the cases. The mutation frequency in Hungarian patients suggestive of mitochondrial disease was similar to other Caucasian populations. Further retrospective studies of different populations are needed in order to accurately assess the importance of mitochondrial diseases and manage these patients.
C1 [Remenyi, Viktoria; Inczedy-Farkas, Gabriella; Pentelenyi, Klara; Gal, Aniko; Molnar, Maria Judit] Semmelweis Univ, Inst Genom Med & Rare Disorders, H-1083 Budapest, Hungary.
   [Inczedy-Farkas, Gabriella] LIJ Hlth Syst, Zucker Hillside Hosp North Shore, Glen Oaks, NY USA.
   [Komlosi, Katalin; Maasz, Anita; Janicsek, Ingrid; Melegh, Bela] Univ Pecs, Dept Med Genet, Pecs, Hungary.
   [Horvath, Rita] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Karcagi, Veronika] Natl Inst Environm Hlth, Dept Mol Genet, Budapest, Hungary.
C3 Semmelweis University; Northwell Health; University of Pecs; Newcastle University - UK
RP Molnar, MJ (corresponding author), Semmelweis Univ, Inst Genom Med & Rare Disorders, Tomo Str 25-29, H-1083 Budapest, Hungary.
EM molnar.mariajudit@med.semmelweis-univ.hu
FU [TAMOP-4-2-1/B-03/1/KMR-2010-001];  [KTIA_AIK_12-1-2013-0017];  [BIOINF09-TET_10-1-2011-0058]; MRC [G1000848] Funding Source: UKRI
CR Aniko G, 2010, CENT EUR J MED, V5, P322, DOI 10.2478/s11536-009-0118-2
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Cao YY, 2010, MITOCHONDRION, V10, P330, DOI 10.1016/j.mito.2010.01.008
   Carrozzo R, 1999, J NEUROL SCI, V170, P24, DOI 10.1016/S0022-510X(99)00193-8
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   Francisco G, 2005, DIABETES METAB, V31, P621, DOI 10.1016/S1262-3636(07)70240-9
   Gal Aniko, 2008, ORVOSI HETILAP, V149, P1593, DOI 10.1556/OH.2008.28398
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Inczedy-Farkas G, 2011, CENT EUR J MED, V6, P758, DOI 10.2478/s11536-011-0096-z
   Iwanicka-Pronicka K, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044054
   Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2
   Klemm T, 2001, EXP CLIN ENDOCR DIAB, V109, P283, DOI 10.1055/s-2001-16348
   Komlósi K, 2005, PATHOL ONCOL RES, V11, P82, DOI 10.1007/BF02893371
   Komlosi Katalin, 2004, ORVOSI HETILAP, V145, P1805
   Kwon SJ, 2004, ANN NY ACAD SCI, V1011, P339, DOI 10.1196/annals.1293.034
   Lee YC, 2007, J NEUROL SCI, V254, P65, DOI 10.1016/j.jns.2007.01.005
   Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Martikainen MH, 2012, NEUROEPIDEMIOLOGY, V38, P114, DOI 10.1159/000336112
   Martin-Kleiner I, 2004, ACTA DIABETOL, V41, P179, DOI 10.1007/s00592-004-0163-x
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Muravchick S, 2008, ADV DRUG DELIVER REV, V60, P1553, DOI 10.1016/j.addr.2008.03.019
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   POULTON J, 1989, LANCET, V1, P236
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Rodríguez-Hernández M, 2000, REV NEUROLOGIA, V30, P1001, DOI 10.33588/rn.3011.2000037
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Salles JEN, 2007, ARQ BRAS ENDOCRINOL, V51, P559, DOI 10.1590/S0004-27302007000400009
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schroder JM, 1997, MOL CELL BIOCHEM, V174, P277, DOI 10.1023/A:1006829129079
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Wang Zhao-xia, 2008, ZHONGHUA YI XUE ZA ZHI, V88, P3254
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
NR 56
TC 3
Z9 3
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1940-1736
EI 1940-1744
J9 MITOCHONDR DNA
JI Mitochondrial DNA
PD AUG 15
PY 2015
VL 26
IS 4
BP 572
EP 578
DI 10.3109/19401736.2013.878901
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA CP7VW
UT WOS:000360098200013
PM 24438288
DA 2024-11-01
ER

PT J
AU Scuderi, C
   Borgione, E
   Castello, F
   Lo Giudice, M
   Paola, SS
   Giambirtone, M
   Di Blasi, FD
   Elia, M
   Amato, C
   Città, S
   Gagliano, C
   Barbarino, G
   Vitello, GA
   Musumeci, SA
AF Scuderi, Carmela
   Borgione, Eugenia
   Castello, Filippa
   Lo Giudice, Mariangela
   Paola, Sandro Santa
   Giambirtone, Mariaconcetta
   Di Blasi, Francesco Domenico
   Elia, Maurizio
   Amato, Carmelo
   Citta, Santina
   Gagliano, Catalda
   Barbarino, Giuliano
   Vitello, Girolamo Aurelio
   Musumeci, Sebastiano Antonino
TI The in cis T251I and P587L POLG1 base changes: Description of a new family and literature review
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Gene mutation; Mental retardation; Mitochondrial disease; Polymerase gamma
ID dna-polymerase-gamma; progressive external ophthalmoplegia; mitochondrial-dna; mutations; consequence; phenotypes; frequency; depletion; deletions; twinkle
AB Mutations in the polymerase gamma-1 (POLG1) gene, encoding the catalytic subunit of the mtDNA-specific polymerase-gamma, compromise the stability of mitochondrial DNA (mtDNA) and are responsible for numerous clinical presentations as autosomal dominant or recessive progressive external ophthalmoplegia (PEO), sensory ataxia, neuropathy, dysarthria and ophthalmoparesis (SANDO), spinocerebellar ataxia with epilepsy (SCAB) and Alpers syndrome. POLG1 mutations result in extremely heterogeneous phenotypes which often have overlapping clinical findings, making it difficult to categorize patients into syndromes, and genotype phenotype correlations are still unclear. We describe a new family with a particular spectrum of clinical signs, that carried the c.752C>T mutation in exon 3 (T251I) and the c.1760C>T in exon 10 (P587L) in cis. These mutations were associated in the proband and in her brother with the new probably pathogenic mutation c.347C>A in exon 2 (P116Q). The proband presented a progressive cognitive impairment, mild myopathy, dilated cardiac right atrium and posterior white matter mild signal alteration, while her brother had migraine, mild myopathy, palpebral ptosis and posterior white matter mild signal alteration. Their mother and their sister carried the in cis T251I and the P587L mutations. The first presented neurosensorial hypoacusia, fatigue, heart block and a cerebral arteriovenous malformation nidus, while the latter had borderline intellectual functioning and signs of muscular involvement. Their father, with the P116Q mutation, had diabetes and myopathy. The complexity of the genotype-phenotype correlations associated with POLG1 mutations is reinforced in this work as evidenced by the presence of different clinic features in patients carrying the same mutations. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Scuderi, Carmela; Borgione, Eugenia; Castello, Filippa; Lo Giudice, Mariangela; Paola, Sandro Santa; Giambirtone, Mariaconcetta; Gagliano, Catalda; Barbarino, Giuliano] IRCCS Oasi Maria SS, Unita Operat Malattie Neuromuscolari, I-94018 Troina, EN, Italy.
   [Di Blasi, Francesco Domenico; Citta, Santina] IRCCS Oasi Maria SS, Unita Operat Psicol, I-94018 Troina, EN, Italy.
   [Elia, Maurizio] IRCCS Oasi Maria SS, Unita Operat Neurol & Neurofisiopatol Clin & Stru, I-94018 Troina, EN, Italy.
   [Amato, Carmelo] IRCCS Oasi Maria SS, Unita Operat Neuroradiol, I-94018 Troina, EN, Italy.
   [Vitello, Girolamo Aurelio; Musumeci, Sebastiano Antonino] IRCCS Oasi Maria SS, Unita Operat Neurol Ritardo Mentale, I-94018 Troina, EN, Italy.
C3 IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS; IRCCS Oasi Maria SS
RP Scuderi, C (corresponding author), IRCCS Oasi Maria SS, Unita Operat Malattie Neuromuscolari, V Conte Ruggero 73, I-94018 Troina, EN, Italy.
EM cscuderi@oasi.en.it
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Aitken H, 2009, NEUROLOGY, V72, PE86, DOI 10.1212/WNL.0b013e3181a411b8
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Burusnukul P, 2009, J CHILD NEUROL, V24, P482, DOI 10.1177/0883073808324539
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chinnery Patrick F, 2008, NEUROMUSCUL DISORD, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Lamantea E, 2004, ANN NEUROL, V56, P454, DOI 10.1002/ana.20219
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Scuderi C, 2007, NEUROMUSCULAR DISORD, V17, P258, DOI 10.1016/j.nmd.2006.11.006
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2009.01212.x
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Walker RL, 1997, GENOMICS, V40, P376, DOI 10.1006/geno.1996.4580
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wong LJ, 2008, HUM MUTAT, V29, P150
NR 34
TC 20
Z9 20
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR 15
PY 2015
VL 25
IS 4
BP 333
EP 339
DI 10.1016/j.nmd.2015.01.004
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CG2CE
UT WOS:000353081700007
PM 25660390
DA 2024-11-01
ER

PT J
AU Da Pozzo, P
   Rubegni, A
   Rufa, A
   Cardaioli, E
   Taglia, I
   Gallus, GN
   Malandrini, A
   Federico, A
AF Da Pozzo, Paola
   Rubegni, Anna
   Rufa, Alessandra
   Cardaioli, Elena
   Taglia, Ilaria
   Gallus, Gian Nicola
   Malandrini, Alessandro
   Federico, Antonio
TI Sporadic PEO caused by a novel POLG variation and a Twinkle mutation: digenic inheritance?
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE PEO; POLG gene; C10orf2/Twinkle gene; Digenic disorder
ID progressive external ophthalmoplegia; ant1
AB Progressive external ophthalmoplegia (PEO) with multiple deletions of mitochondrial DNA (mtDNA) is associated with several mutations in nuclear genes. They include POLG, POLG2, ANT1, C10orf2/Twinkle, and OPA1. However, digenic inheritance in mitochondrial disorders has been documented in a few cases over the years. Here we describe an 80-year-old man with sporadic PEO associated with mtDNA deletions. Sequencing of the POLG revealed a novel heterozygous mutation (c.2831A > G; p.Glu944Gly), predicted in silico as damaging, in the patient who also carried a heterozygous mutation in C10orf2/Twinkle (c.1142T > C; p.Leu381Pro). This case provides a second report of a PEO with different mutations in the POLG and C10orf2/Twinkle genes, supporting the hypothesis that the PEO phenotype can be determined by the co-existence of two abnormalities in separate genes, both involved in the maintenance and stability of mtDNA. Finally, this study expands the spectrum of POLG mutations and highlights the need to sequence the whole set of nuclear genes associated with PEO and multiple mtDNA deletions.
C1 [Da Pozzo, Paola; Rufa, Alessandra; Cardaioli, Elena; Taglia, Ilaria; Gallus, Gian Nicola; Malandrini, Alessandro; Federico, Antonio] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy.
   [Rubegni, Anna] IRCCS Stella Maris, Mol Med Neuromuscular & Neurodegenerat Unit, Pisa, Italy.
C3 University of Siena; IRCCS Fondazione Stella Maris
RP Federico, A (corresponding author), Univ Siena, Dept Med Surg & Neurosci, Viale Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
FU Region of Tuscany; Ministry of Public Health
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 7
TC 3
Z9 4
U1 0
U2 0
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD SEP 15
PY 2015
VL 36
IS 9
BP 1713
EP 1715
DI 10.1007/s10072-015-2247-5
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CQ0NE
UT WOS:000360292200031
PM 26050231
DA 2024-11-01
ER

PT J
AU Sato, T
   Muroya, K
   Hanakawa, J
   Iwano, R
   Asakura, Y
   Tanaka, Y
   Murayama, K
   Ohtake, A
   Hasegawa, T
   Adachi, M
AF Sato, Takeshi
   Muroya, Koji
   Hanakawa, Junko
   Iwano, Reiko
   Asakura, Yumi
   Tanaka, Yukichi
   Murayama, Kei
   Ohtake, Akira
   Hasegawa, Tomonobu
   Adachi, Masanori
TI Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Review
DE Pearson marrow-pancreas syndrome; Mitochondrial respiratory chain complexes; 3-Methylglutaconic aciduria; Organic aciduria
ID adrenal insufficiency; dna rearrangements; organic aciduria; mtdna deletion; i deficiency; patient; disorders; children; myopathy; infant
AB Pearson marrow-pancreas syndrome (PS) is a rare mitochondrial disorder. Impaired mitochondrial respiratory chain complexes (MRCC) differ among individuals and organs, which accounts for variable clinical pictures. A subset of PS patients develop 3-methylglutaconic aciduria (3-MGA-uria), but the characteristic symptoms and impaired MRCC remain unknown. Our patient, a girl, developed pancytopenia, hyperlactatemia, steatorrhea, insulin-dependent diabetes mellitus, liver dysfunction, Fanconi syndrome, and 3-MGA-uria. She died from cerebral hemorrhage at 3 years of age. We identified a novel 5.4-kbp deletion of mitochondrial DNA. The enzymatic activities of MRCC I and IV were markedly reduced in the liver and muscle and mildly reduced in skin fibroblasts and the heart. To date, urine organic acid analysis has been performed on 29 PS patients, including our case. Eight patients had 3-MGA-uria, while only one patient did not. The remaining 20 patients were not reported to have 3-MGA-uria. In this paper, we included these 20 patients as PS patients without 3-MGA-uria. PS patients with and without 3-MGA-uria have similar manifestations. Only a few studies have examined the enzymatic activities of MRCC. Conclusion: No clinical characteristics distinguish between PS patients with and without 3-MGA-uria. The correlation between 3-MGA-uria and the enzymatic activities of MRCC remains to be elucidated.
C1 [Sato, Takeshi; Muroya, Koji; Hanakawa, Junko; Iwano, Reiko; Asakura, Yumi; Adachi, Masanori] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Minami Ku, Yokohama, Kanagawa 2328555, Japan.
   [Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Dept Pathol, Yokohama, Kanagawa 2328555, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Midori Ku, Chiba, Chiba 2660007, Japan.
   [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Fac Med, Moroyama, Saitama 3500495, Japan.
   [Sato, Takeshi; Hasegawa, Tomonobu] Keio Univ, Dept Pediat, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan.
C3 Chiba Children's Hospital; Saitama Medical University; Keio University
RP Muroya, K (corresponding author), Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Minami Ku, Mutsukawa 2-138-4, Yokohama, Kanagawa 2328555, Japan.
EM sato_tksjp@yahoo.co.jp; kmuroya@kcmc.jp; hanajun0624@yahoo.co.jp; rosso-nero1996sapporo@hotmail.co.jp; yumi79@mvb.biglobe.ne.jp; ytanaka@kcmc.jp; kmuraya@mri.biglobe.ne.jp; akira_oh@saitama-med.ac.jp; thaseg@a6.keio.jp; madachi@mars.sannet.ne.jp
CR Atale A, 2009, EUR J MED GENET, V52, P23, DOI 10.1016/j.ejmg.2008.10.003
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8
   HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022
   Jacobs LJAM, 2004, J INHERIT METAB DIS, V27, P47, DOI 10.1023/B:BOLI.0000016601.49372.18
   JAKOBS C, 1991, EUR J PEDIATR, V150, P684, DOI 10.1007/BF02072635
   KAPSA R, 1994, J INHERIT METAB DIS, V17, P521, DOI 10.1007/BF00711584
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Knerr I, 2003, J PEDIAT HEMATOL ONC, V25, P948, DOI 10.1097/00043426-200312000-00008
   Krähenbühl S, 1999, J HEPATOL, V31, P550, DOI 10.1016/S0168-8278(99)80050-6
   Krauch G, 2002, AM J MED GENET, V110, P57, DOI 10.1002/ajmg.10410
   Lacbawan F, 2000, AM J MED GENET, V95, P266, DOI 10.1002/1096-8628(20001127)95:3<266::AID-AJMG13>3.3.CO;2-S
   LICHTERKONECKI U, 1993, EUR J PEDIATR, V152, P378, DOI 10.1007/BF01956761
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Morel AS, 2009, EUR J PEDIATR, V168, P311, DOI 10.1007/s00431-008-0756-4
   MULLERHOCKER J, 1991, VIRCHOWS ARCH A, V419, P355, DOI 10.1007/BF01606527
   Murayama K, 2009, EUR J PEDIATR, V168, P297, DOI 10.1007/s00431-008-0753-7
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   SANO T, 1993, PEDIATR RES, V34, P105, DOI 10.1203/00006450-199307000-00024
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   Shimada M, 1999, HEPATO-GASTROENTEROL, V46, P401
   SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515
   Topaloglu R, 2008, TURKISH J PEDIATR, V50, P572
   Tumino M, 2011, AM J MED GENET A, V155A, P3063, DOI 10.1002/ajmg.a.34288
   Warris A, 1999, PEDIATR INFECT DIS J, V18, P739, DOI 10.1097/00006454-199908000-00023
   Williams TB, 2012, MOL GENET METAB, V106, P104, DOI 10.1016/j.ymgme.2012.01.018
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
NR 36
TC 12
Z9 12
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6199
EI 1432-1076
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD DEC 15
PY 2015
VL 174
IS 12
BP 1593
EP 1602
DI 10.1007/s00431-015-2576-7
PG 10
WC Pediatrics
SC Pediatrics
GA CX6BS
UT WOS:000365786800005
PM 26074369
DA 2024-11-01
ER

PT J
AU Coughlin, CR
   Scharer, GH
   Friederich, MW
   Yu, HC
   Geiger, EA
   Creadon-Swindell, G
   Collins, AE
   Vanlander, AV
   Van Coster, R
   Powell, CA
   Swanson, MA
   Minczuk, M
   Van Hove, JLK
   Shaikh, TH
AF Coughlin, Curtis R., II
   Scharer, Gunter H.
   Friederich, Marisa W.
   Yu, Hung-Chun
   Geiger, Elizabeth A.
   Creadon-Swindell, Geralyn
   Collins, Abigail E.
   Vanlander, Arnaud V.
   Van Coster, Rudy
   Powell, Christopher A.
   Swanson, Michael A.
   Minczuk, Michal
   Van Hove, Johan L. K.
   Shaikh, Tamim H.
TI Mutations in the mitochondrial cysteinyl-tRNA synthase gene, <i>CARS2</i>, lead to a severe epileptic encephalopathy and complex movement disorder
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID respiratory-chain defects; synthetase gene; leigh-syndrome; human-disease; deficiency; children; liver; compendium; diagnosis; features
AB Background Mitochondrial disease is often suspected in cases of severe epileptic encephalopathy especially when a complex movement disorder, liver involvement and progressive developmental regression are present. Although mutations in either mitochondrial DNA or POLG are often present, other nuclear defects in mitochondrial DNA replication and protein translation have been associated with a severe epileptic encephalopathy. Methods and results We identified a proband with an epileptic encephalopathy, complex movement disorder and a combined mitochondrial respiratory chain enzyme deficiency. The child presented with neurological regression, complex movement disorder and intractable seizures. A combined deficiency of mitochondrial complexes I, III and IV was noted in liver tissue, along with increased mitochondrial DNA content in skeletal muscle. Incomplete assembly of complex V, using blue native polyacrylamide gel electrophoretic analysis and complex I, using western blotting, suggested a disorder of mitochondrial transcription or translation. Exome sequencing identified compound heterozygous mutations in CARS2, a mitochondrial aminoacyl-tRNA synthetase. Both mutations affect highly conserved amino acids located within the functional ligase domain of the cysteinyl-tRNA synthase. A specific decrease in the amount of charged mt-tRNACys was detected in patient fibroblasts compared with controls. Retroviral transfection of the wild-type CARS2 into patient skin fibroblasts led to the correction of the incomplete assembly of complex V, providing functional evidence for the role of CARS2 mutations in disease aetiology. Conclusions Our findings indicate that mutations in CARS2 result in a mitochondrial translational defect as seen in individuals with mitochondrial epileptic encephalopathy.
C1 [Coughlin, Curtis R., II; Scharer, Gunter H.; Friederich, Marisa W.; Yu, Hung-Chun; Geiger, Elizabeth A.; Creadon-Swindell, Geralyn; Swanson, Michael A.; Van Hove, Johan L. K.; Shaikh, Tamim H.] Univ Colorado, Sch Med, Genet Sect, Dept Pediat, Aurora, CO 80045 USA.
   [Scharer, Gunter H.; Shaikh, Tamim H.] Univ Colorado, Sch Med, Intellectual & Dev Disabil Res Ctr, Aurora, CO 80045 USA.
   [Scharer, Gunter H.] Med Coll Wisconsin, Clin Genet Sect, Dept Pediat, Milwaukee, WI 53226 USA.
   [Collins, Abigail E.] Univ Colorado, Sch Med, Neurol Sect, Dept Pediat, Aurora, CO 80045 USA.
   [Vanlander, Arnaud V.; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium.
   [Powell, Christopher A.; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical College of Wisconsin; University of Colorado System; University of Colorado Anschutz Medical Campus; Ghent University; Ghent University Hospital
RP Shaikh, TH (corresponding author), Univ Colorado, Sch Med, Genet Sect, Dept Pediat, Aurora, CO 80045 USA.
EM tamim.shaikh@ucdenver.edu
FU National Institutes of Health [GM081519]; Colorado Intellectual and Developmental Disabilities Research Center; Miracles for Mito; National Institute of Diabetes, Digestive and Kidney Diseases [DK062453]; Medical Research Council, UK [MC_U105697135]; MRC [MC_U105697135] Funding Source: UKRI
CR Almalki A, 2014, BBA-MOL BASIS DIS, V1842, P56, DOI 10.1016/j.bbadis.2013.10.008
   Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   García-Cazorla A, 2006, J PEDIATR-US, V149, P401, DOI 10.1016/j.jpeds.2006.05.036
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Hallmann K, 2014, NEUROLOGY, V83, P2183, DOI 10.1212/WNL.0000000000001055
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Panetta J, 2005, NEUROPEDIATRICS, V36, P256, DOI 10.1055/s-2005-865866
   Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208
   Sadleir LG, 2004, EUR J NEUROL, V11, P103, DOI 10.1046/j.1351-5101.2003.00724.x
   Schwartzentruber J, 2014, HUM MUTAT, V35, P1285, DOI 10.1002/humu.22629
   Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smet J, 2005, CELL BIOL LAB HDB, V4, P259
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Sofou K, 2012, EUR J PAEDIATR NEURO, V16, P379, DOI 10.1016/j.ejpn.2011.12.006
   Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vanlander AV, 2015, HUM MUTAT, V36, P222, DOI 10.1002/humu.22728
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022
NR 44
TC 56
Z9 59
U1 0
U2 16
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD AUG 15
PY 2015
VL 52
IS 8
BP 532
EP 540
DI 10.1136/jmedgenet-2015-103049
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA CN5BG
UT WOS:000358443800004
PM 25787132
DA 2024-11-01
ER

PT J
AU Wang, L
   Liu, XL
   Nie, J
   Zhang, J
   Kimball, SR
   Zhang, H
   Zhang, WPJ
   Jefferson, LS
   Cheng, ZN
   Ji, QH
   Shi, YG
AF Wang, Li
   Liu, Xiaolei
   Nie, Jia
   Zhang, Jun
   Kimball, Scot R.
   Zhang, Hai
   Zhang, Weiping J.
   Jefferson, Leonard S.
   Cheng, Zeneng
   Ji, Qiuhe
   Shi, Yuguang
TI ALCAT1 Controls Mitochondrial Etiology of Fatty Liver Diseases, Linking Defective Mitophagy to Steatosis
SO HEPATOLOGY
LA English
DT Article
ID insulin-resistance; oxidative stress; skeletal-muscle; mitofusin 2; cardiolipin; autophagy; obesity; mfn2; elimination; dysfunction
AB Defective autophagy is implicated in the pathogenesis of nonalcoholic fatty liver diseases (NAFLD) through poorly defined mechanisms. Cardiolipin is a mitochondrial phospholipid required for bioenergetics and mitophagy from yeast to mammals. Here we investigated a role for ALCAT1 in the development of NAFLD. ALCAT1 is a lysocardiolipin acyltransferase that catalyzes pathological cardiolipin remodeling in several aging-related diseases. We show that the onset of diet-induced NAFLD caused autophagic arrest in hepatocytes, leading to oxidative stress, mitochondrial dysfunction, and insulin resistance. In contrast, targeted deletion of ALCAT1 in mice prevented the onset of NAFLD. ALCAT1 deficiency also restored mitophagy, mitochondrial architecture, mitochondrial DNA (mtDNA) fidelity, and oxidative phosphorylation. In support of a causative role of the enzyme in a mitochondrial etiology of the disease, hepatic ALCAT1 expression was significantly up-regulated in mouse models of NAFLD. Conclusion: Forced expression of ALCAT1 in primary hepatocytes led to multiple defects that are highly reminiscent of NAFLD, including steatosis, defective autophagy, and mitochondrial dysfunction, linking pathological cardiolipin remodeling by ALCAT1 to the pathogenesis of NAFLD. (Hepatology 2015;61:486-496)
C1 [Wang, Li; Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China.
   [Wang, Li; Liu, Xiaolei; Nie, Jia; Zhang, Jun; Kimball, Scot R.; Zhang, Hai; Jefferson, Leonard S.; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.
   [Zhang, Hai; Zhang, Weiping J.; Shi, Yuguang] Second Mil Med Univ, Dept Pathophysiol, Shanghai, Peoples R China.
   [Cheng, Zeneng] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China.
C3 Air Force Military Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Naval Medical University; Central South University
RP Shi, YG (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr,H166, Hershey, PA 17033 USA.
EM jqiuhe@fmmu.edu.cn; yus11@psu.edu
FU NIH [DK076685, DK13499]; National Natural Science Foundation of China [31371192, 81100606]
CR Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Chu CT, 2010, HUM MOL GENET, V19, PR28, DOI 10.1093/hmg/ddq143
   Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009
   Hamasaki M, 2013, NATURE, V0, P0
   Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24
   Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Li J, 2012, P NATL ACAD SCI USA, V109, P6975, DOI 10.1073/pnas.1120043109
   Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Liu XL, 2012, MOL CELL BIOL, V32, P4493, DOI 10.1128/MCB.01092-12
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011
   Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Taylor WA, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0048628
   Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
NR 26
TC 115
Z9 130
U1 2
U2 62
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD FEB 15
PY 2015
VL 61
IS 2
BP 486
EP 496
DI 10.1002/hep.27420
PG 11
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA AZ9UX
UT WOS:000348563200014
PM 25203315
DA 2024-11-01
ER

PT J
AU Kettwig, M
   Schubach, M
   Zimmermann, FA
   Klinge, L
   Mayr, JA
   Biskup, S
   Sperl, W
   Gärtner, J
   Huppke, P
AF Kettwig, Matthias
   Schubach, Max
   Zimmermann, Franz A.
   Klinge, Lars
   Mayr, Johannes A.
   Biskup, Saskia
   Sperl, Wolfgang
   Gaertner, Jutta
   Huppke, Peter
TI From ventriculomegaly to severe muscular atrophy: Expansion of the clinical spectrum related to mutations in AIFM1
SO MITOCHONDRION
LA English
DT Article
DE AIFM1; X-chromosomal mitochondriopathy; Leukodystrophy; External ophthalmoplegia; Muscle wasting
ID apoptosis-inducing factor; mitochondrial neurogastrointestinal encephalomyopathy; disease; deficiency; disorder
AB The apoptosis-inducing factor (AIF) functions as a FAD-dependent NADH oxidase in mitochondria. Upon apoptotic stimulation it is released from mitochondria and migrates to the nucleus where it induces chromatin condensation and DNA fragmentation. So far mutations in AIFM1, a X-chromosomal gene coding for AIF, have been described in three families with 11 affected males. We report here on a further patient thereby expanding the clinical and mutation spectrum. In addition, we review the known phenotypes related to AIFM1 mutations. The clinical course in the male patient described here was characterized by phases with rapid deterioration and long phases without obvious progression of disease. At age 2.5 years he developed hearing loss and severe ataxia and at age 10 years muscle wasting, swallowing difficulties, respiratory insufficiency and external opthamoplegia. By next generation sequencing of whole exome we identified a hemizygous missense mutation in the AIFM1 gene, c.727G>T (p.Va1243Leu) affecting a highly conserved residue in the FAD-binding domain. Summarizing what is known today, mutations in AIFM1 are associated with a progressive disorder with myopathy, ataxia and neuropathy. Severity varies greatly even within one family with onset of symptoms between birth and adolescence. 3 of 12 patients died before age 5 years while others were still able to walk during young adulthood. Less frequent symptoms were hearing loss, seizures and psychomotor regression. Results from clinical chemistry, brain imaging and muscle biopsy were unspecific and inconsistent. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Kettwig, Matthias; Klinge, Lars; Gaertner, Jutta; Huppke, Peter] Univ Gottingen, Fac Med, Div Pediat Neurol, Dept Pediat & Adolescent Med, D-37075 Gottingen, Germany.
   [Schubach, Max; Biskup, Saskia] CeGaT GmbH, Ctr Genom & Transcript, Tubingen, Germany.
   [Zimmermann, Franz A.; Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Dept Paediat, Salzburg, Austria.
C3 University of Gottingen; CeGaT; Paracelsus Private Medical University
RP Kettwig, M (corresponding author), Univ Gottingen, Fac Med, Div Pediat Neurol, Dept Pediat & Adolescent Med, D-37075 Gottingen, Germany.
EM matthias.kettwig@med.uni-goettingen.de
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   AMOULT D, 2002, J CELL BIOL, V159, P923
   Berger I, 2011, MOL GENET METAB, V104, P517, DOI 10.1016/j.ymgme.2011.09.020
   Dubovitz V, 2007, MUSCLE BIOPSY, V0, P0
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Feichtinger RG, 2010, BMC CANCER, V10, P0, DOI 10.1186/1471-2407-10-149
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Flicek P, 2012, NUCLEIC ACIDS RES, V40, PD84, DOI 10.1093/nar/gkr991
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Kapur RP, 2011, AM J SURG PATHOL, V35, P714, DOI 10.1097/PAS.0b013e31821433af
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Nishino I, 2000, ANN NEUROL, V47, P792
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200
   Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194
   Wong LJC, 2012, SEMIN NEUROL, V32, P55, DOI 10.1055/s-0032-1306387
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
NR 27
TC 43
Z9 49
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2015
VL 21
IS 
BP 12
EP 18
DI 10.1016/j.mito.2015.01.001
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CD8ET
UT WOS:000351328700003
PM 25583628
DA 2024-11-01
ER

PT J
AU Charif, M
   Titah, SMC
   Roubertie, A
   Desquiret-Dumas, V
   Gueguen, N
   Meunier, I
   Leid, J
   Massal, F
   Zanlonghi, X
   Mercier, J
   de Mauverger, ER
   Procaccio, V
   de Camaret, BM
   Lenaers, G
   Hamel, CP
AF Charif, Majida
   Titah, Salah Mohamed Cherif
   Roubertie, Agathe
   Desquiret-Dumas, Valerie
   Gueguen, Naig
   Meunier, Isabelle
   Leid, Jean
   Massal, Frederic
   Zanlonghi, Xavier
   Mercier, Jacques
   de Mauverger, Eric Raynaud
   Procaccio, Vincent
   de Camaret, Benedicte Mousson
   Lenaers, Guy
   Hamel, Christian P.
TI Optic neuropathy, cardiomyopathy, cognitive disability in patients with a homozygous mutation in the nuclear <i>MTO1</i> and a mitochondrial <i>MT-TF</i> variant
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE optic neuropathy; cardiomyopathy; cognitive disability; mitochondria; mtDNA; respiratory chain; MTO1; mitochondrial tRNA
ID hypertrophic cardiomyopathy; coupling defect; lactic-acidosis; transfer-rna; disorders; database; disease; humans; dna
AB We report on clinical, genetic and metabolic investigations in a family with optic neuropathy, non-progressive cardiomyopathy and cognitive disability. Ophthalmic investigations (slit lamp examination, funduscopy, OCT scan of the optic nerve, ERG and VEP) disclosed mild or no decreased visual acuity, but pale optic disc, loss of temporal optic fibers and decreased VEPs. Mitochondrial DNA and exome sequencing revealed a novel homozygous mutation in the nuclear MTO1 gene and the homoplasmic m.593T>G mutation in the mitochondrial MT-TF gene. Muscle biopsy analyses revealed decreased oxygraphic Vmax values for complexes I+III+IV, and severely decreased activities of the respiratory chain complexes (RCC) I, III and IV, while muscle histopathology was normal. Fibroblast analysis revealed decreased complex I and IV activity and assembly, while cybrid analysis revealed a partial complex I deficiency with normal assembly of the RCC. Thus, in patients with a moderate clinical presentation due to MTO1 mutations, the presence of an optic atrophy should be considered. The association with the mitochondrial mutation m.593T>G could act synergistically to worsen the complex I deficiency and modulate the MTO1-related disease. (c) 2015 Wiley Periodicals, Inc.
C1 [Charif, Majida; Meunier, Isabelle; Lenaers, Guy; Hamel, Christian P.] INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France.
   [Charif, Majida; Meunier, Isabelle; Lenaers, Guy; Hamel, Christian P.] Univ Montpellier I, Montpellier, France.
   [Charif, Majida; Meunier, Isabelle; Lenaers, Guy; Hamel, Christian P.] Univ Montpellier 2, Montpellier, France.
   [Titah, Salah Mohamed Cherif; Meunier, Isabelle; Hamel, Christian P.] CHRU Montpellier, Ctr Reference Malad Sensorielles Genet, Montpellier, France.
   [Roubertie, Agathe] CHRU Montpellier, Serv Neuropediat, Montpellier, France.
   [Desquiret-Dumas, Valerie; Gueguen, Naig; Procaccio, Vincent] CHRU Angers, Dept Biochim & Genet, Angers, France.
   [Desquiret-Dumas, Valerie; Gueguen, Naig; Procaccio, Vincent] Univ Angers, INSERM U1083, UMR CNRS 6214, Angers, France.
   [Leid, Jean; Massal, Frederic] Ctr Eye, Ophthalmol, Pau, France.
   [Zanlonghi, Xavier] Clin Sourdille, Visual Explorat, Nantes, France.
   [Mercier, Jacques; de Mauverger, Eric Raynaud] CHRU Montpellier, CERAMM, Montpellier, France.
   [Mercier, Jacques; de Mauverger, Eric Raynaud] INSERM, U1046, Med & Physiol Expt Coeur & Muscles, Montpellier, France.
   [de Camaret, Benedicte Mousson] CHU Lyon, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, Bron, France.
C3 Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU Lyon
RP Hamel, CP (corresponding author), Hop St Eloi, Inst Neurosci Montpellier, INSERM U 1051, BP 74103,80 Rue Augustin Fliche, F-34091 Montpellier 5, France.
EM christian.hamel@inserm.fr
FU French Ministry of Health; Union Nationale des Aveugles et Deficients Visuels; Ouvrir Les Yeux
CR Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Nochez Y, 2009, MOL VIS, V15, P598
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Ouhabi R, 1998, ANAL BIOCHEM, V263, P169, DOI 10.1006/abio.1998.2776
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Rötig A, 2004, BBA-BIOENERGETICS, V1659, P129, DOI 10.1016/j.bbabio.2004.07.007
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257
   Schmiedel J, 2003, J NEUROL, V250, P267, DOI 10.1007/s00415-003-0978-3
   Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008
   Terasaki F, 2001, JPN CIRC J, V65, P691, DOI 10.1253/jcj.65.691
   Thomas C, 2004, J APPL PHYSIOL, V97, P2132, DOI 10.1152/japplphysiol.00387.2004
   Tonska K, 2010, BBA-BIOENERGETICS, V1797, P1119, DOI 10.1016/j.bbabio.2010.02.032
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002
   Zhang AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026511
NR 25
TC 21
Z9 22
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD OCT 15
PY 2015
VL 167
IS 10
BP 2366
EP 2374
DI 10.1002/ajmg.a.37188
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA CR2TS
UT WOS:000361184100021
PM 26061759
DA 2024-11-01
ER

PT J
AU Hanisch, F
   Kornhuber, M
   Alston, CL
   Taylor, RW
   Deschauer, M
   Zierz, S
AF Hanisch, Frank
   Kornhuber, Malte
   Alston, Charlotte L.
   Taylor, Robert W.
   Deschauer, Marcus
   Zierz, Stephan
TI SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID sensory ataxic neuropathy; progressive external ophthalmoplegia; probable germline mosaicism; polg mutations; gene mutation; disease; spectrum; ant1; disorders; c10orf2
AB Objective The sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) syndrome is a subgroup of mitochondrial chronic progressive external ophthalmoplegia (CPEO)-plus disorders associated with multiple mitochondrial DNA (mtDNA) deletions. There is no systematic survey on SANDO in patients with CPEO with either single or multiple large-scale mtDNA deletions. Methods In this retrospective analysis, we characterised the frequency, the genetic and clinical phenotype of 107 index patients with mitochondrial CPEO (n=66 patients with single and n=41 patients with multiple mtDNA deletions) and assessed these for clinical evidence of a SANDO phenotype. Patients with multiple mtDNA deletions were additionally screened for mutations in the nuclear-encoded POLG, SLC25A4, PEO1 and RRM2B genes. The clinical, histological and genetic data of 11 patients with SANDO were further analysed. Results None of the 66 patients with single, large-scale mtDNA deletions fulfilled the clinical criteria of SANDO syndrome. In contrast, 9 of 41 patients (22%) with multiple mtDNA deletions and two additional family members fulfilled the clinical criteria for SANDO. Within this subgroup, multiple mtDNA deletions were associated with the following nuclear mutations: POLG (n=6), PEO1 (n=2), unidentified (n=2). The combination of sensory ataxic neuropathy with ophthalmoparesis (SANO) was observed in 70% of patients with multiple mtDNA deletions but only in 4% with single deletions. The combination of CPEO and sensory ataxic neuropathy (SANO, incomplete SANDO) was found in 43% of patients with multiple mtDNA deletions but not in patients with single deletions. Conclusion The SANDO syndrome seems to indicate a cluster of symptoms within the wide range of multisystemic symptoms associated with mitochondrial CPEO. SANO seems to be the most frequent phenotype associated with multiple mtDNA deletions in our cohort but not or is rarely associated with single, large-scale mtDNA deletions.
C1 [Hanisch, Frank; Kornhuber, Malte; Deschauer, Marcus; Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, D-06108 Halle, Saale, Germany.
   [Alston, Charlotte L.; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Martin Luther University Halle Wittenberg; Newcastle University - UK
RP Hanisch, F (corresponding author), Univ Hosp Halle Saale, Dept Neurol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.
EM neurologie@uk-halle.de
FU German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung BMBF, Bonn, Germany) [01M1113AA-F]; Wellcome Trust [096919/Z/11/Z]; UK NHS; MRC [MR/K000608/1] Funding Source: UKRI
CR BASTIAENSEN LAK, 1978, ACTA NEUROL SCAND, V58, P9
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   CORMIER V, 1991, AM J HUM GENET, V48, P643
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3
   Deschauer M, 2010, CLIN NEUROPHYSIOL, V121, P0
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Hansen N, 2012, NEUROL SCI, V33, P209, DOI 10.1007/s10072-011-0631-3
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kawai H, 1975, MUSCLE NERVE, V18, P753
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Okun MS, 2004, AM J OPHTHALMOL, V137, P951, DOI 10.1016/j.ajo.2003.10.046
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   ROWLAND LP, 1980, ARCH NEUROL-CHICAGO, V37, P256, DOI 10.1001/archneur.1980.00500530094031
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 29
TC 34
Z9 37
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD JUN 15
PY 2015
VL 86
IS 6
BP 630
EP 634
DI 10.1136/jnnp-2013-306748
PG 5
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA CI1DN
UT WOS:000354482000008
PM 25143630
DA 2024-11-01
ER

PT J
AU Kabunga, P
   Lau, AK
   Phan, K
   Puranik, R
   Liang, C
   Davis, RL
   Sue, CM
   Sy, RW
AF Kabunga, Peter
   Lau, Antony K.
   Phan, Kevin
   Puranik, Rajesh
   Liang, Christina
   Davis, Ryan L.
   Sue, Carolyn M.
   Sy, Raymond W.
TI Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Review
DE Kearns-Sayre; Mitochondrial cytopathy; Bundle branch block; Heart block; Ventricular tachycardia; Sudden death; Permanent pacemaker; Implantable cardioverter-defibrillator
ID progressive external ophthalmoplegia; long qt syndrome; 1555a-greater-than-g mutation; hypertrophic cardiomyopathy; myocardial ultrastructure; endomyocardial biopsy; dna mutations; heart-block; prevalence; deficiency
AB Kearns-Sayre syndrome (KSS) is a mitochondrial disorder characterised by onset before the age of 20 years, progressive external ophthalmoplegia, and pigmentary retinopathy, accompanied by either cardiac conduction defects, elevated cerebrospinal fluid protein or cerebellar ataxia. 50% of patients with KSS develop cardiac complications. The most common cardiac manifestation is conduction disease which may progress to complete atrioventricular block or bradycardia-related polymorphic ventricular tachycardia (PMVT). The management of cardiac electrical disease associated with KSS and mitochondrial cytopathy is systematically reviewed including the case of a 23 year-old female patient with KSS who developed a constellation of cardiac arrhythmias including rapidly progressive conduction system disease and monomorphic ventricular tachycardia with myocardial scarring. The emerging role of cardiac magnetic resonance imaging (CMR) in detecting subclinical cardiac involvement is also highlighted. This review illustrates the need for cardiologists to be informed about this rare but emerging condition. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Kabunga, Peter; Puranik, Rajesh; Sy, Raymond W.] Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW 2050, Australia.
   [Kabunga, Peter; Phan, Kevin; Puranik, Rajesh; Liang, Christina; Davis, Ryan L.; Sue, Carolyn M.; Sy, Raymond W.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Lau, Antony K.] Prince Wales Hosp, Dept Cardiol, Randwick, NSW, Australia.
   [Lau, Antony K.] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia.
   [Liang, Christina; Davis, Ryan L.; Sue, Carolyn M.] Royal N Shore Hosp, Dept Neurol, St Leonards, NSW, Australia.
   [Liang, Christina; Davis, Ryan L.; Sue, Carolyn M.] Royal N Shore Hosp, Dept Neurogenet, St Leonards, NSW, Australia.
C3 University of Sydney; NSW Health; Royal Prince Alfred Hospital; University of Sydney; University of New South Wales Sydney; Prince of Wales Hospital (POWH); University of New South Wales Sydney; Royal North Shore Hospital; Royal North Shore Hospital
RP Sy, RW (corresponding author), Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW 2050, Australia.
EM raymond.sy01@gmail.com
CR Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Barakpour H, 1900, V5, V0, P265
   Barrera-Ramírez CF, 2005, REV ESP CARDIOL, V58, P443
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Brignole M, 2013, EUROPEAN HEART J, V150, P0
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Chen L, 2012, J AM HEART ASSOC, V1, P0, DOI 10.1161/JAHA.112.003012
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CLARK DS, 1975, CHEST, V68, P727, DOI 10.1378/chest.68.5.727
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   DiMauro S, 1998, NAT GENET, V19, P214, DOI 10.1038/883
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   GALLASTEGUI J, 1987, AM J CARDIOL, V60, P385, DOI 10.1016/0002-9149(87)90255-4
   Goffart S, 2004, CARDIOVASC RES, V64, P198, DOI 10.1016/j.cardiores.2004.06.030
   Hara K, 2004, J CLIN ANESTH, V16, P539, DOI 10.1016/j.jclinane.2004.08.002
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Karanikis P, 2005, INT J CARDIOL, V101, P147, DOI 10.1016/j.ijcard.2004.01.027
   Katsanos KH, 2002, INT J CARDIOL, V83, P179, DOI 10.1016/S0167-5273(02)00040-2
   KEARNS THOMAS P, 1965, TRANS AMER OPHTHALMOL SOC, V63, P559
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lazarus A, 2002, J AM COLL CARDIOL, V40, P1645, DOI 10.1016/S0735-1097(02)02339-2
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lutz S, 2000, INT J LEGAL MED, V113, P155, DOI 10.1007/s004140050288
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Manwaring N, 2008, ANN NEUROL, V64, P471, DOI 10.1002/ana.21469
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   NAKANO T, 1987, ANGIOLOGY, V38, P28, DOI 10.1177/000331978703800104
   Oginosawa Y, 2003, PACE, V26, P1911, DOI 10.1046/j.1460-9592.2003.00292.x
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Partington SL, 2011, CIRCULATION, V123, PE227, DOI 10.1161/CIRCULATIONAHA.110.973305
   PETERS TJ, 1977, BRIT HEART J, V39, P1333
   POLAK PE, 1989, EUR HEART J, V10, P281, DOI 10.1093/oxfordjournals.eurheartj.a059477
   Rashid A, 2002, J CARDIOVASC ELECTR, V13, P184, DOI 10.1046/j.1540-8167.2002.00184.x
   REIS RJS, 1983, J BIOL CHEM, V258, P9078
   SCHWARTZKOPFF B, 1988, J AM COLL CARDIOL, V12, P1522, DOI 10.1016/S0735-1097(88)80020-2
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   Skinner JR, 2007, HEART RHYTHM, V4, P1568, DOI 10.1016/j.hrthm.2007.08.013
   Subbiah RN, 2007, PACE, V30, P137
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Tracy CM, 2012, J AM COLL CARDIOL, V60, P1297, DOI 10.1016/j.jacc.2012.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Vardas P, 2007, EUROPACE, V9, P959, DOI 10.1093/europace/eum189
   Wilmin Stephan, 2012, PRACT NEUROL, V12, P199, DOI 10.1136/practneurol-2012-000256
   Yilmaz A, 2012, CLIN RES CARDIOL, V101, P255, DOI 10.1007/s00392-011-0387-z
NR 54
TC 70
Z9 74
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD FEB 15
PY 2015
VL 181
IS 
BP 303
EP 310
DI 10.1016/j.ijcard.2014.12.038
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6DK
UT WOS:000351926500073
PM 25540845
DA 2024-11-01
ER

PT J
AU Gorman, GS
   Schaefer, AM
   Ng, Y
   Gomez, N
   Blakely, EL
   Alston, CL
   Feeney, C
   Horvath, R
   Yu-Wai-Man, P
   Chinnery, PF
   Taylor, RW
   Turnbull, DM
   McFarland, R
AF Gorman, Grainne S.
   Schaefer, Andrew M.
   Ng, Yi
   Gomez, Nicholas
   Blakely, Emma L.
   Alston, Charlotte L.
   Feeney, Catherine
   Horvath, Rita
   Yu-Wai-Man, Patrick
   Chinnery, Patrick F.
   Taylor, Robert W.
   Turnbull, Douglass M.
   McFarland, Robert
TI Prevalence of Nuclear and Mitochondrial DNA Mutations Related to Adult Mitochondrial Disease
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID diabetes-mellitus; encephalomyopathy; epidemiology; population; deletions; myopathy; england
AB ObjectiveThe prevalence of mitochondrial disease has proven difficult to establish, predominantly as a result of clinical and genetic heterogeneity. The phenotypic spectrum of mitochondrial disease has expanded significantly since the original reports that associated classic clinical syndromes with mitochondrial DNA (mtDNA) rearrangements and point mutations. The revolution in genetic technologies has allowed interrogation of the nuclear genome in a manner that has dramatically improved the diagnosis of mitochondrial disorders. We comprehensively assessed the prevalence of all forms of adult mitochondrial disease to include pathogenic mutations in both nuclear and mtDNA. MethodsAdults with suspected mitochondrial disease in the North East of England were referred to a single neurology center from 1990 to 2014. For the midyear period of 2011, we evaluated the minimum prevalence of symptomatic nuclear DNA mutations and symptomatic and asymptomatic mtDNA mutations causing mitochondrial diseases. ResultsThe minimum prevalence rate for mtDNA mutations was 1 in 5,000 (20 per 100,000), comparable with our previously published prevalence rates. In this population, nuclear mutations were responsible for clinically overt adult mitochondrial disease in 2.9 per 100,000 adults. InterpretationCombined, our data confirm that the total prevalence of adult mitochondrial disease, including pathogenic mutations of both the mitochondrial and nuclear genomes (approximate to 1 in 4,300), is among the commonest adult forms of inherited neurological disorders. These figures hold important implications for the evaluation of interventions, provision of evidence-based health policies, and planning of future services. Ann Neurol 2015 Ann Neurol 2015;77:753-759
C1 [Gorman, Grainne S.; Schaefer, Andrew M.; Ng, Yi; Gomez, Nicholas; Blakely, Emma L.; Alston, Charlotte L.; Feeney, Catherine; Horvath, Rita; Yu-Wai-Man, Patrick; Chinnery, Patrick F.; Taylor, Robert W.; Turnbull, Douglass M.; McFarland, Robert] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gorman, Grainne S.; Schaefer, Andrew M.; Ng, Yi; Gomez, Nicholas; Blakely, Emma L.; Alston, Charlotte L.; Feeney, Catherine; Taylor, Robert W.; Turnbull, Douglass M.; McFarland, Robert] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Horvath, Rita; Yu-Wai-Man, Patrick; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK
RP Gorman, GS (corresponding author), Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
FU Wellcome Trust [096919Z/11/Z, 074454/Z/04/Z]; Medical Research Council [G0601943, G0800674]; UK National Institute for Health Research (NIHR) Biomedical Research Centre for Ageing and Age-Related Diseases; UK NHS Specialized Services and Newcastle upon Tyne Hospitals NHS Foundation Trust; EU; Fight for Sight (UK); UK NIHR as part of the Rare Diseases Translational Research Collaboration; MRC [G0502157, G0400074, G1002570, G0601943, G1100540, G0701386, G0800674, G0900652, MR/L016451/1] Funding Source: UKRI
CR Altman DG, 1990, PRACTICAL STATISTICS FOR MEDICAL RESEARCH, V0, P0
   [Anonymous], 2011, AG ETHN MIN POP ENGL, V0, P0
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236
   Office for National Statistics (UK Government), 2011, 2011 CENS POP EST UK, V0, P0
   Office of National Statistics, 2011, ETHN NAT ID ENGL WAL, V0, P0
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 22
TC 624
Z9 701
U1 2
U2 69
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD MAY 15
PY 2015
VL 77
IS 5
BP 753
EP 759
DI 10.1002/ana.24362
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CG4EF
UT WOS:000353235400005
PM 25652200
DA 2024-11-01
ER

PT J
AU Reyes, A
   Melchionda, L
   Nasca, A
   Carrara, F
   Lamantea, E
   Zanolini, A
   Lamperti, C
   Fang, MY
   Zhang, JG
   Ronchi, D
   Bonato, S
   Fagiolari, G
   Moggio, M
   Ghezzi, D
   Zeviani, M
AF Reyes, Aurelio
   Melchionda, Laura
   Nasca, Alessia
   Carrara, Franco
   Lamantea, Eleonora
   Zanolini, Alice
   Lamperti, Costanza
   Fang, Mingyan
   Zhang, Jianguo
   Ronchi, Dario
   Bonato, Sara
   Fagiolari, Gigliola
   Moggio, Maurizio
   Ghezzi, Daniele
   Zeviani, Massimo
TI <i>RNASEH1</i> Mutations Impair mtDNA Replication and Cause Adult-Onset Mitochondrial Encephalomyopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID dna replication; h1; polymerase; expression; subunit; disease; cells; mice
AB Chronic progressive external ophthalmoplegia (CPEO) is common in mitochondrial disorders and is frequently associated with multiple mtDNA deletions. The onset is typically in adulthood, and affected subjects can also present with general muscle weakness. The underlying genetic defects comprise autosomal-dominant or recessive mutations in several nuclear genes, most of which play a role in mtDNA replication. Next-generation sequencing led to the identification of compound-heterozygous RNASEH1 mutations in two singleton subjects and a homozygous mutation in four siblings. RNASEH1, encoding ribonuclease H1 (RNase H1), is an endonuclease that is present in both the nucleus and mitochondria and digests the RNA component of RNA-DNA hybrids. Unlike mitochondria, the nucleus harbors a second ribonuclease (RNase H2). All affected individuals first presented with CPEO and exercise intolerance in their twenties, and these were followed by muscle weakness, dysphagia, and spino-cerebellar signs with impaired gait coordination, dysmetria, and dysarthria. Ragged-red and cytochrome c oxidase (COX)-negative fibers, together with impaired activity of various mitochondrial respiratory chain complexes, were observed in muscle biopsies of affected subjects. Western blot analysis showed the virtual absence of RNase H1 in total lysate from mutant fibroblasts. By an in vitro assay, we demonstrated that altered RNase H1 has a reduced capability to remove the RNA from RNA-DNA hybrids, confirming their pathogenic role. Given that an increasing amount of evidence indicates the presence of RNA primers during mtDNA replication, this result might also explain the accumulation of mtDNA deletions and underscores the importance of RNase H1 for mtDNA maintenance.
C1 [Reyes, Aurelio; Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Melchionda, Laura; Nasca, Alessia; Carrara, Franco; Lamantea, Eleonora; Zanolini, Alice; Lamperti, Costanza; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Fang, Mingyan; Zhang, Jianguo] Beijing Genom Inst, Shenzhen 518083, Peoples R China.
   [Ronchi, Dario; Bonato, Sara] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, I-20122 Milan, Italy.
   [Fagiolari, Gigliola; Moggio, Maurizio] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neuromuscular Unit,Neurosci Sect,Dino Ferrari Ctr, I-20122 Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Beijing Genomics Institute (BGI); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
EM daniele.ghezzi@istituto-besta.it; mdz21@mrc-mbu.cam.ac.uk
FU "Cell Lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks [GTB12001J]; EurobiobanK Network; Medical Research Council; Pierfranco and Luisa Mariani Foundation; Telethon [GGP11011]; Italian Ministry of Health [GR2010-2316392]; European Research Council [FP7-322424]; MRC [MC_UP_1002/1] Funding Source: UKRI
CR Alla NR, 2012, FEBS J, V279, P4492, DOI 10.1111/febs.12035
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Cerritelli SM, 1998, GENOMICS, V53, P300, DOI 10.1006/geno.1998.5497
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Kazak L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0062340
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lamperti C, 2009, ACTA MYOL, V28, P2
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Pohjoismäki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
NR 22
TC 78
Z9 86
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JUL 2
PY 2015
VL 97
IS 1
BP 186
EP 193
DI 10.1016/j.ajhg.2015.05.013
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA CN1OO
UT WOS:000358189500017
PM 26094573
DA 2024-11-01
ER

PT J
AU Rygiel, KA
   Grady, JP
   Taylor, RW
   Tuppen, HAL
   Turnbull, DM
AF Rygiel, Karolina A.
   Grady, John P.
   Taylor, Robert W.
   Tuppen, Helen A. L.
   Turnbull, Doug M.
TI Triplex real-time PCR-an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID mtdna; mutations; quantification; replication; reveals; origin
AB Mitochondrial DNA (mtDNA) mutations are commonly found in the skeletal muscle of patients with mitochondrial disease, inflammatory myopathies and sarcopenia. The majority of these mutations are mtDNA deletions, which accumulate to high levels in individual muscle fibres causing a respiratory defect. Most mtDNA deletions are major arc deletions with breakpoints located between the origin of light strand (OL) and heavy strand (OH) replication within the major arc. However, under certain disease conditions, rarer, minor arc deletions are detected. Currently, there are few techniques which would allow the detection and quantification of both types of mtDNA deletions in single muscle fibres. We have designed a novel triplex real-time PCR assay which simultaneously amplifies the MT-ND4 gene in the major arc, the MT-ND1 gene in the minor arc, and the non-coding D-Loop region. We demonstrate that this assay is a highly sensitive and reliable tool for the detection and quantification of a broad range of major and minor arc mtDNA deletions with the potential to investigate the molecular pathogenesis in both research and diagnostic settings.
C1 [Rygiel, Karolina A.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   Newcastle Univ, Ctr Ageing & Vital, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Rygiel, KA (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM karolina.rygiel@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [G906919]; Newcastle University Centre for Ageing and Vitality; MRC Centre for Neuromuscular Disease [G000608-1]; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; Medical Research Council [M501700]; Biotechnology and Biological Sciences Research Council; UK NIHR Biomedical Research Centre; UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children" Service; Wellcome Trust [090194/Z/09/Z]; MRC [G0700718, MR/L016451/1, MR/K000608/1, G0900652, G0800674, G0502157, G0400074, MR/K006312/1, G1100540] Funding Source: UKRI; Wellcome Trust [090194/Z/09/Z] Funding Source: Wellcome Trust
CR Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Budowle B, 2002, INT J LEGAL MED, V116, P212, DOI 10.1007/s00414-001-0283-6
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Grady JP, 2014, PLOS ONE IN PRESS, V0, P0
   Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888
   Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P244, DOI 10.1016/0006-291X(91)90512-6
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   Razali NM, 2011, MATH, V2, P21
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
NR 27
TC 28
Z9 29
U1 0
U2 12
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD MAY 19
PY 2015
VL 5
IS 
BP 
EP 
DI 10.1038/srep09906
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ2DE
UT WOS:000355293600001
PM 25989140
DA 2024-11-01
ER

PT J
AU Körver-Keularts, IMLW
   de Visser, M
   Bakker, HD
   Wanders, RJA
   Vansenne, F
   Scholte, HR
   Dorland, L
   Nicolaes, GAF
   Spaapen, LMJ
   Smeets, HJM
   Hendrickx, ATM
   van den Bosch, BJC
AF Korver-Keularts, I. M. L. W.
   de Visser, M.
   Bakker, H. D.
   Wanders, R. J. A.
   Vansenne, F.
   Scholte, H. R.
   Dorland, L.
   Nicolaes, G. A. F.
   Spaapen, L. M. J.
   Smeets, H. J. M.
   Hendrickx, A. T. M.
   van den Bosch, B. J. C.
TI Two Novel Mutations in the <i>SLC25A4</i> Gene in a Patient with Mitochondrial Myopathy
SO JIMD REPORTS, VOL 22
LA English
DT Article; Book Chapter
ID adenine-nucleotide translocator; progressive external ophthalmoplegia; adp/atp carrier; muscle; cardiomyopathy; deficiency; expression; atp; dna; sequences
AB In a 28-year-old male with a mild mitochondrial myopathy manifesting as exercise intolerance and early signs of cardiomyopathy without muscle weakness or ophthalmoplegia, we identified two novel mutations in the SLC25A4 gene: c.707G>C in exon 3 (p.(R236P)) and c.116_137del in exon 2 (p.(Q39Lfs*14)). Serum lactate levels at rest were elevated (12.7 mM). Both the patient's father and brother were heterozygous carriers of the c.707G>C mutation and were asymptomatic. The second mutation causes a 22 bp deletion leading to a frame shift likely giving rise to a premature stop codon and nonwsense-mediated decay (NMD). The segregation of the mutations could not be tested directly as the mother had died before. However, indirect evidence from NMD experiments showed that the two mutations were situated on two different alleles in the patient. This case is unique compared to other previously reported patients with either progressive external ophthalmoplegia (PEO) or clear hypertrophic cardiomyopathy with exercise intolerance and/or muscle weakness carrying recessive mutations leading to a complete absence of the SLC25A4 protein. Most likely in our patient, although severely reduced, SLC25A4 is still partially present and functional.
C1 [Korver-Keularts, I. M. L. W.; Dorland, L.; Spaapen, L. M. J.] Maastricht Univ, Med Ctr, Lab Biochem Genet, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands.
   [de Visser, M.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands.
   [Bakker, H. D.] Univ Amsterdam, Acad Med Ctr, Dept Paediat, NL-1105 AZ Amsterdam, Netherlands.
   [Wanders, R. J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
   [Vansenne, F.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands.
   [Scholte, H. R.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.
   [Nicolaes, G. A. F.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands.
   [Smeets, H. J. M.; Hendrickx, A. T. M.; van den Bosch, B. J. C.] Maastricht Univ, Med Ctr, Dept Clin Genet, Unit Clin Genom, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Maastricht University
RP Körver-Keularts, IMLW (corresponding author), Maastricht Univ, Med Ctr, Lab Biochem Genet, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands.
EM irene.keularts@mumc.nl
CR ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   BAKKER HD, 1993, J INHERIT METAB DIS, V16, P548, DOI 10.1007/BF00711678
   BAKKER HD, 1993, PEDIATR RES, V33, P412
   COZENS AL, 1989, J MOL BIOL, V206, P261, DOI 10.1016/0022-2836(89)90477-4
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j
   HOULDSWORTH J, 1988, P NATL ACAD SCI USA, V85, P377, DOI 10.1073/pnas.85.2.377
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KLINGENBERG M, 1981, NATURE, V290, P449, DOI 10.1038/290449a0
   KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   KU DH, 1990, J BIOL CHEM, V265, P16060
   LI K, 1989, J BIOL CHEM, V264, P13998
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
NR 25
TC 23
Z9 25
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2015
VL 22
IS 
BP 39
EP 45
DI 10.1007/8904_2015_409
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BE8SO
UT WOS:000376987200006
PM 25732997
DA 2024-11-01
ER

PT J
AU Shimizu, A
   Mito, T
   Hashizume, O
   Yonekawa, H
   Ishikawa, K
   Nakada, K
   Hayashi, J
AF Shimizu, Akinori
   Mito, Takayuki
   Hashizume, Osamu
   Yonekawa, Hiromichi
   Ishikawa, Kaori
   Nakada, Kazuto
   Hayashi, Jun-ichi
TI G7731A mutation in mouse mitochondrial <i>tRNA<SUP>LYs</SUP></i> regulates late-onset disorders in transmitochondrial mice
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE G7731A mtDNA mutation; Mitochondrial tRNA(Lys) gene; Transmitochondrial mice; Respiration defects; Late-onset disorders; Mitochondrial disease models
ID mito-mice; primary prevention; protein-synthesis; dna mutations; mtdna; cells; gene; disease; generation; myopathy
AB We previously generated mito-mice-tRNA(Lys7731) as a model for primary prevention of mitochondrial diseases. These mice harbour a G7731A mtDNA mutation in the tRNA(Lys) gene, but express only muscle weakness and short body length by four months. Here, we examined the effects of their aging on metabolic and histologic features. Unlike young mito-mice-tRNA(Lys7731), aged mito-mice-tRNA(Lys7731) developed muscle atrophy, renal failures, and various metabolic abnormalities, such as lactic acidosis and anemia, characteristic of patients with mitochondrial diseases. These observations provide convincing evidence that the respiration defects induced by high G7731A mtDNA levels cause these late-onset disorders that are relevant to mitochondrial diseases. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Shimizu, Akinori; Mito, Takayuki; Hashizume, Osamu; Ishikawa, Kaori; Nakada, Kazuto; Hayashi, Jun-ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
   [Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Setagaya Ku, Tokyo 1568506, Japan.
   [Nakada, Kazuto; Hayashi, Jun-ichi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058572, Japan.
   [Hayashi, Jun-ichi] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan.
C3 University of Tsukuba; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; University of Tsukuba
RP Hayashi, J (corresponding author), Univ Tsukuba, TARA Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.
EM jih45@biol.tsukuba.ac.jp
FU Japan Society for the Promotion of Science [25250011, 23240058, 24117503]; World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology Japan; Grants-in-Aid for Scientific Research [24117503, 25250011, 23240058] Funding Source: KAKEN
CR Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HAYASHI JI, 1983, EXP CELL RES, V147, P51, DOI 10.1016/0014-4827(83)90270-7
   Houshmand M, 1999, HUM MUTAT, V13, P203, DOI 10.1002/(SICI)1098-1004(1999)13:3<203::AID-HUMU4>3.0.CO;2-3
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Mito T, 2015, BIOCHEM BIOPH RES CO, V456, P933, DOI 10.1016/j.bbrc.2014.12.009
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nedergaard A, 2013, BEST PRACT RES CL OB, V27, P673, DOI 10.1016/j.bpobgyn.2013.06.001
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Shimizu A, 2014, P NATL ACAD SCI USA, V111, P3104, DOI 10.1073/pnas.1318109111
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048
NR 27
TC 12
Z9 12
U1 1
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 15
PY 2015
VL 459
IS 1
BP 66
EP 70
DI 10.1016/j.bbrc.2015.02.070
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE8UU
UT WOS:000352120400011
PM 25721669
DA 2024-11-01
ER

PT J
AU Knierim, E
   Seelow, D
   Gill, E
   von Moers, A
   Schuelke, M
AF Knierim, Ellen
   Seelow, Dominik
   Gill, Esther
   von Moers, Arpad
   Schuelke, Markus
TI Clinical application of whole exome sequencing reveals a novel compound heterozygous <i>TK2</i>-mutation in two brothers with rapidly progressive combined muscle-brain atrophy, axonal neuropathy, and <i>status epilepticus</i>
SO MITOCHONDRION
LA English
DT Article
DE Thymidine kinase 2; mtDNA depletion syndrome; Myopathy; Brain atrophy; Status epilepticus; Identity-by-state analysis
ID mitochondrial-dna depletion; thymidine kinase; tk2 gene; mutations; spectrum; mice
AB Mutations in several genes cause mtDNA depletion associated with encephalomyopathy. Due to phenotypic overlap, it is difficult to conclude from clinical phenotype to genetic defect. Here we report on two brothers who presented with rapid fatty muscle degeneration, axonal neuropathy, rapid loss of supratentorial white and gray matter, and status epilepticus. Whole exome sequencing coupled with 'identity-by-state' (IBS) analysis revealed a compound heterozygous missense mutation (p.M117V, p.A139V) in the thymidine kinase 2 (TK2) gene that segregated with the phenotype. Both mutations were located in the thymidine binding pouch of the enzyme. Residual mtDNA copy numbers in muscle were 8.5%, but normal in blood and fibroblasts. Our results broaden the clinical phenotype spectrum of TK2 mutations and promote WES as a useful method in the clinical setting for mutation detection, even in untypical cases. If two or more affected siblings from a non-consanguineous family can be investigated, IBS-analysis provides a powerful tool to narrow the number of disease candidates, similarly to autozygosity mapping in consanguineous families. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Knierim, Ellen; Seelow, Dominik; Gill, Esther; Schuelke, Markus] Charite, NCRC, D-13353 Berlin, Germany.
   [Knierim, Ellen; Seelow, Dominik; Schuelke, Markus] Charite, Dept Neuropediat, D-13353 Berlin, Germany.
   [von Moers, Arpad] Childrens Hosp, DRK Kliniken Westend, Berlin, Germany.
C3 Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin
RP Schuelke, M (corresponding author), Charite Campus Virchow Klinikum, D-13353 Berlin, Germany.
EM markus.schuelke@charite.de
FU Deutsche Forschungsgemeinschaft (DFG) [SFB 665 TP C4]; German Bundesministerium fur Bildung und Forschung
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Mikkelsen NE, 2003, BIOCHEMISTRY-US, V42, P5706, DOI 10.1021/bi0340043
   Nemesure BB, 1999, GENET EPIDEMIOL, V17, P0
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pfaffl MW, 2001, RT PCR NUCL ACIDS RE, V29, P2001
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 21
TC 14
Z9 16
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2015
VL 20
IS 
BP 1
EP 6
DI 10.1016/j.mito.2014.10.007
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CA0UQ
UT WOS:000348632200001
PM 25446393
DA 2024-11-01
ER

PT J
AU Mito, T
   Ishizaki, H
   Suzuki, M
   Morishima, H
   Ota, A
   Ishikawa, K
   Nakada, K
   Maeno, A
   Shiroishi, T
   Hayashi, JI
AF Mito, Takayuki
   Ishizaki, Hikari
   Suzuki, Michiko
   Morishima, Hitomi
   Ota, Azusa
   Ishikawa, Kaori
   Nakada, Kazuto
   Maeno, Akiteru
   Shiroishi, Toshihiko
   Hayashi, Jun-Ichi
TI Transmitochondrial mito-miceΔ and mtDNA mutator mice, but not aged mice, share the same spectrum of musculoskeletal disorders
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE mtDNA mutator mice; Mito-mice Delta; Mitochondrial diseases; Aging; Osteoporosis; Sarcopenia
ID mitochondrial-dna mutations; dysfunction; phenotypes; nuclear
AB The spectra of phenotypes associated with aging and mitochondrial diseases sometimes appear to overlap with each other. We used aged mice and a mouse model of mitochondrial diseases (transmitochondrial mito-mice Delta with deleted mtDNA) to study whether premature aging phenotypes observed in mtDNA mutator mice are associated with aging or mitochondrial diseases. Here, we provide convincing evidence that all the mice examined had musculoskeletal disorders of osteoporosis and muscle atrophy, which correspond to phenotypes prevalently observed in the elderly. However, precise investigation of musculoskeletal disorders revealed that the spectra of osteoporosis and muscle atrophy phenotypes in mtDNA mutator mice were very close to those in mito-mice Delta, but different from those of aged mice. Therefore, mtDNA mutator mice and mito-mice Delta, but not aged mice, share the spectra of musculoskeletal disorders. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Mito, Takayuki; Ishizaki, Hikari; Suzuki, Michiko; Morishima, Hitomi; Ota, Azusa; Ishikawa, Kaori; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
   [Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058572, Japan.
   [Maeno, Akiteru; Shiroishi, Toshihiko] Natl Inst Genet, Mammalian Genet Lab, Mishima, Shizuoka 411, Japan.
   [Hayashi, Jun-Ichi] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan.
C3 University of Tsukuba; University of Tsukuba; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tsukuba
RP Hayashi, JI (corresponding author), Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan.
EM jih45@biol.tsukuba.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23240058, 25250011];  [26-467]; Grants-in-Aid for Scientific Research [25250011, 23240058] Funding Source: KAKEN
CR Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9
   HAYASHI JI, 1994, J BIOL CHEM, V269, P6878
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Mito T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0055789
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nedergaard A, 2013, BEST PRACT RES CL OB, V27, P673, DOI 10.1016/j.bpobgyn.2013.06.001
   ROSENBERG AE, 1991, RADIOL CLIN N AM, V29, P19
   Sakuma K, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00230
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
NR 18
TC 7
Z9 7
U1 1
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 24
PY 2015
VL 456
IS 4
BP 933
EP 937
DI 10.1016/j.bbrc.2014.12.009
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA1UF
UT WOS:000348696100017
PM 25511702
DA 2024-11-01
ER

PT J
AU Khan, IA
   Shaik, NA
   Pasupuleti, N
   Chava, S
   Jahan, P
   Hasan, Q
   Rao, P
AF Khan, Imran Ali
   Shaik, Noor Ahmad
   Pasupuleti, Nagarjuna
   Chava, Srinivas
   Jahan, Parveen
   Hasan, Qurratulain
   Rao, Pragna
TI Screening of mitochondrial mutations and insertion-deletion polymorphism in gestational diabetes mellitus in the Asian Indian population
SO SAUDI JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE GDM; MELAS; A3243G; MERRF; A8344G; Mitochondria
ID gene-mutations; prevalence; rna; dna; association; variants; women
AB In this study we scrutinized the association between the A8344G/A3243G mutations and a 9-bp deletion polymorphism with gestational diabetes mellitus (GDM) in an Asian Indian population. The A3243G mutation in the mitochondrial tRNA(Leu(UUR)) causes mitochondrial encephalopathy myopathy, lactic acidosis, and stroke-like episodes (MELAS), while the A8344G mutation in tRNA(Lys) causes myoclonus epilepsy with ragged red fibers (MERRF). We screened 140 pregnant women diagnosed with GDM and 140 non-GDM participants for these mutations by PCR-RFLP analysis. Both A3243G and A8344G were associated with GDM (A3243: OR-3.667, 95% CI = 1.001-13.43, p = 0.03; A8344G: OR-11.00, 95% CI = 0.6026-200.8, p = 0.04). Mitochondrial DNA mutations contribute to the development of GDM. Our results conclude that mitochondrial mutations are associated with the GDM women in our population. Thus it is important to screen other mitochondrial mutations in the GDM women. (C) 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.
C1 [Khan, Imran Ali; Pasupuleti, Nagarjuna; Hasan, Qurratulain] Kamineni Hosp, Dept Genet & Mol Med, Hyderabad 500068, Andhra Pradesh, India.
   [Khan, Imran Ali; Chava, Srinivas; Hasan, Qurratulain] Vasavi Med & Res Ctr, Dept Genet, Hyderabad 500004, Andhra Pradesh, India.
   [Khan, Imran Ali; Jahan, Parveen] Osmania Univ, Dept Genet & Biotechnol, Hyderabad 500007, Andhra Pradesh, India.
   [Shaik, Noor Ahmad] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21413, Saudi Arabia.
   [Rao, Pragna] Manipal Univ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India.
C3 Osmania University; King Abdulaziz University; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal
RP Rao, P (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India.
EM drpragnarao@gmail.com
FU Indian Council for Medical Research [5-3-8-39-2007]
CR Allan CJ, 1997, DIABETES RES CLIN PR, V36, P135, DOI 10.1016/S0168-8227(97)00042-9
   Amer Diabet Assoc, 2009, DIABETES CARE, V32, PS62, DOI 10.2337/dc09-S062
   [Anonymous], 2015, J REPROD HLTH MED, V0, P0
   Bao XY, 2012, MOL BIOL REP, V39, P2447, DOI 10.1007/s11033-011-0995-8
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chen Y, 2000, DIABETES RES CLIN PR, V48, P29, DOI 10.1016/S0168-8227(99)00138-2
   Chou YJ, 2004, PRENATAL DIAG, V24, P367, DOI 10.1002/pd.876
   Crispim D, 2008, ARQ BRAS ENDOCRINOL, V52, P1228, DOI 10.1590/S0004-27302008000800005
   Duraisamy P, 2010, GENET TEST MOL BIOMA, V14, P49, DOI 10.1089/gtmb.2009.0024
   Hirano Michio, 2010, CURR NEUROL NEUROSCI REP, V10, P71
   Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x
   Khan IA, 2014, J RENIN-ANGIO-ALDO S, V15, P566, DOI 10.1177/1470320313502106
   Komandur S, 2011, GENET TEST MOL BIOMA, V15, P361, DOI 10.1089/gtmb.2010.0205
   Larsson NG, 2002, ANN NEUROL, V52, P529, DOI 10.1002/ana.10387
   Lee HC, 1997, J FORMOS MED ASSOC, V96, P770
   Lee H, 2008, DIABETES RES CLIN PR, V81, P124, DOI 10.1016/j.diabres.2008.02.017
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Malecki M T, 2001, POL ARCH MED WEWN, V105 Suppl, P357
   Matharoo K, 2013, GENE, V527, P228, DOI 10.1016/j.gene.2013.05.075
   Mathews CE, 1998, P SOC EXP BIOL MED, V219, P97
   Mkaouar-Rebai E, 2007, BIOCHEM BIOPH RES CO, V355, P1031, DOI 10.1016/j.bbrc.2007.02.083
   OTABE S, 1994, J CLIN ENDOCR METAB, V79, P768, DOI 10.1210/jc.79.3.768
   Padma VV, 2010, MOL CELL BIOCHEM, V345, P223, DOI 10.1007/s11010-010-0576-5
   Padma VV, 2010, BIOL TRACE ELEM RES, V137, P344, DOI 10.1007/s12011-009-8590-8
   Petry CJ, 2011, DIABETES, V60, P3090, DOI 10.2337/db11-0689
   Shen LJ, 2011, J CANCER RES CLIN, V137, P669, DOI 10.1007/s00432-010-0912-x
   Thangaraj K, 2005, HUM GENET, V116, P507, DOI 10.1007/s00439-005-1271-6
   Viola G, 2008, BIOCHEM PHARMACOL, V75, P810, DOI 10.1016/j.bcp.2007.10.007
   Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035
   Wang CY, 2013, MOL BIOL REP, V40, P811, DOI 10.1007/s11033-012-2119-5
   WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529
NR 33
TC 15
Z9 18
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-562X
EI 2213-7106
J9 SAUDI J BIOL SCI
JI Saudi J. Biol. Sci.
PD MAY 15
PY 2015
VL 22
IS 3
BP 243
EP 248
DI 10.1016/j.sjbs.2014.11.001
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA CH4TR
UT WOS:000354026300001
PM 25972744
DA 2024-11-01
ER

PT J
AU Poole, OV
   Hanna, MG
   Pitceathly, RDS
AF Poole, Olivia V.
   Hanna, Michael G.
   Pitceathly, Robert D. S.
TI Mitochondrial Disorders: Disease Mechanisms and Therapeutic Approaches
SO DISCOVERY MEDICINE
LA English
DT Article
ID gene-therapy; dna; transmission; progression; activation; deletions; myopathy; genm; prevent; single
AB Mitochondrial disorders are now well recognized as an important cause of genetic disease. They exhibit remarkable phenotypic, biochemical, and molecular heterogeneity, and frequently involve multiple organ systems. Their complexity partly relates to the dual expression of mitochondrial proteins by both mitochondrial and nuclear genomic DNA. Multiple copies of mitochondrial DNA ( mtDNA) are present in a single human mitochondrion. Each molecule exists as a double-stranded, circular, helical structure containing 37 genes: 13 encode polypeptide subunits, whilst the remaining 24 encode 22 transfer and 2 ribosomal RNAs necessary for their synthesis. These protein subunits contribute towards four of five multimeric enzymes (so-called complex I/III/IV/V, with complex II entirely nuclear-encoded) embedded in the inner mitochondrial membrane. The enzymes catalyze a sequence of redox reactions which ultimately generates adenine triphosphate, the cellular unit of energy, during oxidative phosphorylation (OXPHOS). The remaining OXPHOS subunits (more than 70 in total), in addition to the apparatus required for their transcription, translation, post-translational modification and assembly, are nuclear-encoded. The mitochondrion's dependence on nuclear DNA extends further to include the machinery required for the maintenance, replication, and repair of mtDNA molecules, the proteins for which are synthesized in the cell cytoplasm prior to transport across mitochondrial membrane for replication. Recent advancements in DNA analysis using next generation sequencing technology have provided an unprecedented expansion in the depth of knowledge concerning both molecular mechanisms and biological pathways which underpin many mitochondrial diseases. This understanding has led to the emergence of many potential targets and treatment strategies for these disorders for which there is currently no cure. This review highlights the challenges to therapy development and clinical trial design and outlines the approaches currently being investigated to treat this diverse group of disorders.
C1 [Poole, Olivia V.; Hanna, Michael G.; Pitceathly, Robert D. S.] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Poole, Olivia V.; Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.] Kings Coll London, Dept Basic & Clin Neurosci, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; King's College London
RP Pitceathly, RDS (corresponding author), UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
EM r.pitceathly@ucl.ac.uk
FU MRC Centre for Neuromuscular Diseases grant [G0601943]; UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children; NIHR UCLH/UCL Biomedical Research Centre; Lily Foundation (Clinical Research Fellowship); MRC [G0601943, MR/K000608/1] Funding Source: UKRI
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Cámara Y, 2013, DRUG DISCOV TODAY, V18, P950, DOI 10.1016/j.drudis.2013.06.009
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Golubitzky A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026883
   Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Herbert M, 2015, EMBO REP, V16, P539, DOI 10.15252/embr.201540354
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Libri V, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0051395
   López-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P0, DOI 10.1136/jnnp-2013-306573.69
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Peralta S, 2015, MITOCHONDRION, V23, P71, DOI 10.1016/j.mito.2015.01.007
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Tyynismaa H, 2014, EMBO MOL MED, V6, P155, DOI 10.1002/emmm.201303586
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 40
TC 12
Z9 15
U1 0
U2 5
PU DISCOVERY MEDICINE
PI TIMONIUM
PA 10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA
SN 1539-6509
EI 1944-7930
J9 DISCOV MED
JI Discov. Med.
PD NOV 15
PY 2015
VL 20
IS 111
BP 325
EP 331
DI 
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CY3MH
UT WOS:000366313400007
PM 26645904
DA 2024-11-01
ER

PT J
AU Wang, Y
   Oxer, D
   Hekimi, S
AF Wang, Ying
   Oxer, Daniella
   Hekimi, Siegfried
TI Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis
SO NATURE COMMUNICATIONS
LA English
DT Article
ID coenzyme q(10); skeletal-muscle; dna mutations; caenorhabditis-elegans; coq(10) deficiency; oxidative stress; chain; gene; nephropathy; maintenance
AB Ubiquinone (UQ) is implicated in mitochondrial electron transport, superoxide generation and as a membrane antioxidant. Here we present a mouse model in which UQ biosynthesis can be interrupted and partially restored at will. Global loss of UQ leads to gradual loss of mitochondrial function, gradual development of disease phenotypes and shortened lifespan. However, we find that UQ does not act as antioxidant in vivo and that its requirement for electron transport is much lower than anticipated, even in vital mitochondria-rich organs. In fact, severely depressed mitochondrial function due to UQ depletion in the heart does not acutely impair organ function. In addition, we demonstrate that severe disease phenotypes and shortened lifespan are reversible upon partial restoration of UQ levels and mitochondrial function. This observation strongly suggests that the irreversible degenerative phenotypes that characterize ageing are not secondarily caused by the gradual mitochondrial dysfunction that is observed in aged animals.
C1 [Wang, Ying; Oxer, Daniella; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada.
C3 McGill University
RP Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.
EM Siegfried.Hekimi@mcgill.ca
FU Canadian Institutes of Health Research [MOP-114891, MOP-123295, MOP-97869]; McGill University; Chair of Zoology and Campbell Chair of Developmental Biology
CR Bentinger M, 2007, MITOCHONDRION, V7, PS41, DOI 10.1016/j.mito.2007.02.006
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   CLARKE NE, 1958, AM J MED SCI, V235, P7, DOI 10.1097/00000441-195801000-00002
   de Rijk-van Andel JF, 2000, NEUROLOGY, V55, P1926, DOI 10.1212/WNL.55.12.1926
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350
   Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   Doimo M, 2013, BIOCHIM BIOPHYS ACTA, V1842, P1
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Falk MJ, 2011, EMBO MOL MED, V3, P410, DOI 10.1002/emmm.201100149
   Fernandes J, 2006, INBORN METABOLIC DIS, VFourth, P0
   Filosto M, 2011, J NEUROL, V258, P1763, DOI 10.1007/s00415-011-6104-z
   García-Corzo L, 2013, HUM MOL GENET, V22, P1233, DOI 10.1093/hmg/dds530
   Gilbert DL, 1999, REACTIVE OXYGEN SPEC, V0, P0
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006
   Hughes BG, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026116
   Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200
   Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5
   Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200
   Lapointe J, 2012, J CELL BIOL, V199, P215, DOI 10.1083/jcb.201203090
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   Lenaz G, 2009, BBA-BIOENERGETICS, V1787, P563, DOI 10.1016/j.bbabio.2009.02.019
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu S, 2012, NEUROBIOL DIS, V45, P219, DOI 10.1016/j.nbd.2011.08.006
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nakai D, 2001, BIOCHEM BIOPH RES CO, V289, P463, DOI 10.1006/bbrc.2001.5977
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008
   Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Paumgartner G, 1991, BILE ACIDS THERAPEUT, V0, P0
   Peng M, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000061
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155
   Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sohal RS, 2006, FREE RADICAL BIO MED, V40, P480, DOI 10.1016/j.freeradbiomed.2005.08.037
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   THELIN A, 1992, FEBS LETT, V313, P118, DOI 10.1016/0014-5793(92)81425-L
   Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Wang Y, 2013, HUM MOL GENET, V22, P4768, DOI 10.1093/hmg/ddt330
   Wang Y, 2013, CRIT REV BIOCHEM MOL, V48, P69, DOI 10.3109/10409238.2012.741564
   Williams Robin A, 2008, CLIN BIOCHEM REV, V29, P31
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
NR 70
TC 79
Z9 89
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
EI 
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 15
PY 2015
VL 6
IS 
BP 
EP 
DI 10.1038/ncomms7393
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CF5YN
UT WOS:000352633400006
PM 25744659
DA 2024-11-01
ER

PT J
AU Ajroud-Driss, S
   Fecto, F
   Ajroud, K
   Lalani, I
   Calvo, SE
   Mootha, VK
   Deng, HX
   Siddique, N
   Tahmoush, AJ
   Heiman-Patterson, TD
   Siddique, T
AF Ajroud-Driss, Senda
   Fecto, Faisal
   Ajroud, Kaouther
   Lalani, Irfan
   Calvo, Sarah E.
   Mootha, Vamsi K.
   Deng, Han-Xiang
   Siddique, Nailah
   Tahmoush, Albert J.
   Heiman-Patterson, Terry D.
   Siddique, Teepu
TI Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy
SO NEUROGENETICS
LA English
DT Article
DE Mitochondrial myopathy; Genetics; CHCHD10; Mitochondria
ID disease; genome
AB Mitochondrial myopathies belong to a larger group of systemic diseases caused by morphological or biochemical abnormalities of mitochondria. Mitochondrial disorders can be caused by mutations in either the mitochondrial or nuclear genome. Only 5 % of all mitochondrial disorders are autosomal dominant. We analyzed DNA from members of the previously reported Puerto Rican kindred with an autosomal dominant mitochondrial myopathy (Heimann-Patterson et al. 1997). Linkage analysis suggested a putative locus on the pericentric region of the long arm of chromosome 22 (22q11). Using the tools of integrative genomics, we established chromosome 22 open reading frame 16 (C22orf16) (later designated as CHCHD10) as the only high-scoring mitochondrial candidate gene in our minimal candidate region. Sequence analysis revealed a double-missense mutation (R15S and G58R) in cis in CHCHD10 which encodes a coiled coil-helix-coiled coil-helix protein of unknown function. These two mutations completely co-segregated with the disease phenotype and were absent in 1,481 Caucasian and 80 Hispanic (including 32 Puerto Rican) controls. Expression profiling showed that CHCHD10 is enriched in skeletal muscle. Mitochondrial localization of the CHCHD10 protein was confirmed using immunofluorescence in cells expressing either wild-type or mutant CHCHD10. We found that the expression of the G58R, but not the R15S, mutation induced mitochondrial fragmentation. Our findings identify a novel gene causing mitochondrial myopathy, thereby expanding the spectrum of mitochondrial myopathies caused by nuclear genes. Our findings also suggest a role for CHCHD10 in the morphologic remodeling of the mitochondria.
C1 [Ajroud-Driss, Senda; Fecto, Faisal; Ajroud, Kaouther; Lalani, Irfan; Deng, Han-Xiang; Siddique, Nailah; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA.
   [Siddique, Teepu] Northwestern Univ, Interdepartmental Neurosci Program, Chicago, IL 60611 USA.
   [Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Howard Hughes Med Inst, Chevy Chase, MD USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA.
   [Tahmoush, Albert J.; Heiman-Patterson, Terry D.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.
C3 Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Feinberg School of Medicine; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Jefferson University
RP Ajroud-Driss, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA.
EM s-ajroud@northwestern.edu; t-siddique@northwestern.edu
FU National Institute of Neurological Disorders and Stroke [NS050641]; Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship; David C. Asselin MD Memorial Fund; Vena E. Schaff ALS Research Fund; George Link, Jr. Foundation; Foglia Family Foundation; National Institutes of Health [R01GM097136]; NCI CCSG [P30 CA060553]
CR Ajroud-Driss S, 2012, NEUROLOGY, V78, P0
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Banci L, 2009, FEBS LETT, V583, P1699, DOI 10.1016/j.febslet.2009.03.061
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Baughman JM, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000590
   Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   HeimanPatterson TD, 1997, MUSCLE NERVE, V20, P1219, DOI 10.1002/(SICI)1097-4598(199710)20:10<1219::AID-MUS2>3.0.CO;2-F
   Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060
   Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041
   Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, PD225, DOI 10.1093/nar/gkq1189
   Martherus RSRM, 2010, BIOCHEM BIOPH RES CO, V402, P203, DOI 10.1016/j.bbrc.2010.09.109
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6
   Schug J, 2005, GENOME BIOL, V6, P0, DOI 10.1186/gb-2005-6-4-r33
NR 25
TC 87
Z9 96
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1364-6745
EI 1364-6753
J9 NEUROGENETICS
JI Neurogenetics
PD JAN 15
PY 2015
VL 16
IS 1
BP 1
EP 9
DI 10.1007/s10048-014-0421-1
PG 9
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA AY2HE
UT WOS:000347408700001
PM 25193783
DA 2024-11-01
ER

PT J
AU Sobenin, IA
   Zhelankin, AV
   Sinyov, VV
   Bobryshev, YV
   Orekhov, AN
AF Sobenin, Igor A.
   Zhelankin, Andrey V.
   Sinyov, Vasily V.
   Bobryshev, Yuri V.
   Orekhov, Alexander N.
TI Mitochondrial Aging: Focus on Mitochondrial DNA Damage in Atherosclerosis - A Mini-Review
SO GERONTOLOGY
LA English
DT Review
DE Atherosclerosis; Aging; Mitochondria; Mitochondrial DNA; Cell senescence; Mutations
ID oxidative stress; cholesterol accumulation; telomere length; mutations; cells; disease; mtdna; risk; inflammation; lipoprotein
AB Atherosclerosis is a complex disease which can be described as an excessive fibrofatty, proliferative, inflammatory response to damage to the artery wall involving several cell types such as smooth muscle cells, monocyte- derived macrophages, lymphocytes, dendritic cells and platelets. On the other hand, atherosclerosis is a typical age-related degenerative pathology, which is characterized by signs of cell senescence in the arterial wall including reduced cell proliferation, irreversible growth arrest and apoptosis, increased DNA damage, the presence of epigenetic modifications, shortening of telomere length and mitochondrial dysfunction. The most prominent characteristics of mitochondrial aging are their structural alterations and mitochondrial DNA damage. The mechanisms of mitochondrial genome damage in the development of chronic age-related diseases such as atherosclerosis are not yet well understood. This review focuses on the latest findings from studies of those mutations of the mitochondrial genome which may play an important role in the development of atherosclerosis and which are, at the same time, also markers of mitochondrial aging and cell senescence. (C) 2014 S. Karger AG, Basel
C1 [Sobenin, Igor A.; Zhelankin, Andrey V.; Sinyov, Vasily V.] Russian Acad Med Sci, Inst Clin Cardiol, Russian Cardiol Res & Prod Complex, Med Genet Lab, Moscow, Russia.
   [Sobenin, Igor A.; Zhelankin, Andrey V.; Bobryshev, Yuri V.; Orekhov, Alexander N.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Orekhov, Alexander N.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia.
   [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia.
   [Bobryshev, Yuri V.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.
C3 National Medical Research Center of Cardiology; Russian Academy of Medical Sciences; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; University of New South Wales Sydney; Western Sydney University
RP Bobryshev, YV (corresponding author), Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia.
EM y.bobryshev@unsw.edu.au
FU Russian Scientific Foundation [14-14-01038]; Russian Science Foundation [14-14-01038] Funding Source: Russian Science Foundation
CR Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Bhopal RS, 2009, INT J EPIDEMIOL, V38, P1072, DOI 10.1093/ije/dyp202
   Bobryshev YV, 2011, ATHEROSCLEROSIS, V219, P171, DOI 10.1016/j.atherosclerosis.2011.07.016
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Chung IM, 1998, AM J PATHOL, V152, P913
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d
   Ding Y, 2013, INT J MOL MED, V32, P768, DOI 10.3892/ijmm.2013.1459
   Ding ZF, 2014, CARDIOVASC RES, V103, P619, DOI 10.1093/cvr/cvu114
   Ding ZF, 2013, SCI REP-UK, V3, P0, DOI 10.1038/srep01077
   Gerhard M, 1996, HYPERTENSION, V27, P849, DOI 10.1161/01.HYP.27.4.849
   HARIRI RJ, 1988, AM J PATHOL, V131, P132
   Harrison CM, 2011, ENVIRON HEALTH PERSP, V119, P676, DOI 10.1289/ehp.1002857
   Horan MP, 2014, HUM GENET, V133, P435, DOI 10.1007/s00439-013-1402-4
   Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kroenke CH, 2012, ATHEROSCLEROSIS, V220, P506, DOI 10.1016/j.atherosclerosis.2011.10.041
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lee HY, 2006, ANN HUM GENET, V70, P59, DOI 10.1111/j.1529-8817.2005.00217.x
   Lenaz G, 2006, ANTIOXID REDOX SIGN, V8, P417, DOI 10.1089/ars.2006.8.417
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008
   Marian AJ, 2011, CIRC RES, V108, P784, DOI 10.1161/CIRCRESAHA.111.242768
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Miller YI, 2010, SUBCELL BIOCHEM, V51, P229, DOI 10.1007/978-90-481-8622-8_8
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Mueller EE, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016455
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   OREKHOV AN, 1990, CIRC RES, V66, P311, DOI 10.1161/01.RES.66.2.311
   OREKHOV AN, 1985, EXP MOL PATHOL, V42, P117, DOI 10.1016/0014-4800(85)90022-X
   Raschenberger J, 2013, ATHEROSCLEROSIS, V229, P469, DOI 10.1016/j.atherosclerosis.2013.05.027
   Rizza S, 2014, ATHEROSCLEROSIS, V232, P260, DOI 10.1016/j.atherosclerosis.2013.10.029
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   SCHWARTZ CJ, 1993, AM J CARDIOL, V71, PB9, DOI 10.1016/0002-9149(93)90139-4
   Schwartz SM, 1998, ANNU REV MED, V49, P437
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Sobenin IA, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046573
   Sobenin IA, 2012, CLIN DEV IMMUNOL, V0, P0, DOI DOI 10.1155/2012/832464
   STEMERMAN MB, 1982, P NATL ACAD SCI-BIOL, V79, P3863, DOI 10.1073/pnas.79.12.3863
   TERTOV VV, 1988, TISSUE CELL, V20, P849, DOI 10.1016/0040-8166(88)90026-2
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wang YC, 2011, J NEPHROL, V24, P351, DOI 10.5301/JN.2010.5816
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
   Yao YG, 2013, STEM CELL RES, V10, P361, DOI 10.1016/j.scr.2013.01.006
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
NR 56
TC 26
Z9 27
U1 1
U2 8
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PD JUN 15
PY 2015
VL 61
IS 4
BP 343
EP 349
DI 10.1159/000368923
PG 7
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA CL4TV
UT WOS:000356948800007
PM 25531813
DA 2024-11-01
ER

PT J
AU Chung, YW
   Kang, SM
AF Chung, Youn Wook
   Kang, Seok-Min
TI An experimental approach to study the function of mitochondria in cardiomyopathy
SO BMB REPORTS
LA English
DT Review
DE Cardiomyopathy; Heart; Mitochondria
ID congestive-heart-failure; doxorubicin-induced cardiomyopathy; muscarinic acetylcholine-receptor; desmin-related cardiomyopathy; permeability transition pore; oxygen-free radicals; rat cardiac-muscle; dilated cardiomyopathy; superoxide-dismutase; interfibrillar mitochondria
AB Cardiomyopathy is an inherited or acquired disease of the myocardium, which can result in severe ventricular dysfunction. Mitochondrial dysfunction is involved in the pathological process of cardiomyopathy. Many dysfunctions in cardiac mitochondria are consequences of mutations in nuclear or mitochondrial DNA followed by alterations in transcriptional regulation, mitochondrial protein function, and mitochondrial dynamics and energetics, presenting with associated multi-system mitochondrial disorders. To ensure correct diagnosis and optimal management of mitochondrial dysfunction in cardiomyopathy caused by multiple pathogenesis, multidisciplinary approaches are required, and to integrate between clinical and basic sciences, ideal translational models are needed. In this review, we will focus on experimental models to provide insights into basic mitochondrial physiology and detailed underlying mechanisms of cardiomyopathy and current mitochondria-targeted therapies for cardiomyopathy.
C1 [Chung, Youn Wook; Kang, Seok-Min] Yonsei Univ, Coll Med, Yonsei Cardiovasc Res Inst, Seoul 03722, South Korea.
   [Kang, Seok-Min] Severance Cardiovasc Hosp, Cardiol Div, Seoul 03722, South Korea.
   [Kang, Seok-Min] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul 03722, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System
RP Kang, SM (corresponding author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Res Inst, Seoul 03722, South Korea.
EM smkang@yuhs.ac
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A2A1A11052412]
CR Abozguia K, 2010, CIRCULATION, V122, P1562, DOI 10.1161/CIRCULATIONAHA.109.934059
   AMBROSIO G, 1993, J BIOL CHEM, V268, P18532
   Arakawa K, 2010, CIRC J, V74, P2702, DOI 10.1253/circj.CJ-10-0044
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   ARMSTRONG PW, 1986, CIRCULATION, V74, P1075, DOI 10.1161/01.CIR.74.5.1075
   Ashrafian H, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001000
   Baba A, 2004, EUR HEART J, V25, P1108, DOI 10.1016/j.ehj.2004.05.012
   Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543
   Benjamin IJ, 2005, J CLIN INVEST, V115, P495, DOI 10.1172/JCI200524477
   BERSIN RM, 1994, J AM COLL CARDIOL, V23, P1617, DOI 10.1016/0735-1097(94)90665-3
   Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942
   Buyse GM, 2009, EUR HEART J, V30, P116, DOI 10.1093/eurheartj/ehn406
   Cecchi Franco, 2012, GLOB CARDIOL SCI PRACT, V2012, P4, DOI 10.5339/gcsp.2012.4
   Chen L, 2012, J AM HEART ASSOC, V1, P0, DOI 10.1161/JAHA.112.003012
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723
   DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121
   Delbridge LMD, 2015, AM J PHYSIOL-HEART C, V308, PH1194, DOI 10.1152/ajpheart.00002.2015
   Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073
   Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x
   Engel AG, 1999, ANN NEUROL, V46, P681, DOI 10.1002/1531-8249(199911)46:5<681::AID-ANA1>3.0.CO;2-B
   Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1
   Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2
   Fosslien E, 2003, ANN CLIN LAB SCI, V33, P371
   FU LX, 1993, J CLIN INVEST, V91, P1964, DOI 10.1172/JCI116416
   FU MLX, 1995, J MOL CELL CARDIOL, V27, P427, DOI 10.1016/S0022-2828(08)80039-9
   GILLADOGA AC, 1976, CANCER, V37, P1070, DOI 10.1002/1097-0142(197602)37:2+<1070::AID-CNCR2820370814>3.0.CO;2-6
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Gürlek A, 2000, EUR J HEART FAIL, V2, P189, DOI 10.1016/S1388-9842(00)00064-7
   HAJJAR RJ, 1993, CARDIOVASC RES, V27, P2212, DOI 10.1093/cvr/27.12.2212
   HOPPEL CL, 1982, J BIOL CHEM, V257, P1540
   Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405
   Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357
   Ikeda Y, 2000, CURR OPIN CARDIOL, V15, P197, DOI 10.1097/00001573-200005000-00013
   Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005
   Khairallah M, 2007, J MOL CELL CARDIOL, V43, P119, DOI 10.1016/j.yjmcc.2007.05.015
   Konorev EA, 1999, ARCH BIOCHEM BIOPHYS, V368, P421, DOI 10.1006/abbi.1999.1337
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Lagedrost SJ, 2011, AM HEART J, V161, P639, DOI 10.1016/j.ahj.2010.10.038
   Lauritzen KH, 2015, AM J PHYSIOL-HEART C, V309, PH434, DOI 10.1152/ajpheart.00253.2014
   Lebrecht D, 2007, BRIT J PHARMACOL, V151, P771, DOI 10.1038/sj.bjp.0707294
   Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF
   LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378
   Lewis JF, 1998, CLIN CARDIOL, V21, P888, DOI 10.1002/clc.4960211206
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lionetti V, 2005, CARDIOVASC RES, V66, P454, DOI 10.1016/j.cardiores.2005.02.004
   Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510
   Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007
   Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060
   OZAWA T, 1994, HERZ, V19, P105
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7
   Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142
   Paulin D, 2004, J PATHOL, V204, P418, DOI 10.1002/path.1639
   Recchia FA, 2007, VET RES COMMUN, V31, P35, DOI 10.1007/s11259-007-0005-8
   Rizos I, 2000, AM HEART J, V139, PS120, DOI 10.1067/mhj.2000.103917
   Roger VL, 2012, CIRCULATION, V125, PE2, DOI 10.1161/CIR.0b013e3182456d46
   Roh JI, 2014, CELL REP, V8, P991, DOI 10.1016/j.celrep.2014.07.027
   Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001
   Sakata Y, 1998, CIRCULATION, V97, P1488
   Sawyer DB, 2013, NEW ENGL J MED, V368, P1154, DOI 10.1056/NEJMcibr1214975
   SHENASA H, 1990, CARDIOVASC RES, V24, P591, DOI 10.1093/cvr/24.7.591
   SHIN G, 1989, J MOL CELL CARDIOL, V21, P1029, DOI 10.1016/0022-2828(89)90801-8
   SHIPP JC, 1961, NATURE, V189, P1018, DOI 10.1038/1891018a0
   Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374
   Singh R B, 1998, J ASSOC PHYSICIANS INDIA, V46, P299
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Song MS, 2015, CELL METAB, V21, P195, DOI 10.1016/j.cmet.2014.12.019
   Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011
   Song MS, 2014, CIRC RES, V115, P348, DOI 10.1161/CIRCRESAHA.115.304384
   SPINALE FG, 1990, AM J PHYSIOL, V259, PH218, DOI 10.1152/ajpheart.1990.259.1.H218
   Stanley WC, 1997, CARDIOVASC RES, V33, P243, DOI 10.1016/S0008-6363(96)00245-3
   Stanley WC, 2000, CARDIOVASC RES, V45, P805, DOI 10.1016/S0008-6363(99)00419-8
   Stanley William C, 2002, HEART FAIL REV, V7, P115, DOI 10.1023/A:1015320423577
   Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f
   Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002
   Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a
   VANDERVIJGH WJF, 1988, EUR J CANCER CLIN ON, V24, P1603, DOI 10.1016/0277-5379(88)90052-1
   Vatta M, 2002, LANCET, V359, P936, DOI 10.1016/S0140-6736(02)08026-1
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   WAGNER JA, 1989, CIRC RES, V65, P205, DOI 10.1161/01.RES.65.1.205
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   Walters AM, 2012, CIRC RES, V111, P1222, DOI 10.1161/CIRCRESAHA.112.265660
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402
   WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820
   Yoshizawa A, 2012, EUR J IMMUNOL, V42, P1152, DOI 10.1002/eji.201142104
   Yussman MG, 2002, NAT MED, V8, P725, DOI 10.1038/nm719
   Zhang M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0066779
   Zhang SL, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0129563
NR 97
TC 1
Z9 1
U1 0
U2 12
PU KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, # 801,  635-4 , YEOKSAM-DONG, KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-6696
EI 1976-670X
J9 BMB REP
JI BMB Rep.
PD OCT 15
PY 2015
VL 48
IS 10
BP 541
EP 548
DI 10.5483/BMBRep.2015.48.10.153
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CY0HP
UT WOS:000366087500002
PM 26198095
DA 2024-11-01
ER

PT J
AU Tchikviladze, M
   Gilleron, M
   Maisonobe, T
   Galanaud, D
   Laforet, P
   Durr, A
   Eymard, B
   Mochel, F
   Ogier, H
   Béhin, A
   Stojkovic, T
   Degos, B
   Gourfinkel-An, I
   Sedel, F
   Anheim, M
   Elbaz, A
   Viala, K
   Vidailhet, M
   Brice, A
   Jardel, C
   Lombès, A
AF Tchikviladze, Maya
   Gilleron, Mylene
   Maisonobe, Thierry
   Galanaud, Damien
   Laforet, Pascal
   Durr, Alexandra
   Eymard, Bruno
   Mochel, Fanny
   Ogier, Helene
   Behin, Anthony
   Stojkovic, Tanya
   Degos, Bertrand
   Gourfinkel-An, Isabelle
   Sedel, Frederic
   Anheim, Mathieu
   Elbaz, Alexis
   Viala, Karine
   Vidailhet, Marie
   Brice, Alexis
   Jardel, Claude
   Lombes, Anne
TI A diagnostic flow chart for <i>POLG</i>-related diseases based on signs sensitivity and specificity
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID sensory neuronopathy; ataxic neuropathy; mutations cause; mitochondrial; ophthalmoplegia; mri; deficiency; epilepsy; spectrum; criteria
AB Objective Diseases due to mutations of POLG gene, encoding the mitochondrial DNA polymerase, are reputed to have very diverse clinical presentations and have been proposed to cause up to 25% adult mitochondrial diseases. Our objective was the evaluation of the specificity and sensitivity of the signs encountered with POLG mutations. Design Forty-four patients out of 154 with sequenced POLG gene had mutations affecting either one (POLG(+/) group) or two POLG alleles (POLG(+/+) group). Phenotyping included clinical signs, electroneuromyography and brain imaging while mitochondrial investigations encompassed muscle histochemistry, respiratory chain assays and search for multiple mitochondrial deletions. The specificity and sensitivity of the signs associated with POLG mutations were analysed by comparison between POLG+/+ and patients without POLG mutation. Results High sensitivity but low specificity was observed with single signs such as axonal sensory neuropathy, cerebellar syndrome, movement disorders and weakness involving ocular, pharyngeal, axial and/or limb muscles. Specificity was increased with combination of previous signs plus psychiatric symptoms, cognitive impairment and epilepsy. High specificity and sensitivity was only obtained with sensory neuronopathy associated with one of the following signs: weakness of ocular, pharyngeal, axial and/or limb muscles. Mitochondrial investigations did not suffice for diagnosis. The widespread neuromuscular signs were often present since disease onset and were the rule above 50 years of age leading to a very low probability of POLG mutations in patients with less than three signs and absent sensory neuropathy. Conclusions Phenotypes associated with POLG mutations follow a reproducible pattern, which allows establishing a diagnostic flow chart.
C1 [Tchikviladze, Maya; Degos, Bertrand; Anheim, Mathieu] GHU Pitie Salpetriere, AP HP, Dept Neurol, Paris, France.
   [Tchikviladze, Maya] GHU Pitie Salpetriere, INSERM, CIC9503, Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] CNRS, UMR 8104, Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] GHU Pitie Salpetriere, AP HP, Serv Biochim Metab, Paris, France.
   [Gilleron, Mylene; Jardel, Claude; Lombes, Anne] GHU Pitie Salpetriere, AP HP, Ctr Genet Mol & Chromosom, Paris, France.
   [Gilleron, Mylene; Durr, Alexandra; Eymard, Bruno; Brice, Alexis] Univ Paris 06, UMR S975, Paris, France.
   [Maisonobe, Thierry] GHU Pitie Salpetriere, AP HP, Dept Neurophysiol & Neuropathol, Paris, France.
   [Galanaud, Damien] GHU Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France.
   [Laforet, Pascal; Eymard, Bruno; Behin, Anthony; Stojkovic, Tanya] GHU Pitie Salpetriere, AP HP, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, Paris, France.
   [Durr, Alexandra; Mochel, Fanny; Sedel, Frederic; Brice, Alexis] GHU Pitie Salpetriere, AP HP, Dept Genet, Paris, France.
   [Durr, Alexandra; Eymard, Bruno; Mochel, Fanny; Sedel, Frederic; Vidailhet, Marie; Brice, Alexis] CRICM, INSERM, UMR S975, Paris, France.
   [Durr, Alexandra; Eymard, Bruno; Mochel, Fanny; Sedel, Frederic; Vidailhet, Marie; Brice, Alexis] CNRS, UMR 7225, Paris, France.
   [Durr, Alexandra; Vidailhet, Marie; Brice, Alexis] GH Pitie Salpetriere, ICM Brain & Spine Inst, Paris, France.
   [Mochel, Fanny; Sedel, Frederic; Vidailhet, Marie] GH Pitie Salpetriere, AP HP, Neurometab Unit, Paris, France.
   [Ogier, Helene] GH Robert Debre, AP HP, Malad Hereditaires Metab, Paris, France.
   [Gourfinkel-An, Isabelle] GH Pitie Salpetriere, AP HP, Ctr Reference Epilepsies Rares, Paris, France.
   [Elbaz, Alexis] CESP, INSERM, U1018, Social & Occupat Determinants Hlth, Villejuif, France.
   [Elbaz, Alexis] Univ Versailles St Quentin, UMRS 1018, Villejuif, France.
   [Lombes, Anne] Univ Paris 05, Paris, France.
C3 Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Universite Paris Cite
RP Lombès, A (corresponding author), Inst Cochin Genet Mol, Inserm 1016, Fac Med, 24 Rue Fb St Jacques, F-75014 Paris, France.
EM anne.lombes@inserm.fr
FU FRM (Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies (AFM); Association contre les Maladies Mitochondriales (AMMi); programme 'Investissements d'avenir' [ANR-10-IAIHU-06]
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Barkhof F, 2002, CEREBROVASC DIS, V13, P21, DOI 10.1159/000049146
   Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Camdessanché JP, 2012, J PERIPHER NERV SYST, V17, P331, DOI 10.1111/j.1529-8027.2012.00411.x
   Camdessanché JP, 2009, BRAIN, V132, P1723, DOI 10.1093/brain/awp136
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Dubowitz V, 1973, MUSCLE BIOPSY MODERN, V0, P0
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fazekas F, 2002, CEREBROVASC DIS, V13, P31, DOI 10.1159/000049147
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Synofzik M, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-41
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 41
TC 25
Z9 26
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD JUN 15
PY 2015
VL 86
IS 6
BP 646
EP 654
DI 10.1136/jnnp-2013-306799
PG 9
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA CI1DN
UT WOS:000354482000011
PM 25118206
DA 2024-11-01
ER

PT J
AU Yu, H
   Koilkonda, RD
   Chou, TH
   Porciatti, V
   Mehta, A
   Hentall, ID
   Chiodo, VA
   Boye, SL
   Hauswirth, WW
   Lewin, AS
   Guy, J
AF Yu, Hong
   Koilkonda, Rajeshwari D.
   Chou, Tsung-Han
   Porciatti, Vittorio
   Mehta, Arpit
   Hentall, Ian D.
   Chiodo, Vince A.
   Boye, Sanford L.
   Hauswirth, William W.
   Lewin, Alfred S.
   Guy, John
TI Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
LA English
DT Article
DE gene therapy; adeno-associated virus; mitochondria; Leber hereditary optic neuropathy; blindness
ID hereditary optic neuropathy; complex-i; gene delivery; mutation; mouse; model; degeneration; therapy; transcription; transmission
AB Considerable evidence supports mutations in mitochondrial genes as the cause of maternally inherited diseases affecting tissues that rely primarily on oxidative energymetabolism, usually the nervous system, the heart, and skeletal muscles. Mitochondrial diseases are diverse, and animal models currently are limited. Here we introduced a mutant human mitochondrial gene responsible for Leber hereditary optic neuropathy (LHON) into the mouse germ line using fluorescence imaging for tissue-specific enrichment in the target retinal ganglion cells. A mitochondria-targeted adeno-associated virus (MTS-AAV) containing the mutant human NADH ubiquinone oxidoreductase subunit 4 (ND4) gene followed by mitochondrial-encoded mCherry was microinjected into zygotes. Female founders with mCherry fluorescence on ophthalmoscopy were backcrossed with normal males for eight generations. Mutant human ND4 DNA was 20% of mouse ND4 and did not integrate into the host genome. Translated human ND4 protein assembled into host respiratory complexes, decreasing respiratory chain function and increasing oxidative stress. Swelling of the optic nerve head was followed by progressive demise of ganglion cells and their axons, the hallmarks of human LHON. Early visual loss that began at 3 mo and progressed to blindness 8 mo after birth was reversed by intraocular injection of MTS-AAV expressing wild-type human ND4. The technology of introducing human mitochondrial genes into the mouse germ line has never been described, to our knowledge, and has implications not only for creating animal models recapitulating the counterpart human disorder but more importantly for reversing the adverse effects of the mutant gene using gene therapy to deliver the wild-type allele.
C1 [Yu, Hong; Koilkonda, Rajeshwari D.; Chou, Tsung-Han; Porciatti, Vittorio; Guy, John] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [Mehta, Arpit] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA.
   [Hentall, Ian D.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.
   [Chiodo, Vince A.; Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32603 USA.
   [Lewin, Alfred S.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32603 USA.
C3 University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida
RP Guy, J (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
EM jguy@med.miami.edu
FU NIH [R01 EY017141, EY012355, P30-EY014801]; Research to Prevent Blindness, Inc.
CR Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Chou TH, 2011, INVEST OPHTH VIS SCI, V52, P3604, DOI 10.1167/iovs.10-6340
   Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, PE517, DOI 10.1073/pnas.1218933110
   CLARK MA, 1982, NATURE, V295, P605, DOI 10.1038/295605a0
   Cogné B, 2014, NAT MED, V20, P577, DOI 10.1038/nm.3578
   Collombet JM, 1997, J BIOL CHEM, V272, P5342, DOI 10.1074/jbc.272.8.5342
   Committee on Care and Use of Laboratory Animals, 1996, DHHS PUBL, V0, P0
   Cwerman-Thibault H, 2011, J INHERIT METAB DIS, V34, P327, DOI 10.1007/s10545-010-9131-5
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   Howell N, 1998, VISION RES, V38, P1495, DOI 10.1016/S0042-6989(97)00444-6
   Howell N, 1997, VISION RES, V37, P3495, DOI 10.1016/S0042-6989(96)00167-8
   HOWELL N, 1994, AM J HUM GENET, V55, P203
   Ibrahim N, 2011, PHARM RES-DORDR, V28, P2871, DOI 10.1007/s11095-011-0516-4
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kaeppel C, 2013, NAT MED, V19, P889, DOI 10.1038/nm.3230
   Kanamori A, 2010, BRAIN, V133, P2612, DOI 10.1093/brain/awq105
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Koene S, 2011, J INHERIT METAB DIS, V34, P293, DOI 10.1007/s10545-009-9005-x
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   MAUL GG, 1978, J VIROL, V28, P936, DOI 10.1128/JVI.28.3.936-944.1978
   Mileshina D, 2011, MECH AGEING DEV, V132, P412, DOI 10.1016/j.mad.2011.05.002
   MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   Ni TH, 1998, J VIROL, V72, P2777, DOI 10.1128/JVI.72.4.2777-2787.1998
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8
   Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P1, DOI 10.1167/iovs.06-0789
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200
   Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Shoffner J M, 1992, HEART DIS STROKE, V1, P235
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Yoon YG, 2003, NUCLEIC ACIDS RES, V31, P1407, DOI 10.1093/nar/gkg228
   Yu H, 2012, MOL VIS, V18, P1668
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Yuan H, 2014, ARVO SUPPLEMENT INVE, V55, P3311
NR 49
TC 23
Z9 24
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 20
PY 2015
VL 112
IS 42
BP E5689
EP E5698
DI 10.1073/pnas.1506129112
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT9LN
UT WOS:000363138600008
PM 26438859
DA 2024-11-01
ER

PT J
AU Suzuki, T
   Yamaguchi, H
   Kikusato, M
   Matsuhashi, T
   Matsuo, A
   Sato, T
   Oba, Y
   Watanabe, S
   Minaki, D
   Saigusa, D
   Shimbo, H
   Mori, N
   Mishima, E
   Shima, H
   Akiyama, Y
   Takeuchi, Y
   Yuri, A
   Kikuchi, K
   Toyohara, T
   Suzuki, C
   Kohzuki, M
   Anzai, J
   Mano, N
   Kure, S
   Yanagisawa, T
   Tomioka, Y
   Toyomizu, M
   Ito, S
   Osaka, H
   Hayashi, K
   Abe, T
AF Suzuki, Takehiro
   Yamaguchi, Hiroaki
   Kikusato, Motoi
   Matsuhashi, Tetsuro
   Matsuo, Akihiro
   Sato, Takeya
   Oba, Yuki
   Watanabe, Shun
   Minaki, Daichi
   Saigusa, Daisuke
   Shimbo, Hiroko
   Mori, Nobuyoshi
   Mishima, Eikan
   Shima, Hisato
   Akiyama, Yasutoshi
   Takeuchi, Yoichi
   Yuri, Akinori
   Kikuchi, Koichi
   Toyohara, Takafumi
   Suzuki, Chitose
   Kohzuki, Masahiro
   Anzai, Jun-ichi
   Mano, Nariyasu
   Kure, Shigeo
   Yanagisawa, Teruyuki
   Tomioka, Yoshihisa
   Toyomizu, Masaaki
   Ito, Sadayoshi
   Osaka, Hitoshi
   Hayashi, Ken-ichiro
   Abe, Takaaki
TI Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients with Mitochondrial Diseases
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE indole-3-acetic acid; Leigh syndrome; MELAS; mitochonic acid 5 (MA-5); mitochondrial disease
ID dysfunction; disorders; models; auxin
AB Mitochondria are key organelles implicated in a variety of processes related to energy and free radical generation, the regulation of apoptosis, and various signaling pathways. Mitochondrial dysfunction increases cellular oxidative stress and depletes ATP in a variety of inherited mitochondrial diseases and also in many other metabolic and neurodegenerative diseases. Mitochondrial diseases are characterized by the dysfunction of the mitochondrial respiratory chain, caused by mutations in the genes encoded by either nuclear DNA or mitochondrial DNA. We have hypothesized that chemicals that increase the cellular ATP levels may ameliorate the mitochondrial dysfunction seen in mitochondrial diseases. To search for the potential drugs for mitochondrial diseases, we screened an in-house chemical library of indole-3-acetic-acid analogs by measuring the cellular ATP levels in Hep3B human hepatocellular carcinoma cells. We have thus identified mitochonic acid 5 (MA-5), 4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid, as a potential drug for enhancing ATP production. MA-5 is a newly synthesized derivative of the plant hormone, indole-3-acetic acid. Importantly, MA-5 improved the survival of fibroblasts established from patients with mitochondrial diseases under the stress-induced condition, including Leigh syndrome, MELAS (myopathy encephalopathy lactic acidosis and stroke-like episodes), Leber's hereditary optic neuropathy, and Kearns-Sayre syndrome. The improved survival was associated with the increased cellular ATP levels. Moreover, MA-5 increased the survival of mitochondrial disease fibroblasts even under the inhibition of the oxidative phosphorylation or the electron transport chain. These data suggest that MA-5 could be a therapeutic drug for mitochondrial diseases that exerts its effect in a manner different from anti-oxidant therapy.
C1 [Suzuki, Takehiro; Matsuo, Akihiro; Oba, Yuki; Watanabe, Shun; Mishima, Eikan; Shima, Hisato; Akiyama, Yasutoshi; Takeuchi, Yoichi; Kikuchi, Koichi; Toyohara, Takafumi; Suzuki, Chitose; Ito, Sadayoshi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan.
   [Suzuki, Takehiro] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA.
   [Suzuki, Takehiro] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Yamaguchi, Hiroaki; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi, Japan.
   [Kikusato, Motoi; Toyomizu, Masaaki] Tohoku Univ, Grad Sch Agr Sci, Animal Nutr, Life Sci, Sendai, Miyagi 9808574, Japan.
   [Matsuhashi, Tetsuro; Kure, Shigeo] Tohoku Univ, Grad Sch Med, Div Pediat, Sendai, Miyagi 9808574, Japan.
   [Sato, Takeya; Yanagisawa, Teruyuki] Tohoku Univ, Grad Sch Med, Dept Mol Pharmacol, Sendai, Miyagi 9808574, Japan.
   [Minaki, Daichi; Anzai, Jun-ichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808574, Japan.
   [Saigusa, Daisuke] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Sendai, Miyagi 9808574, Japan.
   [Shimbo, Hiroko] Kanagawa Childrens Med Ctr, Clin Res Inst, Yokohama, Kanagawa, Japan.
   [Mori, Nobuyoshi; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 9808574, Japan.
   [Yuri, Akinori; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Med, Lab Oncol Pharm Practice & Sci, Sendai, Miyagi 9808574, Japan.
   [Kikuchi, Koichi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi 9808574, Japan.
   [Osaka, Hitoshi] Jichi Med Univ, Div Pediat, Shimotsuke, Tochigi, Japan.
   [Hayashi, Ken-ichiro] Okayama Univ Sci, Dept Biochem, Okayama, Okayama, Japan.
   [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi 9808574, Japan.
C3 Tohoku University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Jichi Medical University; Okayama University of Science; Tohoku University
RP Abe, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.
EM takaabe@med.tohohu.ac.jp
FU National grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan [26670070]; Translational Research Network Program [B20]; Grants-in-Aid for Scientific Research [26860624, 26670070, 26293031] Funding Source: KAKEN
CR Avula S, 2014, CURR TREAT OPTION NE, V16, P0, DOI 10.1007/s11940-014-0292-7
   Carelli V, 2013, CURR OPIN NEUROL, V26, P52, DOI 10.1097/WCO.0b013e32835c5f0b
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975
   Coskuner O, 2014, J ALZHEIMERS DIS, V41, P561, DOI 10.3233/JAD-132300
   El-Hattab AW, 2014, INT J BIOCHEM CELL B, V48, P85, DOI 10.1016/j.biocel.2013.12.009
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   GORDON SA, 1972, AM J PHYSIOL, V222, P399, DOI 10.1152/ajplegacy.1972.222.2.399
   Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017
   Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c
   Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje
   Jiang Y, 2011, MUTAT RES-GEN TOX EN, V726, P75, DOI 10.1016/j.mrgentox.2011.08.006
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Lim CK, 2008, MOL PHARMACOL, V74, P225, DOI 10.1124/mol.108.046847
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Pagnussat GC, 2003, PLANT PHYSIOL, V132, P1241, DOI 10.1104/pp.103.022228
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   SINNA GA, 1983, COMP BIOCHEM PHYS C, V74, P433, DOI 10.1016/0742-8413(83)90127-5
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Tanigawa J, 2012, BRAIN DEV-JPN, V34, P861, DOI 10.1016/j.braindev.2012.02.007
   Toyohara T, 2010, HYPERTENS RES, V33, P944, DOI 10.1038/hr.2010.113
   Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
NR 27
TC 35
Z9 42
U1 0
U2 17
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD JUL 15
PY 2015
VL 236
IS 3
BP 225
EP 232
DI 10.1620/tjem.236.225
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA CO0ER
UT WOS:000358823400009
PM 26118651
DA 2024-11-01
ER

PT J
AU Komulainen, T
   Hautakangas, MR
   Hinttala, R
   Pakanen, S
   Vähäsarja, V
   Lehenkari, P
   Olsen, P
   Vieira, P
   Saarenpää-Heikkilä, O
   Palmio, J
   Tuominen, H
   Kinnunen, P
   Majamaa, K
   Rantala, H
   Uusimaa, J
AF Komulainen, Tuomas
   Hautakangas, Milla-Riikka
   Hinttala, Reetta
   Pakanen, Salla
   Vahasarja, Vesa
   Lehenkari, Petri
   Olsen, Paivi
   Vieira, Paivi
   Saarenpaa-Heikkila, Outi
   Palmio, Johanna
   Tuominen, Hannu
   Kinnunen, Pietari
   Majamaa, Kari
   Rantala, Heikki
   Uusimaa, Johanna
TI Mitochondrial DNA Depletion and Deletions in Paediatric Patients with Neuromuscular Diseases: Novel Phenotypes
SO JIMD REPORTS, VOL 23
LA English
DT Article; Book Chapter
ID deoxyguanosine kinase; myotonic-dystrophy; sucla2 mutations; mtdna; gene; encephalomyopathy; quantification; duplications; population; deficiency
AB Objective: To study the clinical manifestations and occurrence of mtDNA depletion and deletions in paediatric patients with neuromuscular diseases and to identify novel clinical phenotypes associated with mtDNA depletion or deletions. Methods: Muscle DNA samples from patients presenting with undefined encephalomyopathies or myopathies were analysed for mtDNA content by quantitative real-time PCR and for deletions by long-range PCR. Direct sequencing of mtDNA maintenance genes and whole-exome sequencing were used to study the genetic aetiologies of the diseases. Clinical and laboratory findings were collected. Results: Muscle samples were obtained from 104 paediatric patients with neuromuscular diseases. mtDNA depletion was found in three patients with severe early-onset encephalomyopathy or myopathy. Two of these patients presented with novel types of mitochondrial DNA depletion syndromes associated with increased serum creatine kinase (CK) and multiorgan disease without mutations in any of the known mtDNA maintenance genes; one patient had pathologic endoplasmic reticulum (ER) membranes in muscle. The third patient with mtDNA depletion was diagnosed with merosine-deficient muscular dystrophy caused by a homozygous mutation in the LAMA2 gene. Two patients with an early-onset Kearns-Sayre/ Pearson-like phenotype harboured a large-scale mtDNA deletion, minor multiple deletions and high mtDNA content. Conclusions: Novel encephalomyopathic mtDNA depletion syndrome with structural alterations in muscle ER was identified. mtDNA depletion may also refer to secondary mitochondrial changes related to muscular dystrophy. We suggest that a large-scale mtDNA deletion, minor multiple deletions and high mtDNA content associated with Kearns-Sayre/Pearson syndromes may be secondary changes caused by mutations in an unknown nuclear gene.
C1 [Komulainen, Tuomas; Hautakangas, Milla-Riikka; Hinttala, Reetta; Pakanen, Salla; Olsen, Paivi; Vieira, Paivi; Rantala, Heikki; Uusimaa, Johanna] Univ Oulu, PEDEGO Res Grp, POB 5000, FIN-90014 Oulu, Finland.
   [Komulainen, Tuomas; Hautakangas, Milla-Riikka; Hinttala, Reetta; Pakanen, Salla; Lehenkari, Petri; Olsen, Paivi; Vieira, Paivi; Majamaa, Kari; Rantala, Heikki; Uusimaa, Johanna] Univ Oulu, Med Res Ctr Oulu, FIN-90014 Oulu, Finland.
   [Komulainen, Tuomas; Hautakangas, Milla-Riikka; Hinttala, Reetta; Pakanen, Salla; Olsen, Paivi; Vieira, Paivi; Rantala, Heikki; Uusimaa, Johanna] Oulu Univ Hosp, Dept Children & Adolescents, Div Pediat Neurol, FI-90029 Oys Oulu, Finland.
   [Vahasarja, Vesa] Oulu Univ Hosp, Dept Children & Adolescents, Div Pediat, FI-90029 Oys Oulu, Finland.
   [Komulainen, Tuomas; Hautakangas, Milla-Riikka; Hinttala, Reetta; Pakanen, Salla; Lehenkari, Petri; Majamaa, Kari; Rantala, Heikki; Uusimaa, Johanna] Oulu Univ Hosp, FIN-90014 Oulu, Finland.
   [Lehenkari, Petri; Kinnunen, Pietari] Oulu Univ Hosp, Dept Surg, FI-90029 Oys Oulu, Finland.
   [Saarenpaa-Heikkila, Outi] Tampere Univ Hosp, Dept Pediat, FI-33521 Tampere, Finland.
   [Palmio, Johanna] Tampere Univ Hosp, Dept Neurol, FI-33521 Tampere, Finland.
   [Tuominen, Hannu] Oulu Univ Hosp, Dept Pathol, FI-90029 Oys Oulu, Finland.
   [Majamaa, Kari] Univ Oulu, Clin Neurosci Ctr, FIN-90014 Oulu, Finland.
   [Majamaa, Kari] Oulu Univ Hosp, Dept Neurol, FIN-90029 Oys Oulu, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Oulu
RP Komulainen, T (corresponding author), Univ Oulu, PEDEGO Res Grp, POB 5000, FIN-90014 Oulu, Finland.
EM mikakomu@student.oulu.fi
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P202, DOI 10.1016/j.spen.2013.10.010
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kornmann B, 2013, CURR OPIN CELL BIOL, V25, P443, DOI 10.1016/j.ceb.2013.02.010
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lezza AMS, 1997, FEBS LETT, V418, P167, DOI 10.1016/S0014-5793(97)01374-4
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Morten KJ, 2007, MITOCHONDRION, V7, P386, DOI 10.1016/j.mito.2007.09.001
   Muqit MMK, 2008, J NEUROL NEUROSUR PS, V79, P68, DOI 10.1136/jnnp.2006.112250
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Odoardi F, 2003, AM J MED GENET A, V118A, P247, DOI 10.1002/ajmg.a.20006
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   POULTON J, 1995, J MED GENET, V32, P732, DOI 10.1136/jmg.32.9.732
   POULTON J, 1992, J INHERIT METAB DIS, V15, P487, DOI 10.1007/BF01799607
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   SAHASHI K, 1992, GERONTOLOGY, V38, P18
   Sulonen AM, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r94
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Wong LJC, 2003, J MED GENET, V40, P0
   Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
NR 40
TC 7
Z9 8
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2015
VL 23
IS 
BP 91
EP 100
DI 10.1007/8904_2015_438
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BE8SP
UT WOS:000376988300012
PM 25940035
DA 2024-11-01
ER

PT J
AU Payne, BA
   Gardner, K
   Chinnery, PF
AF Payne, Brendan Ai
   Gardner, Kristian
   Chinnery, Patrick F.
TI Mitochondrial DNA mutations in ageing and disease: implications for HIV?
SO ANTIVIRAL THERAPY
LA English
DT Review
ID reverse-transcriptase inhibitors; human skeletal-muscle; mtdna control-region; active antiretroviral therapy; cytochrome-c-oxidase; infected patients; alzheimers-disease; nucleoside analogs; oxidative damage; polymerase-gamma
AB Mitochondrial DNA (mtDNA) mutations cause neurological and multisystem disease. Somatic (acquired) mtDNA mutations are also associated with degenerative diseases and with normal human ageing. It is well established that certain nucleoside reverse transcriptase inhibitor (NRTI) antiretroviral drugs cause inhibition of the mtDNA polymerase, pol gamma, leading to a reduction in mtDNA content (depletion). Given this effect of NRTI therapy on mtDNA replication, it is plausible that NRTI treatment may also lead to increased mtDNA mutations. Here we review recent evidence for an effect of HIV infection or NRTI therapy on mtDNA mutations, as well as discussing the methodological challenges in addressing this question. Finally, we discuss the possible implications for HIV-infected persons, with particular reference to ageing.
C1 [Payne, Brendan Ai; Gardner, Kristian; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK
RP Payne, BA (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM Brendan.Payne@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease research [G0601943]; EU FP7 TIR-CON; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle-upon-Tyne Hospitals NHS Foundation Trust; Newcastle University; Medical Research Council, UK [G0800470]; AstraZeneca; MRC [G0800470, MR/K000608/1, G0601943] Funding Source: UKRI
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Balcarek K, 2010, JAIDS-J ACQ IMM DEF, V55, P550, DOI 10.1097/QAI.0b013e3181f25946
   Bartley PB, 2001, AIDS, V15, P419, DOI 10.1097/00002030-200102160-00018
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bilal E, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002421
   Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002
   BISSUEL F, 1994, J INTERN MED, V235, P367, DOI 10.1111/j.1365-2796.1994.tb01088.x
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buffet M, 2005, J CLIN VIROL, V33, P60, DOI 10.1016/j.jcv.2004.09.027
   Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28
   Carr A, 2000, AIDS, V14, PF25, DOI 10.1097/00002030-200002180-00001
   Casademont J, 1996, BRAIN, V119, P1357, DOI 10.1093/brain/119.4.1357
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191
   Cherry CL, 2006, JAIDS-J ACQ IMM DEF, V42, P435, DOI 10.1097/01.qai.0000224974.67962.ce
   Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI 10.1097/00126334-200207010-00002
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chou JP, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064702
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367
   de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Erlandson KM, 2013, JAIDS-J ACQ IMM DEF, V63, P209, DOI 10.1097/QAI.0b013e318289bb7e
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haugaard SB, 2005, J MED VIROL, V77, P29, DOI 10.1002/jmv.20410
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   HELBERT M, 1988, LANCET, V2, P689
   Holt JL, 2012, J NEUROVIROL, V18, P291, DOI 10.1007/s13365-012-0114-1
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Jitratkosol MHJ, 2012, AIDS, V26, P675, DOI 10.1097/QAD.0b013e32835142eb
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lehmann HC, 2011, ANN NEUROL, V69, P100, DOI 10.1002/ana.22150
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu K, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057223
   Martin AM, 2003, AM J HUM GENET, V72, P549, DOI 10.1086/367849
   McComsey G, 2005, JAIDS-J ACQ IMM DEF, V39, P181
   McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002
   McComsey GA, 2010, AIDS, V24, P2503, DOI 10.1097/QAD.0b013e32833ea9bc
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miró O, 2003, ANTIVIR THER, V8, P333
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007
   Ortiz M, 2011, J INFECT DIS, V203, P620, DOI 10.1093/infdis/jiq106
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Rochira V, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028512
   Rylova SN, 2005, BIOCHEM PHARMACOL, V69, P951, DOI 10.1016/j.bcp.2004.12.010
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Torres SM, 2009, ENVIRON MOL MUTAGEN, V50, P10, DOI 10.1002/em.20433
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Venhoff N, 2007, ANTIVIR THER, V12, P1075
   Venhoff N, 2010, AIDS, V24, P345, DOI 10.1097/QAD.0b013e328335cdea
   Walker Dale M, 2004, CARDIOVASC TOXICOL, V4, P133, DOI 10.1385/CT:4:2:133
   Walker UA, 2006, ANTIVIR THER, V11, P25
   Walker UA, 2004, HEPATOLOGY, V39, P311, DOI 10.1002/hep.20074
   Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Waters DL, 2009, MECH AGEING DEV, V130, P315, DOI 10.1016/j.mad.2009.01.006
   Wu YS, 2009, MUTAT RES-FUND MOL M, V664, P28, DOI 10.1016/j.mrfmmm.2009.02.006
   Zanet DL, 2014, CLIN INFECT DIS, V58, P1322, DOI 10.1093/cid/ciu051
   Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399
   Zhang YL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0085637
NR 99
TC 12
Z9 12
U1 1
U2 12
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
EI 
J9 ANTIVIR THER
JI Antivir. Ther.
PD JUN 15
PY 2015
VL 20
IS 2
BP 109
EP 120
DI 10.3851/IMP2824
PG 12
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA CP5GL
UT WOS:000359909200001
PM 25032944
DA 2024-11-01
ER

PT J
AU Mayer, J
   Reichart, G
   Tokay, T
   Lange, F
   Baltrusch, S
   Junghanss, C
   Wolkenhauer, O
   Jaster, R
   Kunz, M
   Tiedge, M
   Ibrahim, S
   Fuellen, G
   Köhling, R
AF Mayer, Johannes
   Reichart, Gesine
   Tokay, Tursonjan
   Lange, Falko
   Baltrusch, Simone
   Junghanss, Christian
   Wolkenhauer, Olaf
   Jaster, Robert
   Kunz, Manfred
   Tiedge, Markus
   Ibrahim, Saleh
   Fuellen, Georg
   Koehling, Ruediger
TI Reduced Adolescent-Age Spatial Learning Ability Associated with Elevated Juvenile-Age Superoxide Levels in Complex I Mouse Mutants
SO PLOS ONE
LA English
DT Article
ID long-term potentiation; mitochondrial-dna mutations; oxidative stress; synaptic plasticity; nadh-dehydrogenase; free-radicals; memory; disease; mice; hippocampus
AB Large-scale, heteroplasmic and generally pathogenic mtDNA defects (as induced by defective mitochondrial DNA polymerase, clonal mutations or DNA deletions) are known to negatively impact on life span and can result in apoptosis and tissue loss in, e.g., skeletal muscle or reduce learning abilities. The functional impact of homoplasmic specific mtDNA point mutations, e.g., in genes coding for the electron transport chain, however, remains a matter of debate. The present study contributes to this discussion and provides evidence that a single point mutation in complex I of the respiratory chain is associated with impairment of spatial navigation in adolescent (6-month-old) mice, i.e., reduced performance in the Morris Water Maze, which goes along with increased production of reactive oxygen species (ROS) in juvenile mice (3 months) but not at the age of phenotype expression. A point mutation in complex III goes along with only a mild and non-significant negative effect on cognitive performance and no significant changes in ROS production. These findings suggest to also consider the ontogenetic development of phenotypes when studying mtDNA mutations and highlights a possible impact of complex I dysfunction on the emergence of neurological deficits.
C1 [Mayer, Johannes; Reichart, Gesine; Tokay, Tursonjan; Lange, Falko; Koehling, Ruediger] Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany.
   [Baltrusch, Simone; Tiedge, Markus] Univ Rostock, Med Ctr, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany.
   [Junghanss, Christian] Univ Rostock, Med Ctr, Dept Hematol Oncol Palliat Med, D-18055 Rostock, Germany.
   [Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany.
   [Jaster, Robert] Univ Rostock, Med Ctr, Dept Med 2, Div Gastroenterol, D-18055 Rostock, Germany.
   [Kunz, Manfred] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany.
   [Ibrahim, Saleh] Lubeck Univ, Med Ctr, Dept Dermatol, Lubeck, Germany.
   [Fuellen, Georg] Inst Biostat & Informat Med & Ageing Res, Rostock, Germany.
   [Fuellen, Georg; Koehling, Ruediger] Univ Rostock, Interdisciplinary Fac, D-18055 Rostock, Germany.
   [Tokay, Tursonjan] Nazarbayev Univ, Ctr Life Sci, Astana, Kazakhstan.
C3 University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; Leipzig University; University of Lubeck; University of Rostock; Nazarbayev University
RP Mayer, J (corresponding author), Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany.
EM johannes.mayer@uni-rostock.de; ruediger.koehling@uni-rostock.de
FU Bundesministerium fur Bildung und Forschung (BMBF) [ROSAge 31P6662]; Rostock University Medical Center FORUN programme [889062]
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Fukui K, 2001, ANN NY ACAD SCI, V928, P168
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N
   Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003
   Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298
   Huang Y, 2013, NEUROSCIENCE, V231, P432, DOI 10.1016/j.neuroscience.2012.11.010
   Ishihara K, 1997, BEHAV BRAIN RES, V83, P235, DOI 10.1016/S0166-4328(97)86077-9
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Kamsler A, 2003, J NEUROSCI, V23, P269
   Keefe JO, 1978, HIPPOCAMPUS COGNITIV, V0, P0
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumar A, 2011, FRONT AGING NEUROSCI, V3, P0, DOI 10.3389/fnagi.2011.00007
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09
   Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128
   Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003
   Maharjan S, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep05896
   MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0
   MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0
   Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038
   Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8
   Olsen RHJ, 2013, J NEUROCHEM, V125, P303, DOI 10.1111/jnc.12187
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Schauer M, 2014, EXP DERMATOL, V23, P0
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Tanaka D, 2008, MOL BRAIN, V16, P1, DOI 10.1186/1756-6606-1-21
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wei Yau-Huei, 2009, CHANG GUNG MED J, V32, P113
   Weiss H, 2013, DIABETOLOGIA, V56, P0
   Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108
NR 55
TC 6
Z9 6
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2015
VL 10
IS 4
BP 
EP 
DI 10.1371/journal.pone.0123863
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CF3WA
UT WOS:000352478400122
PM 25853418
DA 2024-11-01
ER

PT J
AU Born, AP
   Duno, M
   Rafiq, J
   Risom, L
   Wibrand, F
   Ostergaard, E
   Vissing, J
AF Born, Alfred Peter
   Duno, Morten
   Rafiq, Jabin
   Risom, Lotte
   Wibrand, Flemming
   Ostergaard, Elsebet
   Vissing, John
TI A mitochondrial tRNA<SUP>Met</SUP> mutation causing developmental delay, exercise intolerance and limb girdle phenotype with onset in early childhood
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE Mitochondrial tRNA(Met) mutation; Limb-girdle muscle weakness; Exercise intolerance; Lactic acidosis
AB A 10-year-old girl presented with exercise intolerance, learning difficulty, and muscle weakness in a limb girdle distribution. She had delayed achievement of motor milestones and difficulties with social interaction at pre-school age. Muscle biopsy showed no myopathic or dystrophic features, but 90% COX negative fibres and ragged blue fibres. Respiratory chain enzyme analysis in muscle showed a combined deficiency and mitochondrial DNA sequencing revealed the presence of an m.4450G>A mutation in the MT-TM gene encoding the tRNA for methionine. The mutation was only detected in mtDNA extracted from muscle and skin fibroblast, and could not be found in other tissues or in the mother. This is the second patient reported in the literature with a mitochondrial myopathy due to a mt-tRNA(Met) mutation. The first patient, a 30-year-old woman, presented with exercise intolerance, limb girdle muscle weakness, lactic acidosis, learning difficulty, and growth retardation in early childhood. Thus, the two patients exhibit strikingly overlapping phenotypes. (C) 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Born, Alfred Peter] Univ Copenhagen, Rigshosp, Paediat Clin, DK-1168 Copenhagen, Denmark.
   [Duno, Morten; Risom, Lotte; Wibrand, Flemming; Ostergaard, Elsebet] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-1168 Copenhagen, Denmark.
   [Rafiq, Jabin; Vissing, John] Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, DK-1168 Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet
RP Born, AP (corresponding author), Rigshosp, Paediat Clin, Blegdamsvej 9, DK-2100 Copenhagen N, Denmark.
EM peter.born@regionh.dk
CR Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Lombes A, 1998, HUM MUTAT, V0, PS175
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 5
TC 8
Z9 10
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD JAN 15
PY 2015
VL 19
IS 1
BP 69
EP 71
DI 10.1016/j.ejpn.2014.10.006
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AZ5KJ
UT WOS:000348259700010
PM 25468263
DA 2024-11-01
ER

PT J
AU Valentine, RC
   Valentine, DL
AF Valentine, Raymond C.
   Valentine, David L.
TI Revised Mitochondrial Hypothesis of Aging Highlights Energy Deficiency Caused by Errors of Replication (Mutations) of mtDNA
SO HUMAN LONGEVITY: OMEGA-3 FATTY ACIDS, BIOENERGETICS, MOLECULAR BIOLOGY, AND EVOLUTION
LA English
DT Article; Book Chapter
ID dna-polymerase-gamma; progressive external ophthalmoplegia; human-disease; polg mutations; optic atrophy; hearing-loss; mouse; mice; dynamics; defects
C1 [Valentine, Raymond C.] Calgene Inc, Davis, CA USA.
RP Valentine, RC (corresponding author), Univ Calif, Davis, CA 95616 USA.
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bensch KG, 2009, AM J PHYSIOL-ENDOC M, V296, PE672, DOI 10.1152/ajpendo.90839.2008
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Dogan SA, 2011, PHYSIOL RES, V60, PS61, DOI 10.33549/physiolres.932179
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2
   Kukat A, 2011, BIOCHEM BIOPH RES CO, V409, P394, DOI 10.1016/j.bbrc.2011.04.145
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Valentine RC, 2013, NEURONS AND THE DHA PRINCIPLES, V0, P0
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
NR 38
TC 0
Z9 0
U1 0
U2 2
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
SN 
EI 
J9 
PD JUN 15
PY 2015
VL 0
IS 
BP 95
EP 105
DI 
PG 11
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics
GA BC7CR
UT WOS:000354742500011
DA 2024-11-01
ER

PT J
AU Iommarini, L
   Peralta, S
   Torraco, A
   Diaz, F
AF Iommarini, Luisa
   Peralta, Susana
   Torraco, Alessandra
   Diaz, Francisca
TI Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function
SO MITOCHONDRION
LA English
DT Review
DE Mitochondrial DNA; Mitochondrial transcription; Mouse models; Mitochondrial dynamics; Quality control; Mitochondrial diseases
ID adenine-nucleotide translocator; thymidine kinase 2; dominant optic atrophy; m-aaa protease; progressive external ophthalmoplegia; respiratory-chain deficiency; impaired insulin-secretion; apoptosis-inducing factor; multiple mtdna deletions; dna depletion syndrome
AB Mitochondrial disorders are defined as defects that affect the oxidative phosphotylation system (OXPHOS). They are characterized by a heterogeneous array of clinical presentations due in part to a wide variety of factors required for proper function of the components of the OXPHOS system. There is no cure for these disorders owing to our poor knowledge of the pathogenic mechanisms of disease. To understand the mechanisms of human disease numerous mouse models have been developed in recent years. Here we summarize the features of several mouse models of mitochondrial diseases directly related to those factors affecting mtDNA maintenance, replication, transcription, translation as well as other proteins that are involved in mitochondrial dynamics and quality control which affect mitochondrial OXPHOS function without being intrinsic components of the system. We discuss how these models have contributed to our understanding of mitochondrial diseases and their pathogenic mechanisms. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Iommarini, Luisa] Univ Bologna, Dept Pharm & Biotechnol FABIT, I-40128 Bologna, Italy.
   [Peralta, Susana; Diaz, Francisca] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Torraco, Alessandra] IRCCS, Bambino Gesu Childrens Hosp, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, I-00146 Rome, Italy.
C3 University of Bologna; University of Miami; IRCCS Bambino Gesu
RP Diaz, F (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
EM luisa.iommarini2@unibo.it; SPeralta@med.miami.edu; alessandra.torraco@opbg.net; fdiaz1@med.miami.edu
FU James and Esther King Research Program, Florida Department of Health [08KN-01]; National Institute of Health [GM101225]; United Mitochondrial Disease Foundation [14050R]
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003
   Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Almajan ER, 2012, J CLIN INVEST, V122, P4048, DOI 10.1172/JCI64604
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andersson DC, 2011, ANTIOXID REDOX SIGN, V15, P2455, DOI 10.1089/ars.2011.3915
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Baughman JM, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000590
   Bayot A, 2011, BMC MED, V9, P0, DOI 10.1186/1741-7015-9-112
   Bensch KG, 2009, AM J PHYSIOL-ENDOC M, V296, PE672, DOI 10.1152/ajpendo.90839.2008
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bruni F, 2012, MITOCHONDRION, V12, P492, DOI 10.1016/j.mito.2012.06.010
   Cámara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082
   Casalena G, 2014, AM J PHYSIOL-RENAL, V306, PF1372, DOI 10.1152/ajprenal.00608.2013
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2012, J AM HEART ASSOC, V1, P0, DOI 10.1161/JAHA.112.003012
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585
   Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Clozel M, 1999, EXP GERONTOL, V34, P1007, DOI 10.1016/S0531-5565(99)00074-1
   Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925
   Coppola G, 2006, NEUROBIOL DIS, V22, P302, DOI 10.1016/j.nbd.2005.11.014
   Cossée M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219
   Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Di Meo I, 2011, ANTIOXID REDOX SIGN, V15, P353, DOI 10.1089/ars.2010.3520
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Dorman DC, 2002, TOXICOL SCI, V65, P18, DOI 10.1093/toxsci/65.1.18
   DUCHEN LW, 1983, J PHYSIOL-LONDON, V345, P0
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   ELKOUNI MH, 1993, CANCER RES, V53, P3687
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138
   Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gall JM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031074
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Gispert S, 2013, HUM MOL GENET, V22, P4871, DOI 10.1093/hmg/ddt338
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143
   Harmel J, 2013, J BIOL CHEM, V288, P15510, DOI 10.1074/jbc.M113.471649
   He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005
   Käser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034
   Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919
   Koeck T, 2011, CELL METAB, V13, P80, DOI 10.1016/j.cmet.2010.12.007
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kondadi AK, 2014, EMBO J, V33, P1011, DOI 10.1002/embj.201387009
   Kong YXG, 2011, AGING CELL, V10, P572, DOI 10.1111/j.1474-9726.2011.00690.x
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kühl I, 2014, NATURE, V514, PE7, DOI 10.1038/nature13690
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamperti C, 2009, ACTA MYOL, V28, P2
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   LI K, 1989, J BIOL CHEM, V264, P13998
   Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Maltecca F, 2008, J NEUROSCI, V28, P2827, DOI 10.1523/JNEUROSCI.4677-07.2008
   Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009
   Mancuso G, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0036337
   Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Manczak M, 2012, BBA-MOL BASIS DIS, V1822, P862, DOI 10.1016/j.bbadis.2012.02.017
   Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163
   Martelli A, 2012, DIS MODEL MECH, V5, P860, DOI 10.1242/dmm.009829
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Martinelli P, 2009, HUM MOL GENET, V18, P2001, DOI 10.1093/hmg/ddp124
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5
   MERANTE F, 1993, AM J HUM GENET, V53, P481
   Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708
   Merkwirth C, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003021
   Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2
   Moore BA, 2010, MAMM GENOME, V21, P350, DOI 10.1007/s00335-010-9272-8
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nguyen D, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.117
   Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086
   Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10
   Paredes JA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053698
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   PARKER NJ, 1994, GENOMICS, V19, P91, DOI 10.1006/geno.1994.1017
   Peralta S, 2012, BBA-GENE REGUL MECH, V1819, P961, DOI 10.1016/j.bbagrm.2011.11.001
   Perdomini M, 2013, J NEUROCHEM, V126, P65, DOI 10.1111/jnc.12219
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pierson TM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002325
   Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Quirós PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70
   Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/H06-071
   REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025
   Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016
   Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107
   Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013
   Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Sesaki H, 2014, BBA-MOL BASIS DIS, V1842, P1179, DOI 10.1016/j.bbadis.2013.11.024
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Sharoyko VV, 2014, HUM MOL GENET, V23, P5733, DOI 10.1093/hmg/ddu288
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004
   Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Spinazzola A, 2011, SEMIN FETAL NEONAT M, V16, P190, DOI 10.1016/j.siny.2011.04.011
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Steglich G, 1999, MOL CELL BIOL, V19, P3435
   STEPIEN G, 1992, J BIOL CHEM, V267, P14592
   Sterky FH, 2010, BIOCHEM BIOPH RES CO, V398, P759, DOI 10.1016/j.bbrc.2010.07.019
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Terzioglu M, 2013, CELL METAB, V17, P618, DOI 10.1016/j.cmet.2013.03.006
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016
   Villarroya J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0029691
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010
   Williams PA, 2011, VISION RES, V51, P229, DOI 10.1016/j.visres.2010.08.031
   Williams PA, 2012, BRAIN, V135, P493, DOI 10.1093/brain/awr330
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Xiao X, 2014, AM J PHYSIOL-RENAL, V306, PF1318, DOI 10.1152/ajprenal.00036.2014
   Xu FH, 2012, BIOCHEM J, V441, P275, DOI 10.1042/BJ20110985
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Yin H, 2005, INVEST OPHTH VIS SCI, V46, P4555, DOI 10.1167/iovs.05-0695
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, PH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zhou XS, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0058843
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   zum Gottesberge AMM, 2005, HISTOCHEM CELL BIOL, V124, P507, DOI 10.1007/s00418-005-0027-7
   zum Gottesberge AMM, 2012, CELL TISSUE RES, V347, P343, DOI 10.1007/s00441-012-1326-7
   zumGottesberge AMM, 1996, EUR ARCH OTO-RHINO-L, V253, P470, DOI 10.1007/BF00179952
NR 255
TC 17
Z9 19
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY 15
PY 2015
VL 22
IS 
BP 96
EP 118
DI 10.1016/j.mito.2015.01.008
PG 23
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CJ7YD
UT WOS:000355715400012
PM 25640959
DA 2024-11-01
ER

PT J
AU Chatfield, KC
   Coughlin, CR
   Friederich, MW
   Gallagher, RC
   Hesselberth, JR
   Lovell, MA
   Ofman, R
   Swanson, MA
   Thomas, JA
   Wanders, RJA
   Wartchow, EP
   Van Hove, JLK
AF Chatfield, Kathryn C.
   Coughlin, Curtis R., II
   Friederich, Marisa W.
   Gallagher, Renata C.
   Hesselberth, Jay R.
   Lovell, Mark A.
   Ofman, Rob
   Swanson, Michael A.
   Thomas, Janet A.
   Wanders, Ronald J. A.
   Wartchow, Eric P.
   Van Hove, Johan L. K.
TI Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing
SO MITOCHONDRION
LA English
DT Article
DE MHBD disease; HSD10 disease; RNase P; MRPP2; RNA processing
ID 2-methyl-3-hydroxybutyryl-coa dehydrogenase-deficiency; 17-beta-hydroxysteroid-dehydrogenase type 10; amyloid-beta; rnase p; mutations; cardiomyopathy; biogenesis; diagnosis; gene; dna
AB Muscle, heart and liver were analyzed in a male subject who succumbed to HSD10 disease. Respiratory chain enzyme analysis and BN-PAGE showed reduced activities and assembly of complexes I, III, IV, and V. The mRNAs of all RNase P subunits were preserved in heart and overexpressed in muscle, but MRPP2 protein was severely decreased. RNase P upregulation correlated with increased expression of mitochondrial biogenesis factors and preserved mitochondrial enzymes in muscle, but not in heart where this compensatory mechanism was incomplete. We demonstrate elevated amounts of unprocessed pre-tRNAs and mRNA transcripts encoding mitochondrial subunits indicating deficient RNase P activity. This study provides evidence of abnormal mitochondrial RNA processing causing mitochondrial energy failure in HSD10 disease. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Chatfield, Kathryn C.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Pediat Cardiol, Aurora, CO 80045 USA.
   [Coughlin, Curtis R., II; Friederich, Marisa W.; Gallagher, Renata C.; Swanson, Michael A.; Thomas, Janet A.; Van Hove, Johan L. K.] Univ Colorado, Sect Clin Genet & Metab, Dept Pediat, Aurora, CO 80045 USA.
   [Hesselberth, Jay R.] Univ Colorado, Sch Med, Program Mol Biol, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.
   [Lovell, Mark A.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA.
   [Lovell, Mark A.; Wartchow, Eric P.] Childrens Hosp Colorado, Dept Pathol, Aurora, CO USA.
   [Ofman, Rob; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
C3 University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Amsterdam; Academic Medical Center Amsterdam
RP Van Hove, JLK (corresponding author), Univ Colorado, Genet Sect, Dept Pediat, Aurora, CO 80045 USA.
EM Johan.Vanhove@ucdenver.edu
FU NIH/NCATS Colorado CTSI [UL1 TR000154]; Miracles for Mito
CR Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015
   Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219
   Chen JX, 2007, J ALZHEIMERS DIS, V12, P177
   Chen JX, 2010, J ALZHEIMERS DIS, V20, PS569, DOI 10.3233/JAD-2010-100357
   Crosby AH, 2010, AM J HUM GENET, V87, P655, DOI 10.1016/j.ajhg.2010.09.013
   Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072
   Ensenauer R, 2002, ANN NEUROL, V51, P656, DOI 10.1002/ana.10169
   Fersht A, 1985, ENZYME STRUCTURE AND MECHANISM, V2nd ed., P0
   García-Villoria J, 2005, PEDIATR RES, V58, P488, DOI 10.1203/01.pdr.0000176916.94328.cd
   García-Villoria J, 2009, CLIN BIOCHEM, V42, P27, DOI 10.1016/j.clinbiochem.2008.10.006
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005
   Korman SH, 2006, MOL GENET METAB, V89, P289, DOI 10.1016/j.ymgme.2006.07.010
   Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116
   Olpin SE, 2002, J INHERIT METAB DIS, V25, P477, DOI 10.1023/A:1021251202287
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055
   Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208
   ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Sass JO, 2004, BRAIN DEV-JPN, V26, P12, DOI 10.1016/S0387-7604(03)00071-8
   Smet J, 2005, CELL BIOL LAB HDB, V4, P259
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   SMITH L, 1955, METHODS BIOCHEM ANAL, V2, P427, DOI 10.1002/9780470110188.ch13
   Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799
   Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910
   Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006
   Zschocke J, 2000, PEDIATR RES, V48, P852, DOI 10.1203/00006450-200012000-00025
   Zschocke J, 2012, J INHERIT METAB DIS, V35, P81, DOI 10.1007/s10545-011-9415-4
NR 32
TC 48
Z9 55
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2015
VL 21
IS 
BP 1
EP 10
DI 10.1016/j.mito.2014.12.005
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA CD8ET
UT WOS:000351328700001
PM 25575635
DA 2024-11-01
ER

